Sentence,class,file
"http://dx.doi.org/10.1113/jphysiol.2010.188318 Musset, B., S.M.E.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1038/nature10557 Musset, B., R.A. Clark, T.E.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1074/jbc .M111.314955 Pless, S.A., J.D.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/ 10.1038/nchembio.622 Ramsey, I.S., M.M.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1038/nature04700 Ramsey, I.S., Y. Mokrab, I. Carvacho, Z.A.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1038/ nature01523 Demaurex, N. 2012.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi .org/10.1002/wmts.2 Fetter, J.R., J. Qian, J. Shapleigh, J.W.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1073/ pnas.92.5.1604 Fillingame, R.H. 1990.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1016/ S0014-5793(03)01101-3 Fischer, H. 2012.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1002/wmts.17 Fisher, Z., J.A.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1021/bi0480279 Garcia-Horsman, J.A., A. Puustinen, R.B.",Non-OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"34:4428– 4433. http://dx.doi.org/10.1021/bi00013a035 Gonzalez, C., H.P .",Non-OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1038/nsmb.1739 Gunner, M.R., X. Zhu, and M.C.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1002/prot.23124 Henderson, L.M., J.B. Chappell, and O.T.G.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/ 10.1016/j.jmb.2009.02.042 Hessa, T., H. Kim, K. Bihlmaier, C. Lundin, J. Boekel, H. Andersson,  I. Nilsson, S.H.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1038/nature03216 Humphrey, W., A. Dalke, and K. Schulten.",Non-OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/ 10.1016/0263-7855(96)00018-5 Isom, D.G., B.R.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi .org/10.1063/1.445869 Jorgensen, W.L., D.S.",Non-OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1038/nsmb.1826 Smith, S.M.E., D. Morgan, B. Musset, V.V.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1126/science.1185954 Varanasi, L., and J. Hosler.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1021/ bi102002v Varanasi, L., and J.P. Hosler.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/ 10.1016/j.bbabio.2011.10.001 von Ballmoos, C., A. Wiedenmann, and P. Dimroth.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1146/annurev.biochem .78.081307.104803 Wang, Y., S.J.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1074/jbc.M112.345280 Wood, M.L., E.V.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi .org/10.1016/j.bbamem.2011.07.045 Wu, B., C. Steinbronn, M. Alsterfjord, T. Zeuthen, and E. Beitz.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1038/emboj .2009.182 Wu, L.J., G. Wu, M.R.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1038/nn.3059 Yamaguchi, M., C.D.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
"http://dx.doi.org/10.1074/jbc.M204170200 Zeidel, M.L., S. Nielsen, B.L.",OADS,/arxiv_data1/oa_pdf/ea/21/JGP_201311045.PMC3840923.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
The online supplemental mate - rial is available at http://www.jgp.org/cgi/content/full/jgp .201311072/DC1.,Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi .org/10.1016/j.neuron.2008.09.001 Fuchs, P.A., and M.G.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1046/j.1432-1327.2000.01076.x Ha, T.S., M.S.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1016/ S0006-3495(04)74339-8 Hu, H., L.R.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1371/journal .pone.0008698 Johnson, B.E., D.A.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1073/ pnas.1116795108 Jones, E.M.C., M. Gray-Keller, and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi .org/10.1111/j.1469-7793.1999.0653p.x Kim, E.Y., K.-J.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1152/ ajprenal.00140.2008 Ling, S., G. Woronuk, L. Sy, S. Lev, and A.P.",Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1074/jbc.M004292200 Lippiat, J.D., N.B.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1007/s00232-002-1070-0 Livak, K.J., and T.D.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1006/meth .2001.1262 Meredith, A.L., K.S.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1074/jbc .M405621200 Meredith, A.L., S.W.",Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1038/ nn1740 Montgomery, J.R., and A.L.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi .org/10.1073/pnas.1205573109relative interaction of 4’s effects on Ca2+ dependence,  activation, and deactivation kinetics remains to be de- termined for the observed differences between BK 0 and  BK SRKR AP-induced currents.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1085/jgp .20028627 Behrens, R., A. Nolting, F. Reimann, M. Schwarz, R. Waldschütz,  and O. Pongs.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1016/S0014-5793(00)01584-2 Blom, N., S. Gammeltoft, and S. Brunak.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1006/ jmbi.1999.3310 Brayden, J.E., and M.T.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1126/science.1373909 Brenner, R., T.J. Jegla, A. Wickenden, Y. Liu, and R.W.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1038/ 35038011 Butler, A., S. Tsunoda, D.P.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi .org/10.1126/science.7687074 Chen, L., L. Tian, S.H.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1074/jbc.M505383200 Colwell, C.S.",Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/ 10.1038/nrn3086 Contreras, G.F., A. Neely, O. Alvarez, C. Gonzalez, and R. Latorre.",Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/ 10.1152/ajpcell.00302.2012 Orio, P., P. Rojas, G. Ferreira, and R. Latorre.",Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1016/ S0092-8674(02)00722-5 Petersen, O.H., and Y. Maruyama.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1016/ j.neuroscience.2007.07.066 Pitts, G.R., H. Ohta, and D.G.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/ 10.1016/j.brainres.2005.11.078 Pyott, S.J., A.L.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1038/sj.ki.5002369 Robitaille, R., and M.P.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80397-9 Saito, M., C. Nelson, L. Salkoff, and C.J.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1161/01.CIR.0000156448.74296.FEShen, K.Z., A. Lagrutta, N.W.",Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1007/BF00388308 Shipston, M.J. 2001.",Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"11:353– 358. http://dx.doi.org/10.1016/S0962-8924(01)02068-2 Singh, H., R. Lu, J.C. Bopassa, A.L.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1073/ pnas.1302028110 Storm, J.F.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi .org/10.1016/0896-6273(94)90418-9 Wang, B., B.S.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1085/jgp.200509436 Wang, B., B.S.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10 .1085/jgp.200810141 Wu, Y., Y. Yang, S. Ye, and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1038/nature09252 Xie, J., and D.P.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
"http://dx.doi.org/10.1126/science.280.5362.443 Yan, J., and R.W.",OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
http://dx.doi.org/10 .1038/nature10670,Non-OADS,/arxiv_data1/oa_pdf/cc/78/JGP_201311072.PMC3840924.pdf
This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see   http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1002/wrna.3 9 Hochstrasser, M., D. Mathog, Y. Gruenbaum, H. Saumweber, and J.W.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/   10.1083/jcb.102.1.11 2 Jensen, P.V., and L.I.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1007/s00418-004-0648- 2 Jin, Q., E. Trelles-Sticken, H. Scherthan, and J. Loidl.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/   10.1083/jcb.141.1.2 1 Jin, Q.W., J. Fuchs, and J. Loidl.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1016/j.ceb.2009.12.01 0 Kitamura, E., K. Tanaka, Y. Kitamura, and T.U.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1101/gad.44940 7 Klosinska, M.M., C.A.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1101/gad.201131 1 Kumar, P ., and T. Wittmann.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1016/j.tcb.2012.05.00 5 Laporte, D., B. Salin, B. Daignan-Fornier, and I. Sagot.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1083/jcb.20071115 4 Laporte, D., A. Lebaudy, A. Sahin, B. Pinson, J. Ceschin, B. Daignan-Fornier,  and I. Sagot.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/   10.1083/jcb.20100902 8 Lee, B.H., B.M.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1016/j.cub.2004.12.03 3 Liu, I.C., S.W.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1091/mbc.E11-   09-075 2 Markus, S.M., K.A.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1016/j.yexcr   .2012.04.00 6 Meluh, P.B., P. Yang, L. Glowczewski, D. Koshland, and M.M.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81602- 5 Miranda, J.J., P. De Wulf, P.K.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1038/nsmb89 6 Mitchison, T., and M. Kirschner.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1038/312237a 0 Narayanaswamy, R., M. Levy, M. Tsechansky, G.M.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi   .org/10.1073/pnas.081277110 6 Noree, C., B.K.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/   10.1083/jcb.20100300 1 O’Farrell, P.H.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"366:3498– 3507. http://dx.doi.org/10.1098/rstb.2011.007 9 O’Toole, E.T., M. Winey, and J.R. McIntosh.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi   .org/10.1091/mbc.10.6.201 7 Pereira, G., and E. Schiebel.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
http://dx.doi.org/10.1104/pp.109.15206 6expressing Bim1-3GFP or Tub1-RFP are shown respectively in Fig.,Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
Online supplemental mate - rial is available at http://www.jcb.org/cgi/content/full/jcb.201306075/ DC1.,Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201306075.dv.,OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1083/jcb.138.3.62 9 Caydasi, A.K., B. Ibrahim, and G. Pereira.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"5:28. http://dx.doi.org/   10.1186/1747-1028-5-2 8 Coffman, V .C., P .",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1083/jcb.20110607 8 Daignan-Fornier, B., and I. Sagot.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"6:10. http://dx.doi.org/10.1186/1747-   1028-6-1 0 Daignan-Fornier, B., and I. Sagot.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"6:20. http://dx.doi.org/   10.1186/1747-1028-6-2 0 De Virgilio, C. 2012.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
http://dx.doi.org/10.1111/j.1574-6976.2011.00287.,Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10   .1083/jcb.20111112 3 Fuge, E.K., E.L. Braun, and M. Werner-Washburne.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/   10.1016/j.ceb.2010.07.00 7 Guacci, V., E. Hogan, and D. Koshland.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi   .org/10.1091/mbc.8.6.95 7 Hammond, J.W., D. Cai, and K.J.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi   .org/10.1016/j.ceb.2007.11.01 0 He, X., S. Asthana, and P.K.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
http://dx.doi.org/10.1016/S0092-8674(00)80888- 0,OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi   .org/10.1091/mbc.E10-10-084 1 Sagot, I., B. Pinson, B. Salin, and B. Daignan-Fornier.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1091/mbc.E06-04-028 2 Sahin, A., B. Daignan-Fornier, and I. Sagot.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1371/journal.pone.000255 6 Schubert, I., and P. Shaw.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1016/   j.tplants.2011.02.00 2 Shah, K.H., B. Zhang, V. Ramachandran, and P.K.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"193:109– 123. http://dx.doi.org/10.1534/genetics.112.14699 3 Sheeman, B., P. Carvalho, I. Sagot, J. Geiser, D. Kho, M.A.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1016/S0960-9822(03)00013- 7 Stephens, A.D., J. Haase, L. Vicci, R.M.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/   10.1083/jcb.20110313 8 Suzuki, M., R. Igarashi, M. Sekiya, T. Utsugi, S. Morishita, M. Yukawa, and Y.  Ohya.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1534/genetics   .112.14060 8 Tanaka, K., E. Kitamura, and T.U.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1016/j.ymeth.2010.01.01 7 Tirnauer, J.S., E. O’Toole, L. Berrueta, B.E.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1083/jcb.145.5.99 3 van der Vaart, B., A. Akhmanova, and A. Straube.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1126/science.115108 6 Verdaasdonk, J.S., and K. Bloom.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1038/nrm310 7 Wade, R.H. 2009.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1007/s12033-009-9193- 5 Westermann, S., H.W.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi   .org/10.1038/nature0440 9 Westermann, S., D.G.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1534/genetics.111.12871 0 Winey, M., and E.T.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1038/3505066 3 Woodruff, J.B., D.G.",Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
"http://dx.doi.org/10.1091/mbc.E11-08-070 1 Woods, A., T. Sherwin, R. Sasse, T.H.",OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
http://dx.doi.org/10.1083/jcb   .20101005 8,Non-OADS,/arxiv_data1/oa_pdf/34/e7/JCB_201306075.PMC3840927.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi   .org/10.1016/j.cub.2005.02.05 3 Matsumoto, S., A. Bandyopadhyay, D.J.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi   .org/10.1093/emboj/cdg29 8 Matsuo, T., Y. Otsubo, J. Urano, F. Tamanoi, and M. Yamamoto.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1128/MCB.01039-0 6 Nakashima, A., T. Sato, and F. Tamanoi.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi   .org/10.1242/jcs.06031 9 Oh, W.J., and E. Jacinto.",Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.4161/cc.10.14.1658 6 Pearson, R.B., and B.E.",Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1016/0076-6879(91)00127- I Petersen, J., and P. Nurse.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1038/ncb164 6 Reinke, A., J.C. Chen, S. Aronova, and T. Powers.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1074/jbc   .M41449920 0 Sparks, C.A., and D.A.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.4161/   sgtp.1.3.1493 6 Tatebe, H., S. Morigasaki, S. Murayama, C.T.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1016/j.cub.2010.10.02 6 Urano, J., T. Sato, T. Matsuo, Y. Otsubo, M. Yamamoto, and F. Tamanoi.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1073/   pnas.060851010 4 Uritani, M., H. Hidaka, Y. Hotta, M. Ueno, T. Ushimaru, and T. Toda.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi   .org/10.1016/j.gene.2007.09.02 4 Weisman, R., and M. Choder.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1074/jbc   .M01044620 0 Wullschleger, S., R. Loewith, and M.N.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1016/j.cell.2006   .01.01 6 Yang, H., D.G.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
http://dx.doi.org/10.1038/nature1212 2shows that TORC2 regulation in Tor1.1972A still required Ryh1.,Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201305103/DC1.,Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/   10.1091/mbc.10.8.253 1 Alvarez, B., and S. Moreno.",Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi   .org/10.1242/jcs.0324 1 Basi, G., E. Schmid, and K. Maundrell.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1016/0378-1119(93)90552- E Bimbó, A., Y. Jia, S.L.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1128/EC.4.4.799-813.200 5 Caspari, T., M. Dahlen, G. Kanter-Smoler, H.D.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi   .org/10.1128/MCB.20.4.1254-1262.200 0 Chang, X., A.S. Lazorchak, D. Liu, and B. Su.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1002/eji.20114206 6 Copp, J., G. Manning, and T. Hunter.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1242/bio.2012202 2 Egel, R., M. Willer, S. Kjaerulff, J. Davey, and O. Nielsen.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1002/yea   .32010101 2 Fantes, P., and P. Nurse.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1016/0014-4827(77)90359- 7 Hayashi, T., M. Hatanaka, K. Nagao, Y. Nakaseko, J. Kanoh, A. Kokubu, M. Ebe,  and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
12:1357– 1370. http://dx.doi.org/10.1111/j.1365-2443.2007.01141.,Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"1:110007. http://dx.doi.org/10.1098/rsob.11000 7 Jacinto, E., V. Facchinetti, D. Liu, N. Soto, S. Wei, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"127:125– 137. http://dx.doi.org/10.1016/j.cell.2006.08.03 3 Lee, K., K.T.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
"http://dx.doi.org/10.1084/jem.2011147 0 Loewith, R., and M.N.",OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
http://dx.doi.org/10   .1534/genetics.111.13336 3,Non-OADS,/arxiv_data1/oa_pdf/89/58/JCB_201305103.PMC3840928.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1016/j.cell.2008.09.04 0 Miller, R.A., Q. Chu, J. Xie, M. Foretz, B. Viollet, and M.J. Birnbaum.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10   .1038/nature1180 8 Moss, D.K., G. Bellett, J.M.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1242/jcs.01032 2 Nishida, E., M. Hoshi, Y. Miyata, H. Sakai, T. Kadowaki, M. Kasuga, S. Saijo,  H. Ogawara, and T. Akiyama.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/   10.1038/nature1186 2 Perez-Moreno, M., C. Jamora, and E. Fuchs.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi   .org/10.1083/jcb.20101006 5 Reinsch, S., and E. Karsenti.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1083/   jcb.126.6.150 9 Seth, A., P. Sheth, B.C.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1074/jbc.M61059720 0 Shaw, R.M., A.J.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1016/j.cell.2006.12.03 7 Sugimoto, M., A. Inoko, T. Shiromizu, M. Nakayama, P. Zou, S. Yonemura, Y.  Hayashi, I. Izawa, M. Sasoh, Y. Uji, et al.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1083/jcb.20080313 3 Terry, S.J., C. Zihni, A. Elbediwy, E. Vitiello, I.V.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/   10.1038/ncb215 6 Tsukita, S., and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1083/   jcb.108.1.3 1 Tsukita, S., M. Furuse, and M. Itoh.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1038/   3506708 8 Umeda, K., T. Matsui, M. Nakayama, K. Furuse, H. Sasaki, M. Furuse, and S.  Tsukita.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1074/jbc.M40656320 0 Yano, T., Y. Yamazaki, M. Adachi, K. Okawa, P. Fort, M. Uji, S. Tsukita, and  S. Tsukita.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"193:319– 332. http://dx.doi.org/10.1083/jcb.20100910 0 Zhang, L., J. Li, L.H.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1073/   pnas.060853110 3 Zheng, B., and L.C.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"8:777– 786. http://dx.doi.org/10.1016/j.devcel.2005.03.00 3 Bacallao, R., C. Antony, C. Dotti, E. Karsenti, E.H. Stelzer, and K. Simons.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"109:2817– 2832. http://dx.doi.org/10.1083/jcb.109.6.281 7 Bartolini, F., and G.G.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1242/   jcs.0322 7 Baum, B., and M. Georgiou.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1083/jcb.20100914 1 Bornslaeger, E.A., C.M.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1083/jcb.134.4.98 5 Brummelkamp, T.R., R. Bernards, and R. Agami.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1126/science.106899 9 Citi, S., and N. Denisenko.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi   .org/10.1006/jsbi.2000.428 4 D’Atri, F., and S. Citi.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1016/S0014-5793(01)02936- 2 D’Atri, F., F. Nadalutti, and S. Citi.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"277:27757– 27764. http://dx.doi.org/10.1074/jbc.M20371720 0 Etienne-Manneville, S., and A.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1038/nature0114 8 Franke, W.W. 2009.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1101/cshperspect.a00306 1 Furuse, M., T. Hirase, M. Itoh, A. Nagafuchi, S. Yonemura, S. Tsukita, and  S. Tsukita.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/   10.1083/jcb.123.6.177 7 Gumbiner, B.M.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1083/jcb.148.3.39 9 Iden, S., S. Misselwitz, S.S. Peddibhotla, H. Tuncay, D. Rehder, V. Gerke,  H. Robenek, A. Suzuki, and K. Ebnet.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10   .1083/jcb.20110414 3 Itoh, M., A. Nagafuchi, S. Yonemura, T. Kitani-Yasuda, S. Tsukita, and S.  Tsukita.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1083/jcb   .121.3.49 1 Leprivier, G., M. Remke, B. Rotblat, A. Dubuc, A.R.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1016/   j.cell.2013.04.05 5 Lo, B., G. Strasser, M. Sagolla, C.D.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10.1083/jcb.20120808 0 Martin-Belmonte, F., and M. Perez-Moreno.",Non-OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
"http://dx.doi.org/10   .1038/nrc316 9 Meng, W., and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/af/87/JCB_201304194.PMC3840929.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201303052/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201303052.dv.,OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1038/ng.17 1 Benson, M.A., S.E.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1074/jbc.M01041820 0 Benson, M.A., C.L.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi   .org/10.1128/MCB.02045-0 6 Bray, N.J., A. Preece, N.M. Williams, V. Moskvina, P.R.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1007/s00441-011-1281- 8 Sanna, B., O.F.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1086/34546 3 Seeger, T.S., D. Frank, C. Rohr, R. Will, S. Just, C. Grund, R. Lyon, M. Luedde,  M. Koegl, F. Sheikh, et al.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
http://dx.doi.org/10.1111/j.1432- 1033.1995.tb20430.,Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1086/34175 0 Strohmaier, J., J. Frank, J.R. Wendland, J. Schumacher, R.A. Jamra, J.  Treutlein, V. Nieratschker, R. Breuer, M. Mattheisen, S. Herms, et al.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi   .org/10.1016/j.schres.2009.12.02 5 Talbot, K., W.L.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1371/journal.pone.001688 6 Wilkins, B.J., Y.S.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1161/01.RES   .0000109415.17511.1 8 Zhang, X., G. Azhar, J. Chai, P. Sheridan, K. Nagano, T. Brown, J. Yang, K.  Khrapko, A.M. Borras, J. Lawitts, et al.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1074/jbc.M10493420 0Frank, D., C. Kuhn, B. Brors, C. Hanselmann, M. Lüdde, H.A.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"51:309– 318. http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.09804 6 Frank, D., R. Frauen, C. Hanselmann, C. Kuhn, R. Will, J. Gantenberg, L.  Füzesi, H.A.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10   .1016/j.yjmcc.2010.06.00 9 Frank, D., J. Gantenberg, I. Boomgaarden, C. Kuhn, R. Will, K.U.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi   .org/10.1016/j.yjmcc.2011.12.00 1 Frey, N., and E.N.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1146/annurev   .physiol.65.092101.14224 3 Heineke, J., and J.D.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1038/nrm198 3 Höltje, M., A. Hoffmann, F. Hofmann, C. Mucke, G. Grosse, N. Van Rooijen,  H. Kettenmann, I.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1111/j.1471- 4159.2005.03443. x Holzfeind, P.J., H.J.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/   10.1254/jphs.10R28F M Li, W., Q. Zhang, N. Oiso, E.K.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1038/ng122 9 Lien, C.F., C. Vlachouli, D.J.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10   .1016/j.modgep.2004.01.01 5 Miano, J.M.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1038/labinvest.2010.10 4 Miano, J.M., N. Ramanan, M.A.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi   .org/10.1073/pnas.040604110 1 Nelson, T.J., R. Balza Jr., Q. Xiao, and R.P.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi   .org/10.1016/j.yjmcc.2005.05.00 4 Numakawa, T., Y. Yagasaki, T. Ishimoto, T. Okada, T. Suzuki, N. Iwata, N.  Ozaki, T. Taguchi, M. Tatsumi, K. Kamijima, et al.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/   10.1093/hmg/ddh28 0 Parlakian, A., D. Tuil, G. Hamard, G. Tavernier, D. Hentzen, J.P. Concordet,  D. Paulin, Z. Li, and D. Daegelen.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi   .org/10.1128/MCB.24.12.5281-5289.200 4 Parlakian, A., C. Charvet, B. Escoubet, M. Mericskay, J.D.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi.org/10.1111/j.1582-4934   .2011.01463. x Rees, M.L., C.F.",Non-OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
"http://dx.doi   .org/10.1016/j.nmd.2006.11.00 3 Rickelt, S., C. Kuhn, S. Winter-Simanowski, R. Zimbelmann, N. Frey, and W.W.  Franke.",OADS,/arxiv_data1/oa_pdf/e3/14/JCB_201303052.PMC3840930.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1371/ journal.pone.000851 1 Angel, P ., and A. Szabowski.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1016/j.bbamem.2011.11.01 7 Black, A.T., P.J.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.1016/j.taap.2010.09.00 5 Boxman, I.L., C. Ruwhof, O.C.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1007/BF0250710 8 Chavez, M.G., C.A.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1016/j.jtbi.2004.06.01 5 Demetri, G.D., and J.D.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.1016/j.devcel.2009.12.00 8 Dupin, I., E. Camand, and S. Etienne-Manneville.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1083/jcb.20081203 4 Egles, C., H.A.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1371/journal   .pone.001052 8 Farooqui, R., and G. Fenteany.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1242/jcs.0157 7 Florin, L., L. Hummerich, B.T.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/   10.1038/sj.onc.120793 8 Friedl, P., and D. Gilmour.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10   .1016/j.ceb.2010.10.01 5 Galle, J., M. Loeffler, and D. Drasdo.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/   10.1529/biophysj.104.04145 9	d a b copt c bmc_bm c_bm c2c_bm cc_bm c, v v vr rv( )= + +  ˆ ˆ ˆ ˆ 1 2 32 2 22 2   2, with 	 	 ˆ .",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
Online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.201212020/DC1.,Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201212020.dv.,OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1126/science.276.5309.7 5 McKay, I.A., and I.M.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
http://dx.doi   .org/10.1111/j.1365-2133.1991.tb04942.,Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10 .1016/   S0169-409X(02)00121- 7 Moll, R., M. Divo, and L. Langbein.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10   .1007/s00418-008-0435- 6 Mueller, M.M., and N.E.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0215(19991210)83:6<780::AID-IJC14>3.0.CO;2- C Niessen, C.M.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/   10.1038/sj.jid.570086 5 Noble, D. 2006.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1091/mbc.E04-06-046 5 Ono, I., H. Gunji, J.Z.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1016/0923-1811(95)00454- Z Paladini, R.D., K. Takahashi, N.S.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.1083/jcb.132.3.38 1 Palsson, E., and H.G.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1038/sj.jid.570010 1 Proksch, E., J.M.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1111/j.1600- 0625.2008.00786. x Rabinovitz, I., A. Toker, and A.M. Mercurio.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.1083/jcb.146.5.114 7 Radice, G.P.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1016/   0012-1606(80)90360- 7 Rennekampff, H.O., J.F.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.1006/jsre.2000.589 2 Schaller, G., and M. Meyer-Hermann.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.1016/j.jtbi.2007.03.02 3 Schroeder, J.T., K.L.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.4049/jimmunol.080178 2 Singer, A.J., and R.A.F.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1056/NEJM19990902341100 6 Soderholm, J., and R. Heald.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1016/j.chembiol   .2005.03.00 1 Sütterlin, T., S. Huber, H. Dickhaus, and N. Grabe.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.1093/bioinformatics/btp36 1 Sütterlin, T., C. Kolb, H. Dickhaus, D. Jäger, and N. Grabe.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1093/bioinformatics/bts65 9 Takamiya, M., S. Fujita, K. Saigusa, and Y. Aoki.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1007/s00414-007-0183- 5Garlick, J.A.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"21:3541– 3547. http://dx.doi.org/10.1093/bioinformatics/bti58 5 Green, K.J., and C.L.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10 .1038/   sj.jid.570101 5 Grimstad, Ø., Ø. Sandanger, L. Ryan, K. Otterdal, J.K. Damaas, B. Pukstad,  and T. Espevik.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
http://dx.doi   .org/10.1111/j.1524-475X.2011.00668.,Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1038/   nature0703 9 Hayden, P.J., J.P. Petrali, G. Stolper, T.A.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1016/j.tiv.2009.07.02 1 Hu, T., Z.S.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1242/jcs   .03652 5 Jansson, K., G. Kratz, and A. Haegerstrand.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.1007/BF0272298 0 Kaushansky, K., N. Lin, and J.W.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1172/JCI11331 6 Kawada, A., M. Hiruma, H. Noguchi, A. Ishibashi, K. Motoyoshi, and I.  Kawada.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1007/s00403005024 6 Krawczyk, W.S.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1083/jcb.49.2   .247 Laplante, A.F., L. Germain, F.A.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi   .org/10.1096/fj.01-0250co m Liang, C.C., A.Y.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1038/nprot.2007.3 0 Litjens, S.H.M., J.M.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1016/j.tcb.2006.05.00 4 Mallampati, R., R.R.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/   10.1016/j.tiv.2009.08.01 9 Malminen, M., V. Koivukangas, J. Peltonen, S.L.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1046/j.1365-2133   .2003.05438. x Maniotis, A.J., C.S.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
http://dx.doi   .org/10.1046/j.1463-1326.1999.00032.,Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
http://dx.doi.org/10.1111/j.1067-1927.2005.00067.,Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/   10.1038/sj.jid.570078 6 Wong, V., and B.M.",OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"http://dx.doi.org/10.1083/jcb.136.2.39 9 Woodley, D.T.",Non-OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
http://dx.doi   .org/10.1016/j.cca.2010.07.00 6,OADS,/arxiv_data1/oa_pdf/4d/4d/JCB_201212020.PMC3840932.pdf
"Genetic analysis  showed that Caspase ­3, Caspase ­9, and p38 MAPK in ­ teracted with Slit1a ­Robo2 signaling, suggesting that lo ­ calized activation of caspases lie downstream of a ligand  receptor system, acting as key promoters of axonal branch  tip and synaptic dynamics to restrict arbor growth in vivo  in the central nervous system.Local caspase activation interacts with Slit-Robo  signaling to restrict axonal arborization Douglas S. Campbell and Hitoshi Okamoto Laboratory for Developmental Gene Regulation, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan © 2013 Campbell and Okamoto  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1038/nn73 5 Barresi, M.J., L.D.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1242/dev.0192 9 Bashaw, G.J., and R. Klein.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1101/csh - perspect.a00194 1 Biehlmaier, O., S.C. Neuhauss, and K. Kohler.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"306:199– 207. http://dx.doi.org/10.1007/s00441010044 7 Bingol, B., and M. Sheng.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1038/   emboj.2010.17 3 Campbell, D.S., and C.E.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)00551- 7 Campbell, D.S., and C.E.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/S0896-6273(03)00158- 2 Campbell, D.S., A.G. Regan, J.S.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.06.03 4 Carson, C., M. Saleh, F.W.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1101/pdb.prot478 2 Cohen-Cory, S., and S.E.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"378:192– 196. http://dx.doi.org/10.1038/378192a 0 Crawford, E.D., and J.A.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1146/   annurev-biochem-061809-12163 9 Creagh, E.M., and S.J.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1042/BST029069 6 D’Amelio, M., V. Cavallucci, S. Middei, C. Marchetti, S. Pacioni, A. Ferri, A.  Diamantini, D. De Zio, P. Carrara, L. Battistini, et al.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1038/nn.270 9 D’Amelio, M., M. Sheng, and F. Cecconi.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1016/j.tins.2012.06.00 4 Dingwell, K.S., C.E.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1002/1097-4695(200008)44:2<246::AID-NEU13>3.0.CO;2- K Eimon, P.M., E. Kratz, E. Varfolomeev, S.G. Hymowitz, H. Stern, J. Zha, and  A. Ashkenazi.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1038/sj.cdd.440201 5 Fischer, U., R.U.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"10:76– 100. http://dx.doi.org/10.1038/sj.cdd.440116 0 Gallo, G. 2011.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
http://dx.doi.org/10.1002/dneu.2085 2and tectal cell bodies were imaged before and after partial photobleach - ing by exposure to 100% laser power of a 514-nm laser line from a multi - argon line laser (Melles Griot) for 5 min.,OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201303072/DC1.,Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.0223-06.200 6 Ming, G.L., S.T.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1038/   nature74 5 Ndozangue-Touriguine, O., J. Hamelin, and J. Bréard.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/j.bcp   .2008.03.01 6 Nikolaev, A., T. McLaughlin, D.D.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1038/nature0776 7 O’Donnell, M., R.K.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1146/annurev.neuro.051508.13561 4 Ohsawa, S., S. Hamada, K. Kuida, H. Yoshida, T. Igaki, and M. Miura.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1073/pnas.091048810 7 Oshima, K., M. Takeda, E. Kuranaga, R. Ueda, T. Aigaki, M. Miura, and S.  Hayashi.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/j.cub.2006.06.03 2 Pittman, A.J., M.Y.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1038/   nchembio81 4 Ruthazer, E.S., J. Li, and H.T.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.0069-06.200 6 Sato, T., T. Hamaoka, H. Aizawa, T. Hosoya, and H. Okamoto.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .0883-07 .2007 Saxena, S., and P. Caroni.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/   j.pneurobio.2007.07.00 7 Schoenmann, Z., E. Assa-Kunik, S. Tiomny, A. Minis, L. Haklai-Topper, E.  Arama, and A. Yaron.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .0922-10.201 0 Schulte-Merker, S., R.K. Ho, B.G.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1046/j.1471- 4159.1999   .0730961. x Sidi, S., T. Sanda, R.D.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/   j.cell.2008.03.03 7 Simon, D.J., R.M.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3012-12.201 2 Smear, M.C., H.W.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"53:65– 77. http://dx.doi.org/10.1016/j.neuron.2006.12.01 3 Steiner, M.R., F.W.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
http://dx.doi.org/10.1111/j.1749- 6632.2000.tb06545.,Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1242/dev.04644 1 Harris, W.A., C.E.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1074/jbc.M110.16163 8 Huesmann, G.R., and D.F.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"52:1061– 1072. http://dx.doi.org/10.1016/j.neuron.2006.10.03 3 Hutson, L.D., D.S.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1038/nrn322 8 Jiao, S., and Z. Li.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1016/j.neuron.2011.04.00 4 Jin, Y., and C.C.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1146/ annurev.cellbio.23.090506.12341 7 Jung, H., C.M.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10   .1016/j.gde.2011.04.00 4 Kimmel, C.B., W.W. Ballard, S.R.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1002/aja.100203030 2 Kothakota, S., T. Azuma, C. Reinhard, A. Klippel, J. Tang, K. Chu, T.J.  McGarry, M.W.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1126/science.278.5336.29 4 Krens, S.F., S. He, H.P.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/j.modgep.2006.04   .008 Kulkarni, R.P., M. Bak-Maier, and S.E.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1016/j.neuron.2006.07.01 4 Kuranaga, E., and M. Miura.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/j.tcb.2007.01.00 1 Kuranaga, E., H. Kanuka, A. Tonoki, K. Takemoto, T. Tomioka, M. Kobayashi,  S. Hayashi, and M. Miura.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/j.cell.2006.05.04 8 Lee, J.S., R. Ray, and C.B.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1002/dvdy.113 6 Leu, B.H., and J.T.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1002/dneu.2056 1 Li, Z., J. Jo, J.M.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1146/annurev-   neuro-060909-15320 4 Lu, M., W. Witke, D.J.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
http://dx.doi.org/   10.1523/JNEUROSCI.0947-09.200 9,Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1016/S0896-6273(03)00635- 4 Stuermer, C.A.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1083/   jcb.20020711 1 Takemoto, K., E. Kuranaga, A. Tonoki, T. Nagai, A. Miyawaki, and M. Miura.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1038/sj.cdd.440205 9 Ulukaya, E., C. Acilan, and Y. Yilmaz.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1002/cbf.177 4 Waites, C.L., A.M. Craig, and C.C.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1146/ annurev.neuro.27.070203.14433 6 Williams, D.W., S. Kondo, A. Krzyzanowska, Y. Hiromi, and J.W.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1038/nn177 4 Wishart, T.M., S.H.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1097/01.jnen.0000228202.35163.c 4 Wong, M. 2008.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi   .org/10.1586/14737175.8.6.90 7 Wyatt, C., A. Ebert, M.M.",Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1016/j.cell.2011.06.01 6 Yabu, T., S. Kishi, T. Okazaki, and M. Yamashita.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
"http://dx.doi.org/10.1042/0264-6021:360003 9 Yamashita, M., N. Mizusawa, M. Hojo, and T. Yabu.",OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/9b/JCB_201303072.PMC3840933.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi   .org/10.1242/dev.0030 4 Foglietti, C., G. Filocamo, E. Cundari, E. De Rinaldis, A. Lahm, R. Cortese,  and C. Steinkühler.",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1074/   jbc.M51194520 0 Haecker, A., D. Qi, T. Lilja, B. Moussian, L.P. Andrioli, S. Luschnig, and   M. Mannervik.",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1371/journal.pbio.005014 5 Hepker, J., Q.T.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1038/nrm162 2 Hui, C.C., and S. Angers.",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1146/annurev-   cellbio-092910-15404 8 Ingham, P.W., Y .",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1038/nrg298 4 Jia, J., C. Tong, B. Wang, L. Luo, and J. Jiang.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1038/   nature0317 9 Jiang, J., and C.C.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.11.01 0 Karlstrom, R.O., O.V .",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1242/dev.0036 4 Lee, T., and L. Luo.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80701- 1 Méthot, N., and K. Basler.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10   .1016/S0092-8674(00)80592- 9 Müller, B., and K. Basler.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1016/j.ydbio.2006.05.00 1 Robu, M.E., J.D.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1371/journal.pgen.003007 8 Rohr, K.B., K.A.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)   00210- 0 Shahbazian, M.D., and M. Grunstein.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1074/jbc.M112.39947 7 St Johnston, R.D., F.M.",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1101/gad.4.7.111 4 Tay, S.Y ., P.W.",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10   .1242/dev.0160 6 Thisse, C., and B. Thisse.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10   .1038/nprot.2007.51 4 Tyurina, O.V ., B. Guner, E. Popova, J. Feng, A.F.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201306012/DC1.,Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1038/386735a 0 Asai, Y ., D.K.",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/   10.1073/pnas.060345310 3 Aza-Blanc, P., F.A.",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"89:1043– 1053. http://dx.doi.org/10.1016/S0092-8674(00)80292- 5 Charroux, B., M. Freeman, S. Kerridge, and A. Baonza.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10   .1016/j.ydbio.2005.12.01 2 Chen, J.K., J. Taipale, M.K.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1101/gad.102530 2 Chen, M.H., C.W.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"130:386. http://dx.doi.org/10.1016/j.cell.2007.07.01 7 Concordet, J.P., K.E.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1101/gad.101730 2 Erkner, A., A. Roure, B. Charroux, M. Delaage, N. Holway, N. Coré, C. V ola,   C. Angelats, F. Pagès, L. Fasano, and S. Kerridge.",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi   .org/10.1016/j.ydbio.2004.10.00 3 Wang, L., H. Rajan, J.L.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1101/gad.139350 6 Wang, L., B. Charroux, S. Kerridge, and C.C.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1038/embor.2008.6 7 Wang, L., T. Liu, L. Xu, Y .",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi   .org/10.1182/blood-2012-10-46265 5 Wolff, C., S. Roy, and P .W.",Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1016/ S0960-   9822(03)00461- 5 Yang, X., F. Mao, X. Lv, Z. Zhang, L. Fu, Y .",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10   .1242/jcs.12860 3 Yoshida, M., S. Horinouchi, and T. Beppu.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1002/   bies.95017051 0 Zhang, S., L. Xu, J. Lee, and T. Xu.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00630- 4 Zhang, Y ., F. Mao, Y .",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"http://dx.doi   .org/10.1038/cr.2013.2 9 Zhang, Z., X. Lv, W.C. Yin, X. Zhang, J. Feng, W. Wu, C.C.",OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
http://dx.doi   .org/10.1038/nature0622 5,Non-OADS,/arxiv_data1/oa_pdf/23/53/JCB_201306012.PMC3840934.pdf
"In this article, we highlight  their achievements and also pay tribute to the pioneering  scientists before them who set the stage for their remark - able discoveries.A Nobel Prize for membrane traffic: Vesicles find  their journey’s end Ira Mellman1 and Scott D. Emr2 1Genentech, South San Francisco, CA 94080 2Weill Institute for Cell and Molecular Biology and Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14850 © 2013 Mellman and Emr  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/ba/13/JCB_201310134.PMC3840937.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ba/13/JCB_201310134.PMC3840937.pdf
"http://dx.doi.org/10.1016/0092-8674(84)90019- 9 Hata, Y ., C.A.",OADS,/arxiv_data1/oa_pdf/ba/13/JCB_201310134.PMC3840937.pdf
"366:347– 351. http://dx.doi.org/10.1038/366347a 0 Kaiser, C.A., and R. Schekman.",Non-OADS,/arxiv_data1/oa_pdf/ba/13/JCB_201310134.PMC3840937.pdf
"http://dx.doi.org/10.1016/0092-8674(90)90483- U Novick, P., and R. Schekman.",OADS,/arxiv_data1/oa_pdf/ba/13/JCB_201310134.PMC3840937.pdf
"http://dx.doi.org/10   .1073/pnas.76.4.185 8 Perin, M.S., V.A.",OADS,/arxiv_data1/oa_pdf/ba/13/JCB_201310134.PMC3840937.pdf
"http://dx.doi   .org/10.1038/345260a 0 Söllner, T., M.K.",Non-OADS,/arxiv_data1/oa_pdf/ba/13/JCB_201310134.PMC3840937.pdf
"http://dx.doi.org/10.1016/0092-8674(93)   90376- 2 Söllner, T., S.W.",OADS,/arxiv_data1/oa_pdf/ba/13/JCB_201310134.PMC3840937.pdf
http://dx.doi   .org/10.1038/362318a 0,Non-OADS,/arxiv_data1/oa_pdf/ba/13/JCB_201310134.PMC3840937.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201307185/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/j.bbamcr.2007.11.01 0 Bader, M., W. Muse, D.P.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81016- 8 Bell, E.L., T.A.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi   .org/10.1083/jcb.20060907 4 Benham, A.M., A. Cabibbo, A. Fassio, N. Bulleid, R. Sitia, and I. Braakman.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi   .org/10.1093/emboj/19.17.449 3 Benjamini, Y., and Y. Hochberg.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/B978-0-12-386033-0.00005- 0 Bi, M., C. Naczki, M. Koritzinsky, D. Fels, J. Blais, N. Hu, H. Harding, I. Novoa,  M. Varia, J. Raleigh, et al.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1038/sj.emboj.760077 7 Blais, J.D., C.L.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/   10.1126/science.123827 9 Jansens, A., E. van Duijn, and I. Braakman.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"298:2401– 2403. http://dx.doi.org/10.1126/science.107837 6 Kelleher, D.J., and R. Gilmore.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/   10.1093/glycob/cwj06 6 Kim, S., D.P.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1083/jcb.20111009 0 Kobayashi, T., S. Kishigami, M. Sone, H. Inokuchi, T. Mogi, and K. Ito.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi   .org/10.1073/pnas.94.22.1185 7 Koritzinsky, M., M.G.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1038/sj.emboj.760099 8 Koritzinsky, M., K.M.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/   10.1016/j.radonc.2007.04.03 1 Koumenis, C., C. Naczki, M. Koritzinsky, S. Rastani, A. Diehl, N. Sonenberg, A.  Koromilas, and B.G.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1128/MCB.22.21.7405-7416.200 2 Kurniawan, N.D., A.R.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1110/ps.9.7.128 2 Lin, S.M., P. Du, W. Huber, and W.A.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1093/nar/gkm107 5 Maggioni, M.C., I.M.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1038/nsmb89 7 May, D., A. Itin, O. Gal, H. Kalinski, E. Feinstein, and E. Keshet.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1038/sj.onc.120832 5 McLaughlin, M., and K. Vandenbroeck.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1111/j.1476- 5381.2010.01064. x Nguyen, V.D., M.J. Saaranen, A.R.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/j.jmb.2010.12.03 9 Oka, O.B., M.A.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/j.molcel.2013.05.01 4 Otero, J.H., B. Lizák, and L.M.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/ 10.1016/   j.semcdb.2009.12.00 8 Pagani, M., M. Fabbri, C. Benedetti, A. Fassio, S. Pilati, N.J. Bulleid, A. Cabibbo,  and R. Sitia.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1074/jbc   .M00306120 0 Pena, F., A. Jansens, G. van Zadelhoff, and I. Braakman.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10   .1074/jbc.M110.10571 8 Riemer, J., C. Appenzeller-Herzog, L. Johansson, B. Bodenmiller, R. Hartmann- Petersen, and L. Ellgaard.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1146/annurev-biochem-062209-09383 6 Braakman, I., and D.N.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/   10.1101/cshperspect.a01320 1 Braakman, I., J. Helenius, and A. Helenius.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1038/356260a 0 Braakman, I., H. Hoover-Litty, K.R.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1083/jcb.114.3.40 1 Burr, M.L., F. Cano, S. Svobodova, L.H.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1074/jbc.275.7.482 7 Chakravarthi, S., C.E.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/   10.1042/BJ2006151 0 Cojocari, D., R.N.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/S1097-2765(02)00821- 3 Dunning, M.J., M.L.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1093/bioinformatics/btm31 1 Frand, A.R., and C.A.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80198- 7 Gent, J., and I. Braakman.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10   .1007/s00018-004-4090- 3 Ghosh, R., K.L.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1371/ journal.pone.000957 5 Görlich, D., E. Hartmann, S. Prehn, and T.A.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1038/357047a 0 Gross, E., D.B.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/S0092-8674(04)00418- 0 Gross, E., C.S.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi   .org/10.1073/pnas.050644810 3 Harding, H.P., Y. Zhang, H. Zeng, I. Novoa, P.D.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/S1097-2765(03)00105- 9 Hoober, K.L., S.L.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi   .org/10.1074/jbc.274.32.2214 7 Hoseki, J., R. Ushioda, and K. Nagata.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
http://dx.doi.org/10.1093/jb/mvp19 4,Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"8:851– 864. http://dx.doi.org/10.1038/nrc250 1 Zhang, L., E. Lai, T. Teodoro, and A. Volchuk.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1074/jbc.M80547720 0 Zito, E., E.P.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
http://dx.doi.org/10.1016/j.molcel   .2010.11.01 0essential for survival under hypoxic conditions and is required for tumor  growth.,Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-04-160 6 Ron, D., and P. Walter.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1172/JCI4002 7 Rouschop, K.M., L.J.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10   .1073/pnas.121063311 0 Rudenko, G., L. Henry, K. Henderson, K. Ichtchenko, M.S.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi   .org/10.1126/science.107812 4 Rudolf, J., M.A.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1042/BJ2013036 0 Rutkevich, L.A., and D.B.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi   .org/10.1091/mbc.E12-02-010 2 Sato, Y., R. Kojima, M. Okumura, M. Hagiwara, S. Masui, K. Maegawa, M.  Saiki, T. Horibe, M. Suzuki, and K. Inaba.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1038/nrm235 4 Tavender, T.J., J.J. Springate, and N.J. Bulleid.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10   .1038/emboj.2010.27 3 Tu, B.P., S.C. Ho-Schleyer, K.J.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1126/science.290.5496.157 1 Tu, B.P., and J.S.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1016/S1097-   2765(02)00696- 2 Ushioda, R., J. Hoseki, K. Araki, G. Jansen, D.Y.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10   .1126/science.115929 3 van den Beucken, T., M. Koritzinsky, H. Niessen, L. Dubois, K. Savelkouls,  H. Mujcic, B. Jutten, J. Kopacek, S. Pastorekova, A.J.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"284:24204– 24212. http://dx.doi.org/10.1074/jbc.M109.00651 0 Vitu, E., S. Kim, C.S.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi   .org/10.1074/jbc.M109.06493 1 Wajih, N., S.M.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1074/jbc.M60895420 0 Wang, L., S.J.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1074/jbc.M80664520 0 Wang, Y., G.N.",OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-12-047 4 Wei, P.C., Y.H.",Non-OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
http://dx.doi.org/10.1016/j.molcel   .2012.10.00 7,OADS,/arxiv_data1/oa_pdf/c3/d7/JCB_201307185.PMC3840938.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi   .org/10.1073/pnas.100866310 7 Chen, X., Y. Yu, L.-Z.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1093/nar/gkm21 6 Emsley, P., and K. Cowtan.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80622- 4 Gahmberg, C.G., S.C. Fagerholm, S.M.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1016/j.bbagen.2009.03   .007 Huth, J.R., E.T.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1126/ science   .121823 1 Kuhlman, B., G. Dantas, G.C.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1126/science.108942 7 Lee, J.-O., L.A. Bankston, M.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1016/S0969-2126   (01)00271- 4 Lu, C., M. Ferzly, J. Takagi, and T.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi   .org/10.1146/annurev.immunol.25.022106.14161 8 McCoy, A.J., R.W.",Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1107/S002188980702120 6 Mi, L.Z., M.J. Grey, N. Nishida, T. Walz, C. Lu, and T.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1021/bi801006 s Muller, N., P. Girard, D.L.",Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1002/bit.2035 8 Nagae, M., S. Re, E. Mihara, T. Nogi, Y. Sugita, and J. Takagi.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10   .1083/jcb.20111107 7 Nishida, N., C. Xie, M. Shimaoka, Y. Cheng, T. Walz, and T.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1016/   j.immuni.2006.07.01 6 O’Shea, E.K., K.J.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi   .org/10.1016/0960-9822(93)90063- T Reeves, P.J., N. Callewaert, R. Contreras, and H.G.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi   .org/10.1073/pnas.21251929 9 Salas, A., M. Shimaoka, A.N.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
http://dx.doi.org/10.1016/   S1074-7613(04)00082- 2or horizontally on the page.,Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201308083/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1107/S090744490905292 5 Alonso, J.L., M. Essafi, J.P. Xiong, T. Stehle, and M.A.",Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1016/S0960-9822(02)00852- 7 Astrof, N.S., A. Salas, M. Shimaoka, J.F.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1021/bi061566 o Bilsland, C.A.G., M.S.",Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1038/emboj.2011.33 3 Shamri, R., V. Grabovsky, J.M.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1038/ni119 4 Shimaoka, M., J. Takagi, and T.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1016/S1074-   7613(03)00238- 3 Shimaoka, M., T. Xiao, J.-H. Liu, Y. Yang, Y. Dong, C.-D. Jun, A. McCormack,  R. Zhang, A. Joachimiak, J. Takagi, et al.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1016/   S0092-8674(02)01257- 6 Springer, T.A., and M.L.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1083/jcb.20080114 6 Takagi, J., H.P.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1038/8756 9 Takagi, J., B.M.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1016/   S0092-8674(02)00935- 2 Weitz-Schmidt, G., T. Schürpf, and T.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi   .org/10.1074/jbc.M111.28283 0 Whittaker, C.A., and R.O.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi   .org/10.1091/mbc.E02-05-025 9 Xiao, T., J. Takagi, B.S.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1038/nature0297 6 Xie, C., J. Zhu, X. Chen, L. Mi, N. Nishida, and T.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1038/emboj.2009.36 7 Xiong, J.P., T. Stehle, R. Zhang, A. Joachimiak, M. Frech, S.L.",Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"296:151– 155. http://dx.doi.org/10.1126/science.106904 0 Yang, W., M. Shimaoka, A. Salas, J. Takagi, and T.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi   .org/10.1073/pnas.030734010 1 Yu, Y., J. Zhu, L.Z.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1083/   jcb.20111002 3 Zang, Q., and T.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi   .org/10.1074/jbc.M00586820 0 Zhu, J., B.H.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"http://dx.doi.org/10.1016/j.molcel.2008.11.01 8 Zhu, J., J. Zhu, and T.A.",OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
http://dx.doi.org/10.1083/   jcb.20121203 7,Non-OADS,/arxiv_data1/oa_pdf/6b/78/JCB_201308083.PMC3840939.pdf
"Charles Betz and Michael N. Hall Biozentrum, University of Basel, CH-4056 Basel, Switzerland © 2013 Betz and Hall  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1371/journal.pone.000752 3 Appenzeller-Herzog, C., and M.N.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.tcb.2012.02.00 6 Aronova, S., K. Wedaman, S. Anderson, J. Yates III, and T. Powers.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1091/mbc.E07-03-027 4 Aslan, J.E., H. You, D.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1016/j.molcel.2009.04.01 1 Averous, J., and C.G.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/   sj.onc.120988 7 Bar-Peled, L., L.D.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.cell.2012.07.03 2 Bar-Peled, L., L. Chantranupong, A.D. Cherniack, W.W. Chen, K.A.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1126/science.123204 4 Barquilla, A., J.L.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/nature0920 4 Ben-Sahra, I., J.J. Howell, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1126/science.122879 2 Benjamin, D., and M.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/ncb284 9 Benjamin, D., M. Colombi, C. Moroni, and M.N.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/nrd353 1 Berchtold, D., and T.C.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1091/mbc.E08-10-100 1 Bernardi, R., I. Guernah, D. Jin, S. Grisendi, A. Alimonti, J. Teruya-Feldstein,  C. Cordon-Cardo, M.C.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/nature0502 9 Betz, C., D. Stracka, C. Prescianotto-Baschong, M. Frieden, N. Demaurex, and  M.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
http://dx.doi.org/10.1046/j.1471-4159.2003.02113.,Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1016/j.molcel.2009.06.03 3 Blazek, M., C. Betz, M. Reth, M.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1074/mcp.M113.03282 1 Bononi, A., S. Missiroli, F. Poletti, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
http://dx.doi.org/10.1007/   978-94-007-2888-2_1 7functionally distinct substrates at different locations.,Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1104/pp.111.17986 1 Dibble, C.C., W. Elis, S. Menon, W. Qin, J. Klekota, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.molcel.2012.06.00 9 Downes, C.P., S. Walker, G. McConnachie, Y. Lindsay, I.H.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1042/BST032033 8 Durán, R.V., E.D.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.molcel.2012.05.04 3 Engelsberg, A., F. Kobelt, and D. Kuhl.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1042/   BJ2006038 6 Frias, M.A., C.C.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"16:1865– 1870. http://dx.doi.org/10.1016/j.cub.2006.08.00 1 Fujimoto, M., T. Hayashi, and T.-P. Su.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/   j.bbrc.2011.12.02 2 Ganley, I.G., H. Lam, J. Wang, X. Ding, S. Chen, and X. Jiang.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/ jbc.M90057320 0 Gao, X., P.R.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"416:375– 385. http://dx.doi.org/10.1042/BJ2008166 8 Giorgi, C., K. Ito, H.-K. Lin, C. Santangelo, M.R.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1126/science.118915 7 Goh, E.T.H., O.E.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.M109.07878 2 Hagiwara, A., M. Cornu, N. Cybulski, P. Polak, C. Betz, F. Trapani, L. Terracciano,  M.H.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.cmet.2012.03.01 5 Hamasaki, M., N. Furuta, A. Matsuda, A. Nezu, A. Yamamoto, N. Fujita, H.  Oomori, T. Noda, T. Haraguchi, Y. Hiraoka, et al.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1101/gad.199861 1 Harris, T.E., A. Chi, J. Shabanowitz, D.F.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760104 7 Heitman, J., N.R.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1126/science.171509 4 Hemmings, B.A., and D.F.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1101/csh - perspect.a01118 9 Hennig, K.M., J. Colombani, and T.P.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1083/   jcb.20051114 0 Henry, K.W., X. Yuan, N.J. Koszewski, H. Onda, D.J.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.bbrc.2011.08.03 4 Bridges, D., J.-T. Ma, S. Park, K. Inoki, L.S.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1091/mbc.E11-12-103 4 Buerger, C., B. DeVries, and V. Stambolic.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.bbrc.2006.03.22 0 Chang, Y.-Y., and T.P.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"20:2004– 2014. http://dx.doi.org/10.1091/mbc.E08-12-125 0 Chen, C.-H., T. Shaikenov, T.R.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1126/scisignal.200173 1 Chen, C.-H., V. Kiyan, A.A. Zhylkibayev, D. Kazyken, O. Bulgakova, K.E.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/ jbc.M113.49805 5 Clippinger, A.J., T.G.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1128/   JVI.01913-1 0 Colombi, M., K.D.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/onc.2010.53 9 Cordas, E., A. Náray-Fejes-Tóth, and G. Fejes-Tóth.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1093/emboj/18.1.9 6 Csordás, G., C. Renken, P. Várnai, L. Walter, D. Weaver, K.F.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1083/jcb.20060401 6 Cunningham, J.T., J.T.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/nature0632 2 Cybulski, N., and M.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/   j.tibs.2009.09.00 4 Dai, N., J. Christiansen, F.C.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"27:301– 312. http://dx.doi.org/10.1101/gad.209130.11 2 Daniele, N., F. Rajas, B. Payrastre, G. Mauco, C. Zitoun, and G. Mithieux.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/   jbc.274.6.359 7 Datta, S.R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)80405- 5 Dazert, E., and M.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.09.00 3 Desai, B.N., B.R.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1073/pnas.26170269 8 Díaz-Troya, S., F.J. Florencio, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1128/EC.00361-0 7 Díaz-Troya, S., M.E.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"31:1823– 1835. http://dx.doi.org/10.1038/emboj.2012.1 5 Laplante, M., and D.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j   .cub.2009.09.05 8 Laplante, M., and D.M.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.cell.2012.03.01 7 Lebiedzinska, M., G. Szabadkai, A.W.E.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.biocel   .2009.02.01 7 Leem, J., and E.H. Koh.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"2012:242984. http://dx.doi.org/10   .1155/2012/24298 4 Li, H., C.K.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/nature0502 0 Lian, Z., and A.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/sj.onc.120908 9 Lim, M.A., C.K.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.molcel.2013.06.02 0 Loewith, R., and M.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10   .1534/genetics.111.13336 3 Lynes, E.M., M. Bui, M.C.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/emboj.2011.38 4 Ma, X.M., and J. Blenis.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/nrm267 2 Malhotra, J.D., and R.J. Kaufman.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1101/cshperspect.a00442 4 Malik, A.R., M. Urbanska, M. Macias, A. Skalecka, and J. Jaworski.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1016/j.bbapap.2012.12.01 0 Marchi, S., M. Marinello, A. Bononi, M. Bonora, C. Giorgi, A. Rimessi, and  P. Pinton.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/cddis.2012.4 5 Martin, J., J. Masri, A. Bernath, R.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10   .1016/j.bbrc.2008.05.08 6 Martina, J.A., and R. Puertollano.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1083/jcb.20120913 5 Martina, J.A., Y. Chen, M. Gucek, and R. Puertollano.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.4161/auto.1965 3 Menon, S., and B.D.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1042/BST2011075 8 Miyamoto, S., A.N.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/sj.cdd.440228 5 Murata, H., M. Sakaguchi, Y. Jin, Y. Sakaguchi, J.-I.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
http://dx.doi.org/10.1074/jbc.M110.17939 0mediated by steroid hormone receptor family members.,OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.273.32.2053 5 Hill, M.M., J. Feng, and B.A.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/   S0960-9822(02)00973- 9 Holz, M.K., B.A.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"123:569– 580. http://dx.doi.org/10.1016/j.cell.2005.10.02 4 Hosoi, T., K. Hyoda, Y. Okuma, Y. Nomura, and K. Ozawa.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.brainres.2007.03.05 2 Hosokawa, N., T. Hara, T. Kaizuka, C. Kishi, A. Takamura, Y. Miura, S.-I.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/   10.1091/mbc.E08-12-124 8 Hresko, R.C., and M. Mueckler.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"280:40406– 40416. http://dx.doi.org/10.1074/jbc.M50836120 0 Huh, W.-K., J.V.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/nature0202 6 Inoki, K., Y. Li, T. Xu, and K.-L. Guan.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"17:1829– 1834. http://dx.doi.org/10.1101/gad.111000 3 Ishikawa-Ankerhold, H.C., R. Ankerhold, and G.P.C.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.3390/   molecules1704404 7 Jewell, J.L., R.C.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/nrm352 2 Kaizuka, T., T. Hara, N. Oshiro, U. Kikkawa, K. Yonezawa, K. Takehana, S.-I.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.M110.12169 9 Kantidakis, T., B.A.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.M50926220 0 Kikani, C.K., L.Q.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1002/jcb.2065 1 Kim, E., P. Goraksha-Hicks, L. Li, T.P.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/ncb175 3 Kim, J.E., and J. Chen.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1006/bbrc.1997.669 9 Kornmann, B., E. Currie, S.R.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1126/science.117508 8 Korolchuk, V.I., S. Saiki, M. Lichtenberg, F.H.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/ncb220 4 Kunz, J., R. Henriquez, U. Schneider, M. Deuter-Reinhard, N.R.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/0092-8674(93)90144- F Kunz, J., U. Schneider, I. Howald, A. Schmidt, and M.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
http://dx.doi.org/10.1074/jbc.M00729620 0,Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"155:1367– 1382. http://dx.doi.org/10.1104/pp.110.16904 5 Rizzuto, R., P. Pinton, W. Carrington, F.S.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1126/science.280.5370.176 3 Robitaille, A.M., S. Christen, M. Shimobayashi, M. Cornu, L.L.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1126/   science.122877 1 Roccio, M., J.L.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/sj.onc.120910 6 Rosner, M., and M. Hengstschläger.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1007/s00726-007-0541- 0 Rosner, M., and M. Hengstschläger.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1093/hmg/ddn19 2 Rosner, M., and M. Hengstschläger.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10   .4161/cc.10.20.1785 5 Rosner, M., and M. Hengstschläger.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1007/978-1-61779-430-8_ 8 Rosner, M., A. Freilinger, and M. Hengstschläger.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/sj.onc.120981 2 Ruby, J.R., R.F.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1093/jb/mvi04 6 Sancak, Y., T.R.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1126/science.115753 5 Sancak, Y., L. Bar-Peled, R. Zoncu, A.L.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.02 4 Sarbassov, D.D., S.M.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10   .1074/jbc.M60353620 0 Sebastián, D., M.I.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1073/pnas.110822010 9 Shor, B., J. Wu, Q. Shakey, L. Toral-Barza, C. Shi, M. Follettie, and K. Yu.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.M109.07163 9 Simmen, T., J.E.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760055 9 Simmen, T., E.M. Lynes, K. Gesson, and G. Thomas.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.bbamem.2010.04.00 9 Smith, E.M., S.G. Finn, A.R.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.M31020820 0 Nellist, M., M.A.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/   jbc.274.50.3564 7 Noonan, D.J., D. Lou, N. Griffith, and T.C.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"398:132– 140. http://dx.doi.org/10.1006/abbi.2001.268 2 Ögmundsdóttir, M.H., S. Heublein, S. Kazi, B. Reynolds, S.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.4161/cc.10.14.1658 6 Oh, W.J., C.-C. Wu, S.J.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10   .1038/emboj.2010.27 1 Paglin, S., N.-Y.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-05-108 3 Panchaud, N., M.-P. Péli-Gulli, and C. De Virgilio.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10   .1126/scisignal.200411 2 Partovian, C., R. Ju, Z.W.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.molcel.2008.09.01 0 Peterson, T.R., S.S. Sengupta, T.E.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.06.03 4 Petit, C.S., A. Roczniak-Ferguson, and S.M.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1083/   jcb.20130708 4 Plank, T.L., R.S.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1016/j.bbrc.2011.10.07 2 Poston, C.N., S.C. Krishnan, and C.R.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.jprot.2012.12.01 8 Proud, C.G.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1042/BST037022 7 Ramanathan, A., and S.L.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1128/MCB.00824-1 0 Raturi, A., and T. Simmen.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.M31306220 0 Ren, J., L. Wen, X. Gao, C. Jin, Y. Xue, and X. Yao.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
http://dx.doi.org/10.1093/protein/gzn03 9,Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1101/gad.203406.11 2 Wullschleger, S., R. Loewith, and M.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.cell.2006   .01.01 6 Yadav, R.B., P. Burgos, A.W.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.M112.38685 4 Yung, H.W., D.S.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1371/journal.pone.001789 4 Zhang, X., L. Shu, H. Hosoi, K.G.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1074/jbc.M20262520 0 Zhang, F., X. Zhang, M. Li, P. Chen, B. Zhang, H. Guo, W. Cao, X. Wei, X.  Cao, X. Hao, and N. Zhang.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-10-020 7 Zhang, A., C.D.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/ncb282 2 Zhu, Y., P. Hoell, B. Ahlemeyer, and J. Krieglstein.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1007/s10495-006-3714- 5 Zinzalla, V., and M.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1038/454287 a Zoncu, R., L. Bar-Peled, A. Efeyan, S. Wang, Y. Sancak, and D.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"334:678– 683. http://dx.doi.org/10.1126/science.120705 6 Zu, L., X. Zheng, B. Wang, N. Parajuli, C. Steenbergen, L.C.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
http://dx.doi.org/10.1152/ajpheart   .01138.201 0mammalian target of rapamycin by amino acids and certain cellular  stresses.,Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc   .M41449920 0 Sonenberg, N., and A.G. Hinnebusch.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.cell.2009.01.04 2 Sturgill, T.W., A. Cohen, M. Diefenbacher, M. Trautwein, D.E.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1128/EC.00088-0 8 Su, C.-C., J.-Y.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1152/ajpheart.00455.201 1 Szabadkai, G., K. Bianchi, P. Várnai, D. De Stefani, M.R.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1083/jcb.20060807 3 Szado, T., V. Vanderheyden, J.B. Parys, H. De Smedt, K. Rietdorf, L.  Kotelevets, E. Chastre, F. Khan, U. Landegren, O. Söderberg, et al.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.M110.11154 2 Takahara, T., and T. Maeda.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1016/j.molcel.2012.05.01 9 Takai, H., R.C.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.cell.2007.10.05 2 Teleman, A.A., Y.-W. Chen, and S.M.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1016/j.devcel.2005.07.00 4 Thedieck, K., B. Holzwarth, M.T.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.cell.2013.07.03 1 Tsang, C.K., H. Liu, and X.F.S.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.4161/cc.9.5.1087 6 Tsun, Z.-Y., L. Bar-Peled, L. Chantranupong, R. Zoncu, T. Wang, C. Kim, E.  Spooner, and D.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"26:663– 674. http://dx.doi.org/10.1016/j.molcel.2007.04.02 0 van Slegtenhorst, M., M. Nellist, B. Nagelkerken, J. Cheadle, R. Snell, A.  van den Ouweland, A. Reuser, J. Sampson, D. Halley, and P. van der  Sluijs.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1093/hmg/7.6.105 3 Verfaillie, T., N. Rubio, A.D. Garg, G. Bultynck, R. Rizzuto, J.-P. Decuypere, J.  Piette, C. Linehan, S. Gupta, A. Samali, and P. Agostinis.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.1038/cdd.2012.7 4 Vézina, C., A. Kudelski, and S.N.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi   .org/10.7164/antibiotics.28.72 1 Wang, Y., L.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1074/jbc.M109.09577 8 Wedaman, K.P., A. Reinke, S. Anderson, J. Yates III, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1091/mbc.E02-09-060 9 Wippich, F., B. Bodenmiller, M.G.",Non-OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
"http://dx.doi.org/10.1016/j.cell.2013.01.03 3 Wu, Z., T. Sawada, K. Shiba, S. Liu, T. Kanao, R. Takahashi, N. Hattori, Y.   Imai, and B. Lu.",OADS,/arxiv_data1/oa_pdf/ec/24/JCB_201306041.PMC3840941.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"At stage 9, the  distance between the center of the border cell cluster and the anterior co - lumnar follicle cells (“border cell position”) was measured in ImageJ  (http://rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi   .org/10.1038/nrm286 7 Carmona-Fontaine, C., H.K.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1038/nature0744 1 Friedl, P., and D. Gilmour.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10   .1038/ncb254 8 Goslin, K., and G. Banker.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1083/jcb.108.4.150 7 Hahne, P., A. Sechi, S. Benesch, and J.V.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/S0014-5793(01)02239- 6 Hanahan, D., and R.A. Weinberg.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.01 3 Hopwood, N.D., A. Pluck, and J.B. Gurdon.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/   10.1016/0092-8674(89)90612- 0 Innocenti, M., A. Zucconi, A. Disanza, E. Frittoli, L.B.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1038/ncb110 5 Insall, R.H., and L.M.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.08.01 2 Jonchere, V., and D. Bennett.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1146/   annurev.cellbio.19.050103.10335 6 Krause, M., J.D.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/   10.1016/j.devcel.2004.07.02 4 Kunda, P., G. Craig, V. Dominguez, and B. Baum.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j.devcel.2004.07.02 1 Lallemand, Y., V. Luria, R. Haffner-Krausz, and P. Lonai.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)81092- 2 Lebrand, C., E.W.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/S0896-6273(04)00108- 4 Lewandoski, M., and G.R.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1038/ng1097-22 3 Li, A., Y. Ma, X. Yu, R.L.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.07.00 8 Lin, J.Y., and D.E.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1038/nature0566 0 Lyulcheva, E., E. Taylor, M. Michael, A. Vehlow, S. Tan, A. Fletcher, M. Krause,  and D. Bennett.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
http://dx.doi.org/10.1016/j.devcel.2008.09.02 0Online supplemental material Fig.,OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80884- 3 Bear, J.E., M. Krause, and F.B.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/   S0955-0674(00)00193- 9 Bear, J.E., T.M.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/   10.1016/S0092-8674(02)00731- 6 Bianco, A., M. Poukkula, A. Cliffe, J. Mathieu, C.M.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
http://dx.doi   .org/10.1038/nature0596 5,Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10   .1083/jcb.20111211 3 Sviderskaya, E.V., W.F.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j.ydbio.2011.12.04 1 Theveneau, E., L. Marchant, S. Kuriyama, M. Gull, B. Moepps, M. Parsons,  and R. Mayor.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j.devcel   .2010.06.01 2 Todaro, G.J., and H. Green.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1083/jcb.17.2.29 9 Wehrle-Haller, B., M. Meller, and J.A.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1006/dbio.2001.016 7 Wu, C., S.B.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j.cell.2011.12.03 4 Xu, Y., and C.C.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1371/journal.pgen.100305 4 Yan, C., N. Martinez-Quiles, S. Eden, T. Shibata, F. Takeshima, R. Shinkura,  Y. Fujiwara, R. Bronson, S.B.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi   .org/10.1093/emboj/cdg35 0Machesky, L.M., and R.H. Insall.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/   S0960-9822(98)00015- 3 Mackenzie, M.A., S.A. Jordan, P.S.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi   .org/10.1006/dbio.1997.873 8 Matthews, H.K., L. Marchant, C. Carmona-Fontaine, S. Kuriyama, J. Larraín,  M.R.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j   .ydbio.2012.09.01 7 Michael, M., A. Vehlow, C. Navarro, and M. Krause.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10   .1016/j.cub.2010.03.04 8 Miki, H., S. Suetsugu, and T. Takenawa.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1093/emboj/17.23.693 2 Niebuhr, K., F. Ebel, R. Frank, M. Reinhard, E. Domann, U.D.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi   .org/10.1093/emboj/16.17.543 3 Oskarsson, T., M.A.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1101/gad.38120 6 Poukkula, M., A. Cliffe, R. Changede, and P. Rørth.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1083/jcb.20101000 3 Pula, G., and M. Krause.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/   10.1007/978-3-540-72843-6_ 3 Prasad, M., and D.J.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.03.02 1 Prasad, M., A.C. Jang, M. Starz-Gaiano, M. Melani, and D.J.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1038   /nprot.2007.36 3 Quinn, C.C., D.S.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/j.cub   .2008.04.05 0 Rørth, P. 2012.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1038/embor   .2012.14 9 Stavoe, A.K., J.C. Nelson, L.A. Martínez-Velázquez, M. Klein, A.D.  Samuel, and D.A.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10   .1101/gad.193409.11 2 Steffen, A., K. Rottner, J. Ehinger, M. Innocenti, G. Scita, J. Wehland, and  T.E.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/   10.1038/sj.emboj.760008 4 Stradal, T., K.D.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00239- 1 Suetsugu, S., D. Yamazaki, S. Kurisu, and T. Takenawa.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
"http://dx.doi.org/   10.1016/S1534-5807(03)00297- 1 Suraneni, P., B. Rubinstein, J.R. Unruh, M. Durnin, D. Hanein, and R. Li.",OADS,/arxiv_data1/oa_pdf/37/a5/JCB_201304051.PMC3840943.pdf
We thank these  new members—and all of our existing board members—for their  efforts on behalf of the journal and the cell biology community.New editorial board members © 2013 This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/term s).,Non-OADS,/arxiv_data1/oa_pdf/2d/c8/JCB_201310102.PMC3840944.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0 /).Daniel Colón-Ramos Synaptic assembly and neural circuit formation  Daniel A.  Colón-Ramos is Associate Professor in the Cellular Neuroscience, Neurodegeneration, and Repair Program and the  Department of Cell Biology at Yale University.",Non-OADS,/arxiv_data1/oa_pdf/2d/c8/JCB_201310102.PMC3840944.pdf
"OncoImmunology 2013; 2:e25771; http://dx.doi.org/10.4161/Dendritic cells (DCs) occupy a privileged position at the interface  between innate and adaptive immunity, orchestrating a large panel of responses to both physiological and pathological  cues.",Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
"Literature Update During the last 13 mo (July 2012–July 2013, both included), no less than 4,400 articles dealing with DCs have been published in peer-reviewed scientific journals (all types of publication con - founded, source http://www.ncbi.nlm.nih.gov/pubmed/).",OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Immunol 2000; 1:510-4;  PMID:11101873; http://dx.doi.org/10.1038/82763 19.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Immunol  2005; 5:296-306; PMID:15803149; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Science  2001; 294:1540-3; PMID:11711679; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Science  2001; 293:253-6; PMID:11452116; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nature 1998; 392:245-52;  PMID:9521319; http://dx.doi.org/10.1038/32588 23.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nature 2007; 449:419-26; PMID:17898760;  http://dx.doi.org/10.1038/nature06175 24.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Annu Rev Immunol 2013; 31:563- 604; PMID:23516985; http://dx.doi.org/10.1146/ annurev-immunol-020711-074950 25.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Cancer 2012; 12:265-77;  PMID:22437871; http://dx.doi.org/10.1038/nrc3258 26.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Annu Rev Immunol  2003; 21:685-711; PMID:12615891; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:252-4; PMID:22720261;  http://dx.doi.org/10.4161/onci.1.2.18241 29.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Mol Cell  Biol 2012; 13:780-8; PMID:23175281; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Annu  Rev Immunol 2013; 31:51-72; PMID:23157435;  http://dx.doi.org/10.1146/annurev-immu- nol-032712-100008 31.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:1218- 9; PMID:23170286; http://dx.doi.org/10.4161/ onci.20428 32.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:1111-34; PMID:23170259; http://dx.doi.org/10.4161/onci.21494References 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cell 2011; 147:1216-7;  PMID:22263224; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nature 2011; 478:460; PMID:22031432;  http://dx.doi.org/10.1038/478460a 4.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Science 2011; 334:466;  PMID:22034425; http://dx.doi.org/10.1126/sci- ence.1215136 5.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cell  2001; 106:271-4; PMID:11509176; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2003; 19:225-34;  PMID:12932356; http://dx.doi.org/10.1016/S1074-7613(03)00208-5 9.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunol Rev 2007; 220:129-50; PMID:17979844; http://dx.doi.org/10.1111/j.1600-065X.2007.00575.x 10.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunol Rev 2007; 219:118-42; PMID:17850486; http://dx.doi.org/10.1111/j.1600- 065X.2007.00551.x 11.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med  2000; 192:F39-44; PMID:11120782; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2000; 192:1535-44; PMID:11104796;  http://dx.doi.org/10.1084/jem.192.11.1535 13.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2012; 209:109- 21; PMID:22213806; http://dx.doi.org/10.1084/ jem.20110399 14.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Immunol 2009; 182:6815-23; PMID:19454677; http://dx.doi.org/10.4049/jim- munol.080200833.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J T ransl Med 2010; 8:4;  PMID:20078880; http://dx.doi.org/10.1186/1479- 5876-8-4 34.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Cell Mol  Med 2005; 9:643-54; PMID:16202211; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Dermatol  Sci 2006; 42:1-11; PMID:16352421; http://dx.doi.org/10.1016/j.jdermsci.2005.11.004 36.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Annu Rev Immunol 2013; 31:743-91; PMID:23330953; http://dx.doi.org/10.1146/annurev- immunol-020711-074929 37.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev  Immunol 2006; 6:476-83; PMID:16691244; http://dx.doi.org/10.1038/nri1845 38.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Annu Rev Immunol 2012; 30:1- 22; PMID:22136168; http://dx.doi.org/10.1146/annurev-immunol-100311-102839 39.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Proc Natl Acad Sci U S A 1999; 96:1036- 41; PMID:9927689; http://dx.doi.org/10.1073/ pnas.96.3.1036 41.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Biotechnol  2010; 28:813-5; PMID:20697407; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunol Rev  2010; 234:199-212; PMID:20193020; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Immunol  2012; 13:1145-54; PMID:23160217; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Curr Opin Immunol 2013; 25:396- 402; PMID:23725656; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2008; 29:497-510; PMID:18789730; http://dx.doi.org/10.1016/j.immu- ni.2008.07.013 48.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2010; 207:1273-81; PMID:20479115;  http://dx.doi.org/10.1084/jem.20100348,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med  2010; 207:1283-92; PMID:20479118; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2010; 207:1261-71; PMID:20479117; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Immunol 2012; 12:557-69; PMID:22790179; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunol Rev 2010; 234:18-31; PMID:20193009; http://dx.doi.org/10.1111/j.0105-2896.2009.00870.x 54.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2002; 195:953- 8; PMID:11927638; http://dx.doi.org/10.1084/ jem.20020045 57.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med  2001; 194:863-9; PMID:11561001; http://dx.doi.org/10.1084/jem.194.6.863 58.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cell Immunol  2002; 218:74-86; PMID:12470615; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Hum Immunol 2002; 63:1126-32;  PMID:12480256; http://dx.doi.org/10.1016/S0198- 8859(02)00751-6 60.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunol Rev 2013; 254:170- 89; PMID:23772620; http://dx.doi.org/10.1111/ imr.12082 63.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Immunol 2006; 6:715-27;  PMID:16977338; http://dx.doi.org/10.1038/nri193664.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486 65.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798; http://dx.doi.org/10.1038/nrd3626 66.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2013; Forthcoming;  http://dx.doi.org/10.1016/j.immuni.2013.06.014.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2012; 209:495- 506; PMID:22351930; http://dx.doi.org/10.1084/ jem.20111413 68.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Immunol 2010; 184:6151- 60; PMID:20427766; http://dx.doi.org/10.4049/jim- munol.0903519 69.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncogene  2008; 27:5920-31; PMID:18836473; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Med  2006; 12:214-9; PMID:16444265; http://dx.doi.org/10.1038/nm1356 71.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2013; 38:729- 41; PMID:23562161; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Science 2012; 337:1678- 84; PMID:23019653; http://dx.doi.org/10.1126/sci- ence.1224922 73.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347 74.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:1451-3; PMID:23243626; http://dx.doi.org/10.4161/ onci.21356 75.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e22338; PMID:23482834;  http://dx.doi.org/10.4161/onci.22338 76.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer 2001; 91:2136-47;  PMID:11391595; http://dx.doi.org/10.1002/1097-0142(20010601)91:11<2136::AID- CNCR1242>3.0.CO;2-Q 77.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Surg Oncol 1993; 52:207- 12; PMID:8468980; http://dx.doi.org/10.1002/ jso.2930520402 80.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer 1998; 82:1468-75; PMID:9554522; http://dx.doi.org/10.1002/ (SICI)1097-0142(19980415)82:8<1468::AID- CNCR6>3.0.CO;2-5 82.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Lett 2000; 159:103-8;  PMID:10974412; http://dx.doi.org/10.1016/S0304- 3835(00)00542-5 83.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Clin Oncol 2008; 26:3235-41; PMID:18591558; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Cancer Res Clin Oncol  2006; 132:293-301; PMID:16421755; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Br J Cancer  2003; 89:1736-42; PMID:14583778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin  Cancer Res 2007; 13:6666-72; PMID:18006767;  http://dx.doi.org/10.1158/1078-0432.CCR-07-0504 90.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Tohoku J Exp Med 1993; 169:187- 95; PMID:8248911; http://dx.doi.org/10.1620/ tjem.169.187,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Int J Cancer 2003; 104:92- 7; PMID:12532424; http://dx.doi.org/10.1002/ ijc.10915 92.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Clin Oncol  2008; 26:4410-7; PMID:18802153; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Metastasis  Rev 2011; 30:13-25; PMID:21271351; http://dx.doi.org/10.1007/s10555-011-9279-y 94.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Immunol  Immunother 2007; 56:1459-69; PMID:17279413;  http://dx.doi.org/10.1007/s00262-007-0286-3 95.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23887;  PMID:23762788; http://dx.doi.org/10.4161/ onci.23887 97.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Immunol Immunother 2010; 59:389-95;  PMID:19760221; http://dx.doi.org/10.1007/s00262-009-0758-8 98.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Cancer Res 2005; 11:2576-82; PMID:15814636;  http://dx.doi.org/10.1158/1078-0432.CCR-04-1448 99.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Cancer Res 2004; 10:7466-74; PMID:15569976;  http://dx.doi.org/10.1158/1078-0432.CCR-04-0684 100.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer 2012; 118:2476- 85; PMID:21953023; http://dx.doi.org/10.1002/ cncr.26511 101.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:380-2; PMID:22737622; http://dx.doi.org/10.4161/ onci.18801 102.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Med 2010; 16:858-9; PMID:20689548; http://dx.doi.org/10.1038/ nm0810-858 103.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2013; 121:2836-44; PMID:23390195; http://dx.doi.org/10.1182/blood- 2012-09-452078 104.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Science 2004; 305:200- 5; PMID:15247469; http://dx.doi.org/10.1126/sci- ence.1100369 107.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Curr Opin Rheumatol  2013; 25:268-74; PMID:23370378; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
N Engl J Med 2010; 363:411-22;  PMID:20818862; http://dx.doi.org/10.1056/ NEJMoa1001294 111.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Cancer Res 2011; 17:3520-6;  PMID:21471425; http://dx.doi.org/10.1158/1078-0432.CCR-10-3126 113.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Ther Oncol 2002; 2:337-49; PMID:12440225;  http://dx.doi.org/10.1046/j.1359-4117.2002.01050.x 114.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res  2006; 66:8887-96; PMID:16951206; http://dx.doi.org/10.1158/0008-5472.CAN-05-3448 117.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Hepatobiliary  Pancreat Sci 2012; 19:465-75; PMID:21983893;  http://dx.doi.org/10.1007/s00534-011-0457-7 118.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:847-55; PMID:23162752;  http://dx.doi.org/10.4161/onci.20504 119.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23431; PMID:23802086;  http://dx.doi.org/10.4161/onci.23431120.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Int J Cancer 1997; 70:706-15; PMID:9096653;  http://dx.doi.org/10.1002/(SICI)1097- 0215(19970317)70:6<706::AID-IJC13>3.0.CO;2-7 121.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Surg Oncol 1998; 68:79-91; PMID:9624036;  http://dx.doi.org/10.1002/(SICI)1096-9098(199806)68:2<79::AID-JSO3>3.0.CO;2-H 122.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cell Immunol 1998; 185:65-74; PMID:9636684; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Int J Cancer  2001; 93:539-48; PMID:11477558; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Leukemia 2004; 18:1810-5; PMID:15385926; http://dx.doi.org/10.1038/sj.leu.2403517 127.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nature 1998; 392:86-9;  PMID:9510252; http://dx.doi.org/10.1038/32183 129.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 1996;  183:1357-65; PMID:8666894; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 1996; 183:317- 22; PMID:8551239; http://dx.doi.org/10.1084/ jem.183.1.317 134.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 1996; 183:87- 97; PMID:8551248; http://dx.doi.org/10.1084/jem.183.1.87 136.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Stem Cells 1997; 15:94- 103; PMID:9090785; http://dx.doi.org/10.1002/ stem.150094 137.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat  Med 1999; 5:405-11; PMID:10202929; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 1996; 184:465- 72; PMID:8760800; http://dx.doi.org/10.1084/ jem.184.2.465 139.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J  Exp Med 1997; 186:1177-82; PMID:9314567; http://dx.doi.org/10.1084/jem.186.7.1177 140.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Biotechnol 2000; 18:1273-8;  PMID:11101806; http://dx.doi.org/10.1038/82383 142.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 1997; 186:1247- 56; PMID:9334364; http://dx.doi.org/10.1084/ jem.186.8.1247 144.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Eur J Immunol  1997; 27:2702-7; PMID:9368629; http://dx.doi.org/10.1002/eji.1830271033 145.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Hum Gene Ther 1997; 8:1355- 63; PMID:9295130; http://dx.doi.org/10.1089/ hum.1997.8.11-1355 146.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Exp Immunol 1999; 117:244-51;  PMID:10444254; http://dx.doi.org/10.1046/j.1365-2249.1999.00913.x 148.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Gene Med 1999; 1:400-6;  PMID:10753065; http://dx.doi.org/10.1002/ (SICI)1521-2254(199911/12)1:6<400::AID- JGM68>3.0.CO;2-D 149.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cell Immunol 1999; 198:131- 8; PMID:10648127; http://dx.doi.org/10.1006/ cimm.1999.1585 150.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2000;  191:1699-708; PMID:10811863; http://dx.doi.org/10.1084/jem.191.10.1699 151.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Immunother 2000; 23:59-66; PMID:10687138;  http://dx.doi.org/10.1097/00002371-200001000- 00008 152.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Med 2000; 6:1011-7;  PMID:10973321; http://dx.doi.org/10.1038/79519 155.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Neurosurg  2001; 94:474-81; PMID:11235953; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Gene Ther 2002; 9:787- 97; PMID:12189529; http://dx.doi.org/10.1038/ sj.cgt.7700499 158.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Immunother  2003; 26:420-31; PMID:12973031; http://dx.doi.org/10.1097/00002371-200309000-00005160.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Am J Hematol 2004; 75:121-7; PMID:14978690;  http://dx.doi.org/10.1002/ajh.10471 162.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cell Immunol 2002; 220:1-12; PMID:12718934; http://dx.doi.org/10.1016/S0008- 8749(03)00009-1 167.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cell Immunol 2003; 225:65-74;  PMID:14698141; http://dx.doi.org/10.1016/j.cel - limm.2003.09.005 169.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Biochem Biophys Res Commun  2006; 346:829-39; PMID:16780801; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cytotherapy 2011;  13:774-85; PMID:21299362; http://dx.doi.org/10.31 09/14653249.2011.553593 171.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Gene Ther 2006; 13:138-49; PMID:16136162;  http://dx.doi.org/10.1038/sj.gt.3302609 172.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med  2004; 199:815-24; PMID:15024047; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med  2002; 196:1627-38; PMID:12486105; http://dx.doi.org/10.1084/jem.20021598,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2001; 194:769-79; PMID:11560993;  http://dx.doi.org/10.1084/jem.194.6.769 175.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res 2007; 67:8847-55;  PMID:17875726; http://dx.doi.org/10.1158/0008-5472.CAN-07-0321 177.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Biomaterials 2012; 33:4229-39;  PMID:22410170; http://dx.doi.org/10.1016/j.bioma- terials.2012.02.036 179.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood  2012; 119:2284-92; PMID:22234694; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2011; 118:4111-9;  PMID:21860028; http://dx.doi.org/10.1182/blood- 2011-04-346957 181.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Eur J Immunol 2012; 42:1989-98; PMID:22653683;  http://dx.doi.org/10.1002/eji.201142258 182.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood  2011; 118:6836-44; PMID:21967977; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:1398- 400; PMID:23243606; http://dx.doi.org/10.4161/ onci.20982 184.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23040; PMID:23525136;  http://dx.doi.org/10.4161/onci.23040 185.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Med 1998; 4:594-600; PMID:9585234; http://dx.doi.org/10.1038/nm0598- 594 186.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Cell Biol  1999; 147:599-610; PMID:10545503; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res 2010; 70:1281-5;  PMID:20145139; http://dx.doi.org/10.1158/0008- 5472.CAN-09-3276188.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:1074- 83; PMID:23170255; http://dx.doi.org/10.4161/onci.20897 189.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e22664;  PMID:23482679; http://dx.doi.org/10.4161/ onci.22664 190.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J T ransl Med  2011; 9:223; PMID:22208910; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res 2011; 71:4821-33; PMID:21602432;  http://dx.doi.org/10.1158/0008-5472.CAN-11-0950 192.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Immunother  2008; 31:101-12; PMID:18157017; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Methods Mol Biol  2013; 969:111-25; PMID:23296931; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:287-357; PMID:22737604;  http://dx.doi.org/10.4161/onci.18628 195.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e24437; PMID:23762810;  http://dx.doi.org/10.4161/onci.24437 196.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
"Vaccine 2003; 21:883-90;  PMID:12547598; http://dx.doi.org/10.1016/S0264- 410X(02)00536-4 197. van Broekhoven CL, Parish CR, Demangel C, Britton WJ, Altin JG.",Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res 2004; 64:4357-65;  PMID:15205352; http://dx.doi.org/10.1158/0008- 5472.CAN-04-0138 198.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Vaccine 2007; 25:4757-66;  PMID:17512099; http://dx.doi.org/10.1016/j.vac- cine.2007.04.029 199.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Clin Invest 2007; 117:1195-203; PMID:17476349; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Immunol 2007; 7:790-802;  PMID:17853902; http://dx.doi.org/10.1038/nri2173 201.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Immunol 2003; 3:630-41;  PMID:12974478; http://dx.doi.org/10.1038/nri1150 202.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
N Engl J Med 2008; 358:2704-15; PMID:18565863; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23433;  PMID:23734304; http://dx.doi.org/10.4161/ onci.23433 204.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Vaccine Immunol 2011; 18:23-34; PMID:21048000; http://dx.doi.org/10.1128/ CVI.00286-10 206.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Semin Immunol 2010; 22:125-31;  PMID:20403708; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Curr  Med Chem 2009; 16:4779-96; PMID:19929787;  http://dx.doi.org/10.2174/092986709789909648 208.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Cancer Res 2009; 15:5323-37; PMID:19723653; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2011;  118:499-509; PMID:21531979; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Immunol 2008;  8:970-6; PMID:19008897; http://dx.doi.org/10.1038/ nri2438 212.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Clin Oncol 2006; 24:2230- 2; PMID:16710020; http://dx.doi.org/10.1200/ JCO.2006.05.6952 213.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
N Engl J Med 2006; 354:758- 60; PMID:16481646; http://dx.doi.org/10.1056/ NEJMe058307 214.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Crit Rev Immunol 2000; 20:433- 50; PMID:11396680; http://dx.doi.org/10.1615/ CritRevImmunol.v20.i6.10 215.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:579- 80; PMID:22934249; http://dx.doi.org/10.4161/ onci.20730 216.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2012; 1:1557-76; PMID:23264902; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:894-907; PMID:23162757; http://dx.doi.org/10.4161/onci.20931,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:699-716;  PMID:22934262; http://dx.doi.org/10.4161/ onci.20696 220.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2013; 2:e23973; PMID:23734333; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2012; 1:306-15; PMID:22737606; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012;  1:28-37; PMID:22720209; http://dx.doi.org/10.4161/ onci.1.1.17938 223.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23082;  PMID:23525565; http://dx.doi.org/10.4161/onci.23082 224.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:1323- 43; PMID:23243596; http://dx.doi.org/10.4161/ onci.22009 225.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2013; 2:e23803; PMID:23734328; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e24238; PMID:23762803;  http://dx.doi.org/10.4161/onci.24238 227.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2013; 2:e22789; PMID:23482847; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
OncoImmunology 2013;  2:e24612; http://dx.doi.org/10.4161/onci.24612 230.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:493-506;  PMID:22754768; http://dx.doi.org/10.4161/ onci.20459 231.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:179-88; PMID:22720239; http://dx.doi.org/10.4161/onci.1.2.19026 232.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23510; PMID:23687621;  http://dx.doi.org/10.4161/onci.23510 233.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
OncoImmunology 2013; 2:  e25595; http://dx.doi.org/10.4161/onci.24238.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
BMC Cancer 2012; 12:623;  PMID:23270484; http://dx.doi.org/10.1186/1471- 2407-12-623 236.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Immunol  Immunother 2013; 62:125-35; PMID:22847020; http://dx.doi.org/10.1007/s00262-012-1319-0 237.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Neoplasma  2012; 59:440-9; PMID:22489700; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res  2013; 73:19-29; PMID:23087058; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res 2013; 73:1063-75; PMID:23345163; http://dx.doi.org/10.1158/0008- 5472.CAN-12-2583 241.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer 2012; 118:4354- 62; PMID:22252842; http://dx.doi.org/10.1002/ cncr.26734 243.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
World Neurosurg  2012; 77:736-44; PMID:22120301; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin T ransl Oncol 2012; 14:271-9; PMID:22484634;  http://dx.doi.org/10.1007/s12094-012-0795-1 246.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Ann Oncol  2012; 23:997-1005; PMID:21821548; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Immunol Immunother 2012; 61:1033-43;  PMID:22159452; http://dx.doi.org/10.1007/s00262- 011-1176-2 250.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Immunol Immunother 2013; 62:909- 18; PMID:23589106; http://dx.doi.org/10.1007/ s00262-013-1396-8 251.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Ann Surg  2013; PMID:23657083; http://dx.doi.org/10.1097/ SLA.0b013e318292919e 252.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Immunol Immunother 2012; 61:2033-44;  PMID:22527250; http://dx.doi.org/10.1007/s00262- 012-1261-1 253.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23789; PMID:23734325;  http://dx.doi.org/10.4161/onci.23789 254.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e22615; PMID:23482240;  http://dx.doi.org/10.4161/onci.22615 255.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2012; 1:372-4; PMID:22737619; http://dx.doi.org/10.4161/onci.18963 256.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood  2013; 121:423-30; PMID:23100308; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Cancer Res 2013; 19:3640-8;  PMID:23685836; http://dx.doi.org/10.1158/1078- 0432.CCR-13-0282 258.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Cancer Res 2012; 18:5460-70; PMID:22896657;  http://dx.doi.org/10.1158/1078-0432.CCR-11-3368 259.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2013; 121:459-67; PMID:23212525;  http://dx.doi.org/10.1182/blood-2012-06-435644 261.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2012; 120:3936-44;  PMID:22966165; http://dx.doi.org/10.1182/blood- 2012-06-435941 262.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Immunol  Immunother 2012; 61:1279-88; PMID:22294456; http://dx.doi.org/10.1007/s00262-012-1210-z 263.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Invest Dermatol  2012; 132:2395-406; PMID:22696054; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Immunol 2013; 14:364- 71; PMID:23435120; http://dx.doi.org/10.1038/ ni.2541 265.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Med  2013; 19:730-8; PMID:23685841; http://dx.doi.org/10.1038/nm.3197 267.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Proc Natl Acad Sci U S A  2012; 109:18885-90; PMID:23112154; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity  2013; 38:970-83; PMID:23706669; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2013; 38:1164-75; PMID:23770227; http://dx.doi.org/10.1016/j.immuni.2013.02.023 271.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Proc Natl Acad Sci U S A 2012; 109:19380-5; PMID:23129633; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Immunol 2013; 14:172-8;  PMID:23222971; http://dx.doi.org/10.1038/ni.2492 273.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e22796; PMID:23525517;  http://dx.doi.org/10.4161/onci.22796274.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2013; 2:e23186; PMID:23802070; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
PLoS Pathog 2012; 8:e1002846;  PMID:22876184; http://dx.doi.org/10.1371/journal.ppat.1002846 276.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2013; 210:715-28; PMID:23547099;  http://dx.doi.org/10.1084/jem.20112061 277.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Commun 2013; 4:1852; PMID:23673637;  http://dx.doi.org/10.1038/ncomms2874 278.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Immunol  2012; 13:832-42; PMID:22842346; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2013; 38:1211-22; PMID:23791643; http://dx.doi.org/10.1016/j.immu- ni.2013.05.012 280.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res 2012; 72:3664-76;  PMID:22628427; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2791 283.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2013; 210:1069-77; PMID:23712430; http://dx.doi.org/10.1084/jem.20122695 284.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2013; 121:e108-17;  PMID:23430108; http://dx.doi.org/10.1182/blood- 2012-07-445106 285.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2013; 38:514-27;  PMID:23453633; http://dx.doi.org/10.1016/j.immu- ni.2013.02.011288.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2013; 210:1035- 47; PMID:23569327; http://dx.doi.org/10.1084/ jem.20121103 290.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2013; 210:1049-63; PMID:23569326;  http://dx.doi.org/10.1084/jem.20121251 291.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2012; 120:2011-20; PMID:22791285;  http://dx.doi.org/10.1182/blood-2012-01-402370 292.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2013; 2:e23851; PMID:23762786; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2013; 38:943-57; PMID:23623382; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood  2013; 121:4073-81; PMID:23547051; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nature  2013; 496:229-32; PMID:23552896; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood  2013; 121:11-9; PMID:23053574; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med  2013; 210:23-30; PMID:23267013; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2012; 37:1050-60; PMID:23177320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med  2012; 209:2033-47; PMID:23071254; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nature 2012; 490:502-7; PMID:22992524;  http://dx.doi.org/10.1038/nature11531 303.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2012; 36:1031-46; PMID:22749353;  http://dx.doi.org/10.1016/j.immuni.2012.03.027 304.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Immunol 2012; 13:753-60;  PMID:22729249; http://dx.doi.org/10.1038/ni.2360 305.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2013; PMID:23794066;  http://dx.doi.org/10.1182/blood-2013-04-495424 307.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2013; 121:5034-44;  PMID:23482932; http://dx.doi.org/10.1182/blood- 2012-12-473413 308.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2012; 37:60-73; PMID:22795876; http://dx.doi.org/10.1016/j.immuni.2012.04.012 309.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunity 2012; 37:905-16;  PMID:23159228; http://dx.doi.org/10.1016/j.immu- ni.2012.07.019 311.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2012; 119:6052-62;  PMID:22442345; http://dx.doi.org/10.1182/blood-2012-01-406967 312.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23037; PMID:23524451; http://dx.doi.org/10.4161/ onci.23037 313.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23837;  PMID:23734330; http://dx.doi.org/10.4161/ onci.23837 314.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2013; 2:e23140; PMID:23802067; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2012; 120:4982-91;  PMID:23091295; http://dx.doi.org/10.1182/blood- 2012-02-413229 316.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood  2012; 120:3001-6; PMID:22936665; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res  2012; 72:6130-41; PMID:23026134; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer  Res 2012; 72:5240-9; PMID:22850422; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res 2012; 72:5188-97; PMID:22836755;  http://dx.doi.org/10.1158/0008-5472.CAN-11-3468 320.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Endocrine 2012; Forthcoming; PMID:23264145;  http://dx.doi.org/10.1007/s12020-012-9853-2 321.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e22983; PMID:23526329;  http://dx.doi.org/10.4161/onci.22983 322.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Proc Natl Acad Sci U S A  2012; 109:10492-7; PMID:22689996; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Science  2013; 339:328-32; PMID:23329049; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Blood 2013; Forthcoming; PMID:23632887; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2012;  209:653-60; PMID:22430490; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e23083;  PMID:23687620; http://dx.doi.org/10.4161/onci.23083 327.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Med 2013; 19:65-73; PMID:23242473;  http://dx.doi.org/10.1038/nm.3042 328.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2013; 2:e23472; PMID:23802087; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Cancer Res 2013; 19:1858-72;  PMID:23444227; http://dx.doi.org/10.1158/1078-0432.CCR-12-2426 331.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Res  2013; 73:1764-76; PMID:23328583; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2013; 2:e23185; PMID:23802069; http://dx.doi.org/10.4161/onci.23185 334.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:642-8; PMID:22934256;  http://dx.doi.org/10.4161/onci.20298 335.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:726- 34; PMID:22934264; http://dx.doi.org/10.4161/ onci.20171 336.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
"Oncoimmunology 2013; 2:e24212; PMID:23762802;  http://dx.doi.org/10.4161/onci.24212 337. van den Loosdrecht AA, Santegoets SJ, van Wetering S, Kaugh Singh S, Koppes M, Hall A, et al.",OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2013; 2:e22730;  PMID:23524978; http://dx.doi.org/10.4161/onci.22730 340.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Drug Discov 2006; 5:717-8;  PMID:17001803; http://dx.doi.org/10.1038/nrd2135 341.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
N Engl J Med 2010; 362:2260-70; PMID:20525995; http://dx.doi.org/10.1056/NEJMoa1002315 342.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Infect Dis 1975; 132:434-9; PMID:810520;  http://dx.doi.org/10.1093/infdis/132.4.434 344.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:407- 8; PMID:22754758; http://dx.doi.org/10.4161/ onci.20074 345.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Rev Cancer  2009; 9:351-60; PMID:19377507; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Clin Cancer Res  2009; 15:6267-76; PMID:19789309; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
PLoS One 2010; 5:e12711; PMID:20856802; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:1223-5; PMID:23243584; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology  2012; 1:1167-8; PMID:23170267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Immunol Rev 2005; 208:169-80;  PMID:16313348; http://dx.doi.org/10.1111/j.0105- 2896.2005.00339.x 352.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Ann N Y Acad Sci 2009; 1182:28-38;  PMID:20074272; http://dx.doi.org/10.1111/j.1749- 6632.2009.05075.x 353.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Prostate 1999; 39:291- 7; PMID:10344219; http://dx.doi.org/10.1002/ (SICI)1097-0045(19990601)39:4<291::AID- PROS10>3.0.CO;2-9354.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Immunol 2011; 187:6130-42; PMID:22048768; http://dx.doi.org/10.4049/jimmunol.1102209 355.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer Immunol Immunother 2013; 62:383-91;  PMID:22926062; http://dx.doi.org/10.1007/s00262- 012-1343-0 357.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:1661-3; PMID:23264929;  http://dx.doi.org/10.4161/onci.22033 358.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Oncoimmunology 2012; 1:227-8; PMID:22720251;  http://dx.doi.org/10.4161/onci.1.2.18169 359.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Commun 2013;  4:1560; PMID:23463003; http://dx.doi.org/10.1038/ ncomms2566 360.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Lancet Oncol 2013; 14:346-53; PMID:23499546; http://dx.doi.org/10.1016/S1470- 2045(13)70067-6 361.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Nat Immunol 2002; 3:196-200;  PMID:11812998; http://dx.doi.org/10.1038/ni758 362.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Clin Oncol  2006; 24:3089-94; PMID:16809734; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Cancer 2009; 115:3670- 9; PMID:19536890; http://dx.doi.org/10.1002/ cncr.24429 364.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
"Cell Death Differ  2013; Forthcoming; PMID:23811849; http://dx.doi.org/10.1038/cdd.2013.72 365. de Vries IJ, Lesterhuis WJ, Scharenborg NM, Engelen  LP , Ruiter DJ, Gerritsen MJ, et al.",OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Clin Oncol 2005; 23:5779- 87; PMID:16110035; http://dx.doi.org/10.1200/ JCO.2005.06.478 367.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
J Exp Med 2004; 199:1503- 11; PMID:15173207; http://dx.doi.org/10.1084/jem.20032118 368.,Non-OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
Proc Natl Acad Sci U S A  2010; 107:11895-9; PMID:20547850; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/40/onci-2-e25771.PMC3841205.pdf
"Stem Cell Reports Article A Cdx4-Sall4 Regulatory Module Controls the T ransition from Mesoderm Formation to Embryonic Hematopoiesis Elizabeth J. Paik,1Shaun Mahony,2Richard M. White,3Emily N. Price,1Anthony DiBiase,1 Bilguujin Dorjsuren,1Christian Mosimann,4Alan J. Davidson,5David Gifford,6and Leonard I. Zon1,* 1Stem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School and Howard Hughes Medical Institute, Boston, MA 02115, USA 2Department of Biochemistry and Molecular Biology, Center for Eukaryotic Gene Regulation, Pennsylvania State University, University Park, PA 16802, USA 3Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA 4Institute of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland 5Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland, Auckland 1142, New Zealand 6Computer Science and Artiﬁcial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA *Correspondence: zon@enders.tch.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2013.10.001 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e8/b6/main.PMC3841246.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, and two tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/e8/b6/main.PMC3841246.pdf
"Stem Cell Reports Report BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Ampliﬁcation Commonly Found in Human Embryonic Stem Cell Cultures Stuart Avery,1,10,*Adam J. Hirst,1,2Duncan Baker,3Chin Yan Lim,1Sharmini Alagaratnam,4Rolf I. Skotheim,4 Ragnhild A. Lothe,4Martin F. Pera,5,6,7Alan Colman,1Paul Robson,8Peter W. Andrews,2 and Barbara B. Knowles1,9 1Institute of Medical Biology, A-STAR, Immunos, Singapore 138648 2Centre for Stem Cell Biology, Department of Biomedical Science, The University of Shefﬁeld, Shefﬁeld S10 2TN, UK 3Shefﬁeld Diagnostic Genetic Services, Shefﬁeld Children’s NHS Trust, Shefﬁeld S10 2TH, UK 4Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital and Cancer Stem Cell Innovation Center, Oslo University, N-0310 Oslo, Norway 5Stem Cells Australia, University of Melbourne, Melbourne, Victoria 3010, Australia 6Florey Neuroscience and Mental Health Institute, University of Melbourne, Melbourne, Victoria 3010, Australia 7Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3052, Australia 8Genome Institute of Singapore, A-STAR, Singapore 138672 9Present address: The Jackson Laboratory, Bar Harbor, ME 04609, USA 10Present address: Fishawack Communications GmbH, Elisabethenanlage 11, 4051 Basel, Switzerland *Correspondence: stuart.avery@ﬁshawack.com http://dx.doi.org/10.1016/j.stemcr.2013.10.005 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/6b/6a/main.PMC3841249.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and four tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/6b/6a/main.PMC3841249.pdf
"Stem Cell Reports Report Functional Differences in Engineered Myocardium from Embryonic Stem Cell-Derived versus Neonatal Cardiomyocytes Adam W. Feinberg,1,3,4,6Crystal M. Ripplinger,1,3,4,6Peter van der Meer,2,5,6Sean P. Sheehy,1,3,4 Ibrahim Domian,2,3Kenneth R. Chien,2,3and Kevin Kit Parker1,2,3,4,* 1Disease Biophysics Group, School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA 2Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA 02114, USA 3Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA 4Wyss Institute of Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA 5Department of Cardiology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands 6These authors contributed equally to this work *Correspondence: kkparker@seas.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2013.10.004 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c7/2e/main.PMC3841251.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, two ﬁgures, and two movies and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/c7/2e/main.PMC3841251.pdf
"Franklin2 1Department of Clinical Neurosciences, Cambridge University, Cambridge CB2 0PY, UK 2Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, Cambridge University, Cambridge CB3 0ES, UK 3Centre for Neuroregeneration, Edinburgh University, Edinburgh EH16 4SB, UK *Correspondence: srls2@cam.ac.uk http://dx.doi.org/10.1016/j.stemcr.2013.09.006 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/58/49/main.PMC3841262.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and two tables,and can be found with this article online at http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/58/49/main.PMC3841262.pdf
"Luke Wiseman,4Benjamin Wolozin,2Lawreen H. Connors,3John L. Berk,3 David C. Seldin,1,3Gustavo Mostoslavsky,5Darrell N. Kotton,5and George J. Murphy1,5,* 1Sections of Hematology-Oncology and Computational Biomedicine, Departments of Medicine, Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118, USA 2Departments of Pharmacology and Neurology, Boston University School of Medicine, Boston, MA 02118, USA 3The Amyloidosis Center, Boston University School of Medicine, Boston, MA 02118, USA 4Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA 5Center for Regenerative Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA *Correspondence: gjmurphy@bu.edu http://dx.doi.org/10.1016/j.stemcr.2013.10.003 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/1f/ea/main.PMC3841264.pdf
"The three control iPSC lines used in this study were obtained from the Boston University and BostonMedical Center’s Center for Regenerative Medicine (CReM)comprehensive iPSC bank ( http://www.bumc.bu.edu/stemcells/ crem-ips-cell-bank/ ) and were matched with the disease-speciﬁc lines for age, gender, and ethnicity.",OADS,/arxiv_data1/oa_pdf/1f/ea/main.PMC3841264.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, one table, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/1f/ea/main.PMC3841264.pdf
http://amyloidosismutations.com/attr.html .,Non-OADS,/arxiv_data1/oa_pdf/1f/ea/main.PMC3841264.pdf
"Stem Cell Reports Article The CCR4 Deadenylase Acts with Nanos and Pumilio in the Fine-T uning of Mei-P26 Expression to Promote Germline Stem Cell Self-Renewal Willy Joly,1Aymeric Chartier,1Patricia Rojas-Rios,1Isabelle Busseau,1and Martine Simonelig1,* 1mRNA Regulation and Development, Institute of Human Genetics, CNRS UPR1142, 141 Rue de la Cardonille, 34396 Montpellier Cedex 5, France *Correspondence: martine.simonelig@igh.cnrs.fr http://dx.doi.org/10.1016/j.stemcr.2013.09.007 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/4e/7a/main.PMC3841267.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and one table and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2013.",OADS,/arxiv_data1/oa_pdf/4e/7a/main.PMC3841267.pdf
"Key Words :  Cephalometric measurement · Basilar invagination · Odontoid process · Opisthion · C2 end plate · C1 arch.Clinical Article • Received : January 21, 2013  • Revised : June 26, 2013  • Accepted : September 30, 2013 • Address for reprints : Jae Taek Hong, M.D., Ph.D.  Department of Neurosurgery, St. Vincent’s Hospital, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea  Tel : +82-31-249-7196,  Fax : +82-31-249-5208,  E-mail : jatagi15@paran.com  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 275-279, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.275 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e2/dc/jkns-54-275.PMC3841268.pdf
"Department of Preventive Medicine, College of Medicine, Gwandong University, 24 Beomil-ro 579beon-gil, Gangneung 210-701, Korea  Tel : +82-33-610-3258,  Fax : +82-33-641-9706,  E-mail : wspark@kd.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 280-288, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.280 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/77/a8/jkns-54-280.PMC3841269.pdf
"Key Words :  Cerebral aneurysms · C-reactive protein · Subarachnoid hemorrhage · Vasospasm.Clinical Article • Received : July 3, 2013  • Revised : September 17, 2013  • Accepted : September 30, 2013 • Address for reprints : Yong-Sook Park, M.D., Ph.D.  Department of Neurosurgery, Medical Device Clinical Trials Center, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 156-755, Korea  Tel : +82-2-6299-1610,  Fax : +82-2-821-8409,  E-mail : cuttage@cau.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 289-295, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.289 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/c7/7d/jkns-54-289.PMC3841270.pdf
"D.  Department of Neurosurgery, Sanggye Paik Hospital, Inje University College of Medicine, 1342 Dongil-ro, Nowon-gu, Seoul 139-707, Korea  Tel : +82-2-950-1035,  Fax : +82-2-950-1040,  E-mail : zunzae@paik.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 296-301, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.296 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/c7/e2/jkns-54-296.PMC3841271.pdf
"Department of Neurosurgery, Eulji University Hospital, College of Medicine, Eulji University, 95 Dunsanseo-ro, Seo-gu, Daejeon 302-799, Korea  Tel : +82-42-611-3442,  Fax : +82-42-611-3444,  E-mail : neurocsy@eulji.ac.kr  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 302-308, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.302 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/92/37/jkns-54-302.PMC3841272.pdf
"Department of Neurosurgery, College of Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel : +82-2-2258-2820,  Fax : +82-2-594-4248,  E-mail : medi0204@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 309-316, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.309 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e4/77/jkns-54-309.PMC3841273.pdf
"Key Words :  Endoscopy · Revision surgery · Pituitary adenoma.Clinical Article • Received : August 2, 2013  • Revised : October 12, 2013  • Accepted : October 16, 2013 • Address for reprints : Young Seob Chung, M.D., Ph.D.  Department of Neurosurgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 156-707, Korea  Tel : +82-2-870-2301,  Fax : +82-2-870-3863,  E-mail : yschung@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 317-322, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.317 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/3b/da/jkns-54-317.PMC3841274.pdf
"Department of Neurosurgery, Cheongju St. Mary’s Hospital, 173-19 Juseong-ro, Sangdang-gu, Cheongju 360-568, Korea   Tel : +82-43-219-8467,  Fax : +82-43-211-7925,  E-mail : k810a@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 323-328, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.323 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/83/d2/jkns-54-323.PMC3841275.pdf
"Key Words :  Breast cancer · Metastases · Gamma knife radiosurgery · Prognosis.Clinical Article • Received : March 21, 2013  • Revised : September 9, 2013  • Accepted : September 30, 2013 • Address for reprints : Do Hoon Kwon, M.D., Ph.D.  Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea  Tel : +82-2-3010-3550,  Fax : +82-2-476-6738,  E-mail : dhkwon@amc.seoul.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 329-335, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.329 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/69/ef/jkns-54-329.PMC3841276.pdf
"Key Words :  Cerebrospinal fluid leak · Craniotomy · Scalp · Sutures.Clinical Article • Received : July 1, 2013  • Revised : October 8, 2013  • Accepted : October 10, 2013 • Address for reprints : Chang Taek Moon, M.D., Ph.D.  Department of Neurosurgery, Konkuk University Medical Center, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea  Tel : +82-2-2030-7623,  Fax : +82-2-2030-7359,  E-mail : ctmoon@kuh.ac.kr  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 336-339, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.336 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/ee/c5/jkns-54-336.PMC3841277.pdf
"Key Words :  Intracerebral schwannoma · Supratentorial · Precentral gyrus · Treatment · Seizure.Case Report • Received : March 19, 2013  • Revised : July 14, 2013  • Accepted : September 30, 2013 • Address for reprints : Chun Kee Chung, M.D., Ph.D.  Department of Neurosurgery, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel : +82-2-2072-2350,  Fax : +82-2-744-8459,  E-mail : chungc@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 340-343, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.340 Copyright © 2013 The Korean Neurosurgical Society  Print  ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e8/87/jkns-54-340.PMC3841278.pdf
"Key Words :  Lumbar artery · Spinal fusion · Posterolateral fusion.Case Report • Received : July 4, 2013  • Revised : October 8, 2013  • Accepted : October 10, 2013 • Address for reprints : Jong Pil Eun, M.D., Ph.D.  Department of Neurosurgery, Research Institute of Clinical Medicine, Chonbuk National University Medical School/Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea  Tel : +82-63-250-1870,  Fax : +82-63-277-3273,  E-mail : spineeun@jbnu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 344-346, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.344 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/83/b8/jkns-54-344.PMC3841279.pdf
"Key Words :  Vertebral artery anomaly · Cervical myelopathy · Microvascular decompression.Case Report • Received : May 2, 2013  • Revised : July 3, 2013  • Accepted : October 10, 2013 • Address for reprints : Tae-Ahn Jahng, M.D., Ph.D.  Department of Neurosurgery, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Korea  Tel : +82-31-787-7171,  Fax : +82-2-744-8459,  E-mail : taj@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 347-349, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.347 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/d6/c7/jkns-54-347.PMC3841280.pdf
"Department of Neurosurgery, Seoul St. Mary’s Hospital, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel : +82-2-2258-6353,  Fax : +82-2-2258-7925,  E-mail : neurotique79@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 350-354, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.350 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/fa/2d/jkns-54-350.PMC3841281.pdf
"Key Words :  Arachnoid cyst · Cerebrospinal fluid · Thoracolumbar spine.Case Report • Received : February 1, 2013  • Revised : May 28, 2013  • Accepted : September 30, 2013 • Address for reprints : Sung Woo Roh, M.D., Ph.D.  Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea  Tel : +82-2-3010-3550,  Fax : +82-2-476-6738,  E-mail : swroh@amc.seoul.kr  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 355-358, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.355 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/49/29/jkns-54-355.PMC3841282.pdf
"Key Words :  Apnea · Central hypoventilation · Diaphragm pacing · Spinal cord stimulator · Spinal cord injury.Case Report • Received : December 15, 2012  • Revised : August 5, 2013  • Accepted : September 30, 2013 • Address for reprints : Byung-chul Son M.D., Ph.D.  Department of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic Neuroscience Institute, College of Medicine, The Catholic University of Korea College of Medicine,   222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel : +82-2-2258-6122,  Fax : +82-2-594-4248,  E-mail : sbc@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 359-362, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.359 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/eb/20/jkns-54-359.PMC3841283.pdf
"Department of Neurosurgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea  Tel : +82-31- 249-8171,  Fax : +82-31-245-5208,  E-mail : jatagi15@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 363-365, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.363 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/4e/5d/jkns-54-363.PMC3841284.pdf
"Key Words :  Lumbar disc herniation · Microdiscectomy · Facet joint · Laminotomy · Foraminotomy.Technical Note • Received :  April 16, 2013  • Revised : July 14, 2013  • Accepted : September 30, 2013 • Address for reprints : Kyoung-Tae Kim, M.D., Ph.D.  Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea  Tel : +82-53-200-5657,  Fax : +82-53-423-0504,  E-mail : nskimkt7@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 54  : 366-369, 2013http://dx.doi.org/10.3340/jkns.2013.54.4.366 Copyright © 2013 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Table 1.",Non-OADS,/arxiv_data1/oa_pdf/2b/ca/jkns-54-366.PMC3841285.pdf
"As such, the investigators within the ADNI contributed to the design and implementation ofADNI and/or provided data but did not participate in the analysis or writing of this report.Complete listing of ADNI investigators is available at http://www.loni.ucla.edu/ADNI/ Collaboration/ADNI_Manuscript_Citations.pdf ⁎Corresponding author at: Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig Maximilian University, Max-Lebsche-Platz 30, 81377 Munich, Germany.",Non-OADS,/arxiv_data1/oa_pdf/1b/0a/main.PMC3841292.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.018 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/1b/0a/main.PMC3841292.pdf
"Subjects All subjects were recruited within the multicenter Alzheimer's Disease Neuroimaging Initiative (ADNI, http://www.adni-info.org/ ) and all data and scans were obtained from ADNI's publicly available databank ( http://adni.loni.ucla.edu/ ).",OADS,/arxiv_data1/oa_pdf/1b/0a/main.PMC3841292.pdf
"In ADNI, the general inclusion criteria were an age between 55 and 90 years, a modi ﬁed Hachinski score≤4, education of at least 6 grade level, and stable treatment of at least 4 weeks in case of treatment with permitted medication (for full list see http://www.adni-info.org , Procedures Manual).",Non-OADS,/arxiv_data1/oa_pdf/1b/0a/main.PMC3841292.pdf
"MRI and FDG-PET acquisition All MRI data were acquired on 1.5 T MRI scanners using volumetric T1-weighted sequences to map brain structures, optimized for the different scanners as indicated at http://www.loni.ucla.edu/ADNI/ Research/Cores/index (Jack et al., 2008 ).",OADS,/arxiv_data1/oa_pdf/1b/0a/main.PMC3841292.pdf
"For intensity normalization of the FDG-PET scans to the pons, a mask was manually drawn onto the GM template in MNI space, using a 3-D display in the program MIPAV ( http://mipav.cit.nih.gov/ ).",OADS,/arxiv_data1/oa_pdf/1b/0a/main.PMC3841292.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/79/ijn-8-4543.PMC3841294.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4543–4552International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4543RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S51893Immunomagnetic nanoparticle-based assays   for detection of biomarkers Hoyoung Park1,2 Mintai P Hwang1 Kwan Hyi Lee1,2 1Center for Biomaterials, Biomedical  Research Institute, Korea Institute of  Science and T echnology, 2Department  of Biomedical engineering, University  of Science and T echnology, Seoul,   Republic of Korea Correspondence: Kwan Hyi Lee   Korea Institute of Science and  Technology, Hwarangno   14-gil 5 Seongbuk-gu Seoul,   136-791 Republic of Korea   Tel +82 2 958 6804   Fax +82 2 958 5308   email kwanhyi@kist.re.k rAbstract:  The emergence of biomarkers as key players in the paradigm shift towards  preventative  medicine underscores the need for their detection and quantification.",Non-OADS,/arxiv_data1/oa_pdf/08/79/ijn-8-4543.PMC3841294.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/08/79/ijn-8-4543.PMC3841294.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/79/ijn-8-4543.PMC3841294.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/af/ijn-8-4495.PMC3841295.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4495–4506International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4495OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5223 9allergenicity and toxicology of inhaled silver  nanoparticles in allergen-provocation mice  models hsiao-chi chuang1,2,* Ta-chih hsiao3,* cheng-Kuan Wu4 hui-hsien chang5 chii-hong lee6 chih-cheng chang1,2 Tsun-Jen cheng4,7 On behalf of the Taiwan  cardioPulmonary research  group (T -cP r) 1school of respiratory Therapy,   college of Medicine, 2Division of  Pulmonary Medicine, Department  of Internal Medicine, shuang ho  hospital, Taipei Medical University,   Taipei, 3graduate Institute of  environmental engineering, National  central University, Taoyuan, 4Institute  of Occupational Medicine and  Industrial hygiene, college of Public  health, National Taiwan University,   Taipei, 5Institute of environmental  health, college of Public health,   National Taiwan University,   6Department of Pathology, shuang ho  hospital, Taipei Medical University,   Taipei, 7Department of Public health,   college of Public health, National  Taiwan University, Taipei, Taiwan *These authors contributed equally  to this work correspondence: Tsun-Jen cheng   Institute of Occupational Medicine and  Industrial hygiene and Department of  Public health, college of Public health,  National Taiwan University, No.",Non-OADS,/arxiv_data1/oa_pdf/56/af/ijn-8-4495.PMC3841295.pdf
Available from: http://www.ginasthma.org/local/uploads/files/ GINA_Report_March13.pdf.,OADS,/arxiv_data1/oa_pdf/56/af/ijn-8-4495.PMC3841295.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/56/af/ijn-8-4495.PMC3841295.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/af/ijn-8-4495.PMC3841295.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/97/ijn-8-4533.PMC3841296.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4533–4542International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4533OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5441 8“One-stop shop” spectral imaging for rapid   on-site diagnosis of lung cancer: a future   concept in nano-oncology Kaid Darwiche1 Paul Zarogoulidis1,2 leslie Krauss3 Filiz Oezkan1 robert Fred henry  Walter1,4 robert Werner4 Dirk Theegarten4 leonidas sakkas5 antonios sakkas5 Wolfgang hohenforst- scmidt6 Konstantinos Zarogoulidis1 lutz Freitag1 1Department of Interventional  Pneumology, ruhrlandklinik, West  german lung center, University  hospital, University Duisburg- essen, essen, germany; 2Pulmonary  Department, Oncology Unit,    g Papanikolaou general hospital,   aristotle University of Thessaloniki,   Thessaloniki, greece; 3cytoViva,   Inc, auburn, al, Usa; 4Institute of  Pathology and Neuropathology,   University hospital of essen,   University of Duisburg-essen, essen,   germany; 5Pathology Department,   g Papanikolaou general hospital,   Thessaloniki, greece; 6II Medical  Department, coburg regional clinic,   University of Wuerzburg, coburg,   germany correspondence: Paul Zarogoulidis   Pulmonary Department, g Papanikolaou  general hospital, aristotle University   of Thessaloniki,Thessaloniki, greece   Fax +30 21 3099 2433   email pzarog@hotmail.co mBackground:  There are currently many techniques and devices available for the diagnosis of  lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/86/97/ijn-8-4533.PMC3841296.pdf
bizjournals.com/phoenix/news/2011/10/20/visiongate-lands- 2-million-in.htm l) and KZ ( http://www.visiongate3d.com/ about/ collaborator s) who are collaborators of Visiongate Cor - poration in the project for early detection of lung cancer.,Non-OADS,/arxiv_data1/oa_pdf/86/97/ijn-8-4533.PMC3841296.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/86/97/ijn-8-4533.PMC3841296.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/97/ijn-8-4533.PMC3841296.pdf
"www.landesbioscience.com Cell Cycle 2331Cell Cycle 12:15, 2331–2332; August 1, 2013; © 2013 Landes Bioscience EditoriALs: CELL  CyCLE  FEA turEs EditoriALs: CELL  CyCLE  FEA turEs *Correspondence to: Saadi Khochbin; Email: khochbin@ujf-grenoble.fr   Submitted: 06/24/2013; Accepted: 06/25/2013   http://dx.doi.org/10.4161/cc.25545   Comment on: Rousseaux S, et al.",Non-OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
Sci Transl Med 2013; 5:86ra66; PMID:23698379; http://dx.doi.org/10.1126/scitranslmed.3005723The acquisition of at least 8 new biologi - cal capabilities by cells characterizes the  transformation from normal to malignant states.,OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
Cell 2011; 144:646-74;  PMID:21376230 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
Cell 2013; 153:38-55; PMID:23540689 ;  http://dx.doi.org/10.1016/j.cell.2013.03.008 3.,OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
Biochim Biophys Acta 2011; 1809:221- 5; PMID :21530697 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
Sci Transl Med 2013; 5:86ra66;  PMID:23698379 ; http://dx.doi.org/10.1126/ scitranslmed.3005723 5.,Non-OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
FEBS J 2010; 277:599- 604; PMID :20015078 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
EMBO J 2012; 31:3809-20;  PMID:22922464 ; http://dx.doi.org/10.1038/ emboj.2012.233 7.,Non-OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
Science 2010; 330:1824-7; PMID:21205669 ; http://dx.doi.org/10.1126/ science.1195481 8.,OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
"EMBO Mol Med 2013; PMID:23828858 ; http://dx.doi.org/10.1002/ emmm.201202034Figure 1.  the observation of a large-scale activation of normally silent tissue-specific genes and  the demonstration of their critical contribution to the characteristics of malignant cells is at the  basis of a working hypothesis, which postulates that the “out of context” activity of various nor - mally silent genes, is essential to support the acquired capabilities of cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/f3/a9/cc-12-2331.PMC3841303.pdf
"www.landesbioscience.com Cell Cycle 2333Cell Cycle 12:15, 2333–2334; August 1, 2013; © 2013 Landes Bioscience EditoriALs: CELL  CyCLE  FEA turEs EditoriALs: CELL  CyCLE  FEA turEs *Correspondence to: Clare C Davies; Email: c.c.davies@bham.ac.uk  Submitted: 05/31/2013; Accepted: 06/03/2013   http://dx.doi.org/10.4161/cc.25702   Comment on: Davies CC, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
"EMBO J 2013; 32:1556-67; PMID:23624934; http://dx.doi.org/10.1038/emboj.2013.98The functional diversity of the proteome  is enhanced by dynamic post-translational modifications (PTMs), and it is now clear that the cell exploits a wide range of these to enable the coordination of cel - lular responses.",OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
Shaulian E. Cell Signal 2010; 22:894-9;  PMID:20060892; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
Nat Cell Biol 2010; 12:963- 72; PMID:20852630; http://dx.doi.org/10.1038/ ncb2098 3.,OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
EMBO J 2013; 32:1556-67;  PMID:23624934; http://dx.doi.org/10.1038/ emboj.2013.98 4.,Non-OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
Genes Dev 2005; 19:1885-93; PMID:16103216; http://dx.doi.org/10.1101/ gad.1333905 5.,Non-OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
Mol Cell 2008; 32:221-31; PMID:18951090; http://dx.doi.org/10.1016/j.molcel.2008.09.013 6.,OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
Mol Cell 2008; 31:212-21; PMID:18657504; http://dx.doi.org/10.1016/j.molcel.2008.05.025 7.,OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
Nat Rev Cancer 2013; 13:37-50; PMID:23235912; http://dx.doi.org/10.1038/nrc3409 8.,Non-OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
Br J Cancer 2008; 99:2094- 9; PMID:19078953; http://dx.doi.org/10.1038/ sj.bjc.6604807 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/0b/8f/cc-12-2333.PMC3841304.pdf
"www.landesbioscience.com Cell Cycle 2335Cell Cycle 12:15, 2335–2336; August 1, 2013; © 2013 Landes Bioscience EditoriALs: CELL  CyCLE  FEA turEs EditoriALs: CELL  CyCLE  FEA turEs *Correspondence to: Richard I. Morimoto; Email: r-morimoto@northwestern.edu   Submitted: 05/30/2013; Accepted: 06/03/2013  http://dx.doi.org/10.4161/cc.25703   Comment on: Kirstein-Miles J, et al.",Non-OADS,/arxiv_data1/oa_pdf/69/cb/cc-12-2335.PMC3841305.pdf
"EMBO J 2013; 32:1451-68; PMID:23604074; http://dx.doi.org/10.1038/emboj.2013.87The production of newly synthesized pro - teins is a key process of protein homeo - stasis that initiates the biosynthetic flux  of proteins and determines the composi - tion, stability, and functionality of the proteome.",OADS,/arxiv_data1/oa_pdf/69/cb/cc-12-2335.PMC3841305.pdf
EMBO J 2013; 32:1451- 68; http://dx.doi.org/10.1038/emboj.2013.87;  PMID:23604074 2.,OADS,/arxiv_data1/oa_pdf/69/cb/cc-12-2335.PMC3841305.pdf
Science 2011; 334:1081-6;  http://dx.doi.org/10.1126/science.1209038;  PMID:22116877 3.,Non-OADS,/arxiv_data1/oa_pdf/69/cb/cc-12-2335.PMC3841305.pdf
Lindquist S. J Mol Biol 1980; 137:151- 8; PMID:6768893; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/cb/cc-12-2335.PMC3841305.pdf
Mol Cell 2013; 49:453-63; PMID:23290916; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/cb/cc-12-2335.PMC3841305.pdf
Mol Cell 2013; 49:439-52; PMID:23290915; http://dx.doi.org/10.1016/j.molcel.2012.11.028 6.,OADS,/arxiv_data1/oa_pdf/69/cb/cc-12-2335.PMC3841305.pdf
Proc Natl Acad Sci U S A 2009; 106:14914-9; PMID:19706382; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/cb/cc-12-2335.PMC3841305.pdf
"www.landesbioscience.com Cell Cycle 2337Cell Cycle 12:15, 2337–2338; August 1, 2013; © 2013 Landes Bioscience EditoriALs: CELL  CyCLE  FEA turEs EditoriALs: CELL  CyCLE  FEA turEs *Correspondence to: Craig L Peterson; Email: craig.peterson@umassmed.edu   Submitted: 06/03/2013; Accepted: 06/03/2013   http://dx.doi.org/10.4161/cc.25704   Comment on: Watanabe S, et al.",Non-OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
"Science 2013; 340:195-9; PMID:23580526; http://dx.doi.org/10.1126/science.1229758Organization of eukaryotic genomes into  compact, nucleoprotein fibers is key for stuffing a lot of DNA into a tiny nucleus, but these structures also create a require - ment for machineries that promote DNA accessibility for nuclear processes such as gene transcription, DNA repair, recom - bination, and replication.",Non-OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
Annu Rev Biochem 2009; 78:273- 304; PMID:19355820; http://dx.doi.org/10.1146/ annurev.biochem.77.062706.153223 2.,Non-OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
EMBO Rep 2002; 3:319-22; PMID:11943761; http://dx.doi.org/10.1093/ embo-reports/kvf075 3.,Non-OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
Science 2006; 311:844- 7; PMID:16469925; http://dx.doi.org/10.1126/ science.1124000 4.,OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
Science 2013; 340:195-9; PMID:23580526; http://dx.doi.org/10.1126/science.1229758 5.,OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
Cold Spring Harb Symp Quant Biol 2010; 75:35-42; PMID:21502417; http://dx.doi.org/10.1101/sqb.2010.75.063 6.,OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
Cell 2011; 144:200-13; PMID:21241891; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
Genes Dev 2012; 26:2590- 603; PMID:23207916; http://dx.doi.org/10.1101/ gad.199976.112 8.,OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
Curr Biol 2007; 17:R324-6; PMID:17470345; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/7b/cc-12-2337.PMC3841306.pdf
"www.landesbioscience.com Cell Cycle 2339Cell Cycle 12:15, 2339–2340; August 1, 2013; © 2013 Landes Bioscience EditoriALs: CELL  CyCLE  FEA turEs EditoriALs: CELL  CyCLE  FEA turEs *Correspondence to: Bilada Bilican; Email: bilada.bilican@ed.ac.uk   Submitted: 05/12/2013; Accepted: 06/04/2013  http://dx.doi.org/10.4161/cc.25705   Comment on: Serio A, et al.",Non-OADS,/arxiv_data1/oa_pdf/6a/a3/cc-12-2339.PMC3841307.pdf
Nat Neurosci 2007; 10:608-14;  PMID:17435754; http://dx.doi.org/10.1038/nn1885 2.,Non-OADS,/arxiv_data1/oa_pdf/6a/a3/cc-12-2339.PMC3841307.pdf
Nat Neurosci 2007; 10:615-22; PMID:17435755; http://dx.doi.org/10.1038/nn1876 3.,Non-OADS,/arxiv_data1/oa_pdf/6a/a3/cc-12-2339.PMC3841307.pdf
Sci Transl Med 2012; 4:145ra104; PMID:22855461; http://dx.doi.org/10.1126/ scitranslmed.3004052 5.,Non-OADS,/arxiv_data1/oa_pdf/6a/a3/cc-12-2339.PMC3841307.pdf
Proc Natl Acad Sci U S A 2013; 110:4697-702; PMID:23401527; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/a3/cc-12-2339.PMC3841307.pdf
Proc Natl Acad Sci U S A 2013; 110:4069- 74; PMID:23431168; http://dx.doi.org/10.1073/ pnas.1218497110 7.,OADS,/arxiv_data1/oa_pdf/6a/a3/cc-12-2339.PMC3841307.pdf
Cell Death Differ 2012; 19:779-87; PMID:22095276; http://dx.doi.org/10.1038/ cdd.2011.154,Non-OADS,/arxiv_data1/oa_pdf/6a/a3/cc-12-2339.PMC3841307.pdf
"www.landesbioscience.com Cell Cycle 2341Cell Cycle 12:15, 2341–2342; August 1, 2013; © 2013 Landes Bioscience EditoriALs: CELL  CyCLE  FEA turEs EditoriALs: CELL  CyCLE  FEA turEs *Correspondence to: Hiroshi Wakao; Email: hwakao@med.hokudai.ac.jp   Submitted: 05/27/2013; Accepted: 06/04/2013   http://dx.doi.org/10.4161/cc.25706 Wakao H, et al.",Non-OADS,/arxiv_data1/oa_pdf/53/3b/cc-12-2341.PMC3841308.pdf
"Cell Stem Cell 2013; 12:546-58; PMID:23523177; http://dx.doi.org/10.1016/j.stem.2013.03.001Mucosal-associated invariant T (MAIT)  cells are a subset of the innate type T cells and are characterized for the expres - sion of an invariant T cell receptor (TCR) Vα7.2-Jα33, CD161 as a marker for natu - ral killer cells, and the interleukin (IL)-18 receptor chain α (IL-18R α) for T helper  (Th)17 cells.",OADS,/arxiv_data1/oa_pdf/53/3b/cc-12-2341.PMC3841308.pdf
Trends Immunol 2011; 32:212- 8; PMID:21459674; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/3b/cc-12-2341.PMC3841308.pdf
Brain 2011; 134:542-54;  PMID:21216829; http://dx.doi.org/10.1093/brain/ awq354 3.,Non-OADS,/arxiv_data1/oa_pdf/53/3b/cc-12-2341.PMC3841308.pdf
Blood 2012; 119:422-33;  PMID:22086415; http://dx.doi.org/10.1182/ blood-2011-05-353789 4.,Non-OADS,/arxiv_data1/oa_pdf/53/3b/cc-12-2341.PMC3841308.pdf
Cell Stem Cell 2013; 12:546-58; PMID:23523177; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/3b/cc-12-2341.PMC3841308.pdf
FASEB J 2008; 22:2223-31; PMID:18323403; http://dx.doi.org/10.1096/fj.07-104687 7.,Non-OADS,/arxiv_data1/oa_pdf/53/3b/cc-12-2341.PMC3841308.pdf
AIDS 2013; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/3b/cc-12-2341.PMC3841308.pdf
"www.landesbioscience.com Cell Cycle 2343Cell Cycle 12:15, 2343–2344; August 1, 2013; © 2013 Landes Bioscience EditoriALs: CELL  CyCLE  FEA turEs EditoriALs: CELL  CyCLE  FEA turEs *Correspondence to: Tamar Kleinberger; Email: tamark@tx.technion.ac.il   Submitted: 05/24/2013; Accepted: 06/04/2013   http://dx.doi.org/10.4161/cc.25707 Comment on: Pechkovsky A, et al.",Non-OADS,/arxiv_data1/oa_pdf/e4/f4/cc-12-2343.PMC3841309.pdf
Proc Natl Acad Sci U S A  1999; 96:10080-5;  PMID:10468565 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/f4/cc-12-2343.PMC3841309.pdf
J Cell Biol 2000; 150:1037-56; PMID:10973994 ; http://dx.doi.org/10.1083/ jcb.150.5.1037 3.,OADS,/arxiv_data1/oa_pdf/e4/f4/cc-12-2343.PMC3841309.pdf
J Virol 2001; 75:789-98;  PMID:11134292 ; http://dx.doi.org/10.1128/ JVI.75.2.789-798.2001 4.,Non-OADS,/arxiv_data1/oa_pdf/e4/f4/cc-12-2343.PMC3841309.pdf
Nucleic Acids Res 2011;  39:6414-27;  PMID:21546548 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/f4/cc-12-2343.PMC3841309.pdf
J Cell Biol 2001; 154:331-44;  PMID:11470822 ; http://dx.doi.org/10.1083/ jcb.200104104 6.,OADS,/arxiv_data1/oa_pdf/e4/f4/cc-12-2343.PMC3841309.pdf
J Biol Chem 2005; 280:41270-7; PMID:16227198 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e4/f4/cc-12-2343.PMC3841309.pdf
Proc Natl Acad Sci U S A 2013; 110:E1724-33;  PMID:23613593 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/f4/cc-12-2343.PMC3841309.pdf
J Biol Chem 2013; 288:13718-27;  PMID:23530045 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e4/f4/cc-12-2343.PMC3841309.pdf
"Cell Cycle 2013; 12:2113–9;   PMID:23759589; http://dx.doi.org/10.4161/cc.25163 Kshipra M Gharpure1 and Anil K Sood1,2,3,*; 1Department of Gynecologic Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA;  2Center for RNA Interference and Non-Coding RNAs; The University of Texas MD Anderson Cancer Center; Houston, TX USA; 3Department of Cancer Biology;  The University of Texas MD Anderson Cancer Center; Houston, TX USA; *Email: asood@mdanderson.org; http://dx.doi.org/10.4161/cc.25775 enhancer of zeste homolog 2 ( eZH2) has  been found to be overexpressed in ovarian  and other cancers and plays critical roles in  cell proliferation, angiogenesis, and inhibition  of apoptosis.1,2 Among its many functions, it  tri-methylates lysine residue at the 27 position of histone H3 associated with the target gene.",Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Front Oncol 2013; 3:47; PMiD:23494175;  http://dx.doi.org/10.3389/fonc.2013.00047 2.,Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Cancer Cell 2010; 18:185-97;  PMiD:20708159; http://dx.doi.org/10.1016/j.ccr.2010.06.016 3.,Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
s cience 2002; 298:1039-43;  PMiD:12351676; http://dx.doi.org/10.1126/sci- ence.1076997 4.,Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Proc natl Acad s ci U s A 2012; 109:21360- 5; PMiD:23236167; http://dx.doi.org/10.1073/ pnas.1210371110 5.,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
n ature 2012; 492:108-12;  PMiD:23051747; http://dx.doi.org/10.1038/ nature11606 6.,Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Cell Cycle 2013; 12:2113-9; PMiD:23759589; http://dx.doi.org/10.4161/ cc.25163 7.,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
nat Rev Mol Cell Biol 2007; 8:839-45; PMiD:17684528; http://dx.doi.org/10.1038/ nrm2236 8.,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Lab i nvest 2013; 93:528-42;  PMiD:23459371; http://dx.doi.org/10.1038/labin- vest.2013.41 CeLL  CyCLe news & views,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
"CA Cancer J Clin 2013; 63:11-30;  PMiD:23335087; http://dx.doi.org/10.3322/ caac.21166 2. n agrath s , et al.",OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
"n ature 2007; 450:1235-9;  PMiD:18097410; http://dx.doi.org/10.1038/nature06385 3. y ang J, et al.",OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Biophys J 2000; 78:2680-9;  PMiD:10777764; http://dx.doi.org/10.1016/s0006-3495(00)76812-3 4.,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Biomed Microdevices 2009; 11:883-92; PMiD:19387837; http://dx.doi.org/10.1007/s10544- 009-9305-9 5.,Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
"J Clin Oncol 2005; 23:1420-30; PMiD:15735118; http://dx.doi.org/10.1200/ JCO.2005.08.140 6. de Bono Js, et al.",OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Clin Cancer Res 2008; 14:6302-9; PMiD:18829513; http://dx.doi.org/10.1158/1078- 0432.CCR-08-0872 7.,Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
BMC Cancer 2013; 13:202; PMiD:23617715;  http://dx.doi.org/10.1186/1471-2407-13-202 8.,Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
"Cell Cycle 2013; 12:1-12; PMiD:23255116; http://dx.doi.org/10.4161/cc.25165Sizing up circulating tumor cells for personalized therapy Comment on: Gallant J-N, et al.",Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
"Cell Cycle 2013; 12:2132–43;   PMID:23759587; http://dx.doi.org/10.4161/cc.25165 Elizabeth M Matthew1 and Jean-Nicolas Gallant2,*; 1Penn State Hershey Cancer Institute; Hershey, PA USA; 2Vanderbilt University School of Medicine;  Nash  ville, TN USA; *Email: J-N.Gallant@vanderbilt.edu; http://dx.doi.org/10.4161/cc.25776",Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
"Cell Cycle 2013; 12:2423–34  PMID:23839038; http://dx.doi.org/10.4161/cc.25452 Anton A Komar; Center for Gene Regulation in Health and Disease; Department of Biological, Geological and Environmental Sciences; Cleveland State University;  Cleveland, OH USA; Email: a.komar@csuohio.edu; http://dx.doi.org/10.4161/cc.25661 A central dogma in biology states that the  flow of biological information is from D nA to  RnA to proteins.",OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
PLos Genet 2011; 7:e1001393;  PMiD:21695224; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Trends Biochem s ci 2005; 30:506- 14; PMiD:16054366; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
FeBs Lett 2008; 582:1977-86;  PMiD:18342629; http://dx.doi.org/10.1016/j.febs-let.2008.03.004 4.,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
"Biotechnol J 2011; 6:623-40;  PMiD:21538896; http://dx.doi.org/10.1002/ biot.201000327 5. s afina A, et al.",OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
s cience 2003; 301:1094-6;  PMiD:12934007; http://dx.doi.org/10.1126/sci-ence.1085712 7.,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
Cell Reports 2013; PMiD:23831030; http://dx.doi.org/10.1016/j.celrep.2013.06.013 8.,OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
s ci Transl Med 2011; 3:95ra74;  PMiD:21832239; http://dx.doi.org/10.1126/scitrans-lmed.3002530,Non-OADS,/arxiv_data1/oa_pdf/48/b5/cc-12-2345.PMC3841310.pdf
"Cell Cycle 2013; 12:2113–9;   PMID:23759589; http://dx.doi.org/10.4161/cc.25163 Kshipra M Gharpure1 and Anil K Sood1,2,3,*; 1Department of Gynecologic Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA;  2Center for RNA Interference and Non-Coding RNAs; The University of Texas MD Anderson Cancer Center; Houston, TX USA; 3Department of Cancer Biology;  The University of Texas MD Anderson Cancer Center; Houston, TX USA; *Email: asood@mdanderson.org; http://dx.doi.org/10.4161/cc.25775 enhancer of zeste homolog 2 ( eZH2) has  been found to be overexpressed in ovarian  and other cancers and plays critical roles in  cell proliferation, angiogenesis, and inhibition  of apoptosis.1,2 Among its many functions, it  tri-methylates lysine residue at the 27 position of histone H3 associated with the target gene.",Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Front Oncol 2013; 3:47; PMiD:23494175;  http://dx.doi.org/10.3389/fonc.2013.00047 2.,Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Cancer Cell 2010; 18:185-97;  PMiD:20708159; http://dx.doi.org/10.1016/j.ccr.2010.06.016 3.,Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
s cience 2002; 298:1039-43;  PMiD:12351676; http://dx.doi.org/10.1126/sci- ence.1076997 4.,Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Proc natl Acad s ci U s A 2012; 109:21360- 5; PMiD:23236167; http://dx.doi.org/10.1073/ pnas.1210371110 5.,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
n ature 2012; 492:108-12;  PMiD:23051747; http://dx.doi.org/10.1038/ nature11606 6.,Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Cell Cycle 2013; 12:2113-9; PMiD:23759589; http://dx.doi.org/10.4161/ cc.25163 7.,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
nat Rev Mol Cell Biol 2007; 8:839-45; PMiD:17684528; http://dx.doi.org/10.1038/ nrm2236 8.,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Lab i nvest 2013; 93:528-42;  PMiD:23459371; http://dx.doi.org/10.1038/labin- vest.2013.41 CeLL  CyCLe news & views,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
"CA Cancer J Clin 2013; 63:11-30;  PMiD:23335087; http://dx.doi.org/10.3322/ caac.21166 2. n agrath s , et al.",OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
"n ature 2007; 450:1235-9;  PMiD:18097410; http://dx.doi.org/10.1038/nature06385 3. y ang J, et al.",OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Biophys J 2000; 78:2680-9;  PMiD:10777764; http://dx.doi.org/10.1016/s0006-3495(00)76812-3 4.,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Biomed Microdevices 2009; 11:883-92; PMiD:19387837; http://dx.doi.org/10.1007/s10544- 009-9305-9 5.,Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
"J Clin Oncol 2005; 23:1420-30; PMiD:15735118; http://dx.doi.org/10.1200/ JCO.2005.08.140 6. de Bono Js, et al.",OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Clin Cancer Res 2008; 14:6302-9; PMiD:18829513; http://dx.doi.org/10.1158/1078- 0432.CCR-08-0872 7.,Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
BMC Cancer 2013; 13:202; PMiD:23617715;  http://dx.doi.org/10.1186/1471-2407-13-202 8.,Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
"Cell Cycle 2013; 12:1-12; PMiD:23255116; http://dx.doi.org/10.4161/cc.25165Sizing up circulating tumor cells for personalized therapy Comment on: Gallant J-N, et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
"Cell Cycle 2013; 12:2132–43;   PMID:23759587; http://dx.doi.org/10.4161/cc.25165 Elizabeth M Matthew1 and Jean-Nicolas Gallant2,*; 1Penn State Hershey Cancer Institute; Hershey, PA USA; 2Vanderbilt University School of Medicine;  Nash  ville, TN USA; *Email: J-N.Gallant@vanderbilt.edu; http://dx.doi.org/10.4161/cc.25776",Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
"Cell Cycle 2013; 12; In this issue  PMID:23839038; http://dx.doi.org/10.4161/cc.25452 Anton A Komar; Center for Gene Regulation in Health and Disease; Department of Biological, Geological and Environmental Sciences; Cleveland State University;  Cleveland, OH USA; Email: a.komar@csuohio.edu; http://dx.doi.org/10.4161/cc.25661 A central dogma in biology states that the  flow of biological information is from D nA to  RnA to proteins.",OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
PLos Genet 2011; 7:e1001393;  PMiD:21695224; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Trends Biochem s ci 2005; 30:506- 14; PMiD:16054366; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
FeBs Lett 2008; 582:1977-86;  PMiD:18342629; http://dx.doi.org/10.1016/j.febs-let.2008.03.004 4.,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
"Biotechnol J 2011; 6:623-40;  PMiD:21538896; http://dx.doi.org/10.1002/ biot.201000327 5. s afina A, et al.",OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
s cience 2003; 301:1094-6;  PMiD:12934007; http://dx.doi.org/10.1126/sci-ence.1085712 7.,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
Cell Reports 2013; PMiD:23831030; http://dx.doi.org/10.1016/j.celrep.2013.06.013 8.,OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
s ci Transl Med 2011; 3:95ra74;  PMiD:21832239; http://dx.doi.org/10.1126/scitrans-lmed.3002530,Non-OADS,/arxiv_data1/oa_pdf/6b/21/cc-12-2346.PMC3841311.pdf
"Cell Cycle 2013; 12:2113–9;   PMID:23759589; http://dx.doi.org/10.4161/cc.25163 Kshipra M Gharpure1 and Anil K Sood1,2,3,*; 1Department of Gynecologic Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA;  2Center for RNA Interference and Non-Coding RNAs; The University of Texas MD Anderson Cancer Center; Houston, TX USA; 3Department of Cancer Biology;  The University of Texas MD Anderson Cancer Center; Houston, TX USA; *Email: asood@mdanderson.org; http://dx.doi.org/10.4161/cc.25775 enhancer of zeste homolog 2 ( eZH2) has  been found to be overexpressed in ovarian  and other cancers and plays critical roles in  cell proliferation, angiogenesis, and inhibition  of apoptosis.1,2 Among its many functions, it  tri-methylates lysine residue at the 27 position of histone H3 associated with the target gene.",Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Front Oncol 2013; 3:47; PMiD:23494175;  http://dx.doi.org/10.3389/fonc.2013.00047 2.,Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Cancer Cell 2010; 18:185-97;  PMiD:20708159; http://dx.doi.org/10.1016/j.ccr.2010.06.016 3.,Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
s cience 2002; 298:1039-43;  PMiD:12351676; http://dx.doi.org/10.1126/sci- ence.1076997 4.,Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Proc natl Acad s ci U s A 2012; 109:21360- 5; PMiD:23236167; http://dx.doi.org/10.1073/ pnas.1210371110 5.,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
n ature 2012; 492:108-12;  PMiD:23051747; http://dx.doi.org/10.1038/ nature11606 6.,Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Cell Cycle 2013; 12:2113-9; PMiD:23759589; http://dx.doi.org/10.4161/ cc.25163 7.,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
nat Rev Mol Cell Biol 2007; 8:839-45; PMiD:17684528; http://dx.doi.org/10.1038/ nrm2236 8.,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Lab i nvest 2013; 93:528-42;  PMiD:23459371; http://dx.doi.org/10.1038/labin- vest.2013.41 CeLL  CyCLe news & views,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
"CA Cancer J Clin 2013; 63:11-30;  PMiD:23335087; http://dx.doi.org/10.3322/ caac.21166 2. n agrath s , et al.",OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
"n ature 2007; 450:1235-9;  PMiD:18097410; http://dx.doi.org/10.1038/nature06385 3. y ang J, et al.",OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Biophys J 2000; 78:2680-9;  PMiD:10777764; http://dx.doi.org/10.1016/s0006-3495(00)76812-3 4.,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Biomed Microdevices 2009; 11:883-92; PMiD:19387837; http://dx.doi.org/10.1007/s10544- 009-9305-9 5.,Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
"J Clin Oncol 2005; 23:1420-30; PMiD:15735118; http://dx.doi.org/10.1200/ JCO.2005.08.140 6. de Bono Js, et al.",OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Clin Cancer Res 2008; 14:6302-9; PMiD:18829513; http://dx.doi.org/10.1158/1078- 0432.CCR-08-0872 7.,Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
BMC Cancer 2013; 13:202; PMiD:23617715;  http://dx.doi.org/10.1186/1471-2407-13-202 8.,Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
"Cell Cycle 2013; 12:1-12; PMiD:23255116; http://dx.doi.org/10.4161/cc.25165Sizing up circulating tumor cells for personalized therapy Comment on: Gallant J-N, et al.",Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
"Cell Cycle 2013; 12:2132–43;   PMID:23759587; http://dx.doi.org/10.4161/cc.25165 Elizabeth M Matthew1 and Jean-Nicolas Gallant2,*; 1Penn State Hershey Cancer Institute; Hershey, PA USA; 2Vanderbilt University School of Medicine;  Nash  ville, TN USA; *Email: J-N.Gallant@vanderbilt.edu; http://dx.doi.org/10.4161/cc.25776",Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
"Cell Cycle 2013; 12; In this issue  PMID:23839038; http://dx.doi.org/10.4161/cc.25452 Anton A Komar; Center for Gene Regulation in Health and Disease; Department of Biological, Geological and Environmental Sciences; Cleveland State University;  Cleveland, OH USA; Email: a.komar@csuohio.edu; http://dx.doi.org/10.4161/cc.25661 A central dogma in biology states that the  flow of biological information is from D nA to  RnA to proteins.",OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
PLos Genet 2011; 7:e1001393;  PMiD:21695224; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Trends Biochem s ci 2005; 30:506- 14; PMiD:16054366; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
FeBs Lett 2008; 582:1977-86;  PMiD:18342629; http://dx.doi.org/10.1016/j.febs-let.2008.03.004 4.,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
"Biotechnol J 2011; 6:623-40;  PMiD:21538896; http://dx.doi.org/10.1002/ biot.201000327 5. s afina A, et al.",OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
s cience 2003; 301:1094-6;  PMiD:12934007; http://dx.doi.org/10.1126/sci-ence.1085712 7.,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
Cell Reports 2013; PMiD:23831030; http://dx.doi.org/10.1016/j.celrep.2013.06.013 8.,OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
s ci Transl Med 2011; 3:95ra74;  PMiD:21832239; http://dx.doi.org/10.1126/scitrans-lmed.3002530,Non-OADS,/arxiv_data1/oa_pdf/34/b6/cc-12-2347.PMC3841312.pdf
"Higher translation rates can of course be achieved by increasing the abundance of transcripts, and previously induction of the cell cycle inhibitor p21 downstream of p14ARF was primarily ascribed to p53-dependent transcriptional Keywords:  p14ARF, FMN2, p21, p53,  hypoxia, DNA damage, cancer, cell cycle Abbreviations:  ARF, alternative reading  frame; FMN2, formin-2; NF κB, nuclear  factor kappaB; CDK, cyclin-dependent  kinase; ROCK, Rho-associated, coiled-coil containing protein kinase; MAPK, mitogen-activated protein kinase; GFP, green fluorescent protein; ATR, ataxia telangiectasia and Rad3 related; ATM, ataxia telangiectasia mutated; UV, ultra - violet; Chk1, checkpoint kinase 1 Submitted: 05/25/2013Accepted: 06/23/2013http://dx.doi.org/10.4161/cc.25511 *Correspondence to: Sonia Rocha;  Email: s.rocha@dundee.ac.uk",Non-OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
"We have observed by analyzing the public databases in Oncomine (http://www.oncomine.org) that FMN2 mRNA is elevated in certain types of human cancer, such as melanoma and brain cancer, but reduced in other types of cancer, such as prostate.",Non-OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Int J Cancer 2010; 127:2239- 47; PMID:20549699; http://dx.doi.org/10.1002/ ijc.25511 2.,Non-OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Nat  Rev Mol Cell Biol 2007; 8:275-83; PMID:17380161;  http://dx.doi.org/10.1038/nrm2147 3.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Mol Cell 2013; 49:922-33;  PMID:23375502; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Biochem Biophys Res Commun  2005; 331:851-8; PMID:15865941; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Mol Cell Proteomics 2013; 12:638-50; PMID:23242552;  http://dx.doi.org/10.1074/mcp.M112.024547 6.,Non-OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Mol Cell Proteomics  2012; 11:013680; PMID:22002106; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Mol Cell Proteomics 2012; 11:011429;  PMID:21937730; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Curr Biol  2007; 17:749-60; PMID:17446074; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Nat Rev Cancer 2009; 9:400- 14; PMID:19440234; http://dx.doi.org/10.1038/ nrc2657 10.,Non-OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Biochemistry (Mosc) 2012; 77:575-84; PMID:22817456; http://dx.doi.org/10.1134/ S000629791206003X 11.,Non-OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Nat Cell Biol 2002; 4:921-8;  PMID:12447394; http://dx.doi.org/10.1038/ncb880 12.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Nat Biotechnol 2008; 26:1367-72; PMID:19029910; http://dx.doi.org/10.1038/nbt.1511 14.,Non-OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
J  Proteome Res 2011; 10:1794-805; PMID:21254760; http://dx.doi.org/10.1021/pr101065j15.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Science 2007; 316:1160- 6; PMID:17525332; http://dx.doi.org/10.1126/ science.1140321 16.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Cell Cycle  2005; 4:756-9; PMID:15970704; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Mol Cell 2003; 12:15-25; PMID:12887889; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
EMBO J 2005; 24:1157-69;  PMID:15775976; http://dx.doi.org/10.1038/ sj.emboj.7600608 22.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Mol Biol Cell 2011; 22:3032-40; PMID:21737676; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
Cancer Res 2006; 66:929-35; PMID:16424027;  http://dx.doi.org/10.1158/0008-5472.CAN-05-2234,Non-OADS,/arxiv_data1/oa_pdf/0b/2b/cc-12-2348.PMC3841313.pdf
" PaPer ty Pe www.landesbioscience.com Cell Cycle 2395Cell Cycle 12:15, 2395–2408; a ugust 1, 2013; © 2013 Landes BiosciencerePort *Correspondence to: Dean G Tang; Email: dtang@mdanderson.org Submitted: 03/21/2013; Revised: 06/10/2013; Accepted: 06/13/2013http://dx.doi.org/10.4161/cc.25402the current study was undertaken to investigate potential oncogenic functions of NanogP8, a tumor-specific ret - rogene homolog of Nanog (expressed in pluripotent cells), in transgenic animal models.",Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
J Proteome Res 2008; 7:1458-69; PMID:18257521 ;  http://dx.doi.org/10.1021/pr7007829 2.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
BMC Cancer 2008; 8:108;  PMID:18419830 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Clin Cancer Res  2008; 14:4085-95;  PMID:18593985 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
FASEB J  2008; 22:3696-705;  PMID:18614581 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cancer Res 2008; 68:4311-20; PMID:18519691 ; http://dx.doi.org/10.1158/0008- 5472.CAN-08-0364 6.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cancer Res 2008; 68:6533-40;  PMID:18701476 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
J Biol Chem 2008;  283:17635-51;  PMID:18441325 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Stem Cells 2009; 27:993-1005; PMID :19415763 ; http://dx.doi.org/10.1002/stem.29 10.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cancer Res 2010; 70:4624-33; PMID:20484027 ;  http://dx.doi.org/10.1158/0008-5472.CAN-09-3619 12.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cancer Res  2010; 70:10433-44;  PMID:21159654 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
EMBO J 2010; 29:2646-58; PMID:20581804 ;  http://dx.doi.org/10.1038/emboj.2010.13114.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
EMBO  J 2010; 29:2659-74;  PMID:20581802 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Oncogene 2011; 30:3833- 45; PMID:21499299 ; http://dx.doi.org/10.1038/ onc.2011.114 16.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cancer Res  2011; 71:4640-52;  PMID:21712410 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cell Stem Cell  2011; 9:50-63;  PMID:21726833 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
J Biol Chem 2012; 287:18656-73; PMID:22493428 ;  http://dx.doi.org/10.1074/jbc.M111.322883 20.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Hepatology  2012; 56:1004-14;  PMID:22473773 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Stem Cells 2012; 30:2076-87; PMID:22851508 ; http://dx.doi.org/10.1002/ stem.1182 22.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
J Clin Invest  2012; 122:4077-93;  PMID:23093782 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Oncogene 2012;  PMID:22945654 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Oncogene  2012;  PMID:23085761 ; http://dx.doi.org/10.1038/ onc.2012.461 25.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cell Stem Cell 2012; 10:556- 69; PMID:22560078 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cell 2005; 121:465-77; PMID :15882627 ;  http://dx.doi.org/10.1016/j.cell.2005.02.01827.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
PLoS One 2010; 5:e11022; PMID:20548776 ; http://dx.doi.org/10.1371/jour - nal.pone.0011022 28.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Oncogene 1997; 14:1435-44; PMID:9136987 ;  http://dx.doi.org/10.1038/sj.onc.1200980 29.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Differentiation  2009; 77:324-34;  PMID:19272531 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Nat Protoc  2009; 4:1350-62;  PMID:19713956 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
J Invest  Dermatol 2008; 128:1311-8; PMID:18037901 ;  http://dx.doi.org/10.1038/sj.jid.5701178 34.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Nat Genet 2001; 28:165-8;  PMID:11381265 ; http://dx.doi.org/10.1038/88889 36.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cell Stem Cell 2009; 4:427-39; PMID:19427292 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Genome Biol 2008; 9:R126;  PMID:18700969 ; http://dx.doi.org/10.1186/ gb-2008-9-8-r126 38.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
BMC Genomics 2008; 9:269;  PMID:18522731 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
J Invest Dermatol  2011; 131:580-5;  PMID:21179110 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Curr Biol  2001; 11:558-68;  PMID:11369200 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Stem Cells 2007; 25:2534- 42; PMID :17615266 ; http://dx.doi.org/10.1634/ stemcells.2007-0126 43.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Proc Natl Acad Sci U S A 2009; 106:1548-53; PMID:19171902 ; http://dx.doi.org/10.1073/ pnas.080.739.0106 45.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cell Stem Cell 2008; 3:33-43; PMID:18593557 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
J Invest Dermatol  2003; 120:501-11;  PMID:12648211 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Cancer Res 2007; 67:4173-81; PMID:17483328 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-3128 49.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
J Invest Dermatol  2010; 130:1877-86;  PMID:20376064 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Oncogene 2010; 29:4261-75; PMID:20514017 ;  http://dx.doi.org/10.1038/onc.2010.197 52.,Non-OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
Nat Protoc  2010; 5:898-911;  PMID:20431535 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/42/cc-12-2395.PMC3841319.pdf
"Cell Cycle 12:15, 2454–2467; August 1, 2013; © 2013 Landes Bioscience PAPer ty Pe 2454 Cell Cycle Volume 12 Issue 15*Correspondence to: Paola Tucci; Email: paola.tucci@unical.it ; Anne E Willis; Email: aew5@le.ac.uk Submitted: 05/07/2013; Revised: 06/18/2013; Accepted: 06/18/2013  http://dx.doi.org/10.4161/cc.25450the mammalian target of rapamycin (m tOr) kinase is a master regulator of protein synthesis that couples nutrient  sensing to cell growth, and deregulation of this pathway is associated with tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Dis 2012; 3:e397; PMID:23034332;  http://dx.doi.org/10.1038/cddis.2012.140 2.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Dis  2012; 3:e303; PMID:22552280; http://dx.doi.org/10.1038/cddis.2012.41 3.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cancer Cell 2004; 6:91-9; PMID:15261145; http://dx.doi.org/10.1016/j.ccr.2004.06.007 4.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Hum Mol Genet 2009; 18(R1):R94-100; PMID:19297407; http://dx.doi.org/10.1093/hmg/ ddp032 6.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Nat Rev Cancer 2006; 6:729-34;  PMID:16915295; http://dx.doi.org/10.1038/nrc1974 7.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Mol Cell Biol 2010; 30:1478- 85; PMID:20086100; http://dx.doi.org/10.1128/ MCB.01218-09 9.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Differ 2012; 19:107-20;  PMID:21760595; http://dx.doi.org/10.1038/ cdd.2011.96 10.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Differ 2012; 19:1093-5; PMID:22684093; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Differ 2011; 18:1815- 24; PMID:21941372; http://dx.doi.org/10.1038/ cdd.2011.120 12.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Differ 2012; 19:816- 26; PMID:22075982; http://dx.doi.org/10.1038/ cdd.2011.152 13.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death  Dis 2012; 3:e400; PMID:23059819; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Oncogene 2013;  PMID:23416979; http://dx.doi.org/10.1038/ onc.2012.640 15.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Nature  2010; 466:905; PMID:20725003; http://dx.doi.org/10.1038/466905d 17.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Differ 2011; 18:887- 96; PMID:21127502; http://dx.doi.org/10.1038/ cdd.2010.159 19.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Differ  2013; 20:611-9; PMID:23238567; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Dis 2013; 4:e480; PMID:23370280;  http://dx.doi.org/10.1038/cddis.2013.621.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Differ  2011; 18:1924-33; PMID:21637289; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Nat Rev Mol Cell Biol 2011; 12:259- 65; PMID:21427767; http://dx.doi.org/10.1038/ nrm3086 23.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Trends Cell Biol  2008; 18:244-52; PMID:18406616; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A 2007;  104:11999-2004; PMID:17626181; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
J Biol Chem 2007; 282:29152-62; PMID:17693405; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell  Death Differ 2001; 8:1213-23; PMID:11753569;  http://dx.doi.org/10.1038/sj.cdd.4400962groups.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Nature 1999; 399:806-9;  PMID:10391249; http://dx.doi.org/10.1038/21690 32.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
EMBO J 2005; 24:836-48; PMID:15678106; http://dx.doi.org/10.1038/ sj.emboj.7600444 33.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Oncogene  2009; 28:3157-66; PMID:19581926; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci USA  2010; 107:4902-7; PMID:20185758; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A 2010; 107:12877-82; PMID:20615966; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Genes Dev 2008; 22:2677- 91; PMID:18805989; http://dx.doi.org/10.1101/ gad.1695308 38.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Genes Dev  2010; 24:549-60; PMID:20194434; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Nature  2000; 404:99-103; PMID:10716451; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Science 2000; 289:304-6; PMID:10894779;  http://dx.doi.org/10.1126/science.289.5477.30442.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Development 2004; 131:1211-20; PMID:14960496;  http://dx.doi.org/10.1242/dev.01035 43.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A  2011; 108:21093-8; PMID:22160687; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A 2011; 108:21099-104; PMID:22160706; http://dx.doi.org/10.1073/ pnas.1112063108 45.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A 2009; 106:797- 802; PMID:19139399; http://dx.doi.org/10.1073/ pnas.0812096106 46.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Nat Rev Cancer 2004; 4:335- 48; PMID:15122205; http://dx.doi.org/10.1038/ nrc1362 47.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Dis 2013;  4e:549; PMID:23519118; http://dx.doi.org/10.1038/ cddis.2013.76 48.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell 2006; 124:471-84; PMID:16469695; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell 2008; 132:27-42; PMID:18191218;  http://dx.doi.org/10.1016/j.cell.2007.12.018 51.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Nature 2008; 451:1069-75; PMID:18305538;  http://dx.doi.org/10.1038/nature06639 52.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Cell Death Differ 2005; 12(Suppl 2):1457- 62; PMID:16247490; http://dx.doi.org/10.1038/ sj.cdd.440178154.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Mol Cell Biol 2008; 28:5951-64; PMID:18678646; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A 2011;  108:2076-81; PMID:21245298; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A 2010; 107:7455-60; PMID:20378837; http://dx.doi.org/10.1073/ pnas.1001006107 57.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A 2010; 107:7461-6; PMID:20351271; http://dx.doi.org/10.1073/ pnas.1002459107 58.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A 2012; 109:6904- 9; PMID:22509023; http://dx.doi.org/10.1073/ pnas.1204176109 59.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Nature 2013; 493:542-6;  PMID:23242140; http://dx.doi.org/10.1038/ nature11743 60.,Non-OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
Proc Natl Acad Sci U S A 2010; 107:9660-4; PMID:20457898; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/20/cc-12-2454.PMC3841324.pdf
"Do not distribute.Cell Cycle 12:15, 2468–2478; August 1, 2013; © 2013 Landes Bioscience PAP er ty P e 2468  C ell Cycle  V olume 12 Issue 15Correspondence to: Richard B Richardson; Email: richard.richardson@mcgill.ca; richardr@aecl.ca   Submitted: 01/31/2013; Revised: 05/20/2013; Accepted: 06/21/2013   http://dx.doi.org/10.4161/cc.25494TP53 ’s role as guardian of the genome diminishes with age, as the probability of mutation increases.",Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Science  1991; 253:49-53;  PMID:1905840 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Hum Mutat 2002; 19:607-14; PMID:12007217 ;  http://dx.doi.org/10.1002/humu.10081 4.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Nucleic Acids Res 2007; 35:7475-84; PMID:17942417 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Cell Cycle 2007; 6:1006-10;  PMID:17457049 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Nature 2007; 445:661-5;  PMID:17251932 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Nature 2007; 445:656-60; PMID:17251933 ; http://dx.doi.org/10.1038/ nature05529 11.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Cancer 2003; 97:527-36; PMID:12548593 ; http://dx.doi.org/10.1002/ cncr.11080 13.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Mutat Res 2009; 663:69-76; PMID:19428372 ;  http://dx.doi.org/10.1016/j.mrfmmm.2009.01.010 14.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Int J Epidemiol 2005; 34:405-12;  PMID :15737977 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Cell Cycle 2009; 8:2031-40; PMID:19440038 ; http://dx.doi.org/10.4161/ cc.8.13.8814 18.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Lancet Oncol 2009; 10:913-9; PMID:19717093 ; http://dx.doi.org/10.1016/ S1470-2045(09)70198-6 19.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
http://dx.doi.org/10.5580/2cb1 20.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Lancet 2011; 377:557-67;  PMID:21295846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Hum Mutat 2003; 21:229-39;  PMID:12619108 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Emerg Themes Epidemiol 2005; 2:11; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Genes Cancer  2011; 2:475-84;  PMID :21779515 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Br J Cancer 2003; 89:1314-9;  PMID:14520466 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Oncogene 2007; 26:2157-65; PMID:17401424 ; http://dx.doi.org/10.1038/ sj.onc.1210302 29.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Science 2006; 312:1650-3; PMID:16728594 ; http://dx.doi.org/10.1126/ science.1126863 30.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Mol Genet Metab 2001; 72:155-63;  PMID:11161841 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Cancer Cell 2002; 1:289-98; PMID:12086865 ; http://dx.doi.org/10.1016/ S1535-6108(02)00047-833.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Nature 1992; 356:215-21;  PMID:1552940 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Radiat Res 2003; 159:320-7;  PMID:12600234 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
BMJ 2001; 322:1528-32; PMID:11420276 ; http://dx.doi.org/10.1136/ bmj.322.7301.1528 36.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Neoplasia 1999; 1:241-52;  PMID:10935479 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Cancer Res 2006; 66:10505-12;  PMID:17079472 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Lancet 2008; 371:569-78; PMID:18280327 ; http://dx.doi.org/10.1016/ S0140-6736(08)60269-X 39.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Nature 2005; 436:725-30; PMID:16079851 ;  http://dx.doi.org/10.1038/nature03918 41.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Cancer Cell 2010; 18:367-81; PMID:20951946; http://dx.doi.org/10.1016/j.ccr.2010.09.005 42.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Brain Pathol 1998; 8:599-613;  PMID:9804370 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
N Engl J Med 2009; 361:2449-60; PMID:20018966 ;  http://dx.doi.org/10.1056/NEJMra0804588 44.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Br J Cancer 1999; 79:1151-7; PMID:10098750 ; http://dx.doi.org/10.1038/ sj.bjc.6690183 45.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Int J Radiat Biol 2011; 87:343-59; PMID:21204614 ; http://dx.doi.org/10.3109/095530 02.2010.537430 47.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Nature 1998; 396:643-9; PMID:9872311 ; http://dx.doi.org/10.1038/25292,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Proc Natl Acad Sci USA 2007; 104:16633-8; PMID:17921246 ; http://dx.doi.org/10.1073/ pnas.0708043104 49.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Nature 2007; 446 :153-8 ;  PMID:17344846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Science 2011; 331:1553-8; PMID:21436442 ; http://dx.doi.org/10.1126/ science.1204040 51.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Science 2007; 318:1108-13; PMID:17932254 ; http://dx.doi.org/10.1126/ science.1145720 52.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Genes Dev 2007; 21:55-9; PMID:17210788 ; http://dx.doi.org/10.1101/ gad.147040753.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Nature 2007; 446:758-64; PMID:17344859 ; http://dx.doi.org/10.1038/ nature05690 55.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Leuk Res 2011; 35:1425-31;  PMID:21903265 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Cancer Res 2008; 68:4465-78; PMID:18519710 ; http://dx.doi.org/10.1158/0008- 5472.CAN-07-1670 58.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Cell Cycle 2010; 9:3151-6; PMID:20724817 ; http://dx.doi.org/10.4161/ cc.9.16.1312059.,OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Int J Cancer 2010; 127:2893-917;  PMID:21351269 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
Hum Mutat 2007; 28:622-9; PMID:17311302 ; http://dx.doi.org/10.1002/ humu.20495 62.,Non-OADS,/arxiv_data1/oa_pdf/e6/69/cc-12-2468.PMC3841325.pdf
" PaPer ty Pe www.landesbioscience.com Cell Cycle 2505Cell Cycle 12:15, 2505–2509; a ugust 1, 2013; © 2013 Landes BiosciencerePort *Correspondence to: Carolina Vicente-Dueñas; Email: cvd@usal.es; Isidro Sanchez-Garcia; Email: isg@usal.es  Submitted: 06/19/2013; Accepted: 06/25/2013   http://dx.doi.org/10.4161/cc.25544the latest studies of the interactions between oncogenes and its target cell have shown that certain oncogenes may  act as passengers to reprogram tissue-specific stem/progenitor cell into a malignant cancer stem cell state.",Non-OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
EMBO J 2013; 32:1502-13; PMID:23632857; http://dx.doi.org/10.1038/emboj.2013.97 2.,Non-OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Bioessays 2013; 35:413;  PMID:23553938; http://dx.doi.org/10.1002/ bies.201300024 3.,Non-OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Bioessays 2007; 29:1269-80; PMID:18022789; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
N Engl J Med 2009; 360:297-9; PMID:19144947; http://dx.doi.org/10.1056/ NEJMcibr0808031 7.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Semin Cancer Biol 2010; 20:63-4; PMID:20451615;  http://dx.doi.org/10.1016/j.semcancer.2010.05.001 8.,Non-OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Carcinogenesis  2010; 31:1292-7; PMID:20299524; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Proc Natl Acad Sci U S A  2012; 109:10534-9; PMID:22689981; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Cell Cycle 2012; 11:2961-2; PMID:22825253;  http://dx.doi.org/10.4161/cc.21264 13.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
EMBO J 2012; 31:3704-17; PMID:22903061; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Cell Cycle 2012; 11:3715-7; PMID:22983005; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Cell Cycle 2012; 11:1479-80; PMID:22487683; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Nat Commun 2013; 4:1338; PMID:23299888; http://dx.doi.org/10.1038/ ncomms233417.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Cell Cycle 2013; 12:122- 32; PMID:23255106; http://dx.doi.org/10.4161/ cc.23031 18.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Blood 2011; 118:5565-72; PMID:21931114; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Blood  2012; 119:530-9; PMID:22101898; http://dx.doi.org/10.1182/blood-2010-08-303495 21.,Non-OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
Blood 2012; 119:1501- 10; PMID:22184410; http://dx.doi.org/10.1182/blood-2010-12-326843,Non-OADS,/arxiv_data1/oa_pdf/25/16/cc-12-2505.PMC3841328.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/29/thnov03p0816.PMC3841333.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e0/4f/thnov03p0841.PMC3841335.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/97/ca/thnov03p0851.PMC3841336.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/00/thnov03p0865.PMC3841337.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/M anufacturing/UCM295820.pdf   2.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMater ials/ Drugs/MedicalImagingDrugsAdvisoryCommittee/ucm273286.htm   3.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
Food and Drug Modernization  Act of 1997.  http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrug andCosmet i- cActFDCAct/SignificantAmendmentstotheFDCAct/FDAMA/FullT extofFDA MAlaw/default.htm    8.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.gpo.gov/fdsys/pkg/FR-2009-12-10/pdf/E9-29285.pdf,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/M anufacturing/UCM295267.pdf   10.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryIn formation/Guidances/UCM291573.pdf   11.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
"Section 121  Positron emission  tomography, Food and Drug Modernization Act of 1997.  http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrug andCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDAMA/Fu llTextofFDAMAlaw/default.htm#SEC.%20121   12.",Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.gpo.gov/fdsys/pkg/CRPT -105srpt43/pdf/CRPT -105srpt43.pdf   13.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
"Conference Report on S. 830, Food and Drug Adminis tration Modernization  Act of 1997.  http://www.gpo.gov/fdsys/pkg/CREC -1997-11-09/pdf/CREC -1997-11-09 - pt1-PgH10452.pdf   14.",Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
"Food and Drug  Administration Modernization and Accountability Act, pages 52-53. http://www.gpo.gov/fdsys/pkg/CRPT -105srpt43/pdf/CRPT -105srpt43.pdf   15.",Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.gpo.gov/f dsys/pkg/CREC -1997-11-09/pdf/CREC -1997-11-09 - pt1-PgH10452.pdf   16.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=42262   17.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eeaf70fd-46bd-4f ec-ba9d-2366fdf07888#nlm34067-9   18.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee95aa18-9f2f -40 eb-9b4c-583bea6f36bf   19.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://dailymed.nlm.nih.gov/d ailymed/lookup.cfm?setid=bb5a5043-0f51-11 df-8a39-0800200c9a66  20.,OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm3 19201.htm   22.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.gpo.gov/fdsys/granule/USCODE -2010-title21/USCODE-2010- title21-chap9 -subchapV -partE -sec360bbb/content -detail.html   23.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.gpo.gov/fdsys/pkg/FR-2006-12-14/pdf/06-9684.pdf   24.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.gpo.gov/fdsys/pkg/FR-2009-08-13/pdf/E9-19005.pdf   25.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/ default.htm   27.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryIn formation/Guidances/ucm078933.pdf   28.,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?,Non-OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFR Search.cfm?,OADS,/arxiv_data1/oa_pdf/ab/37/thnov03p0885.PMC3841338.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/8e/thnov03p0894.PMC3841339.pdf
This is an open- access article distributed under the t erms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/c5/thnov03p0903.PMC3841340.pdf
Slices were  photographed with a high- resolution digital camera   and planimetered using Image J software  (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/1f/c5/thnov03p0903.PMC3841340.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Very low calorie diet in patients with cirrhosis JC Temmerman and AN Friedman 3 &2013 Macmillan Publishers Limited Nutrition & Diabetes (2013) 1 – 3",Non-OADS,/arxiv_data1/oa_pdf/ea/7a/nutd201336a.PMC3841440.pdf
"Questionnaire on speciﬁc health examination: Japan, 2008 available at http://amda-imic.com/oldpage/amdact/ PDF/eng/spe-he-ex-e.pdf (accessed 27 September 2013).",Non-OADS,/arxiv_data1/oa_pdf/71/8b/nutd201337a.PMC3841441.pdf
"Ethical Guidelines for Epidemiological Research:Japan, 2007, available at http://www.lifescience.mext.go.jp/ﬁles/pdf/n796_01.",Non-OADS,/arxiv_data1/oa_pdf/71/8b/nutd201337a.PMC3841441.pdf
Available at http://www.med.u-toyama.ac.jp/medicin1/.,Non-OADS,/arxiv_data1/oa_pdf/71/8b/nutd201337a.PMC3841441.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Nutrition & Diabetes website (http://www.nature.com/nutd)Aging and metabolic risk factor T Okazawa et al 9 &2013 Macmillan Publishers Limited Nutrition & Diabetes (2013) 1 – 9",Non-OADS,/arxiv_data1/oa_pdf/71/8b/nutd201337a.PMC3841441.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/9a/0b/AJM-4-87.PMC3841482.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/9a/0b/AJM-4-87.PMC3841482.pdf
Author Help: Online submission of the manuscripts Articles can be submitt ed online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/be/f9/AJM-4-92.PMC3841483.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/43/0a/AJM-4-97.PMC3841484.pdf
"[16] South Indians constitute about 21.7% of the  total population of India and residing at four states  (Tamil Nadu, Andhra Pradesh, Kerala and Karnataka)  (http://www.census india.govt.in/2011census, accessed  on August, 2011).",Non-OADS,/arxiv_data1/oa_pdf/e6/d7/IJHG-19-301.PMC3841554.pdf
"The haplotype frequencies of the VKORC1 locus  in South Indians were compared with those of the  HapMap population (http://hapmap.ncbi.nlm.nih.gov/)  by establishing the haplotype structure for Africans,  Caucasians, Han Chinese, Japanese and Indian groups.",OADS,/arxiv_data1/oa_pdf/e6/d7/IJHG-19-301.PMC3841554.pdf
"SETTINGS AND DESIGN: Data mining was carried out  using the homepage “http://www.fish.uniklinikum‑jena.de/ UPD.html,” an online catalog of published cases with UPD.",OADS,/arxiv_data1/oa_pdf/45/d6/IJHG-19-311.PMC3841555.pdf
Available from: http://www.fish.uniklinikum‑jena.,Non-OADS,/arxiv_data1/oa_pdf/45/d6/IJHG-19-311.PMC3841555.pdf
Available from: http://www.fish.uniklinikum‑jena.,Non-OADS,/arxiv_data1/oa_pdf/45/d6/IJHG-19-311.PMC3841555.pdf
Available from: http://www.fish.uniklinikum‑jena.,Non-OADS,/arxiv_data1/oa_pdf/45/d6/IJHG-19-311.PMC3841555.pdf
Available from:  http://www.geneimprint.com.,Non-OADS,/arxiv_data1/oa_pdf/45/d6/IJHG-19-311.PMC3841555.pdf
Available from: http://genome.ucsc.,OADS,/arxiv_data1/oa_pdf/6c/17/IJHG-19-325.PMC3841558.pdf
URL:  http://hereditaryhearingloss.org).,Non-OADS,/arxiv_data1/oa_pdf/68/73/IJHG-19-331.PMC3841559.pdf
http://dx.doi.org/10.1016/j.preteyeres.2013.09.002Progress in Retinal and Eye Research 37 (2013) 163 e181 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/22/5c/main.PMC3841575.pdf
Report –reporting peri- od: January 2008 - December 2009. http://data.unaids.org/pub/ report/2010/southafrica_2010_country_progress_report_en.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/2a/54/198_2013_Article_2373.PMC3841578.pdf
http://www.sahivsoc.org/upload/documents/Clinical_ Guidelines_for_the_Managem ent_of_HIV_AIDS_in_Adults_ Adolescents_2010.pdf 20. WHO (2006) W.H.O.,Non-OADS,/arxiv_data1/oa_pdf/2a/54/198_2013_Article_2373.PMC3841578.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/ab/8f/AIAN-16-465.PMC3841582.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.AnnouncementHow to cite this article: Khadilkar SV.,Non-OADS,/arxiv_data1/oa_pdf/ab/8f/AIAN-16-465.PMC3841582.pdf
Available from: http://www.aiimsnets.org/NeurosurgeryEducation/ General Neurosurgery/Historyofneurosurgery/HISTORYOFNEU  ROSURGERY.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/0c/AIAN-16-467.PMC3841583.pdf
Available from: http://www.neuroscienceacademy.,Non-OADS,/arxiv_data1/oa_pdf/ac/0c/AIAN-16-467.PMC3841583.pdf
"Received:  02-07-13, Revised:  29-07-13, Accepted:  29-08-13 Source of Support:  Nil, Conflict of Interest:  Nil Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/ac/0c/AIAN-16-467.PMC3841583.pdf
Available from: http://www.collegeboard.com/prod_downloads/ yes/4297_MODULE-06.pdf.last accessed on 26 August 2013.,Non-OADS,/arxiv_data1/oa_pdf/e3/10/AIAN-16-483.PMC3841585.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/2f/7a/AIAN-16-504.PMC3841589.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/b1/ff/AIAN-16-509.PMC3841590.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/26/ab/AIAN-16-521.PMC3841592.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/7d/ac/AIAN-16-525.PMC3841593.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/99/04/AIAN-16-530.PMC3841594.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/86/96/AIAN-16-538.PMC3841596.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/c9/bf/AIAN-16-544.PMC3841597.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/14/10/AIAN-16-556.PMC3841599.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/68/56/AIAN-16-561.PMC3841600.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/71/73/AIAN-16-572.PMC3841603.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ed/4c/AIAN-16-577.PMC3841604.pdf
"Available from:  http://www.mocatest.org/references.asp Monday, September 9th,  2013.",Non-OADS,/arxiv_data1/oa_pdf/ee/e2/AIAN-16-585.PMC3841605.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/ee/e2/AIAN-16-585.PMC3841605.pdf
Available from: http://www.rcplondon.,Non-OADS,/arxiv_data1/oa_pdf/ef/c8/AIAN-16-627.PMC3841615.pdf
Available from:  http://www.himachal.nic.in/tribal/tribalarea.htm.,Non-OADS,/arxiv_data1/oa_pdf/6e/aa/AIAN-16-640.PMC3841618.pdf
Available from http://www.cjd.ed.ac.uk/criteria.htm [Last accessed on  2013 May 8].,Non-OADS,/arxiv_data1/oa_pdf/e0/69/AIAN-16-659.PMC3841621.pdf
The 16S rRNA sequences  of the genus Porphyromonas were selected from the  taxonomy database of the National Center for Biotechnology  Information (http://www.ncbi.nlm.nih.gov/Taxonomy/ taxonomyhome.html/).,OADS,/arxiv_data1/oa_pdf/07/46/AIAN-16-723.PMC3841642.pdf
Available from: http://www.sipernat.com/sites/dc/ Downloadcenter/Evonik/Product/SIPERNAT/TI%201367%20us.pdf dFrom product brochure.,Non-OADS,/arxiv_data1/oa_pdf/f7/0b/11095_2013_Article_1114.PMC3841658.pdf
"2007 Oct; Available from: http://www.fujichemical.co.jp/english/newsletter/newsletter_pharma_0710.html fFuji Chemical Industry Co., Ltd. General Properties of Neusilin.",Non-OADS,/arxiv_data1/oa_pdf/f7/0b/11095_2013_Article_1114.PMC3841658.pdf
"2009 2010; Available from: http://www.neusilin.com/product/general_properties.php gFuji Chemical Industry Co., Ltd. Neusilin The Extraordinary Excipient for Oral Solid Dosage Forms.",Non-OADS,/arxiv_data1/oa_pdf/f7/0b/11095_2013_Article_1114.PMC3841658.pdf
2007 Nov; Available from: http://www.fujichemical.co.jp/english/newsletter/newsletter_pharma_0711.html hhttp://www.aquachem.co.kr/product/Sylysia.htm iFuji Silysia Chemical LTD. Sylysia® FCP Product brochure; Available from: http://www.tcrindustries.com/FineChemical/Principals/BROCHURES/fujibrochures/FCP%20Brochure.pdf jCompany product literature.,Non-OADS,/arxiv_data1/oa_pdf/f7/0b/11095_2013_Article_1114.PMC3841658.pdf
Available from: http://www.who.int/mediacentre/ news/releases/2009/world_aids_20091130/en/index.,Non-OADS,/arxiv_data1/oa_pdf/5c/01/IJSTD-34-113.PMC3841661.pdf
Available from: http://www.who.int/hiv/ pub/arv/rapid_advice_art.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5c/01/IJSTD-34-113.PMC3841661.pdf
Available from: http://www.aidsmap.,Non-OADS,/arxiv_data1/oa_pdf/5c/01/IJSTD-34-113.PMC3841661.pdf
Available from: http://www.nursingworld.org/ AJN/2002/june/Wawatch.htmArticle [Last accessed on 1998 Apr 11].,Non-OADS,/arxiv_data1/oa_pdf/5c/01/IJSTD-34-113.PMC3841661.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/5c/01/IJSTD-34-113.PMC3841661.pdf
"HIV Infection → Viramune  Side Effects; Available from: http://www.drugs.com/drug  interactions/nevirapine, viramune.html [Last accessed on  2013 Mar 12].",Non-OADS,/arxiv_data1/oa_pdf/5c/01/IJSTD-34-113.PMC3841661.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/5c/01/IJSTD-34-113.PMC3841661.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/1f/c6/IJSTD-34-119.PMC3841662.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/d0/7e/IJSTD-34-123.PMC3841663.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/5c/14/IJSTD-34-126.PMC3841664.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/31/f1/IJSTD-34-132.PMC3841666.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/7e/80/IJSTD-34-135.PMC3841667.pdf
Available from:  http://www.nacoonline.org/About_NACO/Policy_Guidelines/.,Non-OADS,/arxiv_data1/oa_pdf/3d/b2/IJSTD-34-149.PMC3841672.pdf
Available from: http://www.bashh.org/ documents/92/92.pdf [Last accessed on 2012 Dec 5].,OADS,/arxiv_data1/oa_pdf/3d/b2/IJSTD-34-149.PMC3841672.pdf
Available from: http://www.bashh.org/ documents/92/92.pdf [Last accessed on 2012 Dec 5].,OADS,/arxiv_data1/oa_pdf/71/71/IJSTD-34-151.PMC3841673.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/c3/f3/IJSTD-34-77.PMC3841675.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/c3/f3/IJSTD-34-77.PMC3841675.pdf
Indian J Pract Doct 2007 ;4: Available  from: http://www.indmedica.com/journals.php?,Non-OADS,/arxiv_data1/oa_pdf/81/90/IJSTD-34-83.PMC3841676.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/81/90/IJSTD-34-83.PMC3841676.pdf
Available from: http://www.unaids.org/en/media/unaids/ contentassets/documents/epidemiology/2012/gr2012/20121120_ UNAIDs_Global_Report_2012_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/dc/IJSTD-34-95.PMC3841678.pdf
Available from: http://www.pib.nic.in/newsite/PrintRelease.aspx?,Non-OADS,/arxiv_data1/oa_pdf/47/dc/IJSTD-34-95.PMC3841678.pdf
Available from: http://www.who.int/tb/data  [Last accessed on 2011 Sep 13].,OADS,/arxiv_data1/oa_pdf/73/31/LI-30-277.PMC3841681.pdf
Available from: http://www.whoindia.org/ en/section3/section123.htm [Last accessed on 2012 Jun 12].,Non-OADS,/arxiv_data1/oa_pdf/73/31/LI-30-277.PMC3841681.pdf
Available from: http://www.tbcindia.org/rntcpasp [Last  accessed on 2011 Sep 15].,Non-OADS,/arxiv_data1/oa_pdf/73/31/LI-30-277.PMC3841681.pdf
Available from:   http://www.nso.gov.mt.,Non-OADS,/arxiv_data1/oa_pdf/16/bb/LI-30-280.PMC3841682.pdf
Available from: http://www.ginasthma.org.,Non-OADS,/arxiv_data1/oa_pdf/16/bb/LI-30-280.PMC3841682.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/16/bb/LI-30-280.PMC3841682.pdf
Available  from: http://www.ginasthma.org.,Non-OADS,/arxiv_data1/oa_pdf/2d/2d/LI-30-295.PMC3841685.pdf
Available from : http://www.ginasthma.org/guidelines-gina- report-global-strategy-for-asthma.html.,Non-OADS,/arxiv_data1/oa_pdf/2d/2d/LI-30-295.PMC3841685.pdf
Available from: http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pdf/.,Non-OADS,/arxiv_data1/oa_pdf/2d/2d/LI-30-295.PMC3841685.pdf
Available from: http://www.unaids.org/en/.,Non-OADS,/arxiv_data1/oa_pdf/41/97/LI-30-302.PMC3841686.pdf
"Available from: http://data.unaids.org/ pub/Report/2010/2009_annual_report_en.pdf [Last accessed on  August 14, 2013] 6.",OADS,/arxiv_data1/oa_pdf/41/97/LI-30-302.PMC3841686.pdf
Available from: http://www.who.int/en/.,OADS,/arxiv_data1/oa_pdf/41/97/LI-30-302.PMC3841686.pdf
Available from: http://www.unaids.org/en/media/unaids/co   ntentassets/documents/unaidspublication/ 2011/JC2216_WorldAIDSday_ report_2011_en.,Non-OADS,/arxiv_data1/oa_pdf/41/97/LI-30-302.PMC3841686.pdf
"Available from: http://www.japi.org/october_2009/article_01.pdf [Last  accessed on August 14, 2013].",Non-OADS,/arxiv_data1/oa_pdf/41/97/LI-30-302.PMC3841686.pdf
Available from: http://www.who.int/en/.,OADS,/arxiv_data1/oa_pdf/41/97/LI-30-302.PMC3841686.pdf
"Available from:  http://www.who.int/tb/publications/2010/factsheet_tb_2010.pdf [Last  accessed onAugust 14, 2013].",Non-OADS,/arxiv_data1/oa_pdf/41/97/LI-30-302.PMC3841686.pdf
Available from: http://www.cdc.gov/tb.,Non-OADS,/arxiv_data1/oa_pdf/41/97/LI-30-302.PMC3841686.pdf
Available from:  http://www.cdc.gov/tb/publications/pamphlets/TB-HIVEng.PDF [Last  updated on 2012 April 12; cited on 2012 Nov 1].,Non-OADS,/arxiv_data1/oa_pdf/41/97/LI-30-302.PMC3841686.pdf
Available from: http://www.who.int/tobacco/ mpower/gtcr_download/en/index.html 2.,Non-OADS,/arxiv_data1/oa_pdf/54/1a/LI-30-312.PMC3841688.pdf
Available from: http://www.whoindia.org/en/Section20/ Section25_927.htm .,Non-OADS,/arxiv_data1/oa_pdf/54/1a/LI-30-312.PMC3841688.pdf
Available from: http://www.tobaccofreeunion.org/assets/ Technical%20Resources/Case%20Studies/Chandigarh_Case_Study_Summary_web-ready_EN.pdf  (Last accessed on 06 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/54/1a/LI-30-312.PMC3841688.pdf
Available  from: http://mohfw.nic.in/index1.php?lang&level =2&sublinkid =671&lid   =662 [Last accessed on 21 March 2013].,OADS,/arxiv_data1/oa_pdf/54/1a/LI-30-312.PMC3841688.pdf
Available from: http://tobaccofreecenter.org/files/pdfs/ en/smoke_free_compliance_guide.pdf (Last accessed 2013 Jun 06].,Non-OADS,/arxiv_data1/oa_pdf/54/1a/LI-30-312.PMC3841688.pdf
Available  from: http://www.hriday-shan.org .,Non-OADS,/arxiv_data1/oa_pdf/54/1a/LI-30-312.PMC3841688.pdf
Available from: http://www.tbcindia.nic.in/pdfs/RNTCP%20 TB%20India%202011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/44/LI-30-316.PMC3841689.pdf
Available from: http://www.tbcindia.nic.in/pdfs/ Guidelines%20for%20PMDT%20in%20India%20%20May%202012.,Non-OADS,/arxiv_data1/oa_pdf/db/44/LI-30-316.PMC3841689.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/c7/81/LI-30-351.PMC3841697.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/e9/60/LI-30-354.PMC3841698.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/ca/9c/LI-30-365.PMC3841702.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/ca/9c/LI-30-365.PMC3841702.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ Emmanuel F, et al.Sex Transm Infect 2013; 89:iii23 –iii28.",Non-OADS,/arxiv_data1/oa_pdf/8f/bb/sextrans-2013-051161.PMC3841725.pdf
Geneva: UANIDS; 2010. http://www.unaids.org/documents/20101123_globalreport_em.pdf(accessed 18 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/8f/bb/sextrans-2013-051161.PMC3841725.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Dolan K, Kite B, Black E, et al.",Non-OADS,/arxiv_data1/oa_pdf/cc/c4/sextrans-2013-051295.PMC3841726.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Bohannon J.,Non-OADS,/arxiv_data1/oa_pdf/f5/33/sextrans-2012-050888.PMC3841727.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Federal Ministry of Health of Sudan.,Non-OADS,/arxiv_data1/oa_pdf/90/5d/sextrans-2013-051097.PMC3841728.pdf
March 2012 http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/ 2012countries/ce_SD_Narrative_Report[1].pdf (accessed 15 Nov 2012).,OADS,/arxiv_data1/oa_pdf/90/5d/sextrans-2013-051097.PMC3841728.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ab/3e/2397.PMC3841729.pdf
[Keywords : Nanoparticle; microfluidics; single cell; biomarker; micro- needle; targeted delivery] 10Corresponding authors E-mail ian_wong@brown.edu E-mail mehmet_toner@hms.harvard.edu Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/ab/3e/2397.PMC3841729.pdf
/C2112013 Svingen and Koopman This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months afterthe full-issue publication date (see http://genesdev.cshlp.org/site/ misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/71/3e/2409.PMC3841730.pdf
2Corresponding author E-mail p.koopman@imb.uq.edu.au Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.228080.113.,Non-OADS,/arxiv_data1/oa_pdf/71/3e/2409.PMC3841730.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e2/64/2427.PMC3841731.pdf
4Corresponding author E-mail metp@igbmc.fr Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/e2/64/2427.PMC3841731.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/28/89/2433.PMC3841732.pdf
[Keywords : genome architecture; chromosome conformation capture; p53; apoptosis; long-distance gene regulation] 1Corresponding author E-mail john.abrams@utsouthwestern.edu Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/28/89/2433.PMC3841732.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/50/b4/2439.PMC3841733.pdf
[Keywords : B-cell development; Ag gene rearrangement; gene expression] 5Corresponding author E-mail star1@uic.edu Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/50/b4/2439.PMC3841733.pdf
5C primers were designed using online tools (http://my5C.umassmed.edu).,OADS,/arxiv_data1/oa_pdf/50/b4/2439.PMC3841733.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.,Non-OADS,/arxiv_data1/oa_pdf/0e/78/2445.PMC3841734.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5Corresponding author E-mail aguilo@us.es Article is online at http://www.gen esdev.org/cgi/doi /10.1101/gad.229880.113.",Non-OADS,/arxiv_data1/oa_pdf/0e/78/2445.PMC3841734.pdf
"The results were visualized with the University of California atSanta Cruz Genome Browser, developed and maintained by theGenome Bioinformatics Group (Center for Biomolecular Science and Engineering at the University of California at Santa Cruz; http://genome.ucsc.e du).",OADS,/arxiv_data1/oa_pdf/0e/78/2445.PMC3841734.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/03/76/2459.PMC3841735.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unp orted), as described at http:// creativecommons.org/licenses/by-nc/3.0/.5Corresponding authors E-mail masayuki.yamada@upol.cz E-mail jb@cancer.dk Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.224568.113.",Non-OADS,/arxiv_data1/oa_pdf/03/76/2459.PMC3841735.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/28/35/2473.PMC3841736.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unp orted), as described at http:// creativecommons.org/licenses/by-nc/3.0/.3Corresponding author E-mail jones@salk.edu Article is online at http://www.genesdev.",Non-OADS,/arxiv_data1/oa_pdf/28/35/2473.PMC3841736.pdf
Global phosphoproteome studies indicate that the APC-binding site in a-catenin is frequently tyrosine- phosphorylated at Y177 in transformed cells (http://www.phosphosite.org).,Non-OADS,/arxiv_data1/oa_pdf/28/35/2473.PMC3841736.pdf
Original data files will be made availableat http://www.yeastrc.org within 1 year of publication.,OADS,/arxiv_data1/oa_pdf/28/35/2473.PMC3841736.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http:// creativecommons.org/licenses/by-nc/3.0/.3Corresponding author E-mail jia@biology.columbia.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.226118.113.",Non-OADS,/arxiv_data1/oa_pdf/93/85/2489.PMC3841737.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/24/76/2500.PMC3841738.pdf
"Present addresses:4Department of Molecular and Cellular Biology, Harvard University, 16 Divinity Ave., Cambridge, MA 02138, USA;5Department of Integrative Structural and Computational Biology, The Scripps ResearchInstitute, 10550 North Torrey Pines Rd., La Jolla, CA 92037, USA 6Corresponding author E-mail btn1@psu.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.229385.113.",Non-OADS,/arxiv_data1/oa_pdf/24/76/2500.PMC3841738.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2012-202064).,Non-OADS,/arxiv_data1/oa_pdf/e2/5a/annrheumdis-2012-202064.PMC3841739.pdf
"METHODS This study is based on the PERFECT (PERFormance,Effectiveness and Cost of T reatment episodes; http://www.thl.",Non-OADS,/arxiv_data1/oa_pdf/e2/5a/annrheumdis-2012-202064.PMC3841739.pdf
"In Finland, patients with such conditions receive reimbursement (42 –100%) for necessary drugs (for details, see http://www.kela.",Non-OADS,/arxiv_data1/oa_pdf/e2/5a/annrheumdis-2012-202064.PMC3841739.pdf
Data on deaths were obtained from the Statistics Finland(http://www.stat.,OADS,/arxiv_data1/oa_pdf/e2/5a/annrheumdis-2012-202064.PMC3841739.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 NICE (National Institute for Health and Clinical Excellence).,Non-OADS,/arxiv_data1/oa_pdf/e2/5a/annrheumdis-2012-202064.PMC3841739.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ References BAKER, J. C., AMES, T .",Non-OADS,/arxiv_data1/oa_pdf/33/3e/vetrec-2013-101936.PMC3841740.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ To cite Abu-Raddad LJ, Ghanem KG, Feizzadeh A, et al.Sex Transm Infect 2013; 89:iii1–iii4.",Non-OADS,/arxiv_data1/oa_pdf/20/2f/sextrans-2013-051373.PMC3841741.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Triay E, Bergman L, Nilsson B, et al.",Non-OADS,/arxiv_data1/oa_pdf/44/f0/bjophthalmol-2013-303671.PMC3841742.pdf
"To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2013-203485) 1Leeds Institute of Rheumatic & Musculoskeletal Medicine,University of Leeds, Leeds, UK 2NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHSTrust United Kingdom, Leeds,UK 3Department of Rheumatology, University of South Florida,Tampa, Florida, USA 4Department of Rheumatology, Leiden University Medical Center, Leiden,The Netherlands Correspondence to Professor Paul Emery, Leeds Institute of Rheumatic &Musculoskeletal Medicine,University of Leeds, Leeds LS7 4SA, UK; p.emery@leeds.ac.uk Received 18 February 2013 Revised 20 June 2013Accepted 9 July 2013 Published Online First 5 August 2013 To cite: Emery P, Sebba A, Huizinga TWJ.",Non-OADS,/arxiv_data1/oa_pdf/62/78/annrheumdis-2013-203485.PMC3841743.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Smolen JS, Landewe R, Breedveld FC, et al.",Non-OADS,/arxiv_data1/oa_pdf/62/78/annrheumdis-2013-203485.PMC3841743.pdf
21 Sept 2004. http://www.medicinenet.,Non-OADS,/arxiv_data1/oa_pdf/62/78/annrheumdis-2013-203485.PMC3841743.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Murphy RL, Becklake MR, Brooks SM, et al.",Non-OADS,/arxiv_data1/oa_pdf/be/0b/oemed-2013-101404.PMC3841744.pdf
"Lyon, France: IARC, 1998. http://monographs.iarc.fr/ENG/Monographs/vol14/volume14.pdf (accessed 22 May 2013).",Non-OADS,/arxiv_data1/oa_pdf/be/0b/oemed-2013-101404.PMC3841744.pdf
http://www.cdc.gov/niosh/docs/2011-159/pdfs/2011-159.pdf (accessed22 May 2013).,OADS,/arxiv_data1/oa_pdf/be/0b/oemed-2013-101404.PMC3841744.pdf
http://www.cdc.gov/niosh/docket/archive/pdfs/NIOSH-099A/0099A-030104-Pictorialpresentation.pdf(accessed 22 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/be/0b/oemed-2013-101404.PMC3841744.pdf
http://www.osha.gov/dts/sltc/methods/inorganic/id160/id160.,OADS,/arxiv_data1/oa_pdf/be/0b/oemed-2013-101404.PMC3841744.pdf
Asbestos and other Fibers by PCM-Method 7400. http://www.cdc.gov/niosh/docs/2003-154/pdfs/7400.pdf(accessed 23 May 2013).,OADS,/arxiv_data1/oa_pdf/be/0b/oemed-2013-101404.PMC3841744.pdf
Asbestos by TEM-Method 7402. http://www.cdc.gov/niosh/docs/2003-154/pdfs/7402.pdf (accessed 23 May 2013).,OADS,/arxiv_data1/oa_pdf/be/0b/oemed-2013-101404.PMC3841744.pdf
http://monographs.iarc.fr/ENG/ Monographs/vol100C/index.php (accessed 23 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/be/0b/oemed-2013-101404.PMC3841744.pdf
Adult Smoking Behavior Survey in 2008. http://olap.bhp.doh.gov.tw/ (accessed 8 September 2013).,Non-OADS,/arxiv_data1/oa_pdf/be/0b/oemed-2013-101404.PMC3841744.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Global HIV/AIDS Response.,Non-OADS,/arxiv_data1/oa_pdf/1d/c6/sextrans-2012-050849.PMC3841745.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ heartjnl-2013-304739).,Non-OADS,/arxiv_data1/oa_pdf/8f/46/heartjnl-2013-304739.PMC3841746.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCE 1 Ross R. Atherosclerosis —an in ﬂammatory disease.,Non-OADS,/arxiv_data1/oa_pdf/8f/46/heartjnl-2013-304739.PMC3841746.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Beard RW, Mowbray JF, Pinker GD.",Non-OADS,/arxiv_data1/oa_pdf/4b/34/medhum-2012-010284.PMC3841747.pdf
2012. http://www.nice.org.uk/CG154 104 Moscrop A. Med Humanit 2013; 39:98–104.,Non-OADS,/arxiv_data1/oa_pdf/4b/34/medhum-2012-010284.PMC3841747.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ sextrans-2012-050844).,Non-OADS,/arxiv_data1/oa_pdf/54/3e/sextrans-2012-050844.PMC3841748.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Abu-Raddad L, Akala FA, Semini I, et al.",Non-OADS,/arxiv_data1/oa_pdf/54/3e/sextrans-2012-050844.PMC3841748.pdf
2011. http://www.unaids.org/en/ media/unaids/contentassets/documents/unaidspublication/2011/JC2216_ WorldAIDSday_report_2011_en.pdf (accessed 3 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/54/3e/sextrans-2012-050844.PMC3841748.pdf
http://www.census.gov/ipc/www/idb/ (accessed 24 Jan 2013).,OADS,/arxiv_data1/oa_pdf/54/3e/sextrans-2012-050844.PMC3841748.pdf
http://www.unaids.org/en/dataanalysis/tools/incidencebymodesoftransmission/(accessed 30 April 2012).,OADS,/arxiv_data1/oa_pdf/54/3e/sextrans-2012-050844.PMC3841748.pdf
Spectrum/EPP 2011. http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/54/3e/sextrans-2012-050844.PMC3841748.pdf
"UNAIDS country database 2007. http://www.unaids.org/en/ CountryResponses/Countries/default.asp (accessed 24 Jan 2013).38 Magnani R, Sabin K, Saidel T, et al.",OADS,/arxiv_data1/oa_pdf/54/3e/sextrans-2012-050844.PMC3841748.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Maier PC, Funk J, Schwarzer G, et al .",Non-OADS,/arxiv_data1/oa_pdf/56/22/bjophthalmol-2013-303813.PMC3841749.pdf
HealthTechnology Assessment Programme; 2013. http://www.hta.ac.uk/protocols/ 200900220111.pdf (accessed July 2013).,Non-OADS,/arxiv_data1/oa_pdf/56/22/bjophthalmol-2013-303813.PMC3841749.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bierman AS.,Non-OADS,/arxiv_data1/oa_pdf/a3/f9/jech-2013-202731.PMC3841750.pdf
2007. http://www.who.int/social_determinants/resources/csdh_ framework_action_05_07.pdf (accessed 30 Jan 2013).,OADS,/arxiv_data1/oa_pdf/a3/f9/jech-2013-202731.PMC3841750.pdf
"Alma-Ata, USSR, 1978. http://www.who.int/publications/ almaata_declaration_en.pdf (accessed 1 Mar 2013) 27 World Health Organization.",Non-OADS,/arxiv_data1/oa_pdf/a3/f9/jech-2013-202731.PMC3841750.pdf
2009. http://www.phac-aspc.gc.ca/publicat/2009/ActNowBC/ section2-partie2-eng.php (accessed 19 Jun 2013).,OADS,/arxiv_data1/oa_pdf/a3/f9/jech-2013-202731.PMC3841750.pdf
"Health equity through intersectoral action: an analysis of 18 country case studies, 2008. http://www.phac-aspc.gc.ca/publicat/2008/hetia18-esgai18/pdf/hetia18-esgai18-eng.pdf (accessed 14 Dec 2012).34 Morestin F, Gauvin F-P, Hogue M-C, et al.Method for synthesizing knowledge about public policies .",Non-OADS,/arxiv_data1/oa_pdf/a3/f9/jech-2013-202731.PMC3841750.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Bishop D. An applied research model for the sport sciences.,Non-OADS,/arxiv_data1/oa_pdf/4a/90/bjsports-2013-092764.PMC3841751.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Mumtaz G, Hilmi N, Zidouh A, et al.HIV modes of transmission analysis in Morocco .",Non-OADS,/arxiv_data1/oa_pdf/5b/89/sextrans-2012-050918.PMC3841752.pdf
"Rabat, Morocco: Kingdom of Morocco, Ministry of Health, Department ofEpidemiology and Disease Control, 2010. http://www.unaids.org/en/media/unaids/ contentassets/documents/countryreport/2010/201008_MOT_Morocco_en.pdf (accessed 1 Oct 2012).",Non-OADS,/arxiv_data1/oa_pdf/5b/89/sextrans-2012-050918.PMC3841752.pdf
"http://www.scribd.com/doc/48059335/National-AIDS-Program-Egypt-2008 –2009-Report 3 Abu-Raddad LJ, Hilmi N, Mumtaz G, et al.",Non-OADS,/arxiv_data1/oa_pdf/5b/89/sextrans-2012-050918.PMC3841752.pdf
"Correspondence to Dr Anita E Heywood, School of Public Health andCommunity Medicine, UNSWMedicine, The University of New South Wales, Level 2, Samuels Building, Sydney,NSW 2052, Australia;a.heywood@unsw.edu.au Received 20 May 2013 Revised 15 July 2013 Accepted 19 July 2013Published Online First21 August 2013 ▸http://dx.doi.org/10.1136/ heartjnl-2013-304748 To cite: MacIntyre CR, Heywood AE, Kovoor P, et al.Heart 2013; 99: 1843–1848.ABSTRACT Background Abundant, indirect epidemiological evidence indicates that in ﬂuenza contributes to all-cause mortality and cardiovascular hospitalisations with studiesshowing increases in acute myocardial infarction (AMI)and death during the in ﬂuenza season.",Non-OADS,/arxiv_data1/oa_pdf/d2/aa/heartjnl-2013-304320.PMC3841753.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Nielsen J, Mazick A, Glismann S, et al.",OADS,/arxiv_data1/oa_pdf/d2/aa/heartjnl-2013-304320.PMC3841753.pdf
2006. http://www.wsahs.,Non-OADS,/arxiv_data1/oa_pdf/d2/aa/heartjnl-2013-304320.PMC3841753.pdf
"Canberra: Australian Government Department of Health and Ageing, 2011. http://www.aihw.gov.au (accessed Oct 2012).",Non-OADS,/arxiv_data1/oa_pdf/d2/aa/heartjnl-2013-304320.PMC3841753.pdf
"Canberra: Australian Government Department of Health and Ageing, 2010. http://www.aihw.gov.au (accessed Oct 2012).",Non-OADS,/arxiv_data1/oa_pdf/d2/aa/heartjnl-2013-304320.PMC3841753.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/postgradmedj-2012-131640).,Non-OADS,/arxiv_data1/oa_pdf/45/85/postgradmedj-2012-131640.PMC3841754.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bravo AA, Sheth SG, Chopra S. Liver biopsy.",Non-OADS,/arxiv_data1/oa_pdf/45/85/postgradmedj-2012-131640.PMC3841754.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2012-202031).,Non-OADS,/arxiv_data1/oa_pdf/25/26/annrheumdis-2012-202031.PMC3841758.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Symmons DP, Jones M, Osborne J, et al.",Non-OADS,/arxiv_data1/oa_pdf/25/26/annrheumdis-2012-202031.PMC3841758.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Mathers BM, Degenhardt L, Phillips B, et al.",Non-OADS,/arxiv_data1/oa_pdf/09/5c/sextrans-2013-051201.PMC3841763.pdf
"2012 2013. http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/IRIran%20AIDS%20Progress%20Report%202012%20English%20 ﬁnal1_1.pdf 6 Maity S, Nandi S, Biswas S, et al.",OADS,/arxiv_data1/oa_pdf/09/5c/sextrans-2013-051201.PMC3841763.pdf
"Integrated Prevention Services for HIV Infection, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis for Persons Who Use Drugs Illicitly: Summary Guidance from CDC and the U.S. Department of Health and Human Services, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6105a1.htm 12 Abu-Raddad LJ, Akala FA, Semini I. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action .",Non-OADS,/arxiv_data1/oa_pdf/09/5c/sextrans-2013-051201.PMC3841763.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 National HIV/AIDS committee.,Non-OADS,/arxiv_data1/oa_pdf/20/39/sextrans-2013-051028.PMC3841765.pdf
"AIDS Progress Report on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS, March 2012. http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/IRIran%20AIDS%20Progress%20Report%202012%20English%20 ﬁnal1_1.pdf 3 AIDS of ﬁce Ministry of Health.",Non-OADS,/arxiv_data1/oa_pdf/20/39/sextrans-2013-051028.PMC3841765.pdf
"http://www.who.int/hiv/strategic/en/ bss_fhi2000.pdf 8 Abu-raddad L, Akala FA, Semini I, et al.,Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for strategic action (Orientations inDevelopment) .",Non-OADS,/arxiv_data1/oa_pdf/20/39/sextrans-2013-051028.PMC3841765.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Zauber AG, Winawer SJ, O ’Brien MJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/63/3f/gutjnl-2012-303965.PMC3841766.pdf
To viewthese ﬁles please visit the journal online (http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/4c/gutjnl-2011-301785.PMC3841767.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Kaser A, Blumberg RS.",Non-OADS,/arxiv_data1/oa_pdf/c3/4c/gutjnl-2011-301785.PMC3841767.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ Khajehkazemi R, et al.Sex Transm Infect 2013; 89:iii29 –iii32.",Non-OADS,/arxiv_data1/oa_pdf/42/d8/sextrans-2013-051204.PMC3841768.pdf
http://www.iasociety.org/Abstracts/ A200720902.aspx (accessed 7 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/42/d8/sextrans-2013-051204.PMC3841768.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jclinpath-2012-201391).,Non-OADS,/arxiv_data1/oa_pdf/a5/be/jclinpath-2012-201391.PMC3841770.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Manni A, Arafah B, Pearson OH.",Non-OADS,/arxiv_data1/oa_pdf/a5/be/jclinpath-2012-201391.PMC3841770.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Cartwright K, Jones D, Smith A, et al.I nﬂuenza A and meningococcal disease.",Non-OADS,/arxiv_data1/oa_pdf/8a/fb/jclinpath-2013-201579.PMC3841771.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ jclinpath-2013-201728).,OADS,/arxiv_data1/oa_pdf/df/0d/jclinpath-2013-201728.PMC3841772.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Peters S, Adjei AA, Gridelli C, et al.",Non-OADS,/arxiv_data1/oa_pdf/df/0d/jclinpath-2013-201728.PMC3841772.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 McFarland W, Abu-Raddad LJ, Mahfoud Z, et al.",Non-OADS,/arxiv_data1/oa_pdf/d2/17/sextrans-2013-051169.PMC3841785.pdf
http://www.who.int/ vaccine_research/diseases/soa_std/en/index1.html 4 International Organization for Migration.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/sextrans-2013-051169.PMC3841785.pdf
"Paper Veterinary Record | November 16, 2013of these can be found on the HMA website at http://mri.medagencies.",Non-OADS,/arxiv_data1/oa_pdf/7e/42/vetrec-2012-101454.PMC3841786.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ References BARBOSA, T .",Non-OADS,/arxiv_data1/oa_pdf/7e/42/vetrec-2012-101454.PMC3841786.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jnnp-2012-304700).,Non-OADS,/arxiv_data1/oa_pdf/a9/fe/jnnp-2012-304700.PMC3841793.pdf
"Lateral ﬂexion was measured using an iPhone application goniom-eter (Y ong Li, Angle protractor V .1.0, 2010,retrieved from http://itunes.apple.com/) which mea-sured the angle of deviation from the vertical.",OADS,/arxiv_data1/oa_pdf/a9/fe/jnnp-2012-304700.PMC3841793.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Doherty KM, van de Warrenburg BP, Peralta MC, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/fe/jnnp-2012-304700.PMC3841793.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Health Protection Agency (HPA).,Non-OADS,/arxiv_data1/oa_pdf/ea/a0/practneurol-2013-000689.PMC3841794.pdf
"2008. http://www.bhiva.org/documents/Guidelines/T esting/GlinesHIVT est08.pdf 9 Solomon T , Michael BD, Smith PE, et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/a0/practneurol-2013-000689.PMC3841794.pdf
"http://www.rcplondon.ac.uk/sites/default/files/testing-for-hiv-concise-guideline.pdf 16 Benjamin LA, Bryer A, Emsley HC, et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/a0/practneurol-2013-000689.PMC3841794.pdf
"Health Protection Agency Report, September 2011. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1316424799217 20 Evidence and resources to commission expanded HIV testing in priority medical services in high prevalence areas .",Non-OADS,/arxiv_data1/oa_pdf/ea/a0/practneurol-2013-000689.PMC3841794.pdf
"Health protection Agency Report, April 2012. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317133743551EDITORIAL 356 Nightingale S, et al.Pract Neurol 2013; 13:354–356.",Non-OADS,/arxiv_data1/oa_pdf/ea/a0/practneurol-2013-000689.PMC3841794.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Laurenzi GA, Potter RT, Kass EH.",Non-OADS,/arxiv_data1/oa_pdf/b4/84/thoraxjnl-2012-202917.PMC3841796.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Olesen J, Bousser MG, Diener HC, et al.",Non-OADS,/arxiv_data1/oa_pdf/f6/48/jnnp-2013-305197.PMC3841803.pdf
http://www.lightspeedresearch.com 14 STATA Data Analysis and Statistical Software.,OADS,/arxiv_data1/oa_pdf/f6/48/jnnp-2013-305197.PMC3841803.pdf
"http://www.stata.com 15 Stewart WF, Lipton RB, Dowson AJ, et al.",OADS,/arxiv_data1/oa_pdf/f6/48/jnnp-2013-305197.PMC3841803.pdf
"Niels Lynøe,1Madeleine Leijonhufvud2 1Centre for Healthcare Ethics (CHE), Karolinska Institutet,Stockholm, Sweden 2Department of Law, Stockholm University, Stockholm, Sweden Correspondence to Professor Niels Lynøe, CHE, Karolinska Institutet, 171 77, Stockholm, Sweden;niels.lynoe@ki.se Received 20 March 2012 Revised 16 July 2012 Accepted 31 July 2012 Published Online First30 July 2013 ▸http://dx.doi.org/10.1136/ medethics-2012-100998 ▸http://dx.doi.org/10.1136/ medethics-2012-101000▸http://dx.doi.org/10.1136/ medethics-2013-101724 To cite: Lynøe N, Leijonhufvud M. J Med Ethics 2013; 39:772–775.ABSTRACT During spring 2009 a Swedish senior paediatricintensivist and associate professor was detained andlater prosecuted for mercy-killing a child with severebrain damage.",Non-OADS,/arxiv_data1/oa_pdf/38/8d/medethics-2012-100681.PMC3841804.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Norman E, Malmqvist U, Westrin P, et al.",Non-OADS,/arxiv_data1/oa_pdf/38/8d/medethics-2012-100681.PMC3841804.pdf
http://www.socialstyrelsen.se/sosfs/2011-7 (accessed 5 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/38/8d/medethics-2012-100681.PMC3841804.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Kelsey CR, Marks LB, Hollis D, et al.",Non-OADS,/arxiv_data1/oa_pdf/01/ff/thoraxjnl-2012-203021.PMC3841805.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Stanier P, Moore G. Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts.",Non-OADS,/arxiv_data1/oa_pdf/9c/6a/archdischild-2013-304271.PMC3841806.pdf
"Health and Social Care Information Centre, 2010. http://www.hscic.gov.uk/hes 8O f ﬁce of the Deputy Prime Minister.",Non-OADS,/arxiv_data1/oa_pdf/9c/6a/archdischild-2013-304271.PMC3841806.pdf
"Emergency/disaster medical support in the restoration project for the Fukushima nuclear power plant accident Naoto Morimura,1,2Yasushi Asari,1Yoshihiro Yamaguchi,1,2Kazunari Asanuma,2 Choichiro Tase,1,2Tetsuya Sakamoto,1,2Tohru Aruga,1,2Members of the Japanese Association for Acute Medicine, Emergency, Task Force on the Fukushima Nuclear Power Plant Accident ( JAAM-TF-FNPPA)1 ▸Additional supplementary data are published online only.To view this ﬁle please visit the journal online (http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a5/ba/emermed-2012-201629.PMC3841807.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Tanigawa K, Hosoi Y, Terasawa S, et al.",OADS,/arxiv_data1/oa_pdf/a5/ba/emermed-2012-201629.PMC3841807.pdf
2 http://radioactivity.mext.go.jp/old/ja/1270/2011/05/1305820_20110506.pdf (accessed 6 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/a5/ba/emermed-2012-201629.PMC3841807.pdf
3 http://energy.gov/situation-japan-updated-8312 (accessed 6 Oct 2012).,OADS,/arxiv_data1/oa_pdf/a5/ba/emermed-2012-201629.PMC3841807.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/thoraxjnl-2012-203129).,Non-OADS,/arxiv_data1/oa_pdf/ea/be/thoraxjnl-2012-203129.PMC3841809.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bernard S LBP, Whittom F, Carrier G, et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/be/thoraxjnl-2012-203129.PMC3841809.pdf
The table found at the following website shows the LMM’s sys- tem for classifying variants according to available evidence:  http://pcpgm.partners.org/sites/default/files/LMM/Resources/ LMM_VariantClassification_05.26.11.pdf.,OADS,/arxiv_data1/oa_pdf/47/99/gim201219a.PMC3841913.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Long‑term therapeutic effects of corticoamygdalohippocampectomy  for bilateral mesial temporal lobe epilepsy Zhang Guangming, Zhou Wenjing, Lin Jiuluan, Sun Zhaohui, Zhang Bingqing,   Sun Gaoxiang, Zuo Huancong Epilepsy Center, Neurosurgery Department of Yuquan Hospital Tsinghua University, Beijing, China E‑mail: *Zhang Guangming ‑ zgm05@hotmail.com; Zhou Wenjing ‑ closejeo@hotmail.com; Lin Jiuluan ‑ fj090@sohu.com; Sun Zhaohui ‑ sunzhaohui2000@hotmail.com;  Zhang Bingqing ‑ bingqing_80@163.com; Sun Gaoxiang ‑ sun‑soar@163.com; Zuo Huancong ‑ zuohc@mail.tsinghua.edu.cn   *Corresponding author Received: 08 September 13   Accepted: 17 October 13  Published: 14 November 13 Abstract Background:  Some cases of paradoxical mesial temporal lobe epilepsy (MTLE)  are shown to be bilateral MTLE (BMTLE) by intracranial electrodes.",Non-OADS,/arxiv_data1/oa_pdf/d9/78/SNI-4-147.PMC3841918.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/147/121405 Copyright: © 2013 Guangming Z.,Non-OADS,/arxiv_data1/oa_pdf/d9/78/SNI-4-147.PMC3841918.pdf
"Surgical Neurology International 2013, 4:147  http://www.surgicalneurologyint.com/content/4/1/147However, it is difficult to lateralize paradoxical MTLE  through noninvasive methods (paradoxical in semiology,  electroencephalography (EEG), imaging and positron  emission tomography and computerized tomography  (PET‑CT)).",Non-OADS,/arxiv_data1/oa_pdf/d9/78/SNI-4-147.PMC3841918.pdf
"Surgical Neurology International 2013, 4:147  http://www.surgicalneurologyint.com/content/4/1/147quotient (73.7, 77.3, and 73) at the different postoperative  times were approximately the same.",OADS,/arxiv_data1/oa_pdf/d9/78/SNI-4-147.PMC3841918.pdf
"Surgical Neurology International 2013, 4:147  http://www.surgicalneurologyint.com/content/4/1/147The postoperative average memory quotients at  different times were lower than the preoperative values.",Non-OADS,/arxiv_data1/oa_pdf/d9/78/SNI-4-147.PMC3841918.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Method for securing titanium cerebellar retractors Lindsay J. Lipinski1,2, Regis G. Hoppenot1,2, Robert A. Fenstermaker1,2, Andrew J. Fabiano1,2 1Department of Neurosurgery, Roswell Park Cancer Institute, 2Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo,  State University of New York; Buffalo, NY , USA E‑mail:  Lindsay J. Lipinski ‑ llipinski@ubns.com; Regis G. Hoppenot ‑ Regis.hoppenot@gmail.com; Robert A. Fenstermaker ‑ robert.fenstermaker@roswellpark.org;  *Andrew J. Fabiano ‑ Andrew .Fabiano@roswellpark.org   *Corresponding author Received: 19 September 13  Accepted: 08 October 13  Published: 14 November 13 INTRODUCTION The increasing use of intraoperative magnetic resonance  imaging (ioMRI) and electromagnetic neuronavigation  has necessitated the use of titanium instruments during  craniotomies.",Non-OADS,/arxiv_data1/oa_pdf/2b/8c/SNI-4-146.PMC3841919.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/146/121404 Copyright: © 2013 Lipinski LJ.,Non-OADS,/arxiv_data1/oa_pdf/2b/8c/SNI-4-146.PMC3841919.pdf
"Surgical Neurology International 2013, 4:146  http://www.surgicalneurologyint.com/content/4/1/146describe a simple technique for securing titanium  retractors to maintain their positioning during surgery and avoid the difficulties typically associated with their  use.",Non-OADS,/arxiv_data1/oa_pdf/2b/8c/SNI-4-146.PMC3841919.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comReview Article What the neurosurgeon should know about hemangioblastoma,  both sporadic and in Von Hippel‑Lindau disease: A literature review Sven Bamps, Frank Van Calenbergh, Steven De Vleeschouwer, Johannes Van Loon,   Raf Sciot1, Eric Legius2, Jan Goffin Departments of Neurosurgery, 1Morphology and Molecular Pathology, 2Human Genetics, University Hospitals Leuven, Herestraat, Belgium E‑mail: *Sven Bamps ‑ sven.bamps@uzleuven.be; Frank Van Calenbergh: frank.vancalenbergh@uzleuven.be;   Steven De Vleeschouwer ‑ steven.devleeschouwer@uzleuven.be; Johannes Van Loon ‑ Johannes.vanloon@uzleuven.be; Raf Sciot ‑ raf.sciot@uzleuven.be;   Eric Legius ‑ eric.legius@uzleuven.be; Jan Goffin ‑ jan.goffin@uzleuven.be   *Corresponding author: Received: 26 August 13  Accepted: 28 September 13  Published: 08 November 13 Abstract Background: Hemangioblastomas are associated with Von Hippel‑Lindau  disease (VHLD) in 10‑40% of cases.",Non-OADS,/arxiv_data1/oa_pdf/3c/4e/SNI-4-145.PMC3841920.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/145/121110 Copyright: © 2013 Bamps S.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/3c/4e/SNI-4-145.PMC3841920.pdf
"Surgical Neurology International 2013, 4:145  http://www.surgicalneurologyint.com/content/4/1/145caused by a mutation in the VHL gene on chromosome  3p25‑6 resulting in the loss of the pVHL tumor suppressor  protein function.",Non-OADS,/arxiv_data1/oa_pdf/3c/4e/SNI-4-145.PMC3841920.pdf
"Surgical Neurology International 2013, 4:145  http://www.surgicalneurologyint.com/content/4/1/145and atypia, in contrast to absence of mitotic activity, are  a very typical pattern of hemangioblastomas.",Non-OADS,/arxiv_data1/oa_pdf/3c/4e/SNI-4-145.PMC3841920.pdf
"Surgical Neurology International 2013, 4:145  http://www.surgicalneurologyint.com/content/4/1/145literature.",Non-OADS,/arxiv_data1/oa_pdf/3c/4e/SNI-4-145.PMC3841920.pdf
"Surgical Neurology International 2013, 4:145  http://www.surgicalneurologyint.com/content/4/1/145epidydimis and broad ligament only are mandatory on  indication.",Non-OADS,/arxiv_data1/oa_pdf/3c/4e/SNI-4-145.PMC3841920.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report An unusual case of pediatric bow hunter’s stroke Tony I. Anene‑Maidoh, Rafael A. Vega, Gregory L. Fautheree1, John F .",Non-OADS,/arxiv_data1/oa_pdf/ec/6a/SNI-4-148.PMC3841921.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/148/121647 Copyright: © 2013 Anene-Maidoh TI.,Non-OADS,/arxiv_data1/oa_pdf/ec/6a/SNI-4-148.PMC3841921.pdf
"Surgical Neurology International 2013, 4:148  http://www.surgicalneurologyint.com/content/4/1/148Overall, the incidence of BHS is rare, and there are  about 60 reported cases in the literature.",Non-OADS,/arxiv_data1/oa_pdf/ec/6a/SNI-4-148.PMC3841921.pdf
"Surgical Neurology International 2013, 4:148  http://www.surgicalneurologyint.com/content/4/1/148Since the patient had further thrombotic episodes  due to the dissection, he was admitted and placed on  325 mg aspirin, clopidrogrel (300 mg load followed by  75 mg daily), and a heparin infusion.",Non-OADS,/arxiv_data1/oa_pdf/ec/6a/SNI-4-148.PMC3841921.pdf
"Surgical Neurology International 2013, 4:148  http://www.surgicalneurologyint.com/content/4/1/148Finally, sacrifice of the affected artery is the least  common treatment, but is occasionally required.",Non-OADS,/arxiv_data1/oa_pdf/ec/6a/SNI-4-148.PMC3841921.pdf
"Surgical Neurology International 2013, 4:148  http://www.surgicalneurologyint.com/content/4/1/1489.",Non-OADS,/arxiv_data1/oa_pdf/ec/6a/SNI-4-148.PMC3841921.pdf
"Surgical Neurology International 2013, 4:148  http://www.surgicalneurologyint.com/content/4/1/1483.",Non-OADS,/arxiv_data1/oa_pdf/ec/6a/SNI-4-148.PMC3841921.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Ruptured mycotic cerebral aneurysm development from  pseudoocclusion due to septic embolism Grant C. Sorkin1,4, Naser Jaleel1,4, Maxim Mokin1,4, Travis M. Dumont1,4, Jorge L. Eller1,4,  Adnan H. Siddiqui1,2,3,4 Departments of 1Neurosurgery, 2Radiology, School of Medicine and Biomedical Sciences, and 3T oshiba Stroke and Vascular Research Center, University at Buffalo,  State University of New York and 4Department of Neurosurgery, Gates Vascular Institute, Kaleida Health, Buffalo, New York, USA E‑mail:  Grant C. Sorkin ‑ Gsorkin@ubns.com; Naser Jaleel ‑ njaleel@ubns.com; Maxim Mokin ‑ mmokin@ubns.com;   Travis M. Dumont ‑ travisdumont@gmail.com; Jorge L. Eller ‑ ellerj@hotmail.com; *Adnan H. Siddiqui ‑ asiddiqui@ubns.com   *Corresponding author Received: 16 April 13  Accepted: 03 October 13  Published: 08 November 13 Abstract Background:  Cerebral mycotic aneurysms are rare sequelae of systemic infections  that can cause profound morbidity and mortality with rupture.",Non-OADS,/arxiv_data1/oa_pdf/f9/7f/SNI-4-144.PMC3841922.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/144/121109 Copyright: © 2013 Sorkin GC.,Non-OADS,/arxiv_data1/oa_pdf/f9/7f/SNI-4-144.PMC3841922.pdf
"Surgical Neurology International 2013, 4:144  http://www.surgicalneurologyint.com/content/4/1/144INTRODUCTION Cerebral mycotic aneurysms are rare sequelae of systemic  infections that can cause profound morbidity and  mortality with rupture.",Non-OADS,/arxiv_data1/oa_pdf/f9/7f/SNI-4-144.PMC3841922.pdf
"Surgical Neurology International 2013, 4:144  http://www.surgicalneurologyint.com/content/4/1/144associated with a large intracerebral hemorrhage and midline  shift [ Figure s 5‑8].",Non-OADS,/arxiv_data1/oa_pdf/f9/7f/SNI-4-144.PMC3841922.pdf
"Surgical Neurology International 2013, 4:144  http://www.surgicalneurologyint.com/content/4/1/144formation.",Non-OADS,/arxiv_data1/oa_pdf/f9/7f/SNI-4-144.PMC3841922.pdf
"Surgical Neurology International 2013, 4:144  http://www.surgicalneurologyint.com/content/4/1/144factor for local mycotic aneurysm formation.",Non-OADS,/arxiv_data1/oa_pdf/f9/7f/SNI-4-144.PMC3841922.pdf
"Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S353Are recommended spine operations either unnecessary or too  complex?",Non-OADS,/arxiv_data1/oa_pdf/df/46/SNI-4-353.PMC3841934.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/6/353/120774 Copyright: © 2013 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/df/46/SNI-4-353.PMC3841934.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S359Spontaneous spinal epidural hematoma and spinal cord infarction  following orthotopic liver transplantation: Case report and review of the literature Colin C. Buchanan, Daniel C. Lu, Corinne Buchanan1, Tram T .",Non-OADS,/arxiv_data1/oa_pdf/a1/eb/SNI-4-359.PMC3841936.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/6/359/120775 Copyright: © 2013 Buchanan CC.,Non-OADS,/arxiv_data1/oa_pdf/a1/eb/SNI-4-359.PMC3841936.pdf
"Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S362Vertebral artery injuries in cervical spine surgery Gregory D. Schroeder, Wellington K. Hsu Department of Orthopaedic Surgery, Northwestern University, 676 N. Saint Clair, Suite 1350, Chicago, IL, 60611, USA E-mail: *Gregory D. Schroeder - g-schroeder@md.northwestern.edu; Wellington K. Hsu - whsu@nmff.org *Corresponding author Received: 29 June 13   Accepted: 05 August 13  Published: 29 October 13 Abstract Background:  Vertebral artery injuries during cervical spine surgery are rare, but  potentially fatal.",Non-OADS,/arxiv_data1/oa_pdf/65/cb/SNI-4-362.PMC3841937.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/6/362/120777 Copyright: © 2013 Schroeder GD.,Non-OADS,/arxiv_data1/oa_pdf/65/cb/SNI-4-362.PMC3841937.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S368Primary elective spine arthrodesis: Audit of institutional cross  matched to transfused (C/T) ratio to develop blood product ordering guidelines Muhammad Mehboob Alam, Zain A. Sobani1, Muhammad Shahzad Shamim, Khabir Ahmad2, Fouzia Minai3 Departments of Neurosurgery, 1Biological and Biomedical Sciences, 2Ophthalmology, 3Anesthesiology, Aga Khan University, Karachi, Pakistan E-mail: Mehboob Alam - muhammad.alam@aku.edu; Zain Sobani - zsobani@gmail.com; *Muhammad Shahzad Shamim - shahzad.shamim@aku.ed u; Khabir Ahmed - khabir.ahmad@aku.edu; Fouzia Minai - fauzia.minai@aku.edu*Corresponding author Received: 19 June 13   Accepted: 19 August 13  Published: 29 October 13 Access this article  online Website: www.surgicalneurologyint.com DOI: 10.4103/2152-7806.120778 Quick Response Code: Abstract Background:  Currently, there are no uniform guidelines regarding the appropriate  amount of blood products ordered prior to spine surgery.",Non-OADS,/arxiv_data1/oa_pdf/d6/0e/SNI-4-368.PMC3841938.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/6/368/120778 Copyright: © 2013 Alam MM.,Non-OADS,/arxiv_data1/oa_pdf/d6/0e/SNI-4-368.PMC3841938.pdf
"Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S373Editorial on two chronic low back pain studies: A major change in  surgical management of disc disease?",Non-OADS,/arxiv_data1/oa_pdf/79/f3/SNI-4-373.PMC3841939.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/6/373/120780 Copyright: © 2013 Pawl R. This is an open-access article distributed under the terms of the Creative Commons Attribution Licens e, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/79/f3/SNI-4-373.PMC3841939.pdf
"Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S375$QDO\VLVRILQWHUSURYLGHUFRQÀLFWVDPRQJKHDOWKFDUHSURYLGHUV Mona Stecker, Nancy Epstein, Mark M. Stecker1 Department of Patient Care Services,  Winthrop University Hospital, 1Chairman of Neuroscience, Winthrop University Hospital, 222 Station Plaza North, Suite  408, Mineola, NY 11501, USA E-mail: Mona Stecker - mkstecker@Winthrop.org; Nancy Epstein - nancy.epsteinmd@gmail.com; *Mark M. Stecker - MStecker@Winthrop.org *Corresponding author Received: 03 July 13   Accepted: 13 August 13  Published: 29 October 13 Abstract Background: Patient safety is a top priority of healthcare organizations.",Non-OADS,/arxiv_data1/oa_pdf/13/d5/SNI-4-375.PMC3841940.pdf
"[5] With Institutional  Review Board (IRB#12439) approval, the Provider Conflict  Questionnaire (PCQ) questionnaire [Table 1] was distributed  via email to nursing and physician groups across the US and through a predetermined e-mail list; the survey was placed online at https://www.surveymonkey.com/s/pconflictsurvey.",Non-OADS,/arxiv_data1/oa_pdf/13/d5/SNI-4-375.PMC3841940.pdf
"Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S392Infection with spinal instrumentation: Review of pathogenesis,  diagnosis, prevention, and management Manish K. Kasliwal, Lee A. Tan, Vincent C. Traynelis Department of Neurosurgery, RUSH University Medical Center Chicago, IL, USA E-mail: Manish K. Kasliwal - manish_kasliwal@rush.edul; Lee A. Tan - lee_tan@rush.edu; *Vincent C. Traynelis - vincent_traynelis@r ush.edu *Corresponding author Received: 07 March 13  Accepted: 06 June 13  Published: 29 October 13 Abstract Background:  Instrumentation has become an integral component in the  management of various spinal pathologies.",Non-OADS,/arxiv_data1/oa_pdf/b1/da/SNI-4-392.PMC3841941.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/6/392/120783 Copyright: © 2013 Kasliwal MK.,Non-OADS,/arxiv_data1/oa_pdf/b1/da/SNI-4-392.PMC3841941.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S404A blunt needle (Epimed®) does not eliminate the risk of vascular  penetration during transforaminal epidural injection Yashar Ilkhchoui, Eugene Koshkin Department of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA E-mail: *Yashar Ilkhchoui - yilkhchoui@salud.unm.edu; Eugene Koshkin - ekoshkin@salud.unm.edu *Corresponding author Received: 06 August 13   Accepted: 22 August 13  Published: 29 October 13 Abstract Background: Transforaminal epidural injection of local anesthetics and  corticosteroids is a common practice in patients with radicular pain.",Non-OADS,/arxiv_data1/oa_pdf/ee/0b/SNI-4-404.PMC3841942.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/6/404/120784 Copyright: © 2013 Ilkhchoui Y.,Non-OADS,/arxiv_data1/oa_pdf/ee/0b/SNI-4-404.PMC3841942.pdf
"[6]  United Nations, International response to Malian refugee crisis severely underfunded – UN top official, 2012 http://www.un.org/-apps/news/story.asp?NewsID=42611#.UQPbp7_Aexo [7]  Dobricki M, Komproe IH, de Jong JT, Maercker A.",Non-OADS,/arxiv_data1/oa_pdf/a0/88/CPEMH-9-189.PMC3841965.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/88/CPEMH-9-189.PMC3841965.pdf
Available from: http://www.who.int/cancer/ detection/breastcancer/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/69/ee/PRev-7-117.PMC3841989.pdf
Available from: http://www.ekoloji.com.tr/ [Last  accessed on 2013 Feb 10].,Non-OADS,/arxiv_data1/oa_pdf/c4/50/PRev-7-140.PMC3841992.pdf
Available from:  http://www.schweizerbart.de/journals/botjb [Last accessed on  2013 Feb 10].,Non-OADS,/arxiv_data1/oa_pdf/c4/50/PRev-7-140.PMC3841992.pdf
Available from:  http://www.ijpbs.net/ [Last accessed on 2013 Feb 10].,Non-OADS,/arxiv_data1/oa_pdf/c4/50/PRev-7-140.PMC3841992.pdf
Available from: http://jsmj.ajums.,Non-OADS,/arxiv_data1/oa_pdf/c4/50/PRev-7-140.PMC3841992.pdf
Available  from: http://btd.anadolu.edu.tr/index.php/BTDC/article/viewFile/ 73/31 [Last accessed on 2013 Feb 10].,Non-OADS,/arxiv_data1/oa_pdf/c4/50/PRev-7-140.PMC3841992.pdf
Available from: http://www.landesmuseum.at/pdf_frei_remote/ ANNA_75_0059 -0065.pdf [Last accessed on 2013 Feb 10].,Non-OADS,/arxiv_data1/oa_pdf/c4/50/PRev-7-140.PMC3841992.pdf
Available from: http://www.umm.edu/ altmed/articles/calendula -000228.htm.,Non-OADS,/arxiv_data1/oa_pdf/10/6e/PRev-7-179.PMC3841996.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/a3/37/PRev-7-97.PMC3842001.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/a3/37/PRev-7-97.PMC3842001.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International S383The need to add motor evoked potential monitoring to  somatosensory and electromyographic monitoring in cervical spine surgery Nancy E. Epstein Chief of Neurosurgical Spine and Education, Winthrop University Hospital, Mineola, NY 11051, USA E-mail: *Nancy E. Epstein - nancy.epsteinmd@gmail.com *Corresponding author Received: 22 August 13  Accepted: 26 August 13  Published: 29 October 13 Abstract Intraoperative neural monitoring (IONM), utilizing somatosensory evoked  potentials (SEP) and electromyography (EMG), was introduced to cervical spine surgery in the late 1980’s.",Non-OADS,/arxiv_data1/oa_pdf/18/5e/SNI-4-383.PMC3842003.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/6/383/120782 Copyright: © 2013 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/18/5e/SNI-4-383.PMC3842003.pdf
"An analysis basedon the access to a popular web-capture service site (http://www.cman.jp/BrowserCapture/browser/share_201112.html) suggest thatthe shares for Windows and Mac OS among computer users in Japanat the time of web questionnaire (December 2011) were 90.3% and7.3%, respectively.",OADS,/arxiv_data1/oa_pdf/ff/90/srep03354.PMC3842081.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3354 | DOI: 10.1038/srep03354 5",Non-OADS,/arxiv_data1/oa_pdf/ff/90/srep03354.PMC3842081.pdf
"In the present study, we searched the off-target sites that exactly matches 12–13 bases at the 3 9end and the NGG (N can be A, G, C, or T) with free software, Bowtie (http://bowtie-bio.sourceforge.",OADS,/arxiv_data1/oa_pdf/c0/5a/srep03355.PMC3842082.pdf
The plasmids expressing hCas9 and sgRNA were prepared by ligating oligos into BbsI site of pX330 (http://www.addgene.org/42230/) 7.,OADS,/arxiv_data1/oa_pdf/c0/5a/srep03355.PMC3842082.pdf
"Off target analysis .Potential off-target sites were found using a free software, Bowtie (http://bowtie-bio.sourceforge.net/index.shtml) with rules outlined previously 8,13.",OADS,/arxiv_data1/oa_pdf/c0/5a/srep03355.PMC3842082.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c0/5a/srep03355.PMC3842082.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3355 | DOI: 10.1038/srep03355 6",Non-OADS,/arxiv_data1/oa_pdf/c0/5a/srep03355.PMC3842082.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3350 | DOI: 10.1038/srep03350 7",Non-OADS,/arxiv_data1/oa_pdf/b1/b0/srep03350.PMC3842083.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3353 | DOI: 10.1038/srep03353 9",Non-OADS,/arxiv_data1/oa_pdf/1b/62/srep03353.PMC3842084.pdf
"The SPP-EFM- GUI, the graphical user interface we developed under MATLAB, for image acquisi- tion, processing and analysis, can be downloaded from The software can be down- loaded from: http://www.lilliu.co.uk/toolboxes/SPM/SPC-EFM_GUI.zip.",OADS,/arxiv_data1/oa_pdf/1b/54/srep03352.PMC3842085.pdf
A videotutorial on the SPP-EFM-GUI is available at the following link: http://www.youtube.,Non-OADS,/arxiv_data1/oa_pdf/1b/54/srep03352.PMC3842085.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1b/54/srep03352.PMC3842085.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3352 | DOI: 10.1038/srep03352 7",Non-OADS,/arxiv_data1/oa_pdf/1b/54/srep03352.PMC3842085.pdf
"The C. elegans Research Community, WorkBook, http://dx.doi.org/10.1895/wormbook.",Non-OADS,/arxiv_data1/oa_pdf/43/c8/srep03247.PMC3842086.pdf
"The C. elegans Research Community, WormBook, http://dx.doi.org/10.1895/wormbook.1.126.2.",Non-OADS,/arxiv_data1/oa_pdf/43/c8/srep03247.PMC3842086.pdf
All authors reviewedand approved the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/43/c8/srep03247.PMC3842086.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3247 | DOI: 10.1038/srep03247 8",Non-OADS,/arxiv_data1/oa_pdf/43/c8/srep03247.PMC3842086.pdf
"Mathematics of the Discrete Fourier Transform (DFT) with Audio Applications (W3K Publishing, http://books.w3k.org/, 2007).",Non-OADS,/arxiv_data1/oa_pdf/44/0b/srep03351.PMC3842087.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/44/0b/srep03351.PMC3842087.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3351 | DOI: 10.1038/srep03351 5",Non-OADS,/arxiv_data1/oa_pdf/44/0b/srep03351.PMC3842087.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/52/hyt140.PMC3842101.pdf
"http://hdrstats.undp.org/images/explanations/BGD.pdf(09 October 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/25/52/hyt140.PMC3842101.pdf
"http://www.ban.searo.who.int/en/ Section25.htm (25 August 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/25/52/hyt140.PMC3842101.pdf
"http://www.bangladesh.gov.bd/index.php?Option=com_ content&task=category&id=67&Itemid=27 (29 April 2013, date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/25/52/hyt140.PMC3842101.pdf
"http://www.ban.searo.who.int/LinkFiles/Publication_Cancer_Strategy.pdf.pdf (14 August 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/25/52/hyt140.PMC3842101.pdf
Cancer Registry Report National Institute of Cancer Research and Hospital 2005–07 http://whobangladesh.healthrepository.org/bitstream/1168 Cancer control in Bangladesh,Non-OADS,/arxiv_data1/oa_pdf/25/52/hyt140.PMC3842101.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/f6/mzt069.PMC3842126.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/6f/sft107.PMC3842150.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/71/sft112.PMC3842151.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/68/ddt367.PMC3842174.pdf
"Haplotype analysis Sixty tagged SNPs spanning the ABCA4 gene were selected from the International HapMap Project (http://hapmap.ncbi.nlm.nih.gov) (Supplementary Material, Table S1).",OADS,/arxiv_data1/oa_pdf/dc/68/ddt367.PMC3842174.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/d3/ndt-9-1811.PMC3842215.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1811–1813Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1811Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S3592 2Duloxetine in panic disorder with somatic   gastric pain Matteo preve1 Cristiana Nisita1 Massimo Bellini2 Liliana Dell’osso1 1Department of p sychiatry,   Neurobiology, pharmacology and  Biotechnology, 2Department of  Gastroenterology, Gastrointestinal  Unit, University of pisa, pisa, Italy Correspondence: Matteo preve   Department of psychiatry, Neurobiology,  pharmacology and Biotechnology,  University of pisa, via roma 67,   56100 pisa, Italy   Fax +39 0509 93267   email m_preve@yahoo.co mAbstract:  Panic disorder is the most common type of anxiety disorder, and its most common  expression is panic attacks characterized with sudden attacks of anxiety with numerous symp - toms, including palpitations, tachycardia, tachypnea, nausea, and vertigo: ie, cardiovascular,  gastroenterologic, respiratory, and neuro-otologic symptoms.",Non-OADS,/arxiv_data1/oa_pdf/e3/d3/ndt-9-1811.PMC3842215.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e3/d3/ndt-9-1811.PMC3842215.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/d3/ndt-9-1811.PMC3842215.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/78/copd-8-591.PMC3842216.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Chronic Obstructive Pulmonary Disease 2013:8 591–594International Journal of Chronic Obstructive Pulmonary Disease Dove press submit your manuscript | www.dovepress.co m Dove press  591OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5068 0Diagnostic electrocardiographic dyad criteria   of emphysema in left ventricular hypertrophy swapnil s lanjewar1 lovely Chhabra1 Vinod K Chaubey1 saurabh Joshi1 ganesh Kulkarni1 Chandrasekhar  Kothagundla1 sudesh Kaul1 David h spodick2 1Department of Internal Medicine,   2Department of Cardiovascular  Medicine, saint Vincent hospital,   University of Massachusetts Medical  school, Worcester, M a, Usa Correspondence: lovely Chhabra   saint Vincent hospital, University   of Massachusetts Medical school,   123 summer street, Worcester,   Ma 01608, Usa   Tel +1 508 667 5052   Fax +1 888 598 6647   email lovids@hotmail.co mBackground:  The electrocardiographic diagnostic dyad of emphysema, namely a combination  of the frontal vertical P-vector and a narrow QRS duration, can serve as a quasidiagnostic  marker for emphysema, with specificity close to 100%.",Non-OADS,/arxiv_data1/oa_pdf/c7/78/copd-8-591.PMC3842216.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c7/78/copd-8-591.PMC3842216.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/78/copd-8-591.PMC3842216.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/c1/copd-8-581.PMC3842217.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 581–589International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  581OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5361 9noninvasive positive pressure ventilation   in subjects with s table COPD: a randomized trial surya P Bhatt1 Michael W Peterson2 Jeffrey s Wilson1 lakshmi Durairaj1 1Division of Pulmonary, Critical  Care, and Occupational Medicine,   Department of Internal Medicine,   roy J and lucille a, Carver College of  Medicine, University of Iowa hospital,   Iowa City, Ia, Usa; 2Department  of Medicine, UC sF Fresno Medical  education Program, Fresno, C a, Usa Correspondence: lakshmi Durairaj   Division of Pulmonary, Critical Care,   and Occupational Medicine,   Department of Internal Medicine,   roy J and lucille a, Carver College of  Medicine, University of Iowa hospital,  Iowa City, Ia 52242, Usa   Tel +1 319 356 2653   Fax +1 319 353 6406   email lakshmi-durairaj@uiowa.ed uBackground:  The use of domiciliary noninvasive positive pressure ventilation (NPPV) in  stable chronic obstructive pulmonary disease (COPD) with chronic hypercapnic respiratory  failure has yielded variable effects on survival, quality of life, and dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/34/c1/copd-8-581.PMC3842217.pdf
Available from: http://clinicaltrials.gov/show/NCT01722773.,Non-OADS,/arxiv_data1/oa_pdf/34/c1/copd-8-581.PMC3842217.pdf
Available  from: http://www.thoracic.org/clinical/copd-guidelines /.,Non-OADS,/arxiv_data1/oa_pdf/34/c1/copd-8-581.PMC3842217.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/34/c1/copd-8-581.PMC3842217.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/c1/copd-8-581.PMC3842217.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/43/copd-8-569.PMC3842218.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 569–579International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  569OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S4930 7effect of high-dose n-acetylcysteine on airway  geometry, inflammation, and oxidative stress   in COPD patients Jan De Backer1 Wim Vos1 Cedric Van holsbeke1 samir Vinchurkar1 rita Claes2 Paul M Parizel3 Wilfried De Backer2 1FluidD a nv,  Kontich, Belgium;   2Department respiratory Medicine,   University hospital, antwerp, Belgium;   3Department radiology, University  hospital,  antwerp, Belgium Correspondence: Jan De Backer   FluidDa nv, groeningenlei 132,   2550 Kontich, Belgium   Tel +32 3450 8720   Fax +32 3450 8729   email j an.de backer@ fluidda.co mBackground:  Previous studies have demonstrated the potential beneficial effect of  N- acetylcysteine (NAC) in chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/43/43/copd-8-569.PMC3842218.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/43/43/copd-8-569.PMC3842218.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/43/copd-8-569.PMC3842218.pdf
"Jong-Sup Bae, Tel: +82-53-950-8570; Fax:  +82-53-950-8557; E-mail: baejs@knu.ac.kr, Alireza R. Rezaie, Tel: +314-977-9240; Fax: +314-977-9205; E-mail: rezaiear@slu.edu http://dx.doi.org/10.5483/BMBRep.2013.46.11.056Received 11 March 2013, Revised 22 March 2013, Accepted 1 April 2013Keywords: EPCR, HMGB1, PAR-1, Protein C, Thrombin ISSN: 1976-670X (electronic edition) Copyright ⓒ 2013 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Thrombin inhibits HMGB1-mediated proinflammatory  signaling responses when endothelial protein C receptor is occupied by its natural ligand Jong-Sup Bae1,* & Alireza R. Rezaie2,* 1College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 702-701, Korea,  2Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 6310 4, USA High mobility group box 1 (HMGB1) is involved in the  pathogenesis of vascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/ee/23/BMB-46-544.PMC3842408.pdf
 Effects of thrombin on HMGB1 Jong-Sup Bae and Alireza R. Rezaie 545 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/23/BMB-46-544.PMC3842408.pdf
Effects of thrombin on HMGB1 Jong-Sup Bae and Alireza R. Rezaie 546 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/23/BMB-46-544.PMC3842408.pdf
 Effects of thrombin on HMGB1 Jong-Sup Bae and Alireza R. Rezaie 547 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/23/BMB-46-544.PMC3842408.pdf
Effects of thrombin on HMGB1 Jong-Sup Bae and Alireza R. Rezaie 548 BMB Reports http://bmbreports.orgPC-S195A significantly inhibited the stimulatory effect of  HMGB1 on all three receptors (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/23/BMB-46-544.PMC3842408.pdf
 Effects of thrombin on HMGB1 Jong-Sup Bae and Alireza R. Rezaie 549 http://bmbreports.org BMB Reports16.,Non-OADS,/arxiv_data1/oa_pdf/ee/23/BMB-46-544.PMC3842408.pdf
http://dx.doi.org/10.1016/j.nicl.2013.10.002 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/23/9c/main.PMC3842411.pdf
Inline Supplementary Table S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/9c/main.PMC3842411.pdf
Inline Supplementary Table S2 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/9c/main.PMC3842411.pdf
Inline Supplementary Table S3 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/9c/main.PMC3842411.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/70/jcav04p0691.PMC3842437.pdf
"The publications of Department of Health,  Executive Yuan, Taiwan  2011. http://www.mohw.gov.tw/cht/DOS/   4.",Non-OADS,/arxiv_data1/oa_pdf/8a/70/jcav04p0691.PMC3842437.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/c1/jcav04p0697.PMC3842438.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/10/0a/jcav04p0703.PMC3842439.pdf
"To assess the integrity and specificity of the  Affymetrix probe sets to detect a single unique tra n- script, analysis was carried out using the GeneAnn ot  applicati on (http://genecards.weizmann.ac.il/   geneannot/index.shtml).",OADS,/arxiv_data1/oa_pdf/10/0a/jcav04p0703.PMC3842439.pdf
The high integrity transcripts were used for functional analysis  using the DAVID Bio informatics Resource 6.7  (http://david.abcc.ncifcrf.gov/) .,OADS,/arxiv_data1/oa_pdf/10/0a/jcav04p0703.PMC3842439.pdf
This  is an open -access  article  distributed  under  the terms  of the Creative  Commons  License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/29/jcav04p0724.PMC3842441.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/62/e6/jcav04p0727.PMC3842442.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/cc/jcav04p0736.PMC3842443.pdf
"Other ongoing randomized, phase II,  multicenter, double -blind, placebo -control led studies  are investigating MetMab in combination with  paclitaxel plus cisplatin/carboplatin (NCT00854308) and in combination with bevacizumab plus platinum plus paclitaxel/pemetrexed plus platinum as first -line  treatment (NCT01496742), both in untreated   non- squamous  NSCLC patients  (http://www.clinical trials.gov/ct2/results?term=MetMAb+NSCLC&Search=Search).",Non-OADS,/arxiv_data1/oa_pdf/ae/cc/jcav04p0736.PMC3842443.pdf
"http://www.clinicaltrials.gov/ct2/results?t erm=Pazopanib+NSCLC&Search=Search  Additionally, Vandetanib ( AstraZeneca, Ma c- clesfield, UK, ZACTIMA™ ZD6474) is a once -daily  oral anticancer drug, a dual inhibitor of vascular e n- dothelial growth factor receptor (VEGFR) and ep i- dermal growth factor receptor(EGFR) signaling [191, 192].",Non-OADS,/arxiv_data1/oa_pdf/ae/cc/jcav04p0736.PMC3842443.pdf
XL 184 is a multiple TKIs agent for  MET and VEGFR2 which is currently being invest i- gated in several clinical trials either alone or in co m- bination with other agents such as erlotinib   (http://www.clinicaltrials.gov/ct2/results?term=XL +184+NSCLC&Search=Search).,Non-OADS,/arxiv_data1/oa_pdf/ae/cc/jcav04p0736.PMC3842443.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/5c/jcav04p0755.PMC3842444.pdf
"Copyright © 2013 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 5 EHThttp://e-eht.org/Introduction The recycling of plastics is encouraged worldwide and new  products made from recycled plastics have been developed un - der governmental policies giving incentives for recycling plas - tics.",Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
"Keywords  Cadmium, Leachate, Lead, Phthalate esters, Recycled plasticsCorrespondence:   Jung-Hwan Kwon, PhD 145 Anam-ro, Seongbuk-gu, Seoul  136-701, Korea Tel: +82-2- 3290-3041 Fax: +82- 2-953-0737 E-mail: junghwankwon@korea.ac.kr Received:  August 1, 2013 Accepted:  September 24, 2013 Published online:  November 22, 2013 This article is available from: http:// e-eht.org/Volume: 28, Article ID: e2013013, 5 pages   http://dx.doi.org/10.5620/eht.2013.28.e2013013  EHTEnvironmental Health and Toxicology eISSN: 2233-6567 • Original Article Open Access",Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
Page 2 of 5Environmental Health and Toxicology    2013;28:e2013013 EHT http://e-eht.org/ evaluate the usage and methodology of plastic recycling before  the recycling process and the resulting product is approved by  the Ministry of Environment.,Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
"| ERA of Chemicals from Slope Protection BlocksPage 3 of 5 EHThttp://e-eht.org/is calculated as follows: Cwater=r runoff  ⁄ Q                 (4) In order to estimate r runoff, conservative assumptions were  made.",OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
Page 4 of 5Environmental Health and Toxicology    2013;28:e2013013 EHT http://e-eht.org/ from sub microgram to 10 micrograms per liter using the soil  model.,Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
| ERA of Chemicals from Slope Protection BlocksPage 5 of 5 EHThttp://e-eht.org/Heavy metal exposure assessment of recycled plastic buckets.,Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
Available from: http://www.law.go.kr/lsSc.do?menuId=0&p1=&s ubMenu=1&nwYn=1&query=%EC%9E%90%EC%9B%90%EC %9D%98+%EC%A0%88%EC%95%BD%EA%B3%BC+%EC%9 E%AC%ED%99%9C%EC%9A%A9%EC%B4%89%EC%A7%84 %EC%97%90+%EA%B4%80%ED%95%9C+%EB%B2%95%EB %A5%A0&x=49&y=11#liBgcolor2 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
Available from: http://echa.europa.eu/documents/10162/   8fa0a07f-ec2a-4da6-bbe8-5b5e071b5c16.,Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
Available from: http://publications.jrc.ec.europa.eu/repository/ bitstream/111111111/5648/1/dehpreport042.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
Available from: http://www.kma.go.kr/weather/cli - mate/average_south.jsp (Korean).,Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
Available from:  http://www.wamis.go.kr/wkw/wkw_flwsrrs_lst.aspx (Korean).,Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
Available from: http://www.law.go.kr/ lsSc.do?menuId=0&subMenu=1&query=%EC%86%8C%ED%9 5%98%EC%B2%9C%20%EC%A0%95%EB%B9%84%EB%B2% 95#liBgcolor0 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/3b/a8/eht-28-e2013013.PMC3842448.pdf
"Copyright © 2013 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 8 EHThttp://e-eht.org/Introduction Common health effects of mercury exposure in humans in - clude dysarthria, motor disorders, sensory disturbances, and vi - sual field disorders stemming from nervous system toxicity.",Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
"Keywords  Adult, Coastal area, Mercury, Neurobehavioral functionCorrespondence:   Dae-Seon Kim, PhD 42 Hwangyeong-ro, Seo-gu, Incheon  404-708, Korea Tel: +82-32-560-7122 Fax: +82-32-568-2035 E-mail: kimds4@korea.kr Received:  May 23, 2013 Accepted:  October 31, 2013 Published online:  November 22, 2013 This article is available from: http:// e-eht.org/Volume: 28, Article ID: e2013015, 8 pages   http://dx.doi.org/10.5620/eht.2013.28.e2013015  EHTEnvironmental Health and Toxicology eISSN: 2233-6567 • Original Article Open Access",Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
"Page 2 of 8Environmental Health and Toxicology    2013;28:e2013015 EHT http://e-eht.org/ mercury in Iraq also suffered from disorders such as paresthesia,  ataxia, and dysarthria due to nervous system toxicity [3].",Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
| Neurobehavioral Effects of Low-level Mercury in AdultsPage 3 of 8 EHThttp://e-eht.org/lected from the occipital scalp of each subject and stored in a  polyethylene bag in a desiccator until analysis.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
"Page 4 of 8Environmental Health and Toxicology    2013;28:e2013015 EHT http://e-eht.org/ Association of V ariables with Neurobehavioral T est  Results In univariate analysis, no variables were statistically associated  with the SRT test.",Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
| Neurobehavioral Effects of Low-level Mercury in AdultsPage 5 of 8 EHThttp://e-eht.org/Table 3.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
"Page 6 of 8Environmental Health and Toxicology    2013;28:e2013015 EHT http://e-eht.org/ multivariate analysis, after adjustment for age, gender, smoking  behavior, drinking behavior, education level, monthly house - hold income, and frequency of fish consumption, there was a  significant association between right-hand FTS and urine mer - cury level; that is, when the natural log value of urine mercury  level increased by one unit, the number of finger taps decreased  by 3.86.",OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
| Neurobehavioral Effects of Low-level Mercury in AdultsPage 7 of 8 EHThttp://e-eht.org/establishment of a cause-effect relationship for neurobehavioral  dysfunction.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
Available from:  http://www.who.int/foodsafety/publications/chem/mercuryex - posure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
Available  from: http://www.inchem.org/documents/ehc/ehc/ehc101.htm.,OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
Available from: http://www.nap.edu/openbook.php?record_id=9899&page=147/.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
Page 8 of 8Environmental Health and Toxicology    2013;28:e2013015 EHT http://e-eht.org/ EK.,Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
Available from: http://www.ksoras.co.kr/KCN%20T est%20%EB   %A9%94%EB%89%B4%EC%96%BC.pdf (Korean).,Non-OADS,/arxiv_data1/oa_pdf/41/f0/eht-28-e2013015.PMC3842449.pdf
"Copyright © 2013 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 5 EHThttp://e-eht.org/Introduction Inflammation is the dynamic response of vascularized tissue to  injury, and is an important part of the body’s defense mecha - nisms [1].",Non-OADS,/arxiv_data1/oa_pdf/7b/ee/eht-28-e2013012.PMC3842450.pdf
"E-mail: ychong1@snu.ac.kr Received:  July 1, 2013 Accepted:  October 4, 2013 Published online:  November 22, 2013 This article is available from: http:// e-eht.org/Volume: 28, Article ID: e2013012, 5 pages   http://dx.doi.org/10.5620/eht.2013.28.e2013012  EHTEnvironmental Health and Toxicology eISSN: 2233-6567 • Original Article Open Access",Non-OADS,/arxiv_data1/oa_pdf/7b/ee/eht-28-e2013012.PMC3842450.pdf
Page 2 of 5Environmental Health and Toxicology    2013;28:e2013012 EHT http://e-eht.org/ and lung cancer susceptibility was examined.,Non-OADS,/arxiv_data1/oa_pdf/7b/ee/eht-28-e2013012.PMC3842450.pdf
"Therefore, we first selected nine TNF-α  SNPs  (rs1799964, rs1800630, rs1799724, rs1800629, rs361525,  rs3093661, rs1800610, rs3093664, and rs3093668) that have  more than 5% minor allele frequencies based on the SNP500Can - cer database (http://snp500cancer.nci.nih.gov/home.cfm)   and then the Dan Stram’s haplotype-tagging SNP program   (tagSNPsv2.exe ) was used to determine the best set of haplo - type-tagging SNPs.",OADS,/arxiv_data1/oa_pdf/7b/ee/eht-28-e2013012.PMC3842450.pdf
J-H Kim and Y-C Hong  | TNF-α Polymorphisms and Lung Cancer RiskPage 3 of 5 EHThttp://e-eht.org/tions were compared with expected ones using the χ2-test.,Non-OADS,/arxiv_data1/oa_pdf/7b/ee/eht-28-e2013012.PMC3842450.pdf
"For the  statistical power calculation, a web-based power calculation pro - gram (SISA, http://home.clara.net/sisa/powhlp.htm) was used.",OADS,/arxiv_data1/oa_pdf/7b/ee/eht-28-e2013012.PMC3842450.pdf
"Page 4 of 5Environmental Health and Toxicology    2013;28:e2013012 EHT http://e-eht.org/ In the present study, we repeated the analysis with lung cancer  patients and controls without other diseases related to inflam - mation (lung cancer patients, n = 312; and control, n = 368), be - cause other diseases related to inflammation may affect the effect  of TNF-α  gene polymorphisms on lung cancer risk.",Non-OADS,/arxiv_data1/oa_pdf/7b/ee/eht-28-e2013012.PMC3842450.pdf
"J-H Kim and Y-C Hong  | TNF-α Polymorphisms and Lung Cancer RiskPage 5 of 5 EHThttp://e-eht.org/was supported by the Eco-technopia 21 Project of the Ministry  of Environment, Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/7b/ee/eht-28-e2013012.PMC3842450.pdf
"Copyright © 2013 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9 EHThttp://e-eht.org/Introduction More than eight million metric tons per year of carbon black is  used worldwide, mainly for tire reinforcing purposes [1].",Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
"Keywords  Carbon black, Inhalation, Nano, ObesityCorrespondence:   Cheol-Hong Lim, PhD 359 Expo-ro, Yuseong-gu, Daejeon  305-380, Korea Tel: +82-42-869-0342 Fax: +82-42-863-9001 E-mail: limch@kosha.net Received:  Jun 26, 2013  Accepted:  September 16, 2013 Published online:  November 22, 2013 This article is available from: http:// e-eht.org/Volume: 28, Article ID: e2013014, 9 pages  http://dx.doi.org/10.5620/eht.2013.28.e2013014  EHTEnvironmental Health and Toxicology eISSN: 2233-6567 • Original ArticleOpen Access",Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
Page 2 of 9Environmental Health and Toxicology    2013;28:e2013014 EHT http://e-eht.org/ the “particle overload” effect at high concentrations that cause a  marked inflammatory response [6-8].,Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
| Carbon Black Effects on High Fat-induced Overweight RatsPage 3 of 9 EHThttp://e-eht.org/Japan) [27].,Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
Page 4 of 9Environmental Health and Toxicology    2013;28:e2013014 EHT http://e-eht.org/ 12 10 8 6 4 2 0Concentration (mg/m3) Particle size (µm)backup <0.32<1.0 <3.2<0.56<1.8 <5.6 < 10 50 40 30 20 10 0 0 5 10 15 20 25 30Concentration (mg/m3) Time (d)32.89+3.13 9.88+1.73 2.87+0.68 AB C Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
| Carbon Black Effects on High Fat-induced Overweight RatsPage 5 of 9 EHThttp://e-eht.org/were calculated to be between 0.3 and 0.5 μm with a geometric  standard deviation between 2.06 and 3.19 μm (Figure 1B).,Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
"Page 6 of 9Environmental Health and Toxicology    2013;28:e2013014 EHT http://e-eht.org/ pared to control groups of both normal and overweight rats, but  there was no significant difference in their number between  normal weight and overweight control rats (Figure 3B).",Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
"| Carbon Black Effects on High Fat-induced Overweight RatsPage 7 of 9 EHThttp://e-eht.org/PMNs cells and lymphocytes) and cytotoxicity parameters (i.e.,  LDH activities and albumin concentrations) was undertaken to  identify the chronic inflammation caused by nano-sized carbon  black.",Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
"Page 8 of 9Environmental Health and Toxicology    2013;28:e2013014 EHT http://e-eht.org/ 300 250 200 150 100 50 01,400 1,200 1,000 800 600 400 200 0Concentration of TNF α (pg/mL) Concentration of IL-6  (pg/mL) Control Control*** Low Low Medium Medium High HighNormal Overweight A B 300 250 200 150 100 50 01,400 1,200 1,000 800 600 400 200 0Concentration of TNF α (pg/mL) Concentration of IL-6  (pg/mL) Control Control‡‡† **** * ** Low Low Medium Medium High High C D Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
Available from: http://www.carbon-black.,Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
| Carbon Black Effects on High Fat-induced Overweight RatsPage 9 of 9 EHThttp://e-eht.org/org/index.php/what-is-carbon-black.,Non-OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
Available  from: http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/ OECD-TG413.pdf.,OADS,/arxiv_data1/oa_pdf/ee/af/eht-28-e2013014.PMC3842451.pdf
"designed and conducted the experiments, wrote the paper and performed animal husbandry.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Her Majesty the Queen in right of Canada holds a patent on the monoclonal antibodies PCT/CA2009/000070, ‘‘Monoclonal antibodies for Ebola andMarburg viruses’’.",Non-OADS,/arxiv_data1/oa_pdf/7f/09/srep03365.PMC3842534.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3365 | DOI: 10.1038/srep03365 9",Non-OADS,/arxiv_data1/oa_pdf/7f/09/srep03365.PMC3842534.pdf
"MicroSystems, H. D. PI-2600 Series – Low Stress Applications, Product Bulletin, http://hdmicrosystems.com/HDMicroSystems/en_US/pdf/PI-2600_ProcessGuide.pdf, November 28, 2010.",Non-OADS,/arxiv_data1/oa_pdf/6f/d2/srep03360.PMC3842535.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3360 | DOI: 10.1038/srep03360 7",Non-OADS,/arxiv_data1/oa_pdf/6f/d2/srep03360.PMC3842535.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2a/82/srep03367.PMC3842537.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3367 | DOI: 10.1038/srep03367 7",Non-OADS,/arxiv_data1/oa_pdf/2a/82/srep03367.PMC3842537.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/20/f9/srep03373.PMC3842538.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3373 | DOI: 10.1038/srep03373 8",Non-OADS,/arxiv_data1/oa_pdf/20/f9/srep03373.PMC3842538.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/12/2f/srep03364.PMC3842539.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3364 | DOI: 10.1038/srep03364 7",Non-OADS,/arxiv_data1/oa_pdf/12/2f/srep03364.PMC3842539.pdf
http://www.heliatek.,Non-OADS,/arxiv_data1/oa_pdf/19/82/srep03356.PMC3842540.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/19/82/srep03356.PMC3842540.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3356 | DOI: 10.1038/srep03356 8",Non-OADS,/arxiv_data1/oa_pdf/19/82/srep03356.PMC3842540.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fa/2b/srep03363.PMC3842541.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3363 | DOI: 10.1038/srep03363 8",Non-OADS,/arxiv_data1/oa_pdf/fa/2b/srep03363.PMC3842541.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3349 | DOI: 10.1038/srep03349 4,Non-OADS,/arxiv_data1/oa_pdf/8f/45/srep03349.PMC3842542.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3349 | DOI: 10.1038/srep03349 5",Non-OADS,/arxiv_data1/oa_pdf/8f/45/srep03349.PMC3842542.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Supporting information contains additional figures on PFN size stability, calibration data for individual fluorophores, and videos of calibration performed in dialysis tubing.",OADS,/arxiv_data1/oa_pdf/6d/be/srep03366.PMC3842545.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3366 | DOI: 10.1038/srep03366 6",Non-OADS,/arxiv_data1/oa_pdf/6d/be/srep03366.PMC3842545.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8f/80/srep03368.PMC3842546.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3368 | DOI: 10.1038/srep03368 7",Non-OADS,/arxiv_data1/oa_pdf/8f/80/srep03368.PMC3842546.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Figure 5 |(A) The flow-through type HDEN device.,Non-OADS,/arxiv_data1/oa_pdf/9b/17/srep03370.PMC3842547.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3370 | DOI: 10.1038/srep03370 7",Non-OADS,/arxiv_data1/oa_pdf/9b/17/srep03370.PMC3842547.pdf
Available at: http://www.dnb.nl/en/publications/dnb–publications/dnb–working–papers–series/dnb– working–papers/working–papers–2012/dnb276178.jsp (Accessed: 06/11/2013).,Non-OADS,/arxiv_data1/oa_pdf/bb/fe/srep03357.PMC3842548.pdf
Available at: http://www.dnb.nl/en/publications/ dnb–publications/dnb–working–papers–series/dnb–working–papers/dnb233863.jsp (Accessed: 06/11/2013).,Non-OADS,/arxiv_data1/oa_pdf/bb/fe/srep03357.PMC3842548.pdf
Available at: http://www.bankofengland.co.uk/research/Documents/workingpapers/2004/WP230.pdf (Accessed: 06/11/2013).,Non-OADS,/arxiv_data1/oa_pdf/bb/fe/srep03357.PMC3842548.pdf
Available at: http://www.nber.org/papers/w17000 (Accessed: 06/11/2013).,Non-OADS,/arxiv_data1/oa_pdf/bb/fe/srep03357.PMC3842548.pdf
Available at: http://www.bis.org/speeches/sp120730.,Non-OADS,/arxiv_data1/oa_pdf/bb/fe/srep03357.PMC3842548.pdf
Available at: http://catedrabde.uji.es/naim/images/presentations/langfield_liu_ota_2012_mapping_the_uk_interbank_system_v110.pdf(Accessed: 06/11/2013).,Non-OADS,/arxiv_data1/oa_pdf/bb/fe/srep03357.PMC3842548.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Squartini, T., van Lelyveld, I.",Non-OADS,/arxiv_data1/oa_pdf/bb/fe/srep03357.PMC3842548.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3357 | DOI: 10.1038/srep03357 9",Non-OADS,/arxiv_data1/oa_pdf/bb/fe/srep03357.PMC3842548.pdf
"http://oceancurrents.rsmas.miami.edu/atlantic/img_aoml/azores.html (accessed April 2nd, 2013).",OADS,/arxiv_data1/oa_pdf/2d/8b/srep02685.PMC3842550.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2d/8b/srep02685.PMC3842550.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2685 | DOI: 10.1038/srep02685 8",Non-OADS,/arxiv_data1/oa_pdf/2d/8b/srep02685.PMC3842550.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Data deposition: The density maps of NC and FBB have been deposited in the Electron Microscopy Data Bank, http://www.emdatabank.org/ (accession code: EMD-2520 andEMD-2521).",OADS,/arxiv_data1/oa_pdf/bf/61/srep03369.PMC3842551.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3369 | DOI: 10.1038/srep03369 6",Non-OADS,/arxiv_data1/oa_pdf/bf/61/srep03369.PMC3842551.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e5/da/srep03346.PMC3842621.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3346 | DOI: 10.1038/srep03346 8",Non-OADS,/arxiv_data1/oa_pdf/e5/da/srep03346.PMC3842621.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/8c/0e/NAJMS-5-589.PMC3842699.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/8c/0e/NAJMS-5-589.PMC3842699.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/8b/15/NAJMS-5-594.PMC3842700.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/48/21/NAJMS-5-600.PMC3842701.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/91/74/NAJMS-5-615.PMC3842705.pdf
Availability and implementation: customProDB and related docu- ments are freely available at http://bioconductor.org/packages/2.13/ bioc/html/customProDB.html.,OADS,/arxiv_data1/oa_pdf/68/35/btt543.PMC3842753.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/35/btt543.PMC3842753.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/de/btt546.PMC3842754.pdf
Information about TCGA and the investigators and institutions that constitute the TCGA research network can be found at http://cancergenome.nih.gov/.,OADS,/arxiv_data1/oa_pdf/8b/de/btt546.PMC3842754.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/ec/btt562.PMC3842763.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3371 | DOI: 10.1038/srep03371 8",Non-OADS,/arxiv_data1/oa_pdf/b0/70/srep03371.PMC3842778.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/33/9c/srep03348.PMC3842779.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3348 | DOI: 10.1038/srep03348 7",Non-OADS,/arxiv_data1/oa_pdf/33/9c/srep03348.PMC3842779.pdf
See http://www.lindalliance.org/pdfs/JLA%20Internal%20Reports/090712_summary_ RS_map_%20studies_%20PPI%20&%20Clincians_ reasearch%20prioirites%20.pdf (last checked 21 May2013).,Non-OADS,/arxiv_data1/oa_pdf/6e/4f/10.1177_0141076813493063.PMC3842854.pdf
See http://www.lindalliance.org/pdfs/Methods_page/JLA_Priority_Setting_approaches_ V2_Nov_09.pdf (last checked 21 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/6e/4f/10.1177_0141076813493063.PMC3842854.pdf
"Eyes on Evidence November 2011, issue 31. https://www.evidence.nhs.",Non-OADS,/arxiv_data1/oa_pdf/6e/4f/10.1177_0141076813493063.PMC3842854.pdf
See https://www.evidence.nhs.uk/ about-us/eyes-on-evidence/eyes-on-evidence-2011 (lastchecked 21 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/6e/4f/10.1177_0141076813493063.PMC3842854.pdf
See http://cordis.europa.eu/search/index.cfm?fuseaction ¼proj.document&PJ_RCN ¼13177709 (last checked 21 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/6e/4f/10.1177_0141076813493063.PMC3842854.pdf
See http://www.guard- ian.co.uk/science/blog/2010/nov/16/research-red-rape-suffering-death/print (last checked 21 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/6e/4f/10.1177_0141076813493063.PMC3842854.pdf
See http://www.project-syndicate.org/commentary/ publish-or-perish (last checked 21 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/6e/4f/10.1177_0141076813493063.PMC3842854.pdf
"For example, the absence of membranoproliferativehttp://www.kidney-international.org meeting report &2013 International Society of Nephrology Correspondence: Matthew C. Pickering or H. Terence Cook, Centre for Complement and Inflammation Research, Imperial College London, London W12 0NN, UK.",Non-OADS,/arxiv_data1/oa_pdf/a9/d9/ki2013377a.PMC3842953.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Kidney International (2013) 84, 1079– 1089 1089MC Pickering et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/d9/ki2013377a.PMC3842953.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e0/a9/3585.PMC3842987.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4f/05/3588.PMC3842988.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/18/6c/3603.PMC3842989.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/68/7a/3620.PMC3842990.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/81/12/3634.PMC3842991.pdf
"We  then determined the distribution of the shared FOXM1 genomic  loci using the cis-Regulatory Element Annotation System (CEAS;  http://liulab.dfci.harvard.edu/CEAS/; Zhang et al., 2008; Shin  et al., 2009) implemented in Cistrome (www.cistrome.com/).",OADS,/arxiv_data1/oa_pdf/81/12/3634.PMC3842991.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/29/ab/3651.PMC3842992.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e5/05/3663.PMC3842993.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c4/b5/3675.PMC3842994.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fd/21/3689.PMC3842995.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5e/83/3697.PMC3842996.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cc/72/3710.PMC3842997.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/db/ef/3721.PMC3842998.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4a/73/3736.PMC3842999.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ba/d2/3746.PMC3843000.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a8/ca/3754.PMC3843001.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/56/69/3764.PMC3843002.pdf
"Received: June 13, 2013    Revised: June 14, 2013 Accepted:  June 14, 2013    Available online: September 16, 2013  Correspondence: Jose de Leon, MD  UK Mental Health Research Center at Eastern State Hospital, 1350 Bull Lea Lane, Lexington, KY 40511, USATel: +1-859-246-8440, Fax: +1-859-246-8446, E-mail: jdeleon@uky.edu cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.205SPECIAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/db/f3/pi-10-205.PMC3843011.pdf
The New Y orker 2010; March 1. http://www.newyorker.com/arts/critics/atlarge/2010/03/01/100301crat_atlarge_menand.,Non-OADS,/arxiv_data1/oa_pdf/db/f3/pi-10-205.PMC3843011.pdf
New Y ork Times Available at: http://www.nytimes.com/2013/05/07/health/psychiatrys-new-guide-falls-short-experts-say.html?pagewanted=all&_r=0.,Non-OADS,/arxiv_data1/oa_pdf/db/f3/pi-10-205.PMC3843011.pdf
Available at: http://www.nimh.nih.gov/news/science-news/2013/dsm-5-and-rdoc-shared-interests.shtml.,OADS,/arxiv_data1/oa_pdf/db/f3/pi-10-205.PMC3843011.pdf
Available at: http://www.nytimes.com/2013/05/28/opinion/brooks-heroes-of-uncertainty.html?_r=0.,Non-OADS,/arxiv_data1/oa_pdf/db/f3/pi-10-205.PMC3843011.pdf
"Received: June 4, 2013    Revised: June 13, 2013 Accepted:  July 13, 2013    Available online: September 16, 2013  Correspondence: S. Nassir Ghaemi Department of Psychiatry, Tufts Medical Center, 800 Washington St., Boston, MA 02111, USATel: +1-617-636-5735, Fax: +1-617-636-7795 E-mail: nghaemi@tuftsmedicalcenter.org cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.218REVIEW ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/66/d1/pi-10-218.PMC3843012.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.225   Copyright © 2013 Korean Neuropsychiatric Association   225REVIEW ARTICLE Circadian Rhythm Hypotheses of Mixed Features, Antidepressant  Treatment Resistance, and Manic Switching in Bipolar Disorder Heon-Jeong Lee1 , Gi-Hoon Son2 and Dongho Geum3 1Department of Psychiatry, Korea University College of Medicine, Seoul, Republic of Korea  2Department of Legal Medicine, Korea University College of Medicine, Seoul, Republic of Korea  3Graduate School of Medicine, Korea University, Seoul, Republic of Korea Numerous hypotheses have been put forth over the years to explain the development of bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/93/23/pi-10-225.PMC3843013.pdf
"Received: August 5, 2013    Revised: August 6, 2013 Accepted:  August 6, 2013    Available online: September 16, 2013  Correspondence: Heon-Jeong Lee, MD, PhD Department of Psychiatry, Anam Hospital, Korea University College of Medi-cine, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Republic of KoreaTel: +82-2-920-6721, Fax: +82-2-929-7679, E-mail: leehjeong@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Mood disorders are a major cause of morbidity worldwide  and a potentially life-threatening condition because of the risk  of suicide.1,2 In response to overwhelming stressful life events,  depressive mood may be considered a somewhat normal ph-enomenon.",Non-OADS,/arxiv_data1/oa_pdf/93/23/pi-10-225.PMC3843013.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.233   Copyright © 2013 Korean Neuropsychiatric Association   233REVIEW ARTICLE Clinical Usefulness of Loudness Dependence of Auditory Evoked  Potentials (LDAEP) in Patients with Bipolar Disorder Young-Min Park1 and Seung-Hwan Lee1,2  1Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea  2Clinical Emotion and Cognition Research Laboratory, Goyang, Republic of Korea While it has been reported previously that the loudness dependence of auditory evoked potentials (LDAEP) is a putative biological  marker or a predictor of treatment response, there have been few studies of LDAEP in bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/17/bf/pi-10-233.PMC3843014.pdf
"Received: August 5, 2013    Revised: August 6, 2013 Accepted:  August 6, 2013    Available online: September 16, 2013  Correspondence: Seung-Hwan Lee, MD, PhD Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Med - icine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 411-706, Republic of KoreaTel: +82-31-910-7260, Fax: +82-31-910-7268, E-mail: lshpss@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION The pathophysiology related to serotonin in bipolar disor - der remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/17/bf/pi-10-233.PMC3843014.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.238 238  Copyright © 2013 Korean Neuropsychiatric Association   ORIGINAL ARTICLE Validation of the Dementia Care Assessment Packet-Instrumental  Activities of Daily Living Seok Bum Lee1, Jeong Ran Park1, Jeong-Hwa Yoo1, Joon Hyuk Park2, Jung Jae Lee3,   Jong Chul Yoon4, Jin Hyeong Jhoo5, Dong Young Lee6,7, Jong Inn Woo6,7, Ji Won Han3,   Yoonseok Huh3, Tae Hui Kim3 and Ki Woong Kim3,7  1Department of Psychiatry, Dankook University Hospital, Cheonan, Republic of Korea  2Department of Neuropsychiatry, Jeju National University Hospital, Jeju, Republic of Korea  3Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea  4Department of Neuropsychiatry, Kyunggi Provincial Hospital for the Elderly, Yongin, Republic of Korea  5Department of Psychiatry, Kangwon National University School of Medicine, Chuncheon, Republic of Korea  6Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea  7Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea Objective aaWe aimed to evaluate the psychometric properties of the IADL measure included in the Dementia Care Assessment Packet  (DCAP-IADL) in dementia patients.",Non-OADS,/arxiv_data1/oa_pdf/13/9e/pi-10-238.PMC3843015.pdf
"Received: October 5, 2012    Revised: March 20, 2013 Accepted:  April 2, 2013    Available online: September 16, 2013  Correspondence: Ki Woong Kim, MD, PhD Department of Neuropsychiatry, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam 463-707, Republic of KoreaTel: +82-31-787-7439, Fax: +82-31-787-4058, E-mail: kwkimmd@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION The decline of functional activities is the critical feature in  the diagnosis of dementia.1 Functional assessment instru-ments measure activities of daily living (ADL), a measure of a  person’s ability to live independently.",Non-OADS,/arxiv_data1/oa_pdf/13/9e/pi-10-238.PMC3843015.pdf
"Received: December 22, 2012    Revised: March 15, 2013 Accepted:  March 27, 2013    Available online: September 16, 2013  Correspondence: Boseok Cha, MD, PhD Department of Psychiatry, Gyeongsang National University Hospital, 79 Gang-nam-ro, Jinju 660-702, Republic of KoreaTel: +82-55-750-8082, Fax: +82-55-759-0003, E-mail: cbs324@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.246ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/c2/b3/pi-10-246.PMC3843016.pdf
"Received:  September 14, 2012    Revised:  February 10, 2013   Accepted:  February 20, 2013    Available online:  September 16, 2013  Correspondence:  Bung-Nyun Kim, MD, PhD   Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul  National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul  110-744, Republic of Korea Tel: +82-2-2072-3647, Fax: +82-2-747-5774, E-mail:  kbn1@snu.ac.kr  cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.253ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/22/c3/pi-10-253.PMC3843017.pdf
"Received: July 1, 2012    Revised: March 23, 2013    Accepted:  April 2, 2013    Available online: September 16, 2013  Correspondence: Jun Soo Kwon, MD, PhD Department of Psychiatry, Seoul National University College of Medicine, 101  Daehak-ro, Jongno-gu, Seoul 110-744, Republic of Korea Tel: +82-2-2072-2450, Fax: +82-2-747-9063, E-mail: kwonjs@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.259ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/0b/10/pi-10-259.PMC3843018.pdf
"Received: December 7, 2012    Revised: January 16, 2013 Accepted:  January 16, 2013    Available online: September 16, 2013  Correspondence: Y oung-Chul Jung, MD, PhD  Department of Psychiatry, Y onsei University College of Medicine, Severance Mental Health Hospital, 119 Gyeongchung-daero 1926beon-gil, Gwangju 464-100, Republic of KoreaTel: +82-31-760-9405, Fax: +82-31-761-7582, E-mail: eugenejung@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.266ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/6b/9b/pi-10-266.PMC3843019.pdf
"Received: May 26, 2013    Revised: July 2, 2013 Accepted:  July 2, 2013    Available online: September 16, 2013  Correspondence: Yun-Kyeung Choi, PhD Department of Psychology, Keimyung University, 1095 Dalgubeol-daero, Dalseo-gu, Daegu 704-701, Republic of KoreaTel: +82-53-580-5405, Fax: +82-53-580-5313, E-mail: ykchoi@kmu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.273ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/9c/d8/pi-10-273.PMC3843020.pdf
"Received: October 8, 2012    Revised: January 3, 2013 Accepted:  January 7, 2013    Available online: September 16, 2013  Correspondence: Salih Selek, MD Department of Psychiatry, Istanbul Medeniyet University School of Medicine, D-100 Mevkii, 34700 Kadikoy, Istanbul, TurkeyTel: +90 (216)-280 33 33, Fax: +90 (216)-602 28 05  E-mail: drselek@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.281ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/6b/56/pi-10-281.PMC3843021.pdf
"Received: October 2, 2012    Revised: December 19, 2012 Accepted:  January 5, 2013    Available online: September 16, 2013  Correspondence: Min-Soo Lee, MD, PhD  Department of Psychiatry, Anam Hospital, Korea University College of Medi-cine, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Republic of KoreaTel: +82-2-920-5354, Fax: +82-2-923-3507, E-mail: leeminso@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.286ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/f8/dd/pi-10-286.PMC3843022.pdf
Available at: http://www.cypalleles.ki.se/cyp2d6.htm.,Non-OADS,/arxiv_data1/oa_pdf/f8/dd/pi-10-286.PMC3843022.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.294 294  Copyright © 2013 Korean Neuropsychiatric Association   ORIGINAL ARTICLE Plasma Levels of IL-23 and IL-17 before and after Antidepressant  Treatment in Patients with Major Depressive Disorder Jae-Won Kim1, Yong-Ku Kim1 , Jung-A Hwang1, Ho-Kyoung Yoon1, Young-Hoon Ko1,   Changsu Han1, Heon-Jeong Lee2, Byung-Joo Ham2 and Hong Seock Lee3 1Department of Psychiatry, Korea University, College of Medicine, Ansan Hospital, Ansan, Republic of Korea  2Department of Psychiatry, Korea University, College of Medicine, Anam Hospital, Seoul, Republic of Korea  3Department of Psychiatry, Kangnam Sacred Heart Hospital, Hallym University Medical Center, Seoul, Republic of Korea Objective aaCytokines are believed to have a role in the pathophysiology of major depression.",Non-OADS,/arxiv_data1/oa_pdf/00/62/pi-10-294.PMC3843023.pdf
"Received: November 10, 2012    Revised: April 18, 2013 Accepted:  April 21, 2013    Available online: September 16, 2013  Correspondence: Y ong-Ku Kim, MD, PhD Department of Psychiatry, Korea University Medical Center Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan 425-021, KoreaTel: +82-31-412-5138, Fax: +82-31-412-5132, E-mail: yongku@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Accumulating evidence suggests that dysregulation of im- mune system, particularly the cytokine system, is associated  with the pathophysiology of major depressive disorder (MDD).",Non-OADS,/arxiv_data1/oa_pdf/00/62/pi-10-294.PMC3843023.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.300 300  Copyright © 2013 Korean Neuropsychiatric Association   CASE REPORT  Myasthenia Gravis, Schizophrenia, and Colorectal Cancer   in A Patient: Long-Term Follow-Up with Medication Complexity Haebin Kim1,2, Minha Hong1,2 and Geon Ho Bahn1  1Department of Neuropsychiatry, Kyung Hee University School of Medicine, Seoul, Republic of Korea  2Graduate School, Kyung Hee University, Seoul, Republic of Korea In a case of 46-year-old woman suffering from schizophrenia for over 20 years, she experienced frequent episodes of dyspnea and con- firmed as superimposed with myasthenia gravis (MG).",Non-OADS,/arxiv_data1/oa_pdf/00/73/pi-10-300.PMC3843024.pdf
"Received: October 2, 2012    Revised: February 19, 2013 Accepted:  March 23, 2013    Available online: September 16, 2013  Correspondence: Geon Ho Bahn, MD, PhD Department of Neuropsychiatry, Kyung Hee University School of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Republic of KoreaTel: +82-2-958-8556, Fax: +82-2-957-1997 E-mail: mompeian@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Myasthenia gravis (MG) is an autoimmune disease charac - terized by muscle weakness due to acetylcholine receptor au- toantibodies of the neuromuscular junction.1 Although schi- zophrenia was associated with nearly 50% higher life-time prevalence of one or more autoimmune disorders, 2 it is very  rare for patients with schizophrenia to develop MG.",Non-OADS,/arxiv_data1/oa_pdf/00/73/pi-10-300.PMC3843024.pdf
"Received: October 11, 2012    Revised: January 30, 2013 Accepted:  February 9, 2013    Available online: September 16, 2013  Correspondence: Seok Woo Moon, MD, PhD  Department of Psychiatry, Konkuk University Chungju Hospital, 82 Gugwon-daero, Chungju 380-704, Republic of KoreaTel: +82-43-840-8990, Fax: +82-43-840-8962, E-mail: hessem@kku.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2013.10.3.303CASE REPORT online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/e3/3a/pi-10-303.PMC3843025.pdf
"The Korean Academy of Conservative Dentistry.187This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cardiovascular effect of epinephrine in endodontic microsurgery: a review Epinephrine is one of the most widely-used vasoconstrictors in dental treatment including endodontic microsurgery.",Non-OADS,/arxiv_data1/oa_pdf/35/18/rde-38-187.PMC3843028.pdf
"Jang Y; Kim E, Microscope Center,  Department of Conservative Dentistry and Oral Science Research Center, Yonsei University College of Dentistry, Seoul, Korea*Correspondence to Euiseong Kim, DDS, MSD, PhD.Professor, Microscope Center, Department of Conservative Dentistry and Oral Science Research Center, Yonsei University College of Dentistry, 50 Yonsei-ro, Seodaemun-gu, Seoul, Korea 120-752TEL, +82-2-2228-3145; FAX, +82-2-313-7575; E-mail, andyendo@yuhs.acReview article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.187",Non-OADS,/arxiv_data1/oa_pdf/35/18/rde-38-187.PMC3843028.pdf
"30-34 Therefore epinephrine behaves  as a pure agonist of α adrenergic receptor inducing acute  hypertensive crisis, followed by reflex bradycardia, and cardiac arrest in the worst case when it is administered Jang Y and Kim E http://dx.doi.org/10.5395/rde.2013.38.4.187",Non-OADS,/arxiv_data1/oa_pdf/35/18/rde-38-187.PMC3843028.pdf
"Dose of epinephrine administered on hemostasis Product Racellet #3CollaCote soaked in epinephrine  solution (Racepinephrine)Cotton soaked in epinephrine  solution (Bosmin) Epinephrine concentration  (in effective concentration)N/A 11.25 : 1,000 (Racepinephrine) 1 : 1,000 (Bosmin) Epinephrine dose/pellet (in effective concentration)0.21 - 0.34 mg/pellet 1.05 - 1.25 mg 0.07 - 0.125 mg/cotton Number of pellet used  in microsurgery1 - 7 pellets161 - 3 pellets153 - 10 cottons Total epinephrine dose  (in effective concentration)0.21 - 2.38 mg161.05 - 3.75 mg150.21 - 1.25 mg http://dx.doi.org/10.5395/rde.2013.38.4.187",Non-OADS,/arxiv_data1/oa_pdf/35/18/rde-38-187.PMC3843028.pdf
"(2004)15 Subjects 17 42 Medical status ASA I or II Normal  TreatmentEndodontic surgery  with root-end resection & fillingEndodontic surgery with root-end filling Epinephrine typeRacemic epinephrine (Racellet #3)Racemic epinephrine (Racepinephrine) Collagen sponge (Colla-cote) Epinephrine dose (effective concentration)0.21 - 2.38 mg 1.05 - 3.75 mg BP/HR recordingBefore treatment (baseline) At epinephrine application, and 1, 5, 10 min after placement Before dismissalBefore treatment (baseline) After anesthetic injection After epinephrine application  Before dismissal BP change No significant changesNo significant changes during surgical procedure PR changeNo significant changes Between groupsNo significant changes during surgical procedureJang Y and Kim E http://dx.doi.org/10.5395/rde.2013.38.4.187",Non-OADS,/arxiv_data1/oa_pdf/35/18/rde-38-187.PMC3843028.pdf
(2011)29F/73 unknown110/80 70 180/110 150Myocardiac infarction F/80 0.60100/70  60 140/100  80 Myocardiac infarction http://dx.doi.org/10.5395/rde.2013.38.4.187,Non-OADS,/arxiv_data1/oa_pdf/35/18/rde-38-187.PMC3843028.pdf
J Endod Jang Y and Kim E http://dx.doi.org/10.5395/rde.2013.38.4.187,OADS,/arxiv_data1/oa_pdf/35/18/rde-38-187.PMC3843028.pdf
Cardiovascular effect of epinephrine in endodontic microsurgery http://dx.doi.org/10.5395/rde.2013.38.4.187,Non-OADS,/arxiv_data1/oa_pdf/35/18/rde-38-187.PMC3843028.pdf
"The Korean Academy of Conservative Dentistry.194This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Enamel matrix derivative for replanted teeth in animal models: a systematic review and meta-analysis Objectives:  To investigate the effect of enamel matrix derivative (EMD) on periodontal  healing of replanted teeth in animal models.",Non-OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
"1Kim SG, Division of Endodontics,  College of Dental Medicine, Columbia University, New York, USA 2Ryu SI, Department of Endodontics,  School of Dental Medicine, University of Pennsylvania, Philadelphia, USA*Correspondence to Sahng G. Kim, DDS, MS.Assistant Professor of Clinical Dental Medicine, Division of Endodontics, College of Dental Medicine, Columbia University, 630 W. 168 St. - PH7Stem #128, New York, NY 10032, USATEL, +1-212-305-4594; E-mail, sgk2114@columbia.eduResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.194",Non-OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
"Statistical analysis was performed using the software Comprehensive Meta Analysis version 2 (Biostat, NJ, USA).Enamel matrix derivative for replanted teeth http://dx.doi.org/10.5395/rde.2013.38.4.194",Non-OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
Flow chart of the selection of relevant articles.Kim SG and Ryu SI  http://dx.doi.org/10.5395/rde.2013.38.4.194,OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
"EMD, enamel matrix derivative; EDTA, ethylenediamine tetraacetic acid.Enamel matrix derivative for replanted teeth http://dx.doi.org/10.5395/rde.2013.38.4.194",Non-OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
"EMD, enamel matrix derivative; PDL, periodontal ligament; Std diff, standardized difference; CI, confidence interval.Less inflammatory resorptionMore inflammatory resorptionKim SG and Ryu SI  http://dx.doi.org/10.5395/rde.2013.38.4.194",Non-OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
"Outcomes of animal studies where PDL was removed prior to EMD treatment Study (Year) Animal InterventionNormal healing  (%)Surface resorption (%)Imflammatory resorption (%)Replacement resorption (%) Araujo et al.24  (2003)dogPDL removed, EDTA, EMD 0 49 ± 20 10 ± 6 41 ± 21 PDL removed, EDTA 0 52 ± 20 16 ± 12 31 ± 19 Lam and Sae-Lim25  (2004)monkey1 hr dried, PDL removed 5.24 ± 7.37 * 1.56 ± 3.13 93.20 ± 10.36 1 hr dried, PDL removed, EMD 20.26 ± 15.26 * 5.10 ± 7.40 74.64 ± 14.84 1 hr dried, PDL removed, EDTA, EMD 19.21 ± 13.85 * 8.87 ± 9.07 71.92 ± 15.29 Molina and Brentegani26  (2005)rat20 min saline, PDL removed 14.48 38.7 6.29 20 min saline, PDL removed, EMD 7.8 50.64 4.93 Guzman-Martinez et al.29 (2009)dogPDL removed, EMD 0 12.5 0 87.5 PDL removed, EDTA, EMD 0 12.5 0 87.5 PDL removed, EDTA 0 0 0 100 PDL removed 0 0 0 100 Saito et al.32  (2011) dogPDL removed (part of roots), EDTA, EMD,  cell culture medium for 6 wk* 0.2 ± 0.7 0.0 ± 0.0 PDL removed (part of roots), EDTA,  cell culture medium for 6 wk* 2.1 ± 2.6 0.0 ± 0.0 PDL removed (part of roots), EDTA * 9.6 ± 9.3 24.6 ± 30.3 * no data available.EMD, enamel matrix derivative; EDTA, ethylenediamine tetraacetic acid; PDL, periodontal ligament.Enamel matrix derivative for replanted teeth http://dx.doi.org/10.5395/rde.2013.38.4.194",Non-OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
"25 The exact mechanism of EMD still remains unknown,  while EMD has been clinically used to restore functional Kim SG and Ryu SI  http://dx.doi.org/10.5395/rde.2013.38.4.194",OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
J Clin Periodontol Enamel matrix derivative for replanted teeth http://dx.doi.org/10.5395/rde.2013.38.4.194,Non-OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
Available from: http://www.cochrane-handbook.org/.,OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
Oral Surg Oral Med Oral Pathol Oral Radiol Endod Kim SG and Ryu SI  http://dx.doi.org/10.5395/rde.2013.38.4.194,Non-OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
J Educ Behav Stat 2010;35:215-247.Enamel matrix derivative for replanted teeth http://dx.doi.org/10.5395/rde.2013.38.4.194,Non-OADS,/arxiv_data1/oa_pdf/01/4d/rde-38-194.PMC3843029.pdf
"The Korean Academy of Conservative Dentistry.204This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A comparative evaluation of cytotoxicity of root canal sealers: an in vitro study Objectives:  The objective of this in vitro study was to evaluate and compare the  cytotoxicity of four different root canal sealers i.e.",Non-OADS,/arxiv_data1/oa_pdf/01/d7/rde-38-204.PMC3843030.pdf
"1Badole GP; Badole SG, Department of  Conservative Dentistry & Endodontics, VSPM’s Dental College & Research Center, Nagpur, India 2Warhadpande MM; Tawani SG; Tawani G,  Department of Conservative Dentistry & Endodontics Government Dental College & Hospital, Nagpur, India 3Meshram GK, Department of Conservative  Dentistry & Endodontics, Peoples Dental college, Bhopal, India 4Bahadure RN, Department of  Pedodontics, Sharad Pawar Dental College, Sawangi, Wardha, India*Correspondence to Gautam Pyarelal Badole, MDS.Assistant Professor, Department of Conservative Dentistry & Endodontics VSPM’s Dental College & Research Center, Digdoh hills, Hingna road, Nagpur, Maharashtra, India 440019 TEL, +91-9665410655; FAX, +91-7104-306202; E-mail, badole_g15@yahoo.co.inResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.204",Non-OADS,/arxiv_data1/oa_pdf/01/d7/rde-38-204.PMC3843030.pdf
5Cytotoxicity of root canal sealers http://dx.doi.org/10.5395/rde.2013.38.4.204,Non-OADS,/arxiv_data1/oa_pdf/01/d7/rde-38-204.PMC3843030.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.204,Non-OADS,/arxiv_data1/oa_pdf/01/d7/rde-38-204.PMC3843030.pdf
Cytotoxicity of root canal sealers http://dx.doi.org/10.5395/rde.2013.38.4.204,Non-OADS,/arxiv_data1/oa_pdf/01/d7/rde-38-204.PMC3843030.pdf
[cited 2013 July 9] https://law.resource.org/pub/ie/ibr/is.en.iso.10993.5.2009.html.,Non-OADS,/arxiv_data1/oa_pdf/01/d7/rde-38-204.PMC3843030.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.204,Non-OADS,/arxiv_data1/oa_pdf/01/d7/rde-38-204.PMC3843030.pdf
Cytotoxicity of root canal sealers http://dx.doi.org/10.5395/rde.2013.38.4.204,Non-OADS,/arxiv_data1/oa_pdf/01/d7/rde-38-204.PMC3843030.pdf
"The Korean Academy of Conservative Dentistry.210This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Chlorhexidine gel associated with papain in pulp tissue dissolution Objectives:  This study aimed to evaluate the capacity of 2% chlorhexidine gel  associated with 8% papain gel in comparison with 5.25% sodium hypochlorite in bovine pulp tissue dissolution.",Non-OADS,/arxiv_data1/oa_pdf/9e/bc/rde-38-210.PMC3843031.pdf
"Otávio Santos, 395, sala  705, Centro Odontomédico Dr.  Altamirando da Costa Lima, Vitória da Conquista, Bahia, Brazil 45020- 750 TEL, +55 77 3084-2020; FAX, +55 77 9125-9025; E-mail,  matheuspithon@gmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2013.38.4.210",Non-OADS,/arxiv_data1/oa_pdf/9e/bc/rde-38-210.PMC3843031.pdf
The 2% chlorhexidine and 0.9% saline solution presented no statistically significant dissolution.Chlorhexidine gel associated with papain http://dx.doi.org/10.5395/rde.2013.38.4.210,Non-OADS,/arxiv_data1/oa_pdf/9e/bc/rde-38-210.PMC3843031.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.210,Non-OADS,/arxiv_data1/oa_pdf/9e/bc/rde-38-210.PMC3843031.pdf
J Endod 2009;35:1023-1027.Chlorhexidine gel associated with papain http://dx.doi.org/10.5395/rde.2013.38.4.210,Non-OADS,/arxiv_data1/oa_pdf/9e/bc/rde-38-210.PMC3843031.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.210,Non-OADS,/arxiv_data1/oa_pdf/9e/bc/rde-38-210.PMC3843031.pdf
"The Korean Academy of Conservative Dentistry.215This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Retentive strength of different intracanal posts in restorations of anterior primary teeth: an in vitro study Objectives:  To determine the retentive strength and failure mode of undercut composite  post, glass fiber post and polyethylene fiber post luted with flowable composite resin and resin-cement.",Non-OADS,/arxiv_data1/oa_pdf/63/3d/rde-38-215.PMC3843032.pdf
"1Memarpour M, Oral and Dental Health  Care Research Center, Department of Pediatric Dentistry, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran 2Shafiei F, Oral and Dental Health  Care Research Center, Department of Operative Dentistry, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran 3Abbaszadeh M, Student Research  Committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran*Correspondence to Fereshteh Shafiei, DMD, MScD.Associate Professor, Oral and Dental Health Care Research Center, Department of Operative Dentistry,  School of Dentistry, Shiraz University of Medical Sciences, Shiraz, IranTEL, +98 711 6263193-4; FAX, +98 711 6263192; E-mail, shafief@sums.ac.irResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.215",Non-OADS,/arxiv_data1/oa_pdf/63/3d/rde-38-215.PMC3843032.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.215,Non-OADS,/arxiv_data1/oa_pdf/63/3d/rde-38-215.PMC3843032.pdf
"Cohesive fracture: only core bulk fracture 17,24Retention fiber posts in primary anterior teeth http://dx.doi.org/10.5395/rde.2013.38.4.215",Non-OADS,/arxiv_data1/oa_pdf/63/3d/rde-38-215.PMC3843032.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.215,Non-OADS,/arxiv_data1/oa_pdf/63/3d/rde-38-215.PMC3843032.pdf
Polyethylene fiber post + Flowable resin 149.95 ± 40.07 1 9 10 http://dx.doi.org/10.5395/rde.2013.38.4.215,Non-OADS,/arxiv_data1/oa_pdf/63/3d/rde-38-215.PMC3843032.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.215,Non-OADS,/arxiv_data1/oa_pdf/63/3d/rde-38-215.PMC3843032.pdf
Retention fiber posts in primary anterior teeth http://dx.doi.org/10.5395/rde.2013.38.4.215,Non-OADS,/arxiv_data1/oa_pdf/63/3d/rde-38-215.PMC3843032.pdf
"The Korean Academy of Conservative Dentistry.222This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Influence of operator’s experience level on lifespan of the WaveOne Primary file in extracted teeth Objectives:  The aim of this study was to assess the influence of operator experience  level on the lifespan of the WaveOne Primary file (Dentsply Maillefer, Ballaigues, Switzerland) in extracted teeth.",Non-OADS,/arxiv_data1/oa_pdf/ed/13/rde-38-222.PMC3843033.pdf
"Box 346, Ajman, UAETEL, +9715-0228-3188; FAX, +9716-743-8888; E-mail, drabdulrm@yahoo.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.222",Non-OADS,/arxiv_data1/oa_pdf/ed/13/rde-38-222.PMC3843033.pdf
20.0) was used to conduct all analyses.Lifespan of WaveOne and operator’s experience level http://dx.doi.org/10.5395/rde.2013.38.4.222,OADS,/arxiv_data1/oa_pdf/ed/13/rde-38-222.PMC3843033.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.222,Non-OADS,/arxiv_data1/oa_pdf/ed/13/rde-38-222.PMC3843033.pdf
Questionnaire survey on the use Lifespan of WaveOne and operator’s experience level http://dx.doi.org/10.5395/rde.2013.38.4.222,OADS,/arxiv_data1/oa_pdf/ed/13/rde-38-222.PMC3843033.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.222,Non-OADS,/arxiv_data1/oa_pdf/ed/13/rde-38-222.PMC3843033.pdf
"The Korean Academy of Conservative Dentistry.227This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A preliminary report on histological outcome of pulpotomy with endodontic biomaterials vs calcium hydroxide Objectives:  The purpose of the study was to evaluate human dental pulp response to  pulpotomy with calcium hydroxide (CH), mineral trioxide aggregate (MTA), and calcium enriched mixture (CEM) cement.",Non-OADS,/arxiv_data1/oa_pdf/71/18/rde-38-227.PMC3843034.pdf
"1Nosrat A; Asgary S, Iranian Center  for Endodontic Research, Research Institute for Dental Sciences, Shahid Beheshti University of  Medical Sciences, Tehran, Iran 2Peimani A, Department of Oral and  Maxillofacial Surgery, Dental School,  Rafsanjan University of Medical Sciences, Rafsanjan, Kerman, Iran *Correspondence to Ali Nosrat, DDS, MS.Assistant Professor, Iranian Center for Endodontic Research, Research Institute for Dental Sciences, Shahid Beheshti University of Medical Sciences, Evin Blvd, Tehran, IranTEL, +98-21-22427752; FAX, +98-21-22427753, E-mail, ansrt2@yahoo.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.227",Non-OADS,/arxiv_data1/oa_pdf/71/18/rde-38-227.PMC3843034.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.227,OADS,/arxiv_data1/oa_pdf/71/18/rde-38-227.PMC3843034.pdf
Preoperative         Postoperative http://dx.doi.org/10.5395/rde.2013.38.4.227,Non-OADS,/arxiv_data1/oa_pdf/71/18/rde-38-227.PMC3843034.pdf
100 μm 100 μm 100 μm50 μm 50 μm 50 μmDB                          DB DB                                 DB DB                               DBPulp Pulp PulpDentin Dentin Dentin(a) (b) (c) http://dx.doi.org/10.5395/rde.2013.38.4.227,Non-OADS,/arxiv_data1/oa_pdf/71/18/rde-38-227.PMC3843034.pdf
Pulpotomy with CEM cement http://dx.doi.org/10.5395/rde.2013.38.4.227,Non-OADS,/arxiv_data1/oa_pdf/71/18/rde-38-227.PMC3843034.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.227,OADS,/arxiv_data1/oa_pdf/71/18/rde-38-227.PMC3843034.pdf
Pulpotomy with CEM cement http://dx.doi.org/10.5395/rde.2013.38.4.227,Non-OADS,/arxiv_data1/oa_pdf/71/18/rde-38-227.PMC3843034.pdf
"The Korean Academy of Conservative Dentistry.234This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effects of dentin moisture on the push-out bond strength of a fiber post luted with different self-adhesive resin cements Objectives:  This study evaluated the effects of intraradicular moisture on the push- out bond strength of a fibre post luted with several self-adhesive resin cements.",Non-OADS,/arxiv_data1/oa_pdf/a4/2e/rde-38-234.PMC3843035.pdf
"1Aktemur Türker S, Department  of Endodontics, Bülent Ecevit University Faculty of Dentistry, Zonguldak, Turkey  2Uzunoğlu E; Yılmaz Z, Department  of Endodontics, Hacettepe University Faculty of Dentistry, Ankara, Turkey*Correspondence to Sevinç Aktemur Türker, DDS, PhD.Assistant Professor , Department  of Endodontics, Bülent Ecevit University Faculty of Dentistry, Kozlu 67600, Zonguldak, TurkeyTEL, +90-372-2613427; FAX,  +90-372-2613413; E-mail, sevincaktemur@hotmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.234",Non-OADS,/arxiv_data1/oa_pdf/a4/2e/rde-38-234.PMC3843035.pdf
"Moist: The root canals were dried with a Luer vacuum adapter (Ultradent Products, South Jordan, Utah, USA) Effect of dentin moisture on bond strength http://dx.doi.org/10.5395/rde.2013.38.4.234",Non-OADS,/arxiv_data1/oa_pdf/a4/2e/rde-38-234.PMC3843035.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.234,Non-OADS,/arxiv_data1/oa_pdf/a4/2e/rde-38-234.PMC3843035.pdf
25 20 15 10 50Push out bond strength values (MPa) Dry (1)              Normal (2)             Moist (3)              Wet (4)ClearfilSA RelyX U100GCem http://dx.doi.org/10.5395/rde.2013.38.4.234,Non-OADS,/arxiv_data1/oa_pdf/a4/2e/rde-38-234.PMC3843035.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.234,Non-OADS,/arxiv_data1/oa_pdf/a4/2e/rde-38-234.PMC3843035.pdf
"Mörmann W, Wolf D, Ender A, Bindl A, Göhring T, Attin T. Effect of two self-adhesive cements on marginal adaptation and strength of esthetic ceramic CAD/CAM  http://dx.doi.org/10.5395/rde.2013.38.4.234",OADS,/arxiv_data1/oa_pdf/a4/2e/rde-38-234.PMC3843035.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.234,Non-OADS,/arxiv_data1/oa_pdf/a4/2e/rde-38-234.PMC3843035.pdf
"The Korean Academy of Conservative Dentistry.241This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of Epigallocatechin Gallate on shear bond strength of composite resin to bleached enamel: an in vitro study Objectives:  The aim of this study was to determine the effect of epigallocatechin  gallate (EGCG) on the shear bond strength of composite resin to bleached enamel.",Non-OADS,/arxiv_data1/oa_pdf/af/2a/rde-38-241.PMC3843036.pdf
"1Khamverdi Z; Rezaei-Soufi L;  Kasraei S, Dental Research Center, Department of Operative Dentistry, Dental School, Hamadan University  of Medical Sciences, Hamadan, Iran 2Ronasi N, Dental Research Center,  Department of Oral Medicine,  Dental School, Hamadan University of Medical Sciences, Hamadan, Iran 3Rostami S, Department of  Operative Dentistry, Kordestan University of Medical Sciences, Sanandaj, Iran*Correspondence to Loghman Rezaei-Soufi, DDS, MS.Associate Professor, Dental Research Center, Department of Operative Dentistry, Dental Faculty, Besat Blvd, Hamadan, Iran 65176-59114TEL, 0811-8381059; FAX, 0811-8381085; E-mail, Loghmansofi@umsha.ac.irResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.241",Non-OADS,/arxiv_data1/oa_pdf/af/2a/rde-38-241.PMC3843036.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.241,Non-OADS,/arxiv_data1/oa_pdf/af/2a/rde-38-241.PMC3843036.pdf
Fracture modes of the bonding between composite  resin and bleached enamel after treatment with various concentrations and application times of epigallocatechin gallate  Group Adhesive Mixed Cohesive 1 2 (20%) 7 (70%) 1 (10%) 2 6 (60%) 3 (30%) 1 (10%) 3 2 (20%) 7 (70%) 1 (10%) 4 4 (40%) 5 (50%) 1 (10%) 5 3 (30%) 6 (60%) 1 (10%) 6 3 (30%) 7 (70%) 0 7 3 (30%) 7 (70%) 0 8 3 (30%) 6 (60%) 1 (10%) 9 3 (30%) 5 (50%) 1 (10%) 29 (33%) 53 (58%) 8 (9%) http://dx.doi.org/10.5395/rde.2013.38.4.241,Non-OADS,/arxiv_data1/oa_pdf/af/2a/rde-38-241.PMC3843036.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.241,Non-OADS,/arxiv_data1/oa_pdf/af/2a/rde-38-241.PMC3843036.pdf
"(a) ×250; (b) ×5,000.Epigallocatechin Gallate effect on the bleached enamel http://dx.doi.org/10.5395/rde.2013.38.4.241",Non-OADS,/arxiv_data1/oa_pdf/af/2a/rde-38-241.PMC3843036.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.241,Non-OADS,/arxiv_data1/oa_pdf/af/2a/rde-38-241.PMC3843036.pdf
Epigallocatechin Gallate effect on the bleached enamel http://dx.doi.org/10.5395/rde.2013.38.4.241,Non-OADS,/arxiv_data1/oa_pdf/af/2a/rde-38-241.PMC3843036.pdf
"The Korean Academy of Conservative Dentistry.248This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Washout resistance of fast-setting pozzolan cement under various root canal irrigants Objectives:  Fast-setting pozzolan cement (Endocem, Maruchi) was recently developed.",Non-OADS,/arxiv_data1/oa_pdf/67/66/rde-38-248.PMC3843037.pdf
"1Jang GY; Park SJ, Department of  Conservative Dentistry, Wonkwang University School of Dentistry, Iksan, Korea  2Heo SM, Department of Periodontology,  Chonbuk National University School of Dentistry, Jeonju, Korea 3Yu MK; Lee KW; Min KS, Department  of Conservative Dentistry, Chonbuk National University School of Dentistry, Jeonju, Korea 4Yu MK; Lee KW; Min KS, Research  Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Korea*Correspondence to Kyung-San Min, DDS, PhD.Associate Professor, Department of Conservative Dentistry, Chonbuk National University School of Dentistry, 567 Baekje-daero, Deokjin-gu, Jeonju, Korea 561-756 TEL, +82-63-250-2764; FAX, +82-63-250-2129; E-mail, endomin@gmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2013.38.4.248",Non-OADS,/arxiv_data1/oa_pdf/67/66/rde-38-248.PMC3843037.pdf
(a)                                                    (b)                                                     (c) (d)                                                    (e)                                                     (f) http://dx.doi.org/10.5395/rde.2013.38.4.248,Non-OADS,/arxiv_data1/oa_pdf/67/66/rde-38-248.PMC3843037.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.248,OADS,/arxiv_data1/oa_pdf/67/66/rde-38-248.PMC3843037.pdf
These findings may explain why the washout resistance of the CHX-treated group was lower than that of the NaOCl-treated group in this study.Washout resistance of pozzolan cement http://dx.doi.org/10.5395/rde.2013.38.4.248,Non-OADS,/arxiv_data1/oa_pdf/67/66/rde-38-248.PMC3843037.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.248,OADS,/arxiv_data1/oa_pdf/67/66/rde-38-248.PMC3843037.pdf
"The Korean Academy of Conservative Dentistry.253This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Endodontic treatment of maxillary lateral incisors with anatomical variations Maxillary lateral incisors usually exhibit a single root with a single canal.",Non-OADS,/arxiv_data1/oa_pdf/16/c5/rde-38-253.PMC3843038.pdf
"Lee MH; Ha JH; Jin MU; Kim YK;  Kim SK, Department of Conservative Dentistry, Kyungpook National University School of Dentistry, Daegu, Korea*Correspondence to Sung-Kyo Kim, DDS, MSD, PhD.Professor, Department of Conservative Dentistry, Kyungpook National University School of Dentistry, 188-1 Samdeok-dong 2-ga, Jung-gu, Daegu, Korea 700-705TEL, +82-53-600-7621; FAX, +82-53-426-8958; E-mail, skykim@knu.ac.krCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.253",Non-OADS,/arxiv_data1/oa_pdf/16/c5/rde-38-253.PMC3843038.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.253,Non-OADS,/arxiv_data1/oa_pdf/16/c5/rde-38-253.PMC3843038.pdf
(a)                                 (b)                                 (c)                                              (d) (e)                                 (f)   http://dx.doi.org/10.5395/rde.2013.38.4.253,Non-OADS,/arxiv_data1/oa_pdf/16/c5/rde-38-253.PMC3843038.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.253,Non-OADS,/arxiv_data1/oa_pdf/16/c5/rde-38-253.PMC3843038.pdf
Maxillary lateral incisors with anatomical variations http://dx.doi.org/10.5395/rde.2013.38.4.253,Non-OADS,/arxiv_data1/oa_pdf/16/c5/rde-38-253.PMC3843038.pdf
"The Korean Academy of Conservative Dentistry.258This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Conservative approach of a symptomatic carious immature permanent tooth using a tricalcium silicate cement (Biodentine): a case report The restorative management of deep carious lesions and the preservation of pulp vitality of immature teeth present real challenges for dental practitioners.",Non-OADS,/arxiv_data1/oa_pdf/ec/cd/rde-38-258.PMC3843039.pdf
"1Villat C, Laboratoire des Multimatériaux  et Interfaces, UMR CNRS 5615, Department of Conservative Dentistry and Endodontics, Faculté d’Odontologie, Université de Lyon, Hospices Civils de Lyon, Lyon, France 2Grosgogeat B, Laboratoire des  Multimatériaux et Interfaces, UMR CNRS 5615, Department of Biomaterials, Faculté d’Odontologie, Université de Lyon, Hospices Civils de Lyon, Lyon, France 3Seux D; Farge P, Department of  Conservative Dentistry and Endodontics, Faculté d’Odontologie, Université de Lyon, Hospices Civils de Lyon, France*Correspondence to Cyril Villat, DDS, PhD.Associate Professor, Department of Conservative Dentistry and Endodontics, Université Lyon 1, Faculté d’Odontologie, 11 rue Guillaume Paradin 69365 Lyon Cedex 08 FranceTEL, +33(0)4 78 77 86 89; FAX, +33(0)4 78 77 87 12; E-mail, cyril.villat@univ-lyon1.frCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.258",Non-OADS,/arxiv_data1/oa_pdf/ec/cd/rde-38-258.PMC3843039.pdf
(a)                                     (b)                                           (c) http://dx.doi.org/10.5395/rde.2013.38.4.258,Non-OADS,/arxiv_data1/oa_pdf/ec/cd/rde-38-258.PMC3843039.pdf
(a)                              (b)                                     (c) http://dx.doi.org/10.5395/rde.2013.38.4.258,Non-OADS,/arxiv_data1/oa_pdf/ec/cd/rde-38-258.PMC3843039.pdf
"Villat C, Tran XV, Pradelle-Plasse N, Ponthiaux P, Wenger Management of an extensively carious immature tooth http://dx.doi.org/10.5395/rde.2013.38.4.258",Non-OADS,/arxiv_data1/oa_pdf/ec/cd/rde-38-258.PMC3843039.pdf
http://dx.doi.org/10.5395/rde.2013.38.4.258,Non-OADS,/arxiv_data1/oa_pdf/ec/cd/rde-38-258.PMC3843039.pdf
"The Korean Academy of Conservative Dentistry.263This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Statistical notes for clinical researchers: Understanding standard deviations and standard errors Hae-Young Kim  Department of Dental Laboratory Science and Engineering, College of Health Science & Department of Public Health Science, Graduate School & BK21+ Program in Public Health Sciences, Korea University, Seoul, Korea *Correspondence to Hae-Young Kim, DDS, PhD.Associate Professor,Department of Dental Laboratory Science & Engineering, Korea University College of Health Science, San 1 Jeongneung 3-dong, Seongbuk-gu, Seoul, Korea 136-703TEL, +82-2-940-2845; FAX, +82-2-909-3502, E-mail, kimhaey@korea.ac.krOpen lecture on statistics ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.263 The distinction between standard error and standard deviation is not easy to  explain.",Non-OADS,/arxiv_data1/oa_pdf/2f/e1/rde-38-263.PMC3843040.pdf
"For a large sample, the 95% confidence interval of a  http://dx.doi.org/10.5395/rde.2013.38.4.263",Non-OADS,/arxiv_data1/oa_pdf/2f/e1/rde-38-263.PMC3843040.pdf
mean                     X                                 O                           Z1 (a)                                               (b)                                               (c)        SDSE =              √ n http://dx.doi.org/10.5395/rde.2013.38.4.263,OADS,/arxiv_data1/oa_pdf/2f/e1/rde-38-263.PMC3843040.pdf
"The Korean Academy of Conservative Dentistry.266This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Light curing of dual cure resin cementReaders' forum ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2013.38.4.266 When using dual cure resin cements for cementing indirect restorations such as ceramic inlays or resin inlays, is the  light curing procedure of dual cure resin cements necessary?Q Although dual cure resin cements (DCRCs) are formulated to polymerize without the light curing procedure, the  degree of conversion of these cements without light curing varies a lot according to the manufacturers.",Non-OADS,/arxiv_data1/oa_pdf/02/bd/rde-38-266.PMC3843041.pdf
Restor Dent Endod 2012;37:130-135. http://dx.doi.org/10.5395/rde.2013.38.4.266,Non-OADS,/arxiv_data1/oa_pdf/02/bd/rde-38-266.PMC3843041.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/78/3c/srep03381.PMC3843159.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3381 | DOI: 10.1038/srep03381 5",Non-OADS,/arxiv_data1/oa_pdf/78/3c/srep03381.PMC3843159.pdf
Image processing and cell counting was performed in ImageJ (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/d3/b9/srep03382.PMC3843160.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/b9/srep03382.PMC3843160.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3382 | DOI: 10.1038/srep03382 10",Non-OADS,/arxiv_data1/oa_pdf/d3/b9/srep03382.PMC3843160.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/2f/srep03375.PMC3843161.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3375 | DOI: 10.1038/srep03375 6",Non-OADS,/arxiv_data1/oa_pdf/3d/2f/srep03375.PMC3843161.pdf
"Briefly, rat fibroblast-like (Rat-1) cells were obtained from the RIKEN BRC Cell Bank (Tsukuba, Japan, http://www.brc.riken.jp/lab/cell/english).",Non-OADS,/arxiv_data1/oa_pdf/37/06/srep03379.PMC3843162.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/37/06/srep03379.PMC3843162.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3379 | DOI: 10.1038/srep03379 8",Non-OADS,/arxiv_data1/oa_pdf/37/06/srep03379.PMC3843162.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3377 | DOI: 10.1038/srep03377 4",Non-OADS,/arxiv_data1/oa_pdf/9b/c9/srep03377.PMC3843163.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3384 | DOI: 10.1038/srep03384 4",Non-OADS,/arxiv_data1/oa_pdf/21/f7/srep03384.PMC3843164.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3383 | DOI: 10.1038/srep03383 6",Non-OADS,/arxiv_data1/oa_pdf/02/a1/srep03383.PMC3843166.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2d/ef/srep03248.PMC3843168.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3248 | DOI: 10.1038/srep03248 8",Non-OADS,/arxiv_data1/oa_pdf/2d/ef/srep03248.PMC3843168.pdf
Available from: URL: http://www.hfea.gov.uk/en/1540.html 6.,Non-OADS,/arxiv_data1/oa_pdf/b0/f1/10815_2013_Article_83.PMC3843177.pdf
Available from: http://www.health.bih.nic.in/Docs/ Guidelines‑NPHCE.pdf [Last accessed on 2012 Oct 17].,Non-OADS,/arxiv_data1/oa_pdf/5d/8c/IJPVM-4-1103.PMC3843295.pdf
Available from: http://hpp.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/22/49/IJPVM-4-1122.PMC3843298.pdf
Available  from: http://www.amar.org.ir/Portals/1/Iran/data.,OADS,/arxiv_data1/oa_pdf/22/49/IJPVM-4-1122.PMC3843298.pdf
Available  from: http://seer.cancer.gov/csr/1975_2003/results_ merged/topic_age_dist.pdf.,OADS,/arxiv_data1/oa_pdf/22/49/IJPVM-4-1122.PMC3843298.pdf
Available from: http://meridian.aag.org/callforpapers/ program/AbstractDetail.cfm?AbstractID=47902.,OADS,/arxiv_data1/oa_pdf/22/49/IJPVM-4-1122.PMC3843298.pdf
Available from:  http://www.who.int/whr/1999/en/whr99_en.pdf.,OADS,/arxiv_data1/oa_pdf/75/e3/IJPVM-4-1162.PMC3843303.pdf
Available from: http://www.wpro.,Non-OADS,/arxiv_data1/oa_pdf/75/e3/IJPVM-4-1162.PMC3843303.pdf
Available  from: http://www.aku.edu.pk/AKUH/health_awarness/ pdf/Interdependence‑of‑Physical‑and‑Mental‑Health.,Non-OADS,/arxiv_data1/oa_pdf/47/0a/IJPVM-4-1189.PMC3843306.pdf
Available from:  http://www.who.int/mental_health/prevention/en/.,Non-OADS,/arxiv_data1/oa_pdf/4e/73/IJPVM-4-1200.PMC3843308.pdf
Available from:  http://www.psychiatrictimes.com/suicide/content/ article/10168/2000387.,Non-OADS,/arxiv_data1/oa_pdf/4e/73/IJPVM-4-1200.PMC3843308.pdf
Available from: http://www.psychiatrictimes.,Non-OADS,/arxiv_data1/oa_pdf/4e/73/IJPVM-4-1200.PMC3843308.pdf
Available from: http://www.nihfw.,Non-OADS,/arxiv_data1/oa_pdf/6d/9c/IJPVM-4-1213.PMC3843311.pdf
Available from: http://www.rchiips.com.,Non-OADS,/arxiv_data1/oa_pdf/6d/9c/IJPVM-4-1213.PMC3843311.pdf
Accessed  from: http://www.amar.org.ir/default‑243.aspx  [Last accessed on 2010 Nov 5].,Non-OADS,/arxiv_data1/oa_pdf/5f/2d/IJPVM-4-1217.PMC3843312.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/39/ca/IJPVM-4-1224.PMC3843313.pdf
Available from: http://www.who.int/ageing/ publications/alc_fs_ageing_policy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/39/ca/IJPVM-4-1224.PMC3843313.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs357/en/.,Non-OADS,/arxiv_data1/oa_pdf/39/ca/IJPVM-4-1224.PMC3843313.pdf
Available from: http://www.who.int/nutrition/ topics/ageing/en/index1.html.,Non-OADS,/arxiv_data1/oa_pdf/39/ca/IJPVM-4-1224.PMC3843313.pdf
Available at http://en.wikipedia.org/wiki/2013_North_India_ floods.,Non-OADS,/arxiv_data1/oa_pdf/ad/d6/IJRI-23-189.PMC3843321.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/4b/gft399.PMC3843345.pdf
"Poster presented at the 100th Annual Meeting 2009, American Associ ation for Cancer Research, Denver, CO. Abstract retrieved from http://www.aacr.org/home/ scientists/meetings –workshops/aacr-annual-meeting-2013/previous- annual-meetings/annual-meeting-2009.aspx (Program: pp 411 – 460: Wednesday, April 22, p 33, poster 9).",Non-OADS,/arxiv_data1/oa_pdf/5a/a5/10555_2013_Article_9431.PMC3843370.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/39/cia-8-1561.PMC3843606.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1561–1568Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1561OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5327 0Is a change in functional capacity or dependency  in activities of daily living associated with a   change in mental health among older people   living in residential care facilities?,Non-OADS,/arxiv_data1/oa_pdf/c3/39/cia-8-1561.PMC3843606.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c3/39/cia-8-1561.PMC3843606.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/39/cia-8-1561.PMC3843606.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/38/ijn-8-4553.PMC3843607.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4553–4562International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4553OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5163 3effects of Caryota mitis  profilin-loaded PLGA  nanoparticles in a murine model of allergic  asthma Xiaojun Xiao1,* Xiaowei Zeng2,* Xinxin Zhang3,* li Ma3 Xiaoyu liu1 haiqiong Yu1 lin Mei2 Zhigang liu1 1Institute of allergy and Immunology,  school of Medicine, shenzhen  University, shenzhen, 2Division of life  and health sciences, graduate school  at shenzhen, Tsinghua University,  shenzhen, 3Faculty of Basic Medical  science, Nanchang University,  Nanchang, People’s Republic of China *These authors contributed equally  to this work correspondence: Zhigang liu   school of Medicine, shenzhen University,  shenzhen 518060, guangdong,   People’s Republic of China   Fax +86 755 2653 4902   email lzg @szu.edu.c n    lin Mei   l401, Tsinghua campus, Xili University  Town, shenzhen 518055, guangdong,  People’s Republic of China   Fax +86 755 260 36736   email mei.lin@sz.tsinghua.edu.c nBackground:  Pollen allergy is the most common allergic disease.",Non-OADS,/arxiv_data1/oa_pdf/88/38/ijn-8-4553.PMC3843607.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/88/38/ijn-8-4553.PMC3843607.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/38/ijn-8-4553.PMC3843607.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/55/ndt-9-1827.PMC3843638.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/72/55/ndt-9-1827.PMC3843638.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/55/ndt-9-1827.PMC3843638.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/f9/ndt-9-1821.PMC3843639.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1821–1826Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1821OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4831 8Prevalence of Parkinson’s disease and other   types of Parkinsonism in al Kharga district, egypt hamdy N el-Tallawy1 Wafaa M Farghaly1 ghaydaa a shehata1 Tarek a rageh1 Nabil M abdel hakeem2 Mohamed abd al hamed1 reda Badry1 1Department of Neurology, assiut  University, 2al-azhar University –  assiut branch, assiut, egypt correspondence: reda Badry   Department of Neurology, assiut  University hospital, assiut 71526, egypt   Tel +20 88 236 9541   Fax +20 88 241 3001   email redaalbadry02@gmail.co mAbstract:  Parkinson’ s disease (PD) is a common neurodegenerative disorder in older people.",Non-OADS,/arxiv_data1/oa_pdf/65/f9/ndt-9-1821.PMC3843639.pdf
"Vascular, postencephalitic, and other types of Parkinsonism were defined according to  Seijo-Martinez et al.7 The severity of PD was classified using  the Hoehn and Y ahr (HY) scale.8 PD cases were assessed  using the Unified Parkinson’ s Disease Rating Scale (UPDRS),  version 3.0.9 Statistical analysis SPSS (v 12.0.1; IBM Corporation, Armonk, NY , USA) and   EpiCalc 2000 (Brixton Health; software available from:  http://www.brixtonhealth.com/epicalc.htm l) were used for  data analysis.",OADS,/arxiv_data1/oa_pdf/65/f9/ndt-9-1821.PMC3843639.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/65/f9/ndt-9-1821.PMC3843639.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/f9/ndt-9-1821.PMC3843639.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/ca/ndt-9-1829.PMC3843640.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1829–1834Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1829Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5217 9adjunctive enteral phenobarbital for adult status  epilepticus: a brief report somsak Tiamkao1,2 Kornkanok suttapan1 sineenard Pranbul2,3 siriporn Tiamkao2,4 Kittisak sawanyawisuth1,5 integrated epilepsy  research group2 1Department of Medicine, Faculty  of Medicine, Khon Kaen University,   Khon Kaen, Thailand; 2integrated  epilepsy research Group, Khon Kaen  University, Khon Kaen, Thailand;   3Nursing Division, srinagarind  Hospital, Faculty of Medicine, Khon  Kaen University, Khon Kaen, Thailand;   4Department of Pharmacy, Faculty of  Medicine, Khon Kaen University, Khon  Kaen, Thailand; 5The research and  Training Center for enhancing Quality  of Life of Working- age People, Khon  Kaen University, Khon Kaen, Thailand Correspondence: somsak Tiamkao   Department of Medicine, Faculty of  Medicine, Khon Kaen University,   Khon Kaen, 40002, Thailand   Tel +66 4 336 3664   Fax +66 4 334 8399   email somtia@kku.ac.t hBackground:  Status epilepticus (SE) is a neurological emergency condition.",Non-OADS,/arxiv_data1/oa_pdf/b0/ca/ndt-9-1829.PMC3843640.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b0/ca/ndt-9-1829.PMC3843640.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/ca/ndt-9-1829.PMC3843640.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/12/jpr-6-825.PMC3843641.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 825–835Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  825ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S5032 3Real-world treatment patterns and opioid use  in chronic low back pain patients initiating  duloxetine versus standard of care Jeffrey scott andrews1 ning Wu2 shih-Yin chen2 Xia Yu2 Xiaomei Peng1 Diego novick1 1global health Outcomes, eli lilly  and company, indianapolis, in, Usa;   2evidera, lexington, M a, Usa correspondence: Jeffrey scott andrews   lilly corporate center,   indianapolis, in 46285, Usa   Tel +1 317 452 6813   email andrews_jeffrey_scott@lilly.co mAbstract:  To describe the use of pain medications in patients with chronic low back pain (CLBP)  after initiating duloxetine or standard of care (SOC [muscle relaxants, gabapentin, pregabalin,  venlafaxine, and tricyclic antidepressants]) for pain management, pharmacy and medical claims  from Surveillance Data, Inc (SDI) Health were analyzed.",Non-OADS,/arxiv_data1/oa_pdf/9d/12/jpr-6-825.PMC3843641.pdf
Available from: http://healthypeople.gov/2020/  topicsobjectives2020/overview.aspx?topici d=3.,Non-OADS,/arxiv_data1/oa_pdf/9d/12/jpr-6-825.PMC3843641.pdf
Available from: https://www.icsi.,Non-OADS,/arxiv_data1/oa_pdf/9d/12/jpr-6-825.PMC3843641.pdf
"Indianapolis, IN: Lilly USA, LLC; 2010 [webpage on the internet]  Available from: http://pi.lilly.com/us/cymbalta-pi.pd f. Accessed  July 24, 2012.",Non-OADS,/arxiv_data1/oa_pdf/9d/12/jpr-6-825.PMC3843641.pdf
"Available from: ftp://ftp.cdc.gov/ pub/Health_Statistics/NCHS/Publications/ICD-9/ucod.tx t. Accessed  April 18, 2012.",OADS,/arxiv_data1/oa_pdf/9d/12/jpr-6-825.PMC3843641.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/9d/12/jpr-6-825.PMC3843641.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/12/jpr-6-825.PMC3843641.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/9a/jpr-6-815.PMC3843642.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 815–824Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  815ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S5091 9altered resting state eeg in chronic pancreatitis   patients: toward a marker for chronic pain Marjan de Vries1 Oliver hg Wilder-smith2 Marijtje la Jongsma3 emanuel n van den Broeke1 Martijn arns5,6 harry van goor1 clementina M van Rijn4 1Department of surgery, Radboud  University nijmegen Medical  centre, nijmegen, The netherlands;   2Department of anesthesiology,   Pain and Palliative care, Radboud  University nijmegen Medical  centre, nijmegen, The netherlands;   3Behavioral science institute,    Radboud University nijmegen,   nijmegen, The netherlands;    4Donders institute for Brain,   cognition and Behavior, Radboud  University nijmegen, nijmegen,    The netherlands; 5Research institute   Brainclinics nijmegen, nijmegen,    The netherlands; 6Department of   experimental Psychology, Utrecht   University, Utrecht, The netherlands correspondence: Marjan de Vries   Department of surgery, Radboud  University nijmegen Medical centre,   PO Box 9101, 6500 hB nijmegen,   The netherlands   T el +31 243 610 903   Fax +31 243 540 501   email m.devries@chir.umcn.n lObjectives:  Electroencephalography (EEG) may be a promising source of physiological bio - markers accompanying chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/e0/9a/jpr-6-815.PMC3843642.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/e0/9a/jpr-6-815.PMC3843642.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/9a/jpr-6-815.PMC3843642.pdf
"OECD Publis hing, 2011. http://www.oecd.org/health/ health-systems/healthataglance2011.htm.",Non-OADS,/arxiv_data1/oa_pdf/2a/05/cee-0003-0137.PMC3843922.pdf
Available at http://www.alzh eimers.org.uk/site/scripts/download_info.,Non-OADS,/arxiv_data1/oa_pdf/ed/c9/dee-0003-0417.PMC3843923.pdf
A web -based toric IOL  calculator program was used to determine the optimal cylinder power and alignment axis of  the IOL (available at http://www.acrysoftoriccalculator.com) ( fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/01/cop-0004-0219.PMC3843926.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 KPMG.,Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
2012 http://www.pmi.com/eng/ tobacco_regulation/tobacco_taxation/pages/tobacco_taxation.aspx (accessed 17 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
"Pricing Policies and Control of Tobacco in Europe, 2011 http://www.ppacte.eu/index.php?option=com_docman&task=doc_download&gid=187&Itemid=29 (accessed 22 Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
http://transcrime.cs.unitn.it/tc/fso/pubblicazioni/AP/Transcrime- Analysis_of_the_Draft_Protocol_to_eliminate_ITTP.pdf (accessed 17 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
http://ec.europa.eu/governance/impact/planned_ia/docs/ 46_sanco_tobacco_products_directive_en.pdf (accessed 20 Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
"Brussels: Rand Europe, 2011. http://www.rand.org/content/dam/ rand/pubs/technical_reports/2011/RAND_TR823.pdf (accessed 20 Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
Available at http://www.smoke- free.ca/plain-packaging/documents/industry-responses/LECG_Literature_Review_on_generic_packaging_2010.pdf (accessed 20 aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
"London: Philip Morris Limited, 2012. http://www.pmi.com/eng/tobacco_regulation/submissions/documents/submission% 20and%20all%20annexes%20%28combined%29.pdf (accessed 20 Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
"London: Department of Health, 2012. http://www.dh.gov.uk/prod_consum_dh/ groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_133575.pdf (accessed22 Aug 2012).",OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
"Paris: International Union AgainstTuberculosis and Lung Disease, 2009 http://www.tobaccofreeunion.org/assets/Technical%20Resources/Economic%20Reports/How%20Eliminating%20the% 20Global%20Illicit%20Cigarette%20Trade%20Would%20Increase%20Tax% 20Revenue%20and%20Save%20Lives%20-%20EN.pdf (accessed 13 Nov 2012).",Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
"Victoria: Cancer Council Victoria, 2011. http://www.plainpacksprotect.co.uk/assets/ pdf/Plain_packaging_evidence_review.pdf (accessed 13 Nov 2012).",Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
"Paris: FATF/ OECD, 2012. http://www.fatf-ga ﬁ.org/media/fatf/documents/reports/Illicit% 20Tobacco%20Trade.pdf (accessed 13 Nov 2012).",Non-OADS,/arxiv_data1/oa_pdf/ed/47/tobaccocontrol-2012-050788.PMC3844000.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2012-304190).,OADS,/arxiv_data1/oa_pdf/4a/10/gutjnl-2012-304190.PMC3844066.pdf
"1Department of Medicine, Division of Gastroenterologyand Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina,USA 2Department of Bioinformatics and Genomics, University of North Carolina at Charlotte,Charlotte, North Carolina, USA 3Department of Pediatrics, Division of Gastroenterology, University of North Carolina atChapel Hill, Chapel Hill, NorthCarolina, USA Correspondence to Dr Ajay S Gulati,Department of Pediatrics,Division of Gastroenterology, University of North Carolina at Chapel Hill, CB# 7229, 230MacNider Hall, Chapel Hill,NC 27599, USA; ajay_gulati@med.unc.edu Received 21 November 2012 Revised 3 February 2013Accepted 26 February 2013Published Online First 19 March 2013 ▸http://dx.doi.org/10.1136/ gutjnl-2013-305077 To cite: Shanahan MT, Carroll IM, Grossniklaus E, et al.Gut2014; 63: 903 –910.ABSTRACT Objective Although polymorphisms of the NOD2 gene predispose to the development of ileal Crohn ’s disease, the precise mechanisms of this increased susceptibilityremain unclear.",Non-OADS,/arxiv_data1/oa_pdf/4a/10/gutjnl-2012-304190.PMC3844066.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Jostins L, Ripke S, Weersma RK, et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/10/gutjnl-2012-304190.PMC3844066.pdf
"An ideal therapy to reduce venous stenosis forma-tion would be one that can be delivered selectively to thehttp://www.kidney-international.org basic research &2013 International Society of Nephrology Correspondence: Sanjay Misra, Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, 55905, USA.E-mail: misra.sanjay@mayo.edu 5These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/78/21/ki2013290a.PMC3844094.pdf
Supplementary material is linked to the online version of the paper athttp://www.nature.com/kiREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/21/ki2013290a.PMC3844094.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ 306 Kidney International (2014) 85,2 8 9 – 3 0 6basic research B Yang et al.",Non-OADS,/arxiv_data1/oa_pdf/78/21/ki2013290a.PMC3844094.pdf
@ERSpublications Dual indacaterol/glycopyrronium therapy was safe and more efficacious than monotherapy in moderate-to-severe COPD http://ow.ly/p3H5E This article has supplementary material available from www.erj.ersjournals.com Received: Dec 11 2012 |Accepted after revision: May 15 2013 |First published online: May 30 2013 Clinical trial: This study is registered at www.clinicaltrials.gov with identifier number NCT01202188.,Non-OADS,/arxiv_data1/oa_pdf/ba/d6/erj-42-06-1484.PMC3844137.pdf
@ERSpublications Aetiology of community-acquired pneumonia in children following a pneumococcal conjugate vaccination programme http://ow.ly/p9Wub Received: Dec 09 2012 |Accepted after revision: March 24 2013 |First published online: April 18 2013 Support statement: The work was supported by Pfizer Vaccines UK (0887X1-4479).,Non-OADS,/arxiv_data1/oa_pdf/db/15/erj-42-06-1595.PMC3844138.pdf
"@ERSpublications COPD is related to worse health status: impairment is greater than in self-reported cardiovascular diseases or diabetes http://ow.ly/p1cIx Received: Sept 27 2012 |Accepted after revision: Feb 28 2013 |First published online: May 30 2013 Support statement: The BOLD initiative has been funded in part by unrestricted educational grants to the Operations Center from ALTANA, Aventis, AstraZeneca, Boehringer-Ingelheim, Chiesi, GlaxoSmithKline, Merck, Novartis, Pfizer,Schering-Plough, Sepracor, and University of Kentucky.",Non-OADS,/arxiv_data1/oa_pdf/dc/ee/erj-42-06-1472.PMC3844139.pdf
http://www.ethnologue.com/country/TZ of subordinate document.,Non-OADS,/arxiv_data1/oa_pdf/93/e4/12011_2013_Article_9844.PMC3844147.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced o r disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/87/01/eht095.PMC3844149.pdf
"This is an Open Access article distributed unde r the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use,distri bution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/b0/eht269.PMC3844151.pdf
2011. http://www.euro.who.int/__data/assets/pdf_ﬁle/0008/136466/e94888.pdf.,OADS,/arxiv_data1/oa_pdf/27/b0/eht269.PMC3844151.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/b7/eht273.PMC3844152.pdf
http://www.nice.org.uk/CG071 (30 March 2013).,Non-OADS,/arxiv_data1/oa_pdf/b2/b7/eht273.PMC3844152.pdf
http://heartuk.org.uk/ﬁles/uploads/documents/HUK_ HealthEconomics_FINAL2012_2702.pdf (17 December 2012).Guidance for clinicians to prevent coronary heart disease 3490a,Non-OADS,/arxiv_data1/oa_pdf/b2/b7/eht273.PMC3844152.pdf
http://dx.doi.org/10.1016/j.gpb.2012.08.004⇑Corresponding authors.,OADS,/arxiv_data1/oa_pdf/49/40/main.PMC3844613.pdf
HMSO: London (http://www.comare.org.uk/).,Non-OADS,/arxiv_data1/oa_pdf/fb/3f/bjc2013560a.PMC3844901.pdf
HMSO: London (http://www.comare.org.uk/).,Non-OADS,/arxiv_data1/oa_pdf/fb/3f/bjc2013560a.PMC3844901.pdf
HMSO: London (http://www.comare.org.uk/).,Non-OADS,/arxiv_data1/oa_pdf/fb/3f/bjc2013560a.PMC3844901.pdf
HMSO: London (http://www.comare.org.uk/).,Non-OADS,/arxiv_data1/oa_pdf/fb/3f/bjc2013560a.PMC3844901.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CYP2C19 genotype-based phase I of tivantinib BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.588 2809,Non-OADS,/arxiv_data1/oa_pdf/6f/76/bjc2013588a.PMC3844902.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognostic biomarkers in OED 2874 www.bjcancer.com | DOI:10.1038/bjc.2013.600,Non-OADS,/arxiv_data1/oa_pdf/a1/2d/bjc2013600a.PMC3844903.pdf
"NCIN (2012) ‘Routes to Diagnosis - NCIN Data Briefing.’ Retrieved 19 June 2013, Available at: http://www.ncin.org.uk/publications/data_briefings/routes_to_diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/bjc2013626a.PMC3844906.pdf
"Retrieved 19 June 2013, Available at: http://www.ukacr.org/sites/ default/files/UKACR%20report2011_final_0.pdf.",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/bjc2013626a.PMC3844906.pdf
"All analyses presented here were performed using R 2.13 (http://www.r-project.org/), with the GBM analysis performed using the gbm_2.0-2 package (http://cran.",OADS,/arxiv_data1/oa_pdf/0b/40/bjc2013649a.PMC3844909.pdf
Available at http://cran.r-project.org/web/packages/gbm/vignettes/gbm.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/40/bjc2013649a.PMC3844909.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Multiple serum biomarker evaluation in colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.649 2773,Non-OADS,/arxiv_data1/oa_pdf/0b/40/bjc2013649a.PMC3844909.pdf
"There is a great interest in exploring the possibility that antidiabetic therapies lowering insulin levels may decrease BC incidence and mortality.Metformin, an oral biguanide, has been used worldwide to treat type 2 diabetes and pre-diabetic condition for more than 40 years because of its good tolerability profile and low cost (Drugs.com, 2011 http://www.drugs.com/pro/metformin-html).",Non-OADS,/arxiv_data1/oa_pdf/59/62/bjc2013657a.PMC3844911.pdf
"A potential limitation of our study is the drug cessation 24 h or longer before surgery, which was dictated by safety reasons (Drugs.com, 2011 http://www.drugs.com/pro/ metformin-html).",Non-OADS,/arxiv_data1/oa_pdf/59/62/bjc2013657a.PMC3844911.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Effect of metformin on a BC presurgical trial BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.657 2797,Non-OADS,/arxiv_data1/oa_pdf/59/62/bjc2013657a.PMC3844911.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BMI and oesophageal cancer outcome BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.666 2903,Non-OADS,/arxiv_data1/oa_pdf/75/22/bjc2013666a.PMC3844915.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER The correlation between ING4 and JWA in melanoma 2852 www.bjcancer.com | DOI:10.1038/bjc.2013.670,Non-OADS,/arxiv_data1/oa_pdf/9b/8a/bjc2013670a.PMC3844917.pdf
"Quantitation of signal intensities was performed using densitometry on a Hewlett-Packard ScanJet 5370C (Hewlett- Packard, Palo Alto, CA, USA) with NIH image 1.62 software (http://rsb.info.nih.gov/nih-image).",OADS,/arxiv_data1/oa_pdf/58/3f/bjc2013672a.PMC3844918.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)p53 and p38MAPK are regulated by miR-125b BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.672 2863,Non-OADS,/arxiv_data1/oa_pdf/58/3f/bjc2013672a.PMC3844918.pdf
http://www.comare.org.uk/.Committee on Medical Aspects of Radiation in the Environment) (COMARE) (2011) Fourteenth Report.,Non-OADS,/arxiv_data1/oa_pdf/ec/f8/bjc2013674a.PMC3844919.pdf
http://www.comare.org.uk/.,Non-OADS,/arxiv_data1/oa_pdf/ec/f8/bjc2013674a.PMC3844919.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3390 | DOI: 10.1038/srep03390 6",Non-OADS,/arxiv_data1/oa_pdf/67/55/srep03390.PMC3844941.pdf
"Behavior .To determine overall head movement rate and differences in body posture and head position in long and short grass (grass height was higher or lower than the height of the bird in a normal, head-up body posture, respectively), we coded twelve 15–60 s videos (six in each microhabitat type) of foraging eastern meadowlarks from the Macaulay Library (http://macaulaylibrary.org) and the Internet Bird Collection (http://ibc.lynxeds.com).",Non-OADS,/arxiv_data1/oa_pdf/f6/06/srep03231.PMC3844942.pdf
"), ,http://bna.birds.",Non-OADS,/arxiv_data1/oa_pdf/f6/06/srep03231.PMC3844942.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3231 | DOI: 10.1038/srep03231 6",Non-OADS,/arxiv_data1/oa_pdf/f6/06/srep03231.PMC3844942.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/de/db/srep03388.PMC3844943.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3388 | DOI: 10.1038/srep03388 6",Non-OADS,/arxiv_data1/oa_pdf/de/db/srep03388.PMC3844943.pdf
wrote the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/cb/srep03394.PMC3844944.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3394 | DOI: 10.1038/srep03394 8",Non-OADS,/arxiv_data1/oa_pdf/79/cb/srep03394.PMC3844944.pdf
Thearea of c-Fos-positive staining was measured using the Image J (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/71/20/srep03395.PMC3844946.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3395 | DOI: 10.1038/srep03395 8",Non-OADS,/arxiv_data1/oa_pdf/71/20/srep03395.PMC3844946.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).Endonuclease G executes a-synuclein cytotoxicity SB u¨ttner et al 3052 The EMBO Journal VOL 32 |NO 23 |2013 &2013 European Molecular Biology Organization,OADS,/arxiv_data1/oa_pdf/03/9f/emboj2013228a.PMC3844953.pdf
To view a copy of this licence visit http://creativecommons.org/licenses/by-nc- sa/3.0/.Endonuclease G executes a-synuclein cytotoxicity SB u¨ttner et al 3054 The EMBO Journal VOL 32 |NO 23 |2013 &2013 European Molecular Biology Organization,Non-OADS,/arxiv_data1/oa_pdf/03/9f/emboj2013228a.PMC3844953.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/3b/srep03183.PMC3844964.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3183 | DOI: 10.1038/srep03183 7",Non-OADS,/arxiv_data1/oa_pdf/95/3b/srep03183.PMC3844964.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/37/30/srep03398.PMC3844965.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3398 | DOI: 10.1038/srep03398 9",Non-OADS,/arxiv_data1/oa_pdf/37/30/srep03398.PMC3844965.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3396 | DOI: 10.1038/srep03396 9",Non-OADS,/arxiv_data1/oa_pdf/c6/a5/srep03396.PMC3844966.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c5/f4/srep03392.PMC3844968.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3392 | DOI: 10.1038/srep03392 6",Non-OADS,/arxiv_data1/oa_pdf/c5/f4/srep03392.PMC3844968.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3374 | DOI: 10.1038/srep03374 7",Non-OADS,/arxiv_data1/oa_pdf/08/6e/srep03374.PMC3844969.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/72/bf/srep03399.PMC3844970.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3399 | DOI: 10.1038/srep03399 10",Non-OADS,/arxiv_data1/oa_pdf/72/bf/srep03399.PMC3844970.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003695).,Non-OADS,/arxiv_data1/oa_pdf/71/5c/bmjopen-2013-003695.PMC3845034.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003569).,Non-OADS,/arxiv_data1/oa_pdf/3e/b7/bmjopen-2013-003569.PMC3845035.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003876).,Non-OADS,/arxiv_data1/oa_pdf/a6/94/bmjopen-2013-003876.PMC3845037.pdf
Secondary 2006 Community Profiles 2006. http://www12.statcan.ca/census- recensement/2006/dp-pd/prof/92-591/index.cfm 32.,OADS,/arxiv_data1/oa_pdf/a6/94/bmjopen-2013-003876.PMC3845037.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1. WHO.,Non-OADS,/arxiv_data1/oa_pdf/6d/2c/bmjopen-2013-003367.PMC3845038.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003288).,Non-OADS,/arxiv_data1/oa_pdf/8c/79/bmjopen-2013-003288.PMC3845039.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003461).,Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
http://www.who.int/ tobacco/framework/WHO_FCTC_english.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
"WHO, 2004. http://www.who.int/tobacco/research/secondhand_smoke/en/best_practices_australia.pdf 8.",Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
Updated in 15 December 2010. http://www.tobaccocontrollaws.org/files/live/Georgia/Georgia%20-%20TC%20Law%202010.pdf14.,Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
"Georgian Code of Administrative Offences, due to date 23 September 2012. http://laws.codexserver.com/931.DOC 15. WHO.",Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
Parties to the WHO Framework Convention on Tobacco Control by 2013. http://www.who.int/fctc/signatories_parties/en/index.html 16.,Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
due to date 23 September 2012. http://laws.codexserver.com/183.DOC 17.,Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
"Soroka SN, Wleizen C. Public Preferences and Public Expenditure in the United Kingdom 2003: a study in representation and feedback.http://degreesofdemocracy.mcgill.ca/sorokawlezienmpsa2003.pdf 32.",Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
"WHO, 2009. http://www.who.int/tobacco/surveillance/en_tfi_gats_russian_countryreport.pdf53.",Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
"WHO, 2010. http://www.who.int/tobacco/surveillance/en_tfi_gats_ukraine_report_2010.pdf 55.",Non-OADS,/arxiv_data1/oa_pdf/94/f4/bmjopen-2013-003461.PMC3845040.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003519).,Non-OADS,/arxiv_data1/oa_pdf/89/af/bmjopen-2013-003519.PMC3845041.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003823).,Non-OADS,/arxiv_data1/oa_pdf/5b/bd/bmjopen-2013-003823.PMC3845042.pdf
February 2013. http://www.ico.,Non-OADS,/arxiv_data1/oa_pdf/77/4a/bmjopen-2013-002967.PMC3845048.pdf
"Gan S. Lost in translation: how much is translation costing the NHS, and how can we both cut costs and improve service provision?2020Health, 2012. http://2020health.org/2020health/Publication-2012/Professional-Development/Translation-Services.html.",Non-OADS,/arxiv_data1/oa_pdf/77/4a/bmjopen-2013-002967.PMC3845048.pdf
November 2010. http://www.rcseng.ac.uk/publications/docs/locum-doctor-costs-in-nhs-trusts-in-england/@ @download/pdffile/RCS%20Locum%20doctor%20costs%20-%20NHS%20Trusts%20in%20England%20Oct%2010%20report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/4a/bmjopen-2013-002967.PMC3845048.pdf
November 2012.http://www.rcm.org.uk/EasySiteWeb/GatewayLink.aspx?alId=314009.,Non-OADS,/arxiv_data1/oa_pdf/77/4a/bmjopen-2013-002967.PMC3845048.pdf
nationalarchives.gov.uk/+/http://www.dca.gov.uk/speeches/2007/sp070321.htm.,Non-OADS,/arxiv_data1/oa_pdf/77/4a/bmjopen-2013-002967.PMC3845048.pdf
8th May 2012. http://www.bbc.co.uk/ news/health-17989929.,Non-OADS,/arxiv_data1/oa_pdf/77/4a/bmjopen-2013-002967.PMC3845048.pdf
2009. http://www.rin.ac.uk/system/files/attachments/Innovative_Uses_of_the_FOIA_for_Research__updated_paper_by_Andrew_Booth_Apr_2009.doc.,Non-OADS,/arxiv_data1/oa_pdf/77/4a/bmjopen-2013-002967.PMC3845048.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003307).,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/bmjopen-2013-003307.PMC3845049.pdf
"More information is available at: http://www.hscic.gov.uk/ hes iiAt the time of the study period primary care trusts (PCTs) were the main organisational and commissioning units in the English National Health System, including commissioning primary care and the majority of secondary care services.",Non-OADS,/arxiv_data1/oa_pdf/f4/2e/bmjopen-2013-003307.PMC3845049.pdf
"Report: Health Profile —Liverpool, 2010. http://www.apho.org.uk/resource/item.",Non-OADS,/arxiv_data1/oa_pdf/f4/2e/bmjopen-2013-003307.PMC3845049.pdf
Published Online First: 2011. http://liverpool.gov.uk/council/key-statistics-and-data/data/deprivation/ 11.,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/bmjopen-2013-003307.PMC3845049.pdf
http://surveillance.cancer.gov/joinpoint/ 12.,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/bmjopen-2013-003307.PMC3845049.pdf
http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/bmjopen-2013-003307.PMC3845049.pdf
http://courses.nus.edu.sg/course/ecstabey/tilak bala albert-2.pdf (accessed 6 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/bmjopen-2013-003307.PMC3845049.pdf
2010. http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/bmjopen-2013-003307.PMC3845049.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004121).,Non-OADS,/arxiv_data1/oa_pdf/32/d0/bmjopen-2013-004121.PMC3845050.pdf
12. http://www.hra.nhs.uk/hra-news-and-announcements/ transparent-research/ 13. http://www.alltrials.net/14.,Non-OADS,/arxiv_data1/oa_pdf/32/d0/bmjopen-2013-004121.PMC3845050.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003473).,Non-OADS,/arxiv_data1/oa_pdf/15/3a/bmjopen-2013-003473.PMC3845052.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/15/3a/bmjopen-2013-003473.PMC3845052.pdf
"Addis Ababa, 2012. http://www.most.gov.et/National%20STI%20Policy.htm 32.",Non-OADS,/arxiv_data1/oa_pdf/ab/5b/bmjopen-2013-003616.PMC3845054.pdf
http://www.moh.gov.et/English/Information/Pages/Policies%20and%20Strategies.aspx (accessed 04 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/ab/5b/bmjopen-2013-003616.PMC3845054.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003897).,Non-OADS,/arxiv_data1/oa_pdf/a6/61/bmjopen-2013-003897.PMC3845055.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/61/bmjopen-2013-003897.PMC3845055.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003967).,Non-OADS,/arxiv_data1/oa_pdf/5f/8e/bmjopen-2013-003967.PMC3845056.pdf
"The CopenHeartSF trial is a part of the overall CopenHeart project, consisting of several randomised clinical trials(http://www.CopenHeart.org), designed to develop evidence-based knowledge of rehabilitation among patients with complex cardiac conditions.",Non-OADS,/arxiv_data1/oa_pdf/5f/8e/bmjopen-2013-003967.PMC3845056.pdf
The participant has the opportunity to go through the website http://www.copenheart.org and enter with the login and password.,Non-OADS,/arxiv_data1/oa_pdf/5f/8e/bmjopen-2013-003967.PMC3845056.pdf
abstracts as well as the results will be posted on the website http://www.copenheart.org.,Non-OADS,/arxiv_data1/oa_pdf/5f/8e/bmjopen-2013-003967.PMC3845056.pdf
Data sharing statement Global Adult Tobacco Survey India data are available on request from the International Institute for Population Sciences using DataRequest form available at http://www.iipsindia.org/.,OADS,/arxiv_data1/oa_pdf/a2/a4/bmjopen-2013-003542.PMC3845060.pdf
"http://www.who.int/fctc/en/ 6. International Institute for Population Sciences, Ministry of Health and Family Welfare, Government of India.",Non-OADS,/arxiv_data1/oa_pdf/a2/a4/bmjopen-2013-003542.PMC3845060.pdf
http://www.refreshproject.org.uk/wp-content/ uploads/2012/02/smokefree-interventions-81112.pdf24.,Non-OADS,/arxiv_data1/oa_pdf/a2/a4/bmjopen-2013-003542.PMC3845060.pdf
2011. http://www.who.int/mental_health/prevention/ suicide_rates/en/ (accessed 12 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/6a/b9/bmjopen-2013-003643.PMC3845061.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003749).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
[Online] http://www.unaids.org/en/regionscountries/ countries/botswana/ (accessed 13 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
[Online] http://www.unaids.org/en/dataanalysis/ knowyourresponse/countryprogressreports/2012countries/ce_BW_Narrative_Report%5B1%5D.pdf (accessed 13 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
http://www.hiv.gov.bw/content/prevention-mother-child-hiv-transmission (accessed 13 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
[Online] http://www.who.int/hiv/ pub/mtct/rapid_advice_mtct.pdf (accessed 13 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
[Online] http://www.who.int/hiv/ pub/paediatric/advice/en/ (accessed 13 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
[Online] http://www.child-encyclopedia.com/ documents/GreinerANGxp.pdf (accessed 13 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
[Online] http://www.who.int/nutrition/publications/gs_infant_feeding_text_eng.pdf (accessed 13 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
http://www.who.int/maternal_child_adolescent/documents/9789241599535/en/ (accessed 10 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
[Online] http://apps.who.int/rhl/pregnancy_childbirth/care_after_childbirth/yscom/en/(accessed 13 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
[Online] http://www.who.int/child-adolescenthealth/publications/NUTRITION/consensusstatement.htm (accessed 10 Oct2013).,Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
"Nairobi, Kenya: October 2009.http://www.who.int/healthpromotion/conferences/7gchp/Track1_Inner.pdf (accessed 10 Oct 2013).",Non-OADS,/arxiv_data1/oa_pdf/1a/49/bmjopen-2013-003749.PMC3845062.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003934).,Non-OADS,/arxiv_data1/oa_pdf/9e/b2/bmjopen-2013-003934.PMC3845065.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003397).,Non-OADS,/arxiv_data1/oa_pdf/0e/32/bmjopen-2013-003397.PMC3845066.pdf
New York: United Nations Development Programme; 2010 [cited 21 May 2011]; http://hdr.undp.org/en/statistics/mpi/ 10.,Non-OADS,/arxiv_data1/oa_pdf/0e/32/bmjopen-2013-003397.PMC3845066.pdf
Online: http://www.budget.gov.,Non-OADS,/arxiv_data1/oa_pdf/0e/32/bmjopen-2013-003397.PMC3845066.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004055).,Non-OADS,/arxiv_data1/oa_pdf/8d/55/bmjopen-2013-004055.PMC3845067.pdf
"Health and SaftyExecutive, 2005. http://www.hse.gov.uk/airtransport/docs/baggage.pdf 22.",Non-OADS,/arxiv_data1/oa_pdf/8d/55/bmjopen-2013-004055.PMC3845067.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003614).,Non-OADS,/arxiv_data1/oa_pdf/69/8d/bmjopen-2013-003614.PMC3845068.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/69/8d/bmjopen-2013-003614.PMC3845068.pdf
http://www.isarhome.,Non-OADS,/arxiv_data1/oa_pdf/69/8d/bmjopen-2013-003614.PMC3845068.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004047).,Non-OADS,/arxiv_data1/oa_pdf/5f/a3/bmjopen-2013-004047.PMC3845069.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/a3/bmjopen-2013-004047.PMC3845069.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003807).,Non-OADS,/arxiv_data1/oa_pdf/45/de/bmjopen-2013-003807.PMC3845074.pdf
"These data are available to researchers on request and subject to approval from the relevant data custodians and ethics committees, as outlined on the NSW Centre for Health Record Linkage website (http://www.cherel.org.au).",OADS,/arxiv_data1/oa_pdf/45/de/bmjopen-2013-003807.PMC3845074.pdf
http://www.cherel.org.au26.,Non-OADS,/arxiv_data1/oa_pdf/45/de/bmjopen-2013-003807.PMC3845074.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004042).,Non-OADS,/arxiv_data1/oa_pdf/db/7d/bmjopen-2013-004042.PMC3845075.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003728).,Non-OADS,/arxiv_data1/oa_pdf/fa/24/bmjopen-2013-003728.PMC3845076.pdf
"controlled-trials.com/mrct), Clinical trials.gov (http://www.clinicaltrials.gov) and the WHO International Clinical Trials Registry platform (ICTRP) (http://apps.",Non-OADS,/arxiv_data1/oa_pdf/fa/24/bmjopen-2013-003728.PMC3845076.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/24/bmjopen-2013-003728.PMC3845076.pdf
2011. http://www.cochrane-handbook.org 24.,OADS,/arxiv_data1/oa_pdf/fa/24/bmjopen-2013-003728.PMC3845076.pdf
2011. http://www.cochrane-handbook.org 25.,OADS,/arxiv_data1/oa_pdf/fa/24/bmjopen-2013-003728.PMC3845076.pdf
"There are a lot of problems in elderly people such as wake after sleep onset, decreased sleep time, and E-mail: metode27@keri.re.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(5), 233 e239 http://dx.doi.org/10.1016/j.phrp.2013.09.002 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/9a/30/main.PMC3845225.pdf
"E-mail: mrkhanqau@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(5), 246 e254 http://dx.doi.org/10.1016/j.phrp.2013.09.003 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/4d/90/main.PMC3845226.pdf
"E-mail: gtchung@nih.go.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(5), 225 e232 http://dx.doi.org/10.1016/j.phrp.2013.09.001 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/c6/93/main.PMC3845227.pdf
"Data were analyzed by comparing the database at the multilocussequence typing website ( http://saureus.mlst.net ), and the sequence type (ST) for each strain was determined.",OADS,/arxiv_data1/oa_pdf/c6/93/main.PMC3845227.pdf
"E-mail: vitrajkumar@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(5), 255 e264 http://dx.doi.org/10.1016/j.phrp.2013.09.004 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e7/bd/main.PMC3845228.pdf
"Assuming our containername is my container, you should use the following cre-dentials to connect to the database ( Figures 5 e7): /C15Database host: mycontainer -db.my.phpcloud.com /C15Database port: 3306 /C15Database schema name: my container /C15Database user: my container /C15Database password: our container passwordThe Hospital community cloud can be accessed from the webpage http://cloudhealthcare.my.phpcloud.com/ hospital/index.html The proxy server is implemented on a WAMP s e r v e ra n di su s e da sap r o x yi nc o m m u n i c a t i o nw i t hthe cloud.",OADS,/arxiv_data1/oa_pdf/e7/bd/main.PMC3845228.pdf
"E-mail: park3hee@korea.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(5), 265 e270 http://dx.doi.org/10.1016/j.phrp.2013.09.005 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/b4/77/main.PMC3845229.pdf
"Steven P. Available from: http://www.hpa-bioinformatics.org.uk/ cgi-bin/DICI/DICI.pl [accessed 1.09.13].270 S. Lee, et al",OADS,/arxiv_data1/oa_pdf/b4/77/main.PMC3845229.pdf
"E-mail: mrkhanqau@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(5), 271 e277 http://dx.doi.org/10.1016/j.phrp.2013.09.006 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/47/ec/main.PMC3845230.pdf
"Its job description includespreparing and responding to public health crisis causedby emerging infectious diseases, securing medical re-sources during crisis, activating the emergency response This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(5), 223 e224 http://dx.doi.org/10.1016/j.phrp.2013.09.010 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/02/f5/main.PMC3845231.pdf
"1These authors contribute equally to this paper.Osong Public Health Res Perspect 2013 4(5), 285 e290 http://dx.doi.org/10.1016/j.phrp.2013.09.009 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/16/10/main.PMC3845232.pdf
"According to the Korean Academy of Medical Sci- ences [5], depression is a brain disease that may lead to many severe consequences that include: continuous E-mail: llhhss1018@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(5), 240 e245 http://dx.doi.org/10.1016/j.phrp.2013.09.007 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/74/fa/main.PMC3845249.pdf
"Available from, http://healthcare.joins.com/master/healthmaster_article.asp?",Non-OADS,/arxiv_data1/oa_pdf/74/fa/main.PMC3845249.pdf
"Available from, http://stat.mw.go.kr/ stat/data/cm_data ; 2012 [accessed 17.09.12].",OADS,/arxiv_data1/oa_pdf/74/fa/main.PMC3845249.pdf
"Available from, http://knhanes.cdc.go.kr/knhanes/ index.do ; 2011 [accessed 17.09.12].",OADS,/arxiv_data1/oa_pdf/74/fa/main.PMC3845249.pdf
"Available from, http://www.dailymedi.com/news/ view.html?section=1&category=4&no=720312 ; 2010 [accessed 17.09.12].",Non-OADS,/arxiv_data1/oa_pdf/74/fa/main.PMC3845249.pdf
"Available from,http://www.stat.mw.go.kr/.../publicationView.jsp ;2 0 0 9[ a c c e s s e d 15.09.12].13.Ann LS.",OADS,/arxiv_data1/oa_pdf/74/fa/main.PMC3845249.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003479).,Non-OADS,/arxiv_data1/oa_pdf/e5/65/bmjopen-2013-003479.PMC3845253.pdf
"Mile 3.71/1.56 http://www.taxi.ie Time input Economically active Per Hour 19 CSOEconomically inactive Per Hour 9 CSO CSO, Central Statistics Office, Dublin, Ireland; DOF, Department of Finance, Dublin, Ireland; DOHC, Casemix Unit, Department of Health and Children, Dublin, Ireland; HSE, Salary Scales, Health Service Executive, Dublin, Ireland; MIMS, Monthly Index of Medical Specialties Ireland, Dublin, Ireland; ORC, Office of the Revenue Commissioner, Dublin, Ireland.",Non-OADS,/arxiv_data1/oa_pdf/e5/65/bmjopen-2013-003479.PMC3845253.pdf
http://www.cso.ie17.,Non-OADS,/arxiv_data1/oa_pdf/e5/65/bmjopen-2013-003479.PMC3845253.pdf
2010. http://www.hiqa.ie/publication/guidelines-economic-evaluation-health-technologies-ireland 18.,Non-OADS,/arxiv_data1/oa_pdf/e5/65/bmjopen-2013-003479.PMC3845253.pdf
Available from: http://www.fda.gov/Food/Gu idanceRegulation/GuidanceDo- cumentsRegulatoryInformation/Ju ice/ucm072637.htm.,Non-OADS,/arxiv_data1/oa_pdf/e2/c4/TOMICROJ-7-130.PMC3845258.pdf
Available from: http://www.fda.gov/downloads/-Food/FoodSafety/FoodborneIllne ss/FoodborneIllnessFoodbornePat hogensNaturalToxins/BadBugB ook/UCM297627.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e2/c4/TOMICROJ-7-130.PMC3845258.pdf
Ava ilable from: http://www.fda.gov/- Food/FoodScienceResearch/LaboratoryMethods/ucm070830.htm.,Non-OADS,/arxiv_data1/oa_pdf/e2/c4/TOMICROJ-7-130.PMC3845258.pdf
Availabl e from: http://www.hillagric.ac.- in/edu/covas/vpharma/ winter%20school/lectures/31%20Antibacteri al%20screening%20methods.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e2/c4/TOMICROJ-7-130.PMC3845258.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003498).,Non-OADS,/arxiv_data1/oa_pdf/10/f4/bmjopen-2013-003498.PMC3845392.pdf
The participants access instructional videos which guide the formal meditations through the website (http://www.bemindfulonline.co.uk).,Non-OADS,/arxiv_data1/oa_pdf/10/f4/bmjopen-2013-003498.PMC3845392.pdf
"E-mail: sontaejong@korea.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(5), 278 e284 http://dx.doi.org/10.1016/j.phrp.2013.09.008 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/a5/48/main.PMC3845460.pdf
"Available at, http://www.who.int/csr/don2012_09_23/en/index.",Non-OADS,/arxiv_data1/oa_pdf/a5/48/main.PMC3845460.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/94/tcrm-9-443.PMC3845533.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 443–449Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  443oRiginal ReseaRChopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5200 9Treatment approaches and antibiotic use   for emergency dental treatment in T urkey Rabia Figen Kaptan1 Faruk haznedaroglu2 Fatıma Betul Basturk3 Mehmet Baybora Kayahan1 1Department of endodontics,   Yeditepe University, 2Department  of endodontics, istanbul University,   3Department of endodontics, Marmara  University, istanbul, T urkey Correspondence: Fatıma Betul Basturk   Department of endodontics, Faculty of  Dentistry, Marmara University, Nişantaşı  Campus, 6 Güzelbahçe Büyükçiftlik  Street, Nişantaşı, Istanbul 34365, Turkey   Tel +90 212 343 5050   Fax +90 212 246 5247   email fatimabasturk@gmail.co mAbstract:  The purpose of this study was to gather information about Turkish general dental  practitioners’ treatment approaches towards endodontic emergencies, antibiotic-prescribing habits,  and their participation in lifelong learning programs.",Non-OADS,/arxiv_data1/oa_pdf/4d/94/tcrm-9-443.PMC3845533.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4d/94/tcrm-9-443.PMC3845533.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/94/tcrm-9-443.PMC3845533.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/tcrm-9-427.PMC3845536.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 427–441Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  427Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5417 8Guidelines for overcoming hospital managerial  challenges: a systematic literature review Maria Crema Chiara verbano Department of Management and  engineering, University of Padova,   vicenza, italy Correspondence: Chiara verbano   Department of Management and  engineering, University of Padova,  Stradella San Nicola 3,   36100 vicenza, italy   Tel +39 0444 998 731   Fax +39 0444 998 888   email chiara.verbano@unipd.i tPurpose:  The need to respond to accreditation institutes’ and patients’ requirements and to align  health care results with increased medical knowledge is focusing greater attention on quality  in health care.",Non-OADS,/arxiv_data1/oa_pdf/6f/a0/tcrm-9-427.PMC3845536.pdf
"Available from:  http://archive.ahrq.gov/news/test1028.ht m. Accessed May 10, 2013.",OADS,/arxiv_data1/oa_pdf/6f/a0/tcrm-9-427.PMC3845536.pdf
Available  from: http://www.ahrq.gov/research/findings/nhqrdr/nhqr11/nhqr11.,OADS,/arxiv_data1/oa_pdf/6f/a0/tcrm-9-427.PMC3845536.pdf
Available from: http://www.entnet.org/Practice/ qualityimprovement/upload/GoingLeaninHealthCareWhitePaper-3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/tcrm-9-427.PMC3845536.pdf
"Available from: http://ec.europa.eu/health/reports/docs/health_ glance_2012_en.pd f. Accessed May 9, 2013.",Non-OADS,/arxiv_data1/oa_pdf/6f/a0/tcrm-9-427.PMC3845536.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/6f/a0/tcrm-9-427.PMC3845536.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/tcrm-9-427.PMC3845536.pdf
Accessable at: http://www.cancer.org/treatment/treatmentsand -  sideeffects/complementaryandalternativemedicine/manual - healingandphysicaltouch/electromagnetic -therapy.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/cjc-32-11-573.PMC3845545.pdf
http://ctep.cancer.gov/protocolDevelopment/         electronic -applications/docs/ctcaev3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/2d/cjc-32-11-619.PMC3845548.pdf
"Remaining Challenges  The23approvalsin2012areindeedanappreciable  improvementfrom18in2011and11in2010.However,  themajorityofthe10moleculartargetedNMEs approved Source: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.htm  New molecular entities that are conventionally defined as molecular targeted agents are italicized.",Non-OADS,/arxiv_data1/oa_pdf/5c/d0/cjc-32-05-225.PMC3845551.pdf
"[02/27/2013] http://www.fd a.gov / RegulatoryInformation/ Legislation/Fede ralFoodDrugan dCosmeticActFDC Act/  Signi ficantAmendmentstotheFDC Act/FDASIA/ucm329491.htm  Bi XL, Yang W. Biological functions of deco rin in cancer.",OADS,/arxiv_data1/oa_pdf/5c/d0/cjc-32-05-225.PMC3845551.pdf
"Conferenc e Chairs  荫 Yi鄄 Xin ZENG, M.D., Ph.D.  ProfessorandPresident  SunYat­senUniversityCancerCenter  荫 Ronald A. DePinho, M.D., Ph.D.  ProfessorandPresident  M.D.AndersonCancerCenter  OrganizingCommittee:  FromMDAndersonCancerCenter:BogdanCzeriniak,Michael  Deavers,GregFuller,JinsongLiu,TJLiu,AysequlSahin,  DongfengTan  FromSunYat­senUniversityCancerCenter:JingpingYun,  JianyongShaoandDanXie  Secretariat  SunYat­senUniversityCancerCenter  Address:651DongfengEastRoad  Guangzhou510060,P.R.China  Email:pathology21@sysucc.org.cn  Fax:+86­20­87343807  Phone:+86­20­87343807,+86­15817017970 5th Biennial Pathology Symposium of MD Anderson Cancer   Cente r鄄 Chinese Sister Institu tions  Pathology of the 21st Centu ry: from Molecular Diagnostics to  Personalized Cancer  Therapy  May 31 to June 2, 2013  Guangzhou,China  Onlineregistrationathttp://pathology21.sysucc.org.cn  232",Non-OADS,/arxiv_data1/oa_pdf/5c/d0/cjc-32-05-225.PMC3845551.pdf
"32 Issue 4 plementarymaterials(http://www.cjcsysu.com/enpdf/  supp/12­151.pdf).Thedatasetusedinthisexampleisa  cell­cycleconditional­specifictranscriptionfactor  regulatorynetwork [19] ,andourGOmodulessupportthe  cellcycleprocessindifferentand specificangle,thatis,  thetopsixGOmodulescontainedmanycellcycle­  relatedfunctionalterms.",OADS,/arxiv_data1/oa_pdf/ec/fd/cjc-32-04-195.PMC3845568.pdf
32 Issue 4 functionsinvolvedinthecellcycleprocess.Thesixth  moduleincluded signaltransduction(GO:0007165)and  othersignalpathwaysrelatedfunctions.Alltermsinthe  GOmodulesandtheirfunctionalinformationcanbefound  inSupplementaryMaterials(http://www.cjcsysu.com/  enpdf/supp/12­151.pdf).,OADS,/arxiv_data1/oa_pdf/ec/fd/cjc-32-04-195.PMC3845568.pdf
Available from:  http://www.bioconductor .org/packa ges/release /data/annotation/  html/org.Sc.sgd.db.html.,OADS,/arxiv_data1/oa_pdf/ec/fd/cjc-32-04-195.PMC3845568.pdf
Available  from: http://www.bioconduc tor.org/pack ages /release/data/  annotation/html/org.Hs.eg.db.html.,OADS,/arxiv_data1/oa_pdf/ec/fd/cjc-32-04-195.PMC3845568.pdf
http://app.aporc.org/NOA/.,Non-OADS,/arxiv_data1/oa_pdf/ec/fd/cjc-32-04-195.PMC3845568.pdf
http://david.abcc.ncifcrf.gov/.,Non-OADS,/arxiv_data1/oa_pdf/ec/fd/cjc-32-04-195.PMC3845568.pdf
"Conferenc e Chairs  荫 Yi鄄 Xin ZENG, M.D., Ph.D.  ProfessorandPresident  SunYat­senUniversityCancerCenter  荫 Ronald A. DePinho, M.D., Ph.D.  ProfessorandPresident  M.D.AndersonCancerCenter  OrganizingCommittee:  FromMDAndersonCancerCenter:BogdanCzeriniak,Michael  Deavers,GregFuller,JinsongLiu,TJLiu,AysequlSahin,  DongfengTan  FromSunYat­senUniversityCancerCenter:JingpingYun,  JianyongShaoandDanXie  Secretariat  SunYat­senUniversityCancerCenter  Address:651DongfengEastRoad  Guangzhou510060,P.R.China  Email:pathology21@sysucc.org.cn  Fax:+86­20­87343807  Phone:+86­20­87343807,+86­15817017970 5th Biennial Pathology Symposium of MD Anderson Cancer   Cente r鄄 Chinese Sister Institu tions  Pathology of the 21st Centu ry: from Molecular Diagnostics to  Personalized Cancer  Therapy  May 31 to June 2, 2013  Guangzhou,China  Onlineregistrationathttp://pathology21.sysucc.org.cn  204",Non-OADS,/arxiv_data1/oa_pdf/ec/fd/cjc-32-04-195.PMC3845568.pdf
"Chin J Canc er, 2013,32:155-161.  http://itcr.nci.nih.gov/  modENCODE Cons ortium.",OADS,/arxiv_data1/oa_pdf/51/87/cjc-32-04-153.PMC3845569.pdf
Accessed at http://www.cancer.org/research/cancerfactsfigures/ cancerfactsfigures/cancer -facts -figures -2012.,Non-OADS,/arxiv_data1/oa_pdf/c0/4e/cjc-32-08-419.PMC3845583.pdf
Availiable  at: http://www.cancer.org.,Non-OADS,/arxiv_data1/oa_pdf/54/73/cjc-32-01-012.PMC3845590.pdf
Available online: http://www.iacr.com.fr/iarccrgtool s.htm.,Non-OADS,/arxiv_data1/oa_pdf/08/e2/cjc-32-03-106.PMC3845591.pdf
"Available at: http://www.internalmedicinenews.com/single -view/ fda-panel -rejects -denosumab -against -bone -metastasis -in- prostate -cancer/839e175a56.html [67] Armstrong AP, Miller RE, Jones JC, et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/06/cjc-32-07-380.PMC3845601.pdf
Data and Methods  Data sources  Sequencesof100genesand100relatedcoding  proteinsrelatedtoNSCLCweredownloadedfromthe  NationalCenterforBiotechnologyInformation(NCBI)  databases(http://www.ncbi.nlm.nih.gov/).,OADS,/arxiv_data1/oa_pdf/61/8b/cjc-32-02-091.PMC3845609.pdf
Available at: http://www.seer.cancer.gov/ publications/uscs.html.,Non-OADS,/arxiv_data1/oa_pdf/ad/ac/cjc-32-06-334.PMC3845623.pdf
"Accepted: October 2, 2013 Data deposition: All microarray data have been deposited into the NCBI GEO da tabase under the serial number GSE48395 and are available with the following link http://www.ncbi.nlm.nih.gov/gds/?term=GSE48395 .",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"Compared with the release 7 of Michigan State University (MSU) rice genome annotation database(http://rice.plantbiology.msu.edu/ [last accessed October 28, 2013]; Ouyang et al.",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"In rice, a total of 66,433 gene models were annotated in theMSU rice genome annotation database ( http://rice.plantbiol- ogy.msu.edu/ ;Ouyang et al.",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
Determination of Overrepresented Genes and Their Gene Ontology Categories Gene ontology (GO) assignments for rice genes were obtained from the release 7 of MSU rice genome annotation data- base ( http://rice.plantbiology.msu.edu/ ;Ouyang et al.,OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
Detection of Promoter Motifs and Their Overrepresentation Analysis Nipponbare promoter sequences 1-kb upstream of start codon of each gene were retrieved from the MSU ricegenome annotation database ( http://rice.plantbiology.msu.,OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
1999 ;http://www.dna.affrc.go.jp/PLACE/index.,OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"Genome Sequence and Annotation Databases Nipponbare genomic, cDNA, and protein sequences were downloaded from the release 7 of MSU rice genome annota-tion database ( http://rice.plantbiology.msu.edu/ , last accessed October 28, 2013; Ouyang et al.",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"2009 ;http://www.OryzaSNP.org ,l a s t accessed October 28, 2013).",Non-OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"In addition to these, for genome-wide identiﬁcation of these transcription factors or seven gene family members, their protein motif or domain sequences from seed members were obtained from the Pfam database ( http://pfam.sanger.ac.uk/ , last accessed October 28, 2013).",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"Their seed amino acid sequences were used to con- struct hidden Markov model (HMM) proﬁles using HMMER 2.3.2 ( http://hmmer.janelia.org/ , last accessed October 28, 2013) with default values.",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"We also built a HMM proﬁle using HMMER 2.3.2 ( http://hmmer.janelia.org/ , last accessed October 28, 2013) with default values using seed TIRs and TRs from multiple species to scan the rice genome.",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"In the release 7 of MSU rice genome annotation database ( http://rice.plantbiology.msu.edu/ [last accessed October 28, 2013]; Ouyang et al.",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"Green and pink columns indicate the percentages of this GO term in SNP-affected proteins and total annotated rice proteins in the releas e7o f MSU rice genome annotation database ( http://rice.plantbiology.msu.edu/ [last accessed October 28, 2013]; Ouyang et al.",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"Expression Divergence of Genes with Alternative Spliced Models in Nipponbare and Pokkali In the MSU database, a total of 6,457 genes/loci were anno- tated with alternative splicing models ( http://rice.plantbiology.",OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"Currently, widely used rice array chips were from Affymetrix (http://www.affymetrix.com , last accessed October 28, 2013).",Non-OADS,/arxiv_data1/oa_pdf/b2/94/evt152.PMC3845633.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
"Materials and Methods Data Resources Bombyx mori assembled genomic sequences, expressed sequence tag (EST) sequences, tRNAs, 5S rRNA, and 7SL RNAwere downloaded from Silkworm Genome Database (SilkDBversion 2, http://www.silkdb.org/silkdb/doc/download.html , last accessed October 29, 2013).",OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
"Both Manduca sexta andMe.moldrzyki whole genome shotgun (WGS) sequences were downloaded from NCBI(accession numbers: AIXA01000000 and AGDA00000000).Mengenilla moldrzyki EST sequences were downloaded froma data repository website ( http://datadryad.org/resource /doi:10.5061/dryad.ts058 , last accessed October 29, 2013).",OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
"Heliconius melpomene genomic sequences were downloaded from Butterﬂy Genome Database ( http://www.butterﬂygen ome.org/ , last accessed October 29, 2013).",OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
"Leaf-cutter ant Atta cephalotes genome sequence and transcript sequences were downloaded from Hymen optera Genome Database (http://hymenopteragenome.org/ , last accessed October 29, 2013).",OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
"rotundata were obtained from NCBI ( ftp://ftp.ncbi.nlm.nih.gov/genomes/ ,l a s t accessed October 29, 2013).",OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
"Transposase sequences of otherknown Sola,hAT,a n d Ginger transposons were obtained from Repbase ( http://www.girinst.org/repbase/update/browse.php , last accessed October 29, 2013).",OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
"To determine the relationships of autonomous Sola1 , hAT1 ,a n d Ginger2 elements identiﬁed in this study and known elements from other organisms (downloaded fromRepbase, http://www.girinst.org/repbase/update/browse.php , last accessed October 29, 2013), we aligned amino acid sequences of their transposases using MUSCLE ( Edgar 2004 ).",OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
"By contrast, a signiﬁcant coding region of Ginger2_BM w a sf o u n dw h e nw eu s e di t s nucleotide sequence to perform translated search againstthe Repbase ( http://www.girinst.o rg/censor/index.php ,l a s t accessed October 29, 2013).",Non-OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
Supplementary Material Supplementary tables S1–S3 andﬁgures S1–S5 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/63/8c/evt153.PMC3845634.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/86/evt154.PMC3845635.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/a8/evt155.PMC3845636.pdf
"Notably, Blast ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ,l a s t accessed October 28, 2013) and Blat ( http://genome.ucsc.",OADS,/arxiv_data1/oa_pdf/c9/a8/evt155.PMC3845636.pdf
Supplementary Material Supplementary ﬁgures S1–S2 andtable S1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/c9/a8/evt155.PMC3845636.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/95/evt156.PMC3845637.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/bb/evt157.PMC3845638.pdf
"We combined redundant contigs from the multiple k-mer assembles with CD-HIT-EST ( Li and Godzik 2006 ) and removed all sequences below 100 bp with FASTX-Toolkit ( http://hannonlab.cshl.edu/fastx_toolkit/ ,l a s t accessed November 4, 2013).",OADS,/arxiv_data1/oa_pdf/c3/bb/evt157.PMC3845638.pdf
"The assembled transcriptomes are deposited at the Dryad data depository ( http://datadryad.org ,l a s t accessed November 8, 2013) (dryad accession doi:10.5061/ dryad.r5cq0).",OADS,/arxiv_data1/oa_pdf/c3/bb/evt157.PMC3845638.pdf
Available from: http://www.geneious.com .,Non-OADS,/arxiv_data1/oa_pdf/c3/bb/evt157.PMC3845638.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/d2/evt158.PMC3845639.pdf
Supplementary Material Supplementary tables S1–S3 andﬁgures S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/03/d2/evt158.PMC3845639.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/4e/evt160.PMC3845641.pdf
The sequence contigs of the Neanderthal genome and their alignment to the human reference genome hg18 (all-hg18.bam and all-hg18.bam.bai) was downloaded fromhttp://genome.ucsc.edu/Neandertal (last accessed November FIG.3 .—Individual ancestry inferred by the ADMIXTURE program.,OADS,/arxiv_data1/oa_pdf/f8/4e/evt160.PMC3845641.pdf
"Because the modern human genomes were aligned to the human reference genome hg19, the hg18 coordinates of the Neanderthal contigs were converted to hg19 using theliftOver tool ( http://hgdownload.cse.ucsc.edu/admin/exe/linux.",OADS,/arxiv_data1/oa_pdf/f8/4e/evt160.PMC3845641.pdf
The pruned SNP data set contains ~1.1 M SNPs.Supplementary Material Supplementary tables S1 andS2a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.oxfordjour nals.org/ ).,OADS,/arxiv_data1/oa_pdf/f8/4e/evt160.PMC3845641.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/ff/evt162.PMC3845643.pdf
"Differential expression of ohnolog pairs was tested using the botany array resource ( http://bar.utoronto.ca/wel- come.htm , last accessed November 8, 2013).",OADS,/arxiv_data1/oa_pdf/b3/ff/evt162.PMC3845643.pdf
"Thus, we screened the genomic context of AtGS genes within a narrow window of 3 kb for ﬂanking TE-like sequences, usingthe GEvo function from the CoGe comparative genomics plat-form ( http://genomevolution.org/CoGe/GEvo.pl , last accessed November 8, 2013) ( Lyons and Freeling 2008 ).",OADS,/arxiv_data1/oa_pdf/b3/ff/evt162.PMC3845643.pdf
"Remnants did not show signiﬁcant similarities to any otherlocus in Arabidopsis by deﬁnition, and evolutionary stability was conﬁrmed using the Arabidopsis transpositional history database ( http://nature.berkeley.edu/freelinglab , last accessed November 8, 2013) and data on AtGS syntelogs in B. rapa (Wang et al.",OADS,/arxiv_data1/oa_pdf/b3/ff/evt162.PMC3845643.pdf
"Protein sequence similarityanalysis were performed using the Needle program from the EMBOSS software package ( http://emboss.sourceforge.net/ , last accessed November 8, 2013) ( Rice et al.",OADS,/arxiv_data1/oa_pdf/b3/ff/evt162.PMC3845643.pdf
Supplementary Material Supplementary ﬁgures S1 andS2andtable S1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/b3/ff/evt162.PMC3845643.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/ce/evt163.PMC3845644.pdf
Supplementary Material Supplementary ﬁgures S1–S4 andtable S1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/60/ce/evt163.PMC3845644.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/dd/dmt038.PMC3845679.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2013 |  77  | e50539 | Page 1 of 9Video Article Force Measurement During Contraction to Assess Muscle Function in Zebrafish Larvae Darcée D. Sloboda1, Dennis R. Claflin1,2, James J. Dowling3, Susan V. Brooks1,4 1Department of Biomedical Engineering, University of Michigan 2Department of Surgery, Section of Plastic Surgery, University of Michigan 3Departments of Pediatrics and Neurology, University of Michigan 4Department of Molecular and Integrative Physiology, University of Michigan Correspondence to: James J. Dowling at jamedowl@med.umich.edu , Susan V. Brooks at svbrooks@umich.edu URL: http://www.jove.com/video/50539 DOI: doi:10.3791/50539 Keywords: Developmental Biology, Issue 77, Anatomy, Physiology, Biophysics, Biomedical Engineering, Neurobiology, Neuroscience, Muscle, contraction, force, zebrafish, larvae, muscle function, muscle health, force generation, animal model Date Published: 7/23/2013 Citation: Sloboda, D.D., Claflin, D.R., Dowling, J.J., Brooks, S.V.",Non-OADS,/arxiv_data1/oa_pdf/30/c6/jove-77-50539.PMC3846141.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50539/ Introduction Young zebrafish (Danio rerio ) larvae, 3-7 days post-fertilization (dpf), are increasingly recognized as a useful organism for skeletal muscle research.",Non-OADS,/arxiv_data1/oa_pdf/30/c6/jove-77-50539.PMC3846141.pdf
"Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty Hilary C. Rees1, Voichita Ianas1, Patricia McCracken1, Shannon Smith1, Anca Georgescu1, Tirdad Zangeneh1, Jane Mohler2, Stephen A. Klotz1 1Division of Infectious Diseases, University of Arizona 2Arizona Center on Aging, University of Arizona Correspondence to: Stephen A. Klotz at sklotz@u.arizona.edu URL: http://www.jove.com/video/50537 DOI: doi:10.3791/50537 Keywords: Medicine, Issue 77, Infection, Virology, Infectious Diseases, Anatomy, Physiology, Molecular Biology, Biomedical Engineering, Retroviridae Infections, Body Weight Changes, Diagnostic Techniques and Procedures, Physical Examination, Muscle Strength, Behavior, Virus Diseases, Pathological Conditions, Signs and Symptoms, Diagnosis, Musculoskeletal and Neural Physiological Phenomena, HIV, HIV-1, AIDS, Frailty, Depression, Weight Loss, Weakness, Slowness, Exhaustion, Aging, clinical techniques Date Published: 7/24/2013 Citation: Rees, H.C., Ianas, V., McCracken, P., Smith, S., Georgescu, A., Zangeneh, T., Mohler, J., Klotz, S.A.",Non-OADS,/arxiv_data1/oa_pdf/0a/92/jove-77-50537.PMC3846283.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50537/ Introduction The Centers for Disease Control projects that more than half of HIV-1 infected individuals in the United States will be over the age 50 by the year 2015.,Non-OADS,/arxiv_data1/oa_pdf/0a/92/jove-77-50537.PMC3846283.pdf
"Accessed 1/5/13 at: http://aidsinfo.nih.gov , (2013).",Non-OADS,/arxiv_data1/oa_pdf/0a/92/jove-77-50537.PMC3846283.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2013 |  77  | e50530 | Page 1 of 6Video Article The Crossmodal Congruency Task as a Means to Obtain an Objective Behavioral Measure in the Rubber Hand Illusion Paradigm Regine Zopf1, Greg Savage2,3, Mark A. Williams1,2 1Department of Cognitive Science, Macquarie University 2ARC Centre of Excellence in Cognition and its Disorders, Macquarie University 3Department of Psychology, Macquarie University Correspondence to: Regine Zopf at regine.zopf@mq.edu.au URL: http://www.jove.com/video/50530 DOI: doi:10.3791/50530 Keywords: Behavior, Issue 77, Neuroscience, Neurobiology, Medicine, Anatomy, Physiology, Psychology, Behavior and Behavior Mechanisms, Psychological Phenomena and Processes, Behavioral Sciences, rubber hand illusion, crossmodal congruency task, crossmodal congruency effect, multisensory processing, body ownership, peripersonal space, clinical techniques Date Published: 7/26/2013 Citation: Zopf, R., Savage, G., Williams, M.A.",Non-OADS,/arxiv_data1/oa_pdf/17/18/jove-77-50530.PMC3846377.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50530/ Introduction We demonstrate how an objective measure of effects in the commonly employed rubber hand illusion paradigm can be obtained by combining this paradigm with the well-established crossmodal congruency task.,Non-OADS,/arxiv_data1/oa_pdf/17/18/jove-77-50530.PMC3846377.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Cr eative Commons Attribution- NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/ >.,Non-OADS,/arxiv_data1/oa_pdf/97/5d/S0266462313000524a.PMC3846379.pdf
"NICE to assess high cost drugs for rare conditions [internet] London (UK) NICE 2012 July 20. http://www.nice.org.uk/newsroom/news/NICEToAssessHighCostDrugsForRareConditions.jsp (accessed August 1, 2013).",Non-OADS,/arxiv_data1/oa_pdf/97/5d/S0266462313000524a.PMC3846379.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Cr eative Commons Attribution- NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/ >.,Non-OADS,/arxiv_data1/oa_pdf/9c/bc/S0266462313000494a.PMC3846380.pdf
"2006.http://www.nice.org.uk/aboutnice/whoweare/seniormanagementteam/ meetings/2006/21february2006/disinvestment_project_plan__20_ february_2006_version_1.jsp (accessed October 31, 2012).",Non-OADS,/arxiv_data1/oa_pdf/9c/bc/S0266462313000494a.PMC3846380.pdf
2002. http://www.defense.gov/transcripts/transcript.,OADS,/arxiv_data1/oa_pdf/9c/bc/S0266462313000494a.PMC3846380.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Cr eative Commons Attribution- NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/ >.,Non-OADS,/arxiv_data1/oa_pdf/0e/d7/S0266462313000445a.PMC3846381.pdf
"METHODS Search Strategy The search strategy (Supplementary Table 1, whichcan be viewed online at http://dx.doi.org/10.1017/S0266462313000445, shows the ﬁnal search used in Medline)combined economic search terms (14), with clinical terms froma previous review (13) and validated by checking whether itidentiﬁed publications known to the research team.",OADS,/arxiv_data1/oa_pdf/0e/d7/S0266462313000445a.PMC3846381.pdf
"Four economic evaluations along-side or integrated with randomized controlled trials (RCT)were included (15–18) and are summarized in Table 1 (andSupplementary Table 2, which can be viewed online athttp://dx.doi.org/10.1017/S0266462313000445).",OADS,/arxiv_data1/oa_pdf/0e/d7/S0266462313000445a.PMC3846381.pdf
"Variation in results in the studiescould reﬂect differences in: the perspective and range of costsincluded; the availability and organization of care for long-termconditions and depression between settings and populations; the methods used to estimate costs and beneﬁts; and the character- istics of the study samples recruited.SUPPLEMENTARY MATERIAL Supplementary Tables 1 and 2 can be found at:http://dx.doi.org/10.1017/S0266462313000445 CONTACT INFORMATION Farheen Jeeva, MSc, Research Associate (to May 2013), Col- laboration for Leadership in Applied Health Research and Carefor Greater Manchester, Institute of Population Health andManchester Academic Health Sciences Centre, University ofManchester, Manchester, UKChristopher Dickens, MB, BS, PhD, Professor, University of Exeter Medical School and Peninsula Collaboration for Lead-ership in Applied Health Research and Care (PenCLAHRC),University of Exeter, Exeter, UKPeter Coventry, PhD, Research Fellow, Collaboration for Lead- ership in Applied Health Research and Care for Greater Manch-ester, Institute of Population Health and Manchester AcademicHealth Sciences Centre, University of Manchester, Manchester,UKChristine Bundy, PhD, Lecturer, Institute of Inﬂammation and Repair and Manchester Academic Health Sciences Centre, Uni-versity of Manchester, Manchester, UKLinda Davies, MSc, (linda.davies@manchester.ac.uk) Profes- sor, Collaboration for Leadership in Applied Health Research and Care for Greater Manchester, Institute of Population Health and Manchester Academic Health Sciences Centre, Universityof Manchester, Manchester, UK CONFLICTS OF INTEREST All authors report a grant to their institution from NIHR Collab-oration for Leadership in Applied Health Research and Care forGreater Manchester.",Non-OADS,/arxiv_data1/oa_pdf/0e/d7/S0266462313000445a.PMC3846381.pdf
"http://www.york.ac.uk/inst/crd/pdf/nhseed- handbook2007.pdf (accessed May 20, 2010).",Non-OADS,/arxiv_data1/oa_pdf/0e/d7/S0266462313000445a.PMC3846381.pdf
"http://www.bls.gov/cpi/cpi_dr.htm (accessed October 1, 2012).",Non-OADS,/arxiv_data1/oa_pdf/0e/d7/S0266462313000445a.PMC3846381.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Cr eative Commons Attribution- NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/ >.,Non-OADS,/arxiv_data1/oa_pdf/3a/4c/S0266462313000433a.PMC3846382.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2013 |  78  | e50411 | Page 1 of 10Video Article Techniques for Processing Eyes Implanted With a Retinal Prosthesis for Localized Histopathological Analysis David A. X. Nayagam1,2,3, Ceara McGowan1, Joel Villalobos1, Richard A. Williams2,3, Cesar Salinas-LaRosa2,3, Penny McKelvie2,3, Irene Lo2,3, Meri Basa2,3, Justin Tan1, Chris E. Williams1,3,4 1Bionics Institute 2Department of Anatomical Pathology, St Vincent's Hospital Melbourne 3Department of Pathology, University of Melbourne 4Medical Bionics Department, University of Melbourne Correspondence to: David A. X. Nayagam at DNAYAGAM@bionicsinstitute.org URL: http://www.jove.com/video/50411 DOI: doi:10.3791/50411 Keywords: Medicine, Issue 78, Anatomy, Physiology, Biomedical Engineering, Bioengineering, Surgery, Ophthalmology, Pathology, Tissue Engineering, Prosthesis Implantation, Implantable Neurostimulators, Implants, Experimental, Histology, bionics, Retina, Prosthesis, Bionic Eye, Retinal, Implant, Suprachoroidal, Fixation, Localization, Safety, Preclinical, dissection, embedding, staining, tissue, surgical techniques, clinical techniques Date Published: 8/2/2013 Citation: Nayagam, D.A.X., McGowan, C., Villalobos, J., Williams, R.A., Salinas-LaRosa, C., McKelvie, P., Lo, I., Basa, M., Tan, J., Williams, C.E.",Non-OADS,/arxiv_data1/oa_pdf/dc/55/jove-78-50411.PMC3846726.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50411/ Introduction Retinal prostheses may soon become useful clinical interventions for treating various forms of severe vision loss.,Non-OADS,/arxiv_data1/oa_pdf/dc/55/jove-78-50411.PMC3846726.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2013 |  78  | e50460 | Page 1 of 6Video Article Tissue Engineering of a Human 3D in vitro  Tumor Test System Corinna Moll*1, Jenny Reboredo*1, Thomas Schwarz1, Antje Appelt1, Sebastian Schürlein1, Heike Walles1, Sarah Nietzer1 1Department of Tissue Engineering and Regenerative Medicine, University Hospital Würzburg *These authors contributed equally Correspondence to: Jenny Reboredo at jenny.reboredo@uni-wuerzburg.de URL: http://www.jove.com/video/50460 DOI: doi:10.3791/50460 Keywords: Cancer Biology, Issue 78, Biomedical Engineering, Bioengineering, Medicine, Anatomy, Physiology, Molecular Biology, Cellular Biology, Tissue Engineering, Tumor Cells, Cultured, Biotechnology, Culture Techniques, Cell Engineering, Cellular Microenvironment, Equipment and Supplies, Decellularization, BioVaSc, primary cell isolation, tumor test system, dynamic culture conditions, bioreactor, 3D in vitro  models, cell culture Date Published: 8/6/2013 Citation: Moll, C., Reboredo, J., Schwarz, T., Appelt, A., Schürlein, S., Walles, H., Nietzer, S. Tissue Engineering of a Human 3D in vitro  Tumor Test System.",Non-OADS,/arxiv_data1/oa_pdf/84/20/jove-78-50460.PMC3846813.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50460/ Introduction New pharmaceuticals must be validated in regard to their quality, safety, and efficacy before market authorization.",Non-OADS,/arxiv_data1/oa_pdf/84/20/jove-78-50460.PMC3846813.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2013 |  78  | e50587 | Page 1 of 8Video Article Robust 3D DNA FISH Using Directly Labeled Probes Daniel J. Bolland1, Michelle R. King2, Wolf Reik2,3, Anne E. Corcoran1, Christel Krueger2 1Nuclear Dynamics Programme, The Babraham Institute 2Epigenetics Programme, The Babraham Institute 3Centre for Trophoblast Research, University of Cambridge Correspondence to: Daniel J. Bolland at daniel.bolland@babraham.ac.uk URL: http://www.jove.com/video/50587 DOI: doi:10.3791/50587 Keywords: Genetics, Issue 78, Molecular Biology, Biochemistry, Cellular Biology, Genomics, Epigenetics, Cell Nucleus, Fluorescence, In Situ Hybridization, FISH, 3D DNA FISH, fluorescence in situ  hybridization, nuclear structure, fluorescently labeled probes, visualization, imaging, DNA, chromosomes, sequencing, probes, assay Date Published: 8/15/2013 Citation: Bolland, D.J., King, M.R., Reik, W., Corcoran, A.E., Krueger, C. Robust 3D DNA FISH Using Directly Labeled Probes.",Non-OADS,/arxiv_data1/oa_pdf/59/a7/jove-78-50587.PMC3846859.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50587/ Introduction DNA fluorescence in situ  hybridization (DNA FISH) allows the three-dimensional visualization of individual gene loci, subchromosomal domains and even entire chromosomes during all stages of the cell cycle.",OADS,/arxiv_data1/oa_pdf/59/a7/jove-78-50587.PMC3846859.pdf
"They are available online ( http://www.asas-group.org ) or in print version [ 41] and are as follows: Active inflammatory lesions of the SIJs, i.e.",Non-OADS,/arxiv_data1/oa_pdf/18/2d/13244_2013_Article_293.PMC3846932.pdf
SmPC texts of the ICMs via the College ter Beoordeling van Geneesmiddelen (Medi cines Evaluation Board) in The Netherlands http://www.cbg-meb.nl/cbg/nl Last accessed 24/08/2013: Amidotrizoic acid (Urografin); Iobitridol (Xenet ix); Iodixanol (Visipaque); Iohexol (Omnipaque); Iomeprol (Iomeron) ; Iopromide (Ultravist); Ioversol (Optiray); Ioxaglate ( Hexabrix); Ioxitalaminic acid (Telebrix).,Non-OADS,/arxiv_data1/oa_pdf/7f/4e/13244_2013_Article_291.PMC3846935.pdf
Accesible at: http://www.esur.org/guidelines/ Last accessed 24/08/2013 27.,Non-OADS,/arxiv_data1/oa_pdf/7f/4e/13244_2013_Article_291.PMC3846935.pdf
Version 9 Accessible at: http://www.acr.,Non-OADS,/arxiv_data1/oa_pdf/7f/4e/13244_2013_Article_291.PMC3846935.pdf
Accessible at: http://circ.ahajournals.,Non-OADS,/arxiv_data1/oa_pdf/7f/4e/13244_2013_Article_291.PMC3846935.pdf
"&EMAN (European Medical ALARA Network) that was directed at optimisation, http://www.eman-network.eu/ &MEDRAPET (MEDical RAdiation Protection Education and Training), http://www.medrapet.eu/ &Referral Guidelines project dealing with implementation of the MED requirement ’s on justification (appropriateness), http://www.myesr.org/cms/website.php?id=/en/eu_affairs/ newfilename.htm The ESR was either coordinator or partner in these three EC projects, together with professional and scientific partners, regulatory authorities and expert organisations.",Non-OADS,/arxiv_data1/oa_pdf/64/20/13244_2013_Article_287.PMC3846938.pdf
"The ESR is the European body representing the radiology profession with almost 54,000 individual members and acts as the umbrella organisation of all national radiological societies in Europe as well as Europe ’ss u b s p e c i a l t yo r g a n i s a t i o n s( seehttps://www.myesr.",Non-OADS,/arxiv_data1/oa_pdf/64/20/13244_2013_Article_287.PMC3846938.pdf
Draft presented under Article 31 Euratom Treaty for the opinion of the European Economic and SocialCommittee http://ec.europa.eu/energy/nuclear/radiation_protection/doc/ com_2011_0593.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/64/20/13244_2013_Article_287.PMC3846938.pdf
European Commission (1997) COUNCIL DIRECTIVE 97/43 on health protection of individuals against the dangers of ionizing radia-tion in relation to medical exposure http://ec.europa.eu/energy/nuclear/ radioprotection/doc/legislation/9743_en.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/64/20/13244_2013_Article_287.PMC3846938.pdf
Draft Reports http://ddmed.eu/ 7.,Non-OADS,/arxiv_data1/oa_pdf/64/20/13244_2013_Article_287.PMC3846938.pdf
"PERSPECTIVE Korean J Intern Med 2013;28:635-638 http://dx.doi.org/10.3904/kjim.2013.28.6.635 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgHow far has The Korean Journal of Internal Medicine   advanced in terms of journal metrics?",Non-OADS,/arxiv_data1/oa_pdf/f9/04/kjim-28-635.PMC3846985.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.635lated manually and the H-index from Scopus was de - termined from SCImagoJR.",OADS,/arxiv_data1/oa_pdf/f9/04/kjim-28-635.PMC3846985.pdf
Available from: http://www.scimagojr.com/ [6].,Non-OADS,/arxiv_data1/oa_pdf/f9/04/kjim-28-635.PMC3846985.pdf
"637 Huh S. Journal metrics of The Korean Journal of Internal Medicine www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.635Source journals that cited KJIM  The major source titles, and their frequencies, that cit - ed KJIM papers published from 2008 to 2012 were as  follows: Molecular Biology Reports  (14), PLoS One  (12),  World Journal of Gastroenterology  (12), JKMS (10), Journal  of the Korean Medical Association  (7), Endoscopy  (6), Ne- phrology and Dialysis Transplantation  (6), Asian Pacific  Journal of Cancer Prevention  (5), Human Immunology  (5),  and Journal of Clinical Endocrinology and Metabolism (5).",OADS,/arxiv_data1/oa_pdf/f9/04/kjim-28-635.PMC3846985.pdf
Available from: http://www.scimagojr.com/ [6].Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/kjim-28-635.PMC3846985.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.635successful from the point of view of journal metrics for  review articles and special publication type articles.",Non-OADS,/arxiv_data1/oa_pdf/f9/04/kjim-28-635.PMC3846985.pdf
Available  from: http://komci.org/.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/kjim-28-635.PMC3846985.pdf
Available from: http://www.sci - magojr.com/.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/kjim-28-635.PMC3846985.pdf
"REVIEW Korean J Intern Med 2013;28:639-645 http://dx.doi.org/10.3904/kjim.2013.28.6.639 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgCounteracting the enzymatic activity of dipepti - dylpeptidase 4 for potential therapeutic advantage,  with an emphasis on cord blood transplantation Hal E. Broxmeyer Department of Microbiology and  Immunology, Indiana University  School of Medicine, Indianapolis,  IN, USA Received : July 12, 2013 Accepted: September 10, 2013 Correspondence to Hal E. Broxmeyer, Ph.D. Department of Microbiology and  Immunology, Indiana    University School of Medicine,  950 West Walnut St, R2-302,  Indianapolis, IN 46202-5181, USA Tel: +1-317-274-7510 Fax: +1-317-274-7592 E-mail: hbroxmey@iupui.eduDipeptidylpeptidase (DPP) 4, also known as CD26, is an enzyme present on the  surface of a number of different cell types.",Non-OADS,/arxiv_data1/oa_pdf/4e/9d/kjim-28-639.PMC3846986.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.639different stem and progenitor cell populations, which  include self-renewal (the capacity of these early imma - ture cells to make more of themselves, a function usu - ally reserved for and linked to stem cells rather than  progenitor cells), survival, proliferation, differentia - tion, and movement (migration, homing), are in part  regulated by proteins such as cytokines and chemo - kines (a subset of cytokines) as well as other growth- modulating biomolecules such as hormones [3,5].",Non-OADS,/arxiv_data1/oa_pdf/4e/9d/kjim-28-639.PMC3846986.pdf
"DPP4/CD26 and cellular therapy www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.639[21], functions as a serine protease that can selectively  cleave at the penultimate amino acid from the N-termi - nus of a protein, with degrees of specificity inherent in  this truncation depending on whether that amino acid  is proline or alanine or perhaps some other amino acid  such as serine [22].",Non-OADS,/arxiv_data1/oa_pdf/4e/9d/kjim-28-639.PMC3846986.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.639depleted CB units and sitagliptin in this dosing regi - men, the median time to neutrophil engraftment was  21 days.",Non-OADS,/arxiv_data1/oa_pdf/4e/9d/kjim-28-639.PMC3846986.pdf
"DPP4/CD26 and cellular therapy www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.639A search for other regulatory proteins with putative  truncation sites identified numerous proteins that are  known to have significant influences in many different  cell, tissue, and organ systems [24,40,41].",OADS,/arxiv_data1/oa_pdf/4e/9d/kjim-28-639.PMC3846986.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.639Heslop H, Weitz J, Anastasi J, eds.",OADS,/arxiv_data1/oa_pdf/4e/9d/kjim-28-639.PMC3846986.pdf
DPP4/CD26 and cellular therapy www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.63927.,Non-OADS,/arxiv_data1/oa_pdf/4e/9d/kjim-28-639.PMC3846986.pdf
"REVIEW Korean J Intern Med 2013;28:646-651 http://dx.doi.org/10.3904/kjim.2013.28.6.646 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgThe role of rhinosinusitis in severe asthma An-Soo Jang  Department of Internal Medicine,  Soonchunhyang University  Bucheon Hospital, Bucheon,  Korea Received : August 12, 2013 Accepted: September 10, 2013 Correspondence to An-Soo Jang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/9f/5d/kjim-28-646.PMC3846987.pdf
"Rhinosinusitis in asthma www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.646management of sinusitis in asthmatic patients is  known to improve sinonasal and asthmatic symptoms  with fewer physician visits and decrease the need for  medication in several patients [21,22].",Non-OADS,/arxiv_data1/oa_pdf/9f/5d/kjim-28-646.PMC3846987.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.646more severe rhinitis compared with atopic asthmatics  (severity [ n = atopy/nonatopy], mild intermittent = 99/87  vs. moderate to severe intermittent = 59/35 vs. mild per - sistent = 232/197 vs. moderate to severe persistent =  68/83; p < 0.05).",Non-OADS,/arxiv_data1/oa_pdf/9f/5d/kjim-28-646.PMC3846987.pdf
Rhinosinusitis in asthma www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.646search Program through the National Research Foun - dation of Korea funded by the Ministry of Education  (2013R1A1A2005465) and Soonchunhyang University  Research Fund.,Non-OADS,/arxiv_data1/oa_pdf/9f/5d/kjim-28-646.PMC3846987.pdf
Available from: http://www.allergy.or.kr.,Non-OADS,/arxiv_data1/oa_pdf/9f/5d/kjim-28-646.PMC3846987.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.646phisms at the glutathione S-transferase, GSTP1 locus:  a novel mechanism for susceptibility and development  of atopic airway inf lammation.",Non-OADS,/arxiv_data1/oa_pdf/9f/5d/kjim-28-646.PMC3846987.pdf
Rhinosinusitis in asthma www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.6461996;253:435-439.,Non-OADS,/arxiv_data1/oa_pdf/9f/5d/kjim-28-646.PMC3846987.pdf
"EDITORIAL Korean J Intern Med 2013;28:652-653 http://dx.doi.org/10.3904/kjim.2013.28.6.652 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgIs there enough support for endobronchial    ultrasound-guided transbronchial needle    aspiration as an initial diagnostic tool?",Non-OADS,/arxiv_data1/oa_pdf/42/4a/kjim-28-652.PMC3846988.pdf
653 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.652Rhee CK.,Non-OADS,/arxiv_data1/oa_pdf/42/4a/kjim-28-652.PMC3846988.pdf
"EDITORIAL Korean J Intern Med 2013;28:654-656 http://dx.doi.org/10.3904/kjim.2013.28.6.654 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgA biomarker, osteoprotegerin, in patients under - going hemodialysis Gang Jee Ko Division of Nephrology,  Department of Internal Medicine,  Korea University College of  Medicine, Seoul, Korea Received: August 31, 2013 Accepted: September 10, 2013 Correspondence to  Gang Jee Ko, M.D.",Non-OADS,/arxiv_data1/oa_pdf/27/a5/kjim-28-654.PMC3846989.pdf
655 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.654Ko GJ.,OADS,/arxiv_data1/oa_pdf/27/a5/kjim-28-654.PMC3846989.pdf
    656 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.654The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/27/a5/kjim-28-654.PMC3846989.pdf
"EDITORIAL Korean J Intern Med 2013;28:657-659 http://dx.doi.org/10.3904/kjim.2013.28.6.657 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgPersistent methicillin-resistant Staphylococcus   aureus  bacteremia: do we need a new therapeutic  strategy?",Non-OADS,/arxiv_data1/oa_pdf/54/af/kjim-28-657.PMC3846990.pdf
658 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.657The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/54/af/kjim-28-657.PMC3846990.pdf
659 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.657Kang CI.,OADS,/arxiv_data1/oa_pdf/54/af/kjim-28-657.PMC3846990.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2013;28.660-667 http://dx.doi.org/10.3904/kjim.2013.28.6.660 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  2Medical Devices Clinical Trial  Center, and 3Department of  Thoracic Surgery, Chungbuk  National University College of  Medicine, Cheongju, Korea Received : July 18, 2012 Revised : November 6, 2012 Accepted : February 7, 2013 Correspondence to  Jin Young An, M.D.",Non-OADS,/arxiv_data1/oa_pdf/fc/53/kjim-28-660.PMC3846991.pdf
"The EBUS-TBNA role as initial diagnostic tools www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.660needle aspiration (TBNA) cytology, but general anes - thesia use during mediastinoscopy and the diagnostic  accuracy of TBNA are ongoing challenges.",Non-OADS,/arxiv_data1/oa_pdf/fc/53/kjim-28-660.PMC3846991.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.660tive predictive value were calculated.",OADS,/arxiv_data1/oa_pdf/fc/53/kjim-28-660.PMC3846991.pdf
"The EBUS-TBNA role as initial diagnostic tools www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.660nign disease was diagnosed in significantly fewer pa - tients (11 patients, 19.6%) than malignant disease (45  patients, 80.5%; p < 0.01).",Non-OADS,/arxiv_data1/oa_pdf/fc/53/kjim-28-660.PMC3846991.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.660sarcoidosis (n = 2), and lung cancer (n = 2).",Non-OADS,/arxiv_data1/oa_pdf/fc/53/kjim-28-660.PMC3846991.pdf
"The EBUS-TBNA role as initial diagnostic tools www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.660carinal and right paratracheal areas, but its diagnostic  accuracy is unsatisfactory [11,12].",Non-OADS,/arxiv_data1/oa_pdf/fc/53/kjim-28-660.PMC3846991.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.660focusing on concurrent diagnosis and staging of lung  cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fc/53/kjim-28-660.PMC3846991.pdf
"The EBUS-TBNA role as initial diagnostic tools www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.660Feller-Kopman D, Ernst A. Contraindications and safety  of transbronchial lung biopsy via flexible bronchoscopy:  a survey of pulmonologists and review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/fc/53/kjim-28-660.PMC3846991.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2013;28.668-677 http://dx.doi.org/10.3904/kjim.2013.28.6.668 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  Yongin Severance Hospital,  Yonsei University College of  Medicine, Yongin; 2Department of  Internal Medicine, CHA Bundang  Medical Center, CHA University,  Seongnam; 3Department of  Internal Medicine, Myongji  Hospital, Goyang; 4Department  of Internal Medicine, Gangnam  Severance Hospital, Yonsei  University College of Medicine,  Seoul, Korea Received : September 18, 2012 Revised : October 23, 2012 Accepted : December 4, 2012 Correspondence to  Hyeong Cheon Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
"OPG and CV events in HD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.668Schmidt glycoprotein) is a systemic inhibitor of ecto - pic mineral deposition, particularly in chronic kidney  disease (CKD) patients, who suffer from progressive  arterial calcification [6].",Non-OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.668Statistical analysis All values are expressed as means ± SD.",OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
"OPG and CV events in HD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.668upper OPG tertiles (HR = 4.342, p = 0.004), and PWV  (HR = 1.001, p = 0.047).",OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.668Table 2.",Non-OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
OPG and CV events in HD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.668showed no associations with PWV or CV events in  these HD patients.,Non-OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.668These findings support the hypothesis that OPG is  significantly associated with arterial stiffness in HD  patients.",Non-OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
OPG and CV events in HD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.668association [30].,Non-OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.668osteoprotegerin, arterial stiffness, and mortality in  normoalbuminemic Japanese hemodialysis patients.",Non-OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
OPG and CV events in HD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.6682004;65:1790-1794.,Non-OADS,/arxiv_data1/oa_pdf/bb/ba/kjim-28-668.PMC3846992.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2013;28:678-686 http://dx.doi.org/10.3904/kjim.2013.28.6.678 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  Samsung Changwon Hospital,  Sungkyunkwan University School  of Medicine , Changwon ;  2Department of Medicine, Yonsei  University College of Medicine,  Seoul, Korea Received : September 5, 2011 Revised :  October 24, 2011 Accepted : August 21, 2012 Correspondence to  Yu Mi Wi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d8/51/kjim-28-678.PMC3846993.pdf
Persistent MRSA bacteremia www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.678bacteremia and its poor clinical outcome.,Non-OADS,/arxiv_data1/oa_pdf/d8/51/kjim-28-678.PMC3846993.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.678Microbiological methods  The BacT ALERT 3D culture system (bioMérieux Inc.,  Hazelwood, MO, USA) for blood cultures was used.",Non-OADS,/arxiv_data1/oa_pdf/d8/51/kjim-28-678.PMC3846993.pdf
Persistent MRSA bacteremia www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.678quent multivariate analysis.,Non-OADS,/arxiv_data1/oa_pdf/d8/51/kjim-28-678.PMC3846993.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.6780.606).",Non-OADS,/arxiv_data1/oa_pdf/d8/51/kjim-28-678.PMC3846993.pdf
Persistent MRSA bacteremia www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.678(45.2%) [7].,Non-OADS,/arxiv_data1/oa_pdf/d8/51/kjim-28-678.PMC3846993.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.678prevalence of vancomycin heteroresistance.",Non-OADS,/arxiv_data1/oa_pdf/d8/51/kjim-28-678.PMC3846993.pdf
Persistent MRSA bacteremia www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.6781149.,Non-OADS,/arxiv_data1/oa_pdf/d8/51/kjim-28-678.PMC3846993.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.678remia due to heterogeneous vancomycin-intermediate  Staphylococcus aureus.",Non-OADS,/arxiv_data1/oa_pdf/d8/51/kjim-28-678.PMC3846993.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2013;28.687-693 http://dx.doi.org/10.3904/kjim.2013.28.6.687 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivision of Gastroenterology,  Department of Internal Medicine,  Presbyterian Medical Center,  Jeonju, Korea Received : January 29, 2013 Revised : May 13, 2013 Accepted : June 10, 2013 Correspondence to  Jin Woong Cho, M.D.",Non-OADS,/arxiv_data1/oa_pdf/70/84/kjim-28-687.PMC3846994.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.687remnant is 1.8% to 5% in patients who have undergone  surgical treatment for gastric cancer [9,10], while the  reported incidence of multiple gastric cancers is 9% to  24% in patients who have undergone endoscopic resec - tion of a gastric cancer [6,11-13].",Non-OADS,/arxiv_data1/oa_pdf/70/84/kjim-28-687.PMC3846994.pdf
A study of multiple gastric neoplasms www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.687Statistical analyses We performed chi-square and Mann-Whitney U tests  to compare the clinicopathological factors between the  groups.,Non-OADS,/arxiv_data1/oa_pdf/70/84/kjim-28-687.PMC3846994.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.68774 (14.5%) had synchronous and/or metachronous mul - tiple gastric lesions (Fig.",Non-OADS,/arxiv_data1/oa_pdf/70/84/kjim-28-687.PMC3846994.pdf
"A study of multiple gastric neoplasms www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.687plicity, while Han et al.",OADS,/arxiv_data1/oa_pdf/70/84/kjim-28-687.PMC3846994.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.687multiple lesions may aid the detection of secondary le - sions during follow-up endoscopy.",Non-OADS,/arxiv_data1/oa_pdf/70/84/kjim-28-687.PMC3846994.pdf
A study of multiple gastric neoplasms www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.68715.,Non-OADS,/arxiv_data1/oa_pdf/70/84/kjim-28-687.PMC3846994.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2013;28:694-700 http://dx.doi.org/10.3904/kjim.2013.28.6.694 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivisions of 1Endocrinology  and Metabolism and  2Gastroenterology, Department  of Internal Medicine,  Soonchunhyang University  Bucheon Hospital, Bucheon;  3Division of Endocrinology  and Metabolism, Department  of Internal Medicine,  Soonchunhyang University  Hospital, Seoul; 4Division of  Endocrinology and Metabolism,  Department of Internal Medicine,  Soonchunhyang University  Cheonan Hospital, Cheonan,  Korea Received : February 11, 2012 Revised :  March 6, 2012 Accepted : October 22, 2012 Correspondence to  Dong-Won Byun, M.D.",Non-OADS,/arxiv_data1/oa_pdf/77/cc/kjim-28-694.PMC3846995.pdf
"Endoscopic comparison of alendronate and Maxmarvil www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.694 aminobisphosphonate drugs is well recognized [4,5].",Non-OADS,/arxiv_data1/oa_pdf/77/cc/kjim-28-694.PMC3846995.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.694 One group of patients received tablets of Maxmarvil  (n = 20) and the other group received tablets of alen - dronate (n = 18) in the early morning with a glass of  plain water after an overnight fast.",Non-OADS,/arxiv_data1/oa_pdf/77/cc/kjim-28-694.PMC3846995.pdf
Endoscopic comparison of alendronate and Maxmarvil www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.694 RESULTS General characteristics of the subjects The general characteristics of the study subjects are  presented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/77/cc/kjim-28-694.PMC3846995.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.694 5 to 10 mg appeared to show little GI irritability com - pared to those given a placebo [21,22].",Non-OADS,/arxiv_data1/oa_pdf/77/cc/kjim-28-694.PMC3846995.pdf
Endoscopic comparison of alendronate and Maxmarvil www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.694 with any increased endoscopic lesions in the upper GI  tract compared to a placebo control.,Non-OADS,/arxiv_data1/oa_pdf/77/cc/kjim-28-694.PMC3846995.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.694 fractures from 2 US claims databases.",OADS,/arxiv_data1/oa_pdf/77/cc/kjim-28-694.PMC3846995.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2013;28:701-707 http://dx.doi.org/10.3904/kjim.2013.28.6.701 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivision of Rheumatology,  Department of Internal Medicine,  Korea University College of  Medicine, Seoul, Korea Received : November 29, 2012 Revised : December 27, 2012 Accepted : January 17, 2013 Correspondence to  Young Ho Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/77/d8/kjim-28-701.PMC3846996.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.701pulmonary vascular smooth muscle cells: endothelin  receptor type A (ETA) and B (ETB) [3].",Non-OADS,/arxiv_data1/oa_pdf/77/d8/kjim-28-701.PMC3846996.pdf
Bosentan effects on PAH www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.701fect.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/kjim-28-701.PMC3846996.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.701trols.",OADS,/arxiv_data1/oa_pdf/77/d8/kjim-28-701.PMC3846996.pdf
"Bosentan effects on PAH www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.701DISCUSSION Two endothelin receptor subtypes mediate the effects  of ET-1 [3,23]: the first, ETA, is preferentially expressed  in vascular smooth muscle cells and fibroblasts and  stimulates the vasoconstrictive and promitotic effects  of ET-1 [3].",Non-OADS,/arxiv_data1/oa_pdf/77/d8/kjim-28-701.PMC3846996.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.701group.",Non-OADS,/arxiv_data1/oa_pdf/77/d8/kjim-28-701.PMC3846996.pdf
"Bosentan effects on PAH www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.701hypertension), a randomized, placebo-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/77/d8/kjim-28-701.PMC3846996.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2013;28:708-714 http://dx.doi.org/10.3904/kjim.2013.28.6.708 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  Seoul National University College  of Medicine, Seoul; 2Institute of  Allergy and Clinical Immunology,  Seoul National University  Medical Research Center, Seoul;  3Department of Internal Medicine,  Seoul National University  Bundang Hospital, Seongnam;  4Department of Pediatrics,  Childhood Asthma Atopy Center,  Asan Medical Center, University of  Ulsan College of Medicine, Seoul,  Korea Received : March 22, 2013 Revised : May 2, 2013 Accepted : June 12, 2013 Correspondence to  Heung-Woo Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
"HDAC1  association with corticosteroid response www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.708groups from histones [9,10].",Non-OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.708quencies (higher than 5%) and location (in exons and  5', near the gene).",OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
All statisti - cal analyses were performed with the R version 2.15.3  (http://www.R-project.org/).,OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
HDAC1  association with corticosteroid response www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.708The same tendency was observed in childhood asth - matics.,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.708Corticosteroids are among the most effective treat - ments for asthma [19], and reduce inf lammation via  glucocorticoid receptor-mediated recruitment of  HDAC2 [20].",Non-OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
The Functional Single Nucleotide Polymor - phism (F-SNP; http://compbio.cs.queensu.ca/F-SNP/)  database integrates information obtained from 16 bio - informatics tools and databases about the functional  effects of SNPs [27].,OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
"For rs1741981, F-SNP used TF - Search (http://www.cbrc.jp/research/db/TFSEARCH.",OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
html) [28] and Consite (http://asp.ii.uib.no:8090/cgi- bin/CONSITE/consite) [29] tools.,OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
Predicted results from Consite (http://asp.ii.uib.no:8090/ cgi-bin/CONSITE/consite).,OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
HDAC1  association with corticosteroid response www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.708Acknowledgments This work was supported financially by a grant from  Seoul National University Hospital (No.,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
Available from: http://www.ginasthma.,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
Available from http://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
Available from http://www.sign.,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
"6, November 2013 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.70818.",Non-OADS,/arxiv_data1/oa_pdf/f6/ff/kjim-28-708.PMC3846997.pdf
"Korean J Intern Med 2013;28:715-717 http://dx.doi.org/10.3904/kjim.2013.28.6.715 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgCASE REPORTSuccessful management of colonic perforation  with a covered metal stent Sang Woo Kim, Wook Hyun Lee, Jin Soo Kim, Ha Nee Lee, Soo Jung Kim, and Seok Jong Lee Gastrointestinal Center,  Department of Internal Medicine,  The Catholic University of Korea  College of Medicine, Seoul, Korea Received : September  8, 2012 Revised  : October 5, 2012 Accepted: Nonvember 22, 2012 Correspondence to  Sang Woo Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/dc/46/kjim-28-715.PMC3846998.pdf
"6, November 2013 http://dx.doi.org/10.3904/kjim.2013.28.6.715X-ray showed free air below the diaphragm.",OADS,/arxiv_data1/oa_pdf/dc/46/kjim-28-715.PMC3846998.pdf
"Covered metal stent for colonic perforation http://dx.doi.org/10.3904/kjim.2013.28.6.715DISCUSSION Traditionally, surgery has been the standard treatment  for iatrogenic perforation [1].",Non-OADS,/arxiv_data1/oa_pdf/dc/46/kjim-28-715.PMC3846998.pdf
"Korean J Intern Med 2013;28:718-723 http://dx.doi.org/10.3904/kjim.2013.28.6.718 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org CASE REPORTTwo dislodged and crushed coronary stents: treat - ment of two simultaneously dislodged stents us - ing crushing techniques Dong-Hyeok Yang, Seong-Ill Woo, Dae-Hyeok Kim, Sang-Don Park, Ji-Hun Jang, Jun Kwan,    and Sung-Hee Shin Department of Cardiology, Inha  University Hospital, Incheon,  Korea Received : April  28, 2012 Revised  : June 8, 2012 Accepted: July 27, 2012 Correspondence to  Seong-Ill Woo, M.D.",Non-OADS,/arxiv_data1/oa_pdf/38/3e/kjim-28-718.PMC3846999.pdf
"719 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.718 Yang DH, et al.",OADS,/arxiv_data1/oa_pdf/38/3e/kjim-28-718.PMC3846999.pdf
                             720 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.718The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/38/3e/kjim-28-718.PMC3846999.pdf
"721 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.718 Yang DH, et al.",OADS,/arxiv_data1/oa_pdf/38/3e/kjim-28-718.PMC3846999.pdf
                             722 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.718The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/38/3e/kjim-28-718.PMC3846999.pdf
"723 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.718 Yang DH, et al.",OADS,/arxiv_data1/oa_pdf/38/3e/kjim-28-718.PMC3846999.pdf
"Korean J Intern Med 2013;28:724-727 http://dx.doi.org/10.3904/kjim.2013.28.6.724 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org CASE REPORTPostinfectious Guillain-Barre syndrome in a   patient with methimazole-induced agranulocytosis Yoon Young Cho1, Ji Young Joung1, Hyemin Jeong1, Dongmo Je1, Yun Soo Hong1, Sunghwan Suh2,    and Sun Wook Kim1 1Department of Medicine,  Samsung Medical Center,  Sungkyunkwan University School  of Medicine, Seoul; 2Division of  Endocrinology and Metabolism,  Department of Internal Medicine,  Dong-A Medical Center, Dong-A  University College of Medicine,  Busan, Korea Received : June 19, 2012 Revised  : September 28, 2012 Accepted: January 28, 2013 Correspondence to  Sun Wook Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/8b/ca/kjim-28-724.PMC3847000.pdf
"725 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.724 Cho YY, et al.",OADS,/arxiv_data1/oa_pdf/8b/ca/kjim-28-724.PMC3847000.pdf
                             726 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.724The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/8b/ca/kjim-28-724.PMC3847000.pdf
"727 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.724 Cho YY, et al.",OADS,/arxiv_data1/oa_pdf/8b/ca/kjim-28-724.PMC3847000.pdf
"Korean J Intern Med 2013;28:728-731 http://dx.doi.org/10.3904/kjim.2013.28.6.728 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org CASE REPORTA case of Tsutsugamushi disease presenting with  nephrotic syndrome Ju Hyun Lee, Mi Jung Lee, Dong Ho Shin, Shin-Wook Kang, Kyu Hun Choi, and Tae-Hyun Yoo Division of Nephrology,  Department of Internal Medicine,  Yonsei University College of  Medicine, Seoul, Korea Received : April  16, 2012 Revised  : May 23, 2012 Accepted: June 29, 2012 Correspondence to  Tae-Hyun Yoo, M.D.",Non-OADS,/arxiv_data1/oa_pdf/0c/13/kjim-28-728.PMC3847001.pdf
"729 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.728 Lee JH, et al.",OADS,/arxiv_data1/oa_pdf/0c/13/kjim-28-728.PMC3847001.pdf
                             730 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.728The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/0c/13/kjim-28-728.PMC3847001.pdf
"731 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.728 Lee JH, et al.",OADS,/arxiv_data1/oa_pdf/0c/13/kjim-28-728.PMC3847001.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2013;28:732-735 http://dx.doi.org/10.3904/kjim.2013.28.6.732  Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Cardiovascular Center,  Department of Internal Medicine  and 2Department of Diagnostic  Radiology, Kyung Hee University  Medical Center, Seoul, KoreaAcute regional myocarditis with normal ventric - ular wall motion diagnosed by two-dimensional  speckle tracking imaging  Sang Jin Ha1, Jong Shin Woo1, Se Hwan Kwon2, Chi Hyuk Oh1, Kwon Sam Kim1, Jong-Hoa Bae1, and  Woo-Shik Kim1 Received : January 26, 2013 Revised : May 23, 2013 Accepted : June 12, 2013 Correspondence to  Woo-Shik Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ed/a0/kjim-28-732.PMC3847002.pdf
"733 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.732 Ha SJ, et al.",OADS,/arxiv_data1/oa_pdf/ed/a0/kjim-28-732.PMC3847002.pdf
734 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.732 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ed/a0/kjim-28-732.PMC3847002.pdf
"735 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.732 Ha SJ, et al.",OADS,/arxiv_data1/oa_pdf/ed/a0/kjim-28-732.PMC3847002.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2013;28:736-738 http://dx.doi.org/10.3904/kjim.2013.28.6.736  Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartments of 1Internal  Medicine, 2Neuropsychiatry,  and 3Neurology, Seoul National  University Bundang Hospital,  Seongnam, KoreaAcute respiratory failure caused by phenytoin  overdose Chang Kyung Kang1, Min-Kyung Kim1, Min Jae Kim1, Kang Il Jun1, Ki Woong Kim2, Seong-Ho Park3,  and Kyoung-Ho Song1 Received : February 14, 2013 Revised : May 27, 2013 Accepted : May 28, 2013 Correspondence to  Kyoung-Ho Song, M.D.",Non-OADS,/arxiv_data1/oa_pdf/57/0c/kjim-28-736.PMC3847003.pdf
"737 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.736 Kang CK, et al.",OADS,/arxiv_data1/oa_pdf/57/0c/kjim-28-736.PMC3847003.pdf
738 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.736 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/57/0c/kjim-28-736.PMC3847003.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2013;28:739-742 http://dx.doi.org/10.3904/kjim.2013.28.6.739 Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartment s of 1Endocrinology  and Metabolism  and 2Cardiology ,  Kyung Hee University School of  Medicine, Seoul, KoreaA case of primary aldosteronism presenting as  non-ST elevation myocardial infarction Ja Min Byun1, Suk Chon1, and Soo-Joong Kim2 Received : January 23, 2013 Revised : March 4, 2013 Accepted : May 27, 2013 Correspondence to Suk Chon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/fd/9f/kjim-28-739.PMC3847004.pdf
740 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.739 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/9f/kjim-28-739.PMC3847004.pdf
"741 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.739 Byun JM, et al.",OADS,/arxiv_data1/oa_pdf/fd/9f/kjim-28-739.PMC3847004.pdf
742 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.739 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/fd/9f/kjim-28-739.PMC3847004.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2013;28:743-745 http://dx.doi.org/10.3904/kjim.2013.28.6.743  Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartments of 1Internal  Medicine, 2Orthopaedic Surgery,  and 3Urology, Seoul National  University Bundang Hospital,  Seongnam, KoreaPenicillin G-induced hemorrhagic cystitis: a case  and review of the literature Min-Kyung Kim1, Chang Kyung Kang1, Min Jae Kim1, Kang Il Jun1, Young-Kyun Lee2, Seong Jin Jeong3,  and Kyoung-Ho Song1 Received : April 15, 2013 Revised : June 25, 2013 Accepted : July 18, 2013 Correspondence to Kyoung-Ho Song, M.D.",Non-OADS,/arxiv_data1/oa_pdf/a8/f6/kjim-28-743.PMC3847005.pdf
744 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.743 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/a8/f6/kjim-28-743.PMC3847005.pdf
"745 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.743 Kim MK, et al.",OADS,/arxiv_data1/oa_pdf/a8/f6/kjim-28-743.PMC3847005.pdf
"Korean J Intern Med 2013;28:746-747  http://dx.doi.org/10.3904/kjim.2013.28.6.746  Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org IMAGE OF INTERESTA 48-year-old woman was referred to  our hospital for evaluation of a large  subepithelial rectal mass, which had  been incidentally detected on abdomi - nopelvic computed tomography (CT)  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/21/4a/kjim-28-746.PMC3847006.pdf
"747 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.746 Kahng DH, et al.",OADS,/arxiv_data1/oa_pdf/21/4a/kjim-28-746.PMC3847006.pdf
"Korean J Intern Med 2013;28:748-749 http://dx.doi.org/10.3904/kjim.2013.28.6.748  Copyright © 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org IMAGE OF INTERESTAn 85-year-old Korean female present - ed with continuous weight loss.",Non-OADS,/arxiv_data1/oa_pdf/2e/0f/kjim-28-748.PMC3847007.pdf
"749 www.kjim.org http://dx.doi.org/10.3904/kjim.2013.28.6.748 Kim JJ, et al.",OADS,/arxiv_data1/oa_pdf/2e/0f/kjim-28-748.PMC3847007.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Catalase nanoparticles protect human neurons A Singhal et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/a3/91/cddis2013362a.PMC3847304.pdf
"These shared characteristics deﬁne DAG functions during selection, and conﬁrm the control of PLC and DGK activities in RasGRP1/ERK axis activation.The similar developmental regulation of their expression implies coordinated RasGRP1/DGK afunctions; both proteins are upregulated after b-selection, and reach maximum expression in DP thymocytes27,37(Immunological Genome Project data bank; http://www.immgen.org/).",Non-OADS,/arxiv_data1/oa_pdf/bd/82/cddis2013396a.PMC3847306.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Enhanced DAG metabolism and T-cell development M Almena et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/bd/82/cddis2013396a.PMC3847306.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/CD40-activating bifunctional TRAIL fusion proteins M El-Mesery et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/aa/73/cddis2013402a.PMC3847307.pdf
"In addition, we were able to obtain similar results by quantifying total GFP and mCherry ﬂuorescence in fullspinal cord tissue sections or individual cells using an automatic measurement of the intensit y using ImageJ software from the National Institutes of Health (http://rsbweb.nih.gov/ij/)(Figures 2d and e), indicating that this method can be used to quantify LC3 ﬂux with different image analysis approaches.",OADS,/arxiv_data1/oa_pdf/74/a6/cddis2013421a.PMC3847309.pdf
Kymographdescription and plugins using to calculate particle velocities can be downloadedfrom http://www.embl.de/eamnet/html/body_kymograph.html.,OADS,/arxiv_data1/oa_pdf/74/a6/cddis2013421a.PMC3847309.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Autophagy ﬂux in vivo K Castillo et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/74/a6/cddis2013421a.PMC3847309.pdf
"miR-24 target sites on PAK4, Tks5 and ArhGAP19 3’UTR were predicted by the TargetScan 5.1 software available at http//www.targetscan.org and with rna22 available at http://cbcsrv.watson.ibm.com/rna22.html.",OADS,/arxiv_data1/oa_pdf/f6/a9/cddis2013426a.PMC3847310.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/miR-24 in hair follicle I Amelio et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f6/a9/cddis2013426a.PMC3847310.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)miRNA-mediated conversion of hMSCs to hepatocytes L Cui et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e4/a7/cddis2013429a.PMC3847311.pdf
The project wasfunded by Fondazione Cellule Staminali di Terni and partly by the Brains for Brain Foundation (http://www.brains4brain.eu).1.,Non-OADS,/arxiv_data1/oa_pdf/26/50/cddis2013430a.PMC3847312.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)IDS-ko NSCs model Hunter Disease E Fusar Poli et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/26/50/cddis2013430a.PMC3847312.pdf
"This suggests that the BCL-x Linteraction is depen- dent on particular post-translational modiﬁcation(s) of the protein and only a subpopulation of the AVEN interacts withBCL-x L. In silico analysis of the Aven promoter region, using Matbase from Genomatix (http://www.genomatix.de),enabled the identiﬁcation of a progesterone receptor-binding site and potential CDE/CHR cell-dependent element, which is known to regulate cell cycle-dependent transcription 26 (Supplementary Figure S1c).",Non-OADS,/arxiv_data1/oa_pdf/52/c2/cddis2013435a.PMC3847313.pdf
"Fluoresceine-tagged Aven morpholino (50-GGCCC CGCTCCATGTGTTCGGTATC-30) and control morpholino (50-CCTCTTACCT CAGTTACAATTTATA-30) were obtained from Gene Tools, LLC (Philomath, OR, USA) (http://www.gene-tools.com).",OADS,/arxiv_data1/oa_pdf/52/c2/cddis2013435a.PMC3847313.pdf
"Proteins were visualized using Enhanced ChemiluminescenceWestern Blotting substrate (Thermo Scientiﬁc, Rockford, IL, USA; #32106).Densitometry was performed using the ImageJ program (http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/52/c2/cddis2013435a.PMC3847313.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Aven is required for oocyte survival L O’Shea et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/52/c2/cddis2013435a.PMC3847313.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Bcl-2 mimicry M Kvansakul and MG Hinds 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c7/0c/cddis2013436a.PMC3847314.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Ab42promotes adult hippocampal NSPCs senescence NH e et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7d/3c/cddis2013437a.PMC3847315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)DCA induced autophagy in LoVo cells F Gong et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/56/cd/cddis2013438a.PMC3847316.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Nuclear NHERF1 expression in breast cancer A Paradiso et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5f/cb/cddis2013439a.PMC3847317.pdf
"Our ﬁndings have important implications for the use of Bortezomib in combination therapies for the treatment ofcancers such as neuroblastoma, especially as Bortezomib in combination with chemotherapeutics, including taxanes, is being evaluated in clinical trials 30(http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/42/49/cddis2013440a.PMC3847318.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Rescue of antitubulin drugs by Bortezomib F Rapino et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/42/49/cddis2013440a.PMC3847318.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)AEBP1 and BRAF inhibitor resistance WH u et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/00/64/cddis2013441a.PMC3847319.pdf
"Five housekeeping genes (HKGs) ( ACTB ,B2M,GAPDH ,HPRT1 andRPL13A ) and ﬁve assay quality controls (one human genomic DNA contamination, two reversetranscription controls, two positive PCR control) were used as assay controls.Data in the form of threshold cycle numbers ( C t) were uploaded to the online data analysis portal (http://pcrdataanalysis.sabiosciences.com/pcr/arrayanaly-sis.php) to calculate the delta- C t(DCt).Ctwas determined through the SDS (version 2.3) software (Applied Biosystems) by setting the baseline between cycle2 of the run (total run: 40 cycles) and two cycles before the start of the ﬁrst log-phase ampliﬁcation.",OADS,/arxiv_data1/oa_pdf/0b/73/cddis2013442a.PMC3847320.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)EMT spectrum deﬁnes a reversible intermediate state RY-J Huang et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/0b/73/cddis2013442a.PMC3847320.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Tanshinone-1 kills MDR and parental tumor cells LX u et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/18/5b/cddis2013443a.PMC3847321.pdf
"Proteins with a predicted N-terminal signalsequence were identiﬁed by using SignalP 4.0, 51available at http://www.cbs.dtu.dk/services/SignalP/ (set for eukaryotes using both neural networksand hidden Markov models), and were considered to be secreted via a classicalpathway (endoplasmic reticulum/Golgi-dependent pathway).",OADS,/arxiv_data1/oa_pdf/37/6d/cddis2013445a.PMC3847322.pdf
Identiﬁed proteins werealso analyzed for secretion pathways according to SecretomeP 2.0 Server(http://www.cbs.dtu.dk/ services/SecretomeP/).,OADS,/arxiv_data1/oa_pdf/37/6d/cddis2013445a.PMC3847322.pdf
A2228) used for blot normalization.Densitometry analysis was performed with ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/37/6d/cddis2013445a.PMC3847322.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)IGFBP4 and IGFBP7 promote premature senescence V Severino et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/37/6d/cddis2013445a.PMC3847322.pdf
"Nuclei were counterstained with Hoechst33342, and the images werecaptured with a Zeiss LSM510 confocal microscope (Oberkochen, Germany).For the measurement of the intensity of TH immunoreactivity, all images were captured under identical conditions, and staining intensity within cell bodies or inthe striatum was obtained using the ImageJ program (http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/2a/50/cddis2013447a.PMC3847323.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/PARP-1-mediated AMPK activation in Parkinson’s disease TW Kim et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/2a/50/cddis2013447a.PMC3847323.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)SM induce inﬂammation and tumour cell death D Lecis et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/80/da/cddis2013449a.PMC3847325.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)FUT family and multidrug resistance L Cheng et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5d/08/cddis2013450a.PMC3847326.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/The effect of ceramide composition on TNFR1 signaling M Ali et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/22/c4/cddis2013451a.PMC3847327.pdf
RSM932A (also named TCD- 717)26has been selected among several molecules as it provided the best results in vitro and in vivo and is in the Phase I clinical trial for the treatment of solid tumors (http://clinicaltrials.gov/ct2/show/NCT01215864).,Non-OADS,/arxiv_data1/oa_pdf/27/0a/cddis2013453a.PMC3847329.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)ER stress apoptosis induced by ChoK ainhibitors E Sanchez-Lopez et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/27/0a/cddis2013453a.PMC3847329.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/The role of Livin in platelets production I Abd-Elrahman et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/97/18/cddis2013454a.PMC3847330.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Sox9 axis controls sex determination D Sun et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f2/92/cddis2013456a.PMC3847332.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)DR5 is required for Smac mimetic-induced apoptosis I Eckhardt et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d8/8e/cddis2013457a.PMC3847333.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer X Liu et al 15 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7f/3a/cddis2013458a.PMC3847334.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/p38 MAPK in platelet apoptosis N Rukoyatkina et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/45/1c/cddis2013459a.PMC3847335.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)p63-FoxN1 regulatory axis in thymic aging P Burnley et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/47/62/cddis2013460a.PMC3847336.pdf
"According to the Biological General Repository for Interaction Data sets (BioGRID; http://www.thebiogrid.org), 18Expression of integrin alpha in mouse osteoblasts BE Engel et al 2 Cell Death and Disease",OADS,/arxiv_data1/oa_pdf/b4/c4/cddis2013461a.PMC3847337.pdf
"Bioinformatic analysis of the integrin a10 promoter was conducted to look for putative binding sites for these145 interactors using the Genomatix program MatInspector (Genomatix Software GmbH, Munich; http://www.genomatix.",OADS,/arxiv_data1/oa_pdf/b4/c4/cddis2013461a.PMC3847337.pdf
"The pGL3-p27, 31Rb wt LP, Rb 7 LP,32pEGFPc2 (GenBank Accession #U57606), pcDNA3-E2F1,17pcDNA3-E2F3,33CMV- Sp1(Plasmid 12097 purchased from http://www.addgene.org), and pGL3-CIITA-D195 (Gift from Ken Wright, Mofﬁtt Cancer Center; Ghosh et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/c4/cddis2013461a.PMC3847337.pdf
"Cells were imaged by the Mofﬁtt Cancer CenterMicroscopy Core with a Leica SP5, Chicago, IL, USA AOBS tandem scanninginverted confocal microscope.Table 1 Oncomine (http://www.oncomine.org, Compendia Bioscience, Ann Arbor, MI, USA) was used for analysis of integrin expression in seven common solid tumor types Database Integrin a7 Integrin a8 Integrin a10 Integrin b4 Fold Change P-value Fold Change P-value Fold Change P-value Fold Change P-value Dyrskjot Bladder 3 /C01.587 /C01.63E-05 /C01.475 2.25E-04 /C01.604 3.99E-07 2.313 1.82E-05 Haqq Melanoma NC 2.68E-01 /C01.504 3.00E-03 /C03.471 2.04E-04 N/A N/A Hou Lung /C01.734 1.64E-14 /C05.742 1.91E-15 /C01.828 2.88E-18 3.591 8.92E-10 Jones Renal /C01.523 2.45E-05 /C03.993 7.00E-17 /C01.499 5.91E-10 2.500 2.00E-03 Kaiser Colon NC 9.40E-02 /C01.494 1.00E-03 /C01.222 6.09E-06 2.852 5.81E-05 Landi Lung /C01.239 1.01E-07 /C02.375 4.58E-17 /C01.357 9.02E-14 1.588 3.36E-07 Richardson Breast /C05.362 3.41E-06 NC 1.70E-02 /C03.491 2.00E-06 /C02.735* 1.86E-08 The fold change value is determined by comparing the means of the two classes in an analysis on a log2 scale and then converting that difference to a linea r scale (http://www.oncomine.org).",OADS,/arxiv_data1/oa_pdf/b4/c4/cddis2013461a.PMC3847337.pdf
"(e–h) Oncomine (http://www.oncomine.org, Compendia Bioscience, Ann Arbor, MI, USA) was used for analysis and visualization of integrin a10 expression in four common solid tumor types.",OADS,/arxiv_data1/oa_pdf/b4/c4/cddis2013461a.PMC3847337.pdf
"Microarray studies conducted on cancers included in the National Cancer Institute’s list of the 10 most common solidtumors (bladder, breast, colon and rectal, endometrial, kidney (renal cell), lung,melanoma, pancreatic, prostate, thyroid; http://www.cancer.gov/cancertopics/types/commoncancers) were analyzed using Oncomine (http://www.oncomine.org,Compendia Bioscience, Ann Arbor, MI, USA).",OADS,/arxiv_data1/oa_pdf/b4/c4/cddis2013461a.PMC3847337.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Expression of integrin alpha in mouse osteoblasts BE Engel et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b4/c4/cddis2013461a.PMC3847337.pdf
Predicted targets of miR-133 were identiﬁed using the program TargetScan (http://www.targetscan.org/).,OADS,/arxiv_data1/oa_pdf/9e/7c/cddis2013462a.PMC3847338.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Feedback loop between miR-133 and ERK pathway Y Feng et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/9e/7c/cddis2013462a.PMC3847338.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)HECTD3 ubiquitinates caspase-8 YL i et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/28/72/cddis2013464a.PMC3847339.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis) 1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Street 32, Moscow 119991, Russia *Corresponding author: AA Makarov, Laboratory of Conformational Stability of Proteins and Physical Methods of Analysis, Engelhardt Institute of M olecular Biology, Russian Academy of Sciences, Vavilov Street 32, Moscow 119991, Russia.",Non-OADS,/arxiv_data1/oa_pdf/08/c8/cddis2013492a.PMC3847340.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3405 | DOI: 10.1038/srep03405 6",Non-OADS,/arxiv_data1/oa_pdf/53/ae/srep03405.PMC3847699.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3409 | DOI: 10.1038/srep03409 5",Non-OADS,/arxiv_data1/oa_pdf/22/00/srep03409.PMC3847700.pdf
"Eriksson, E. That voice sounds familiar: factors in speaker recognition (2007) at ,http://umu.diva-portal.org/smash/record.jsf?pid 5diva2:140217 .. Accessed 29 October 2013.",Non-OADS,/arxiv_data1/oa_pdf/fa/24/srep03407.PMC3847701.pdf
"INTERSPEECH 813–816 (2008) at ,http://basil.is.konan-u.ac.jp/ pub/is2008.pdf .. Accessed 21 July 2013.",Non-OADS,/arxiv_data1/oa_pdf/fa/24/srep03407.PMC3847701.pdf
"1536–1552 (1988) at ,http://link.aip.org/link/jasman/v83/i4/p1536/s1 .. Accessed 16 May 2013.",Non-OADS,/arxiv_data1/oa_pdf/fa/24/srep03407.PMC3847701.pdf
"Boersma, P. & Weenink, D. Praat: doing phonetics by computer (2013), at ,http://www.praat.org/ .. Accessed 30 October 2013.",Non-OADS,/arxiv_data1/oa_pdf/fa/24/srep03407.PMC3847701.pdf
"Boersma, P. & Weenink, D. Praat: doing phonetics by computer (2013), at ,http://www.praat.org/ .. Accessed 30 October 2013.",Non-OADS,/arxiv_data1/oa_pdf/fa/24/srep03407.PMC3847701.pdf
"Jones, D. L. FATHOM for Matlab at ,http://www.marine.usf.edu/user/djones/ matlab/matlab.html .. Accessed 30 October 2013.",OADS,/arxiv_data1/oa_pdf/fa/24/srep03407.PMC3847701.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Supplementary audio files are available online.,Non-OADS,/arxiv_data1/oa_pdf/fa/24/srep03407.PMC3847701.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3407 | DOI: 10.1038/srep03407 7",Non-OADS,/arxiv_data1/oa_pdf/fa/24/srep03407.PMC3847701.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dc/e7/srep03408.PMC3847702.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3408 | DOI: 10.1038/srep03408 5",Non-OADS,/arxiv_data1/oa_pdf/dc/e7/srep03408.PMC3847702.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f6/e1/srep03404.PMC3847705.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3404 | DOI: 10.1038/srep03404 6",Non-OADS,/arxiv_data1/oa_pdf/f6/e1/srep03404.PMC3847705.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.1Corresponding author E-mail jm12@sanger.ac.uk Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/2e/56/1961.PMC3847767.pdf
Article and publication date are athttp://www.genome.org/cgi/doi/10.1101/gr.161315.113.,OADS,/arxiv_data1/oa_pdf/2e/56/1961.PMC3847767.pdf
"Furthermore, we can integrate RNA-seq data produced by the Illumina Human BodyMap 2.0 project, which captures transcrip- tion in 16 human tissues (http://www.ebi.ac.uk/arrayexpress/ experiments/E-MTAB-513).",Non-OADS,/arxiv_data1/oa_pdf/2e/56/1961.PMC3847767.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/2d/89/1974.PMC3847768.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.Present addresses:7Department of Biology, University of Fribourg, Fribourg, 1700, Switzerland;8Department of Human Genetics, Uni- versity of Chicago, Chicago, IL 60637, USA 9Corresponding author E-mail junzli@med.umich.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/2d/89/1974.PMC3847768.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.154971.113.",Non-OADS,/arxiv_data1/oa_pdf/2d/89/1974.PMC3847768.pdf
"(2012), which can be accessed at http://www.ncbi.nlm.nih.gov/projects/SNP/snp_viewBatch.cgi?sbid =1056695.",Non-OADS,/arxiv_data1/oa_pdf/2d/89/1974.PMC3847768.pdf
"We oriented all variants along the human ancestral sequence, as defined by members of The 1000 Genomes ProjectConsortium (http://ftp.1000genomes.ebi.ac.uk/vol1/ftp/phase1/ analysis_results/supporting/ancestral_alignments/; date accessed: January 3, 2012).",OADS,/arxiv_data1/oa_pdf/2d/89/1974.PMC3847768.pdf
"We then removed all regions that were not uniquely alignedin the four-way alignments between human, chimpanzee, orang- utan, and macaque (ftp://ftp.ensembl.org/pub/release-54/emf/ ensembl-compara/epo_4_catarrhini/; date accessed: December 7,2011).",Non-OADS,/arxiv_data1/oa_pdf/2d/89/1974.PMC3847768.pdf
"Substitution data Substitutions between human and chimpanzee were obtained using the four-way alignments between human, chimpanzee, orangutan, and rhesus macaque (ftp://ftp.ensembl.org/pub/ release-54/emf/ensembl-compara/epo_4_catarrhini/; date accessed:December 7, 2011).",OADS,/arxiv_data1/oa_pdf/2d/89/1974.PMC3847768.pdf
"ESP rare variants Variants from the NHLBI Exome Sequencing Project (ESP) from 5400 individuals were downloaded from the Exome Variant Server (Exome Variant Server, NHLBI ESP, Seattle, WA, URL: http://evs.gs.washington.edu/EVS/; date accessed: December 2, 2011]).",OADS,/arxiv_data1/oa_pdf/2d/89/1974.PMC3847768.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.6These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/a7/49/1985.PMC3847769.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.157339.113.",OADS,/arxiv_data1/oa_pdf/a7/49/1985.PMC3847769.pdf
Data access The sequence containing the first exon of canine HMGA2 has been submitted to the National Center for Biotechnology Information (NCBI) GenBank (http://www.ncbi.nlm.nih.gov/genbank) underaccession number KC529659.,OADS,/arxiv_data1/oa_pdf/a7/49/1985.PMC3847769.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3a/b9/1996.PMC3847770.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.6Corresponding author E-mail jacob@mcw.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/3a/b9/1996.PMC3847770.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.160283.113.",Non-OADS,/arxiv_data1/oa_pdf/3a/b9/1996.PMC3847770.pdf
"To date, we have demonstrated the ability to edit genes on multiple backgrounds (e.g., FHH, SHR, and SS-BN 13 consomic) (http://rgd.mcw.edu/wg/physgenknockouts), enablingthe possibility of testing GWAS-nominated haplotypes in experi- mental models with inherently different disease etiologies (e.g., high renin hypertension in SHR vs. low renin hypertension in SS).Testing other experimental parameters, such as diet (e.g., high fat, high glucose, or caloric restriction), environmental stressors (e.g., sleep deprivation), response to pharmacological inhibitors (e.g., ACE inhibitor or diuretics), and biomarkers (e.g., circulating Nppa Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/3a/b9/1996.PMC3847770.pdf
Analysis of human SNPs and haplotype blocks LD (defined here as r2>0.6) for human SNPs from the CEU cohort from the HapMap (http://hapmap.ncbi.nlm.nih.gov/; The Inter- national HapMap Consortium 2003) and 1000 genome (http://browser.1000genomes.org/index.html; The 1000 Genomes Proj-ect Consortium 2012) projects were calculated using SNAP (http:// www.broadinstitute.org/mpg/snap/ldsearch.php; Johnson et al.,OADS,/arxiv_data1/oa_pdf/3a/b9/1996.PMC3847770.pdf
SNPs associated with gene regulatory mechanisms werecurated from the ENCODE study (The ENCODE Project Consortium 2011) using the RegulomeDB database (http://www.regulomedb.,OADS,/arxiv_data1/oa_pdf/3a/b9/1996.PMC3847770.pdf
"This article, published in Genome Research , is avail- able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.4These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/d2/70/2003.PMC3847771.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.157941.113.",OADS,/arxiv_data1/oa_pdf/d2/70/2003.PMC3847771.pdf
Raw NGS data have been submitted to the Sequence Read Archive (SRA;http://www.ncbi.nlm.nih.gov/Traces/sra/) under accession num-ber SRP024282.,OADS,/arxiv_data1/oa_pdf/d2/70/2003.PMC3847771.pdf
http://www.repeatmasker.org.,Non-OADS,/arxiv_data1/oa_pdf/d2/70/2003.PMC3847771.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/66/fa/2030.PMC3847773.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.7Corresponding author E-mail wadep2@niehs.nih.govArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/66/fa/2030.PMC3847773.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.155473.113.",Non-OADS,/arxiv_data1/oa_pdf/66/fa/2030.PMC3847773.pdf
NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/66/fa/2030.PMC3847773.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.Present addresses:7Department of Biological Sciences, University at Buffalo, State University of New York, Buffalo, New York 14260, USA; 8The Jackson Laboratory Institute for Genomic Medicine, Farming- ton, Connecticut 06030, USA.",Non-OADS,/arxiv_data1/oa_pdf/87/3f/2042.PMC3847774.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.154625.113.",OADS,/arxiv_data1/oa_pdf/87/3f/2042.PMC3847774.pdf
"Aligning reads For our analysis, we used only reads that could not be mapped tothe reference genome by The 1000 Genomes Project Consortium (The 1000 Genomes Project Consortium 2012; ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/phase1/data).",OADS,/arxiv_data1/oa_pdf/87/3f/2042.PMC3847774.pdf
S3–S22) with graphical representa-tion of gene models generated by the UCSC Genome Browser (http://genome.ucsc.edu).,OADS,/arxiv_data1/oa_pdf/87/3f/2042.PMC3847774.pdf
The same sequence was also aligned against all as-sembled human contigs using Megablast (http://blast.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/87/3f/2042.PMC3847774.pdf
"being acceptable to run the PCR reaction, and by PrimerBlast ser- ver (http://www.ncbi.nlm.nih.gov/tools/primer-blast) to yield no amplicons from the reference genome.",Non-OADS,/arxiv_data1/oa_pdf/87/3f/2042.PMC3847774.pdf
"To calculate the sequence identities between pseudogenes and their parent genes, exons of each se-quence were concatenated and aligned by ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) with default parameters.",OADS,/arxiv_data1/oa_pdf/87/3f/2042.PMC3847774.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b1/47/2053.PMC3847775.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.1Present address: Department of Biosciences, University of Oslo, N-0316 Oslo, Norway.",Non-OADS,/arxiv_data1/oa_pdf/b1/47/2053.PMC3847775.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.155028.113.",Non-OADS,/arxiv_data1/oa_pdf/b1/47/2053.PMC3847775.pdf
Wiggle tracks were generatedin a WCB Edinburgh Galaxy server (http://galaxy.psu.edu/) using a 200-bp window with a 20-bp step normalized to reads per million reads per base pair (RPM/bp).,OADS,/arxiv_data1/oa_pdf/b1/47/2053.PMC3847775.pdf
"The number of reads in 20 500-bp windows 65k ba r o u n d the enhancer midpoint was determined using coverageBED, nor- malized to reads per million, and clustered based on the sum ofwindows for H4K16ac using the CreateTreeView Files in the WCBEdinburgh Galaxy server, then visualized using the Java TreeView (http://jtreeview.sourceforge.net/) using the same settings for each heatmap.",OADS,/arxiv_data1/oa_pdf/b1/47/2053.PMC3847775.pdf
Data access Microarray and ChIP-sequencing data for this study have beensubmitted to the the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE43103.,OADS,/arxiv_data1/oa_pdf/b1/47/2053.PMC3847775.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/94/27/2078.PMC3847777.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.4Present address: Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA.",Non-OADS,/arxiv_data1/oa_pdf/94/27/2078.PMC3847777.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.156919.113.",OADS,/arxiv_data1/oa_pdf/94/27/2078.PMC3847777.pdf
Python scripts used to annotate poly(A) sites from 3P-seq data are available online at http://bitbucket.org/nspies/buildpolyaclusters.,OADS,/arxiv_data1/oa_pdf/94/27/2078.PMC3847777.pdf
"tactD=0,0,1,2,4,8 (two biological replicates at t =0) using SciPy (http://www.scipy.org/).",OADS,/arxiv_data1/oa_pdf/94/27/2078.PMC3847777.pdf
Data access Raw 2P-seq and 3P-seq sequencing data have been submitted tothe NCBI Gene Expression Omnibus (GEO; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/94/27/2078.PMC3847777.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/15/34/2091.PMC3847778.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.6Present address: Max Planck Institute for Developmental Biology, 72076 Tu ¨bingen, Germany.",Non-OADS,/arxiv_data1/oa_pdf/15/34/2091.PMC3847778.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.157610.113.",Non-OADS,/arxiv_data1/oa_pdf/15/34/2091.PMC3847778.pdf
Data access Data from this study have been submitted to the NCBI Gene Ex-pression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) un- der accession number GSE44799.Ibrahim et al.,OADS,/arxiv_data1/oa_pdf/15/34/2091.PMC3847778.pdf
https://sites.google.com/site/anshulkundaje/projects/idr.,Non-OADS,/arxiv_data1/oa_pdf/15/34/2091.PMC3847778.pdf
"After six months, it is available un-der a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/9b/1f/2103.PMC3847779.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.159467.113.",Non-OADS,/arxiv_data1/oa_pdf/9b/1f/2103.PMC3847779.pdf
Patient and sample metadata have beensubmitted to dbGAp (http://www.ncbi.nlm.nih.gov/gap) underaccession number phs000266.v3.p1.,OADS,/arxiv_data1/oa_pdf/9b/1f/2103.PMC3847779.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/bc/b1/2115.PMC3847780.pdf
"After six months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.4Corresponding author E-mail mel.greaves@icr.ac.ukArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/bc/b1/2115.PMC3847780.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.159913.113.",OADS,/arxiv_data1/oa_pdf/bc/b1/2115.PMC3847780.pdf
bAccording to COSMIC (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/).Genetic analysis of single cancer cells Genome Research 2119 www.genome.org,Non-OADS,/arxiv_data1/oa_pdf/bc/b1/2115.PMC3847780.pdf
"BAC and fosmid probes for this and other regions of interest were obtained from the BACPAC Resource Center (Children’s Hospital,Oakland Research Institute) (http://bacpac.chori.org).",OADS,/arxiv_data1/oa_pdf/bc/b1/2115.PMC3847780.pdf
Data access The whole-exome sequencing data generated in this studyhave been submitted to The European Genome-phenome Archive(EGA; http://www.ebi.ac.uk/ ega/) under accession number EGAD00001000636.,OADS,/arxiv_data1/oa_pdf/bc/b1/2115.PMC3847780.pdf
Single nucleotide polymorphism and copy number analysis by SNP array data have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE49215.,OADS,/arxiv_data1/oa_pdf/bc/b1/2115.PMC3847780.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/0f/07/2126.PMC3847781.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.3These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/0f/07/2126.PMC3847781.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.161679.113.",OADS,/arxiv_data1/oa_pdf/0f/07/2126.PMC3847781.pdf
The remaining truncated reads were then aligned to the mm9 mouse reference genome(downloaded from the UCSC Genome Browser) using the Bismarktool (http://www.bioinformatics.,OADS,/arxiv_data1/oa_pdf/0f/07/2126.PMC3847781.pdf
The subsequent statistical computing and graphics were performed with customized Perl scripts and R packages (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/0f/07/2126.PMC3847781.pdf
Data access All sequencing data have been submitted to the NCBI Gene Ex- pression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) un- der accession number GSE47343.,OADS,/arxiv_data1/oa_pdf/0f/07/2126.PMC3847781.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.12These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/b3/34/2136.PMC3847782.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.158261.113.",Non-OADS,/arxiv_data1/oa_pdf/b3/34/2136.PMC3847782.pdf
Interactive SOM viewer for visualization and mining We created an interactive JavaScript web-based SOM viewer withan associated map segment database to facilitate these explora- tions (http://woldlab.caltech.edu/ENCODESOM).,OADS,/arxiv_data1/oa_pdf/b3/34/2136.PMC3847782.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/4e/b5/2149.PMC3847783.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.4These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/4e/b5/2149.PMC3847783.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.151878.112.",OADS,/arxiv_data1/oa_pdf/4e/b5/2149.PMC3847783.pdf
"The most favorable fragments were used to design gene-specific primers using the Primer3 algorithm (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi), and the resulting PCR productswere sequence verified on an Applied Biosystems 3730 Genetic Analyzer (Applied Biosystems) according to the manufacturer’s instructions.",OADS,/arxiv_data1/oa_pdf/4e/b5/2149.PMC3847783.pdf
20.Consorcium for Genomics Research on All Salmon Project cGRASP http://web.uvic.,Non-OADS,/arxiv_data1/oa_pdf/f1/14/srep03376.PMC3847856.pdf
NIH Genetic Sequence Database http://www.ncbi.nlm.nih.gov/ genbank/ (October 2013).,OADS,/arxiv_data1/oa_pdf/f1/14/srep03376.PMC3847856.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f1/14/srep03376.PMC3847856.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3376 | DOI: 10.1038/srep03376 8",Non-OADS,/arxiv_data1/oa_pdf/f1/14/srep03376.PMC3847856.pdf
SequeNCe vARiANtS AND tuMOR  MiSSeNSe MutAtiONS  Sequencing of the BRCA2 gene in the  high risk or disease population has revealed  a complex and varied landscape of mutations  scattered throughout the 70 kilobase ge - nomic DNA (breast cancer information core  (BIC) (http://research.nhgri.nih.gov/bic/).,Non-OADS,/arxiv_data1/oa_pdf/2e/03/yjbm_86_4_479.PMC3848102.pdf
We downloaded the TCGA serous ovarian cancer data packages from the TCGA public-access ftp ( ohttps://tcga-data.nci.nih.gov/ tcgaﬁles/ftp_auth/distro_ftpusers/anonymous/tumour/ov/ 4).,OADS,/arxiv_data1/oa_pdf/24/8d/41467_2013_Article_BFncomms2629.PMC3848248.pdf
A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/.,OADS,/arxiv_data1/oa_pdf/24/8d/41467_2013_Article_BFncomms2629.PMC3848248.pdf
"Information about TCGA,and the investigators and institutions who constitute the TCGA research network, can be found at http://cancergenome.nih.gov/.",OADS,/arxiv_data1/oa_pdf/24/8d/41467_2013_Article_BFncomms2629.PMC3848248.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/24/8d/41467_2013_Article_BFncomms2629.PMC3848248.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Shen, H., Fridley, B. L., Song, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/24/8d/41467_2013_Article_BFncomms2629.PMC3848248.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Hui Shen1,*, Brooke L. Fridley2,*, Honglin Song3,*, Kate Lawrenson4, Julie M. Cunningham5, Susan J. Ramus4, Mine S. Cicek6, Jonathan Tyrer3, Douglas Stram4, Melissa C. Larson7, Martin Ko ¨bel8, PRACTICAL Consortium9, Argyrios Ziogas10, Wei Zheng11, Hannah P. Yang12, Anna H. Wu4, Eva L. Wozniak13, Yin Ling Woo14, Boris Winterhoff15, Elisabeth Wik16,17, Alice S. Whittemore18, Nicolas Wentzensen12, Rachel Palmieri Weber19, Allison F. Vitonis20, Daniel Vincent21, Robert A. Vierkant7, Ignace Vergote22,23, David Van Den Berg4, Anne M. Van Altena24, Shelley S. Tworoger25,26, Pamela J. Thompson27, Daniel C. Tessier21, Kathryn L. Terry20,26, Soo-Hwang Teo28,29, Claire Templeman30, Daniel O. Stram4, Melissa C. Southey31, Weiva Sieh18, Nadeem Siddiqui32, Yurii B. Shvetsov27, Xiao-Ou Shu10, Viji Shridhar5, Shan Wang-Gohrke33, Gianluca Severi34,35, Ira Schwaab36, Helga B. Salvesen16,17, Iwona K. Rzepecka37, Ingo B. Runnebaum38, Mary Anne Rossing39,40, Lorna Rodriguez-Rodriguez41, Harvey A. Risch42, Stefan P. Renner43, Elizabeth M. Poole25,26, Malcolm C. Pike4,44, Catherine M. Phelan45, Liisa M. Pelttari46, Tanja Pejovic47,48, James Paul49, Irene Orlow44, Siti Zawiah Omar14, Sara H. Olson44, Kunle Odunsi50, Stefan Nickels51, Heli Nevanlinna46, Roberta B. Ness52, Steven A. Narod53, Toru Nakanishi54, Kirsten B. Moysich55, Alvaro N.A.",Non-OADS,/arxiv_data1/oa_pdf/24/8d/41467_2013_Article_BFncomms2629.PMC3848248.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dc/57/cia-8-1579.PMC3848376.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1579–1584Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1579OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5435 2Overall and abdominal obesity indicators had  different association with central arterial stiffness  and hemodynamics independent of age, sex, blood  pressure, glucose, and lipids in Chinese community- dwelling adults shihui Fu1 leiming luo1 Ping Ye1 Yuan liu1 Bing Zhu1 Jin Zheng1 Y ongyi Bai1 Jie Bai2 1Department of geriatric Cardiology,   2Department of Clinical Biochemistry,   Chinese People’s liberation Army  general hospital, Beijing, People’s  republic of China Correspondence: leiming luo   Department of geriatric Cardiology,   Chinese People’s liberation Army  general hospital, Fuxing   road 28, haidian District, Beijing 100853,   People’s republic of China   Tel +86 10 8862 6362   email lleim@sina.co mObjective:  Limited large sample studies have specially compared overall and abdominal  obesity  in relation to central arterial stiffness and hemodynamics in community-dwelling adults, espe - cially in the People’ s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/dc/57/cia-8-1579.PMC3848376.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/dc/57/cia-8-1579.PMC3848376.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/57/cia-8-1579.PMC3848376.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ac/d2/cia-8-1569.PMC3848378.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1569–1577Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1569OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5252 8Fall-related admissions after fast-track total   hip and knee arthroplasty − cause of concern   or consequence of success?,Non-OADS,/arxiv_data1/oa_pdf/ac/d2/cia-8-1569.PMC3848378.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT01515670.,Non-OADS,/arxiv_data1/oa_pdf/ac/d2/cia-8-1569.PMC3848378.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ac/d2/cia-8-1569.PMC3848378.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/d2/cia-8-1569.PMC3848378.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/20/ceor-5-597.PMC3848379.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2013:5 597–609ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  597REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S5177 6Health economic evidence of 5% lidocaine   medicated plaster in post-herpetic neuralgia Hiltrud Liedgens1 Marko Obradovic1 Mark Nuijten2 1Grunenthal GmbH, Aachen,  Germany; 2Ars Accessus Medica,  Amsterdam, the Netherlands Correspondence: Hiltrud Liedgens   Grunenthal GmbH, Zieglerstrasse 6,  Aachen, 52099, Germany   Tel +49 241 5 69 2679   Fax +49 241 5 69 2986   Email hiltrud.liedgens@grunenthal.co mBackground:  Post-herpetic neuralgia (PHN) is the most common and most debilitating   complication of herpes zoster, and involves considerable associated costs.",Non-OADS,/arxiv_data1/oa_pdf/16/20/ceor-5-597.PMC3848379.pdf
Available  from: http://www.medicines.org.uk/emc/medicine/1465 1.,Non-OADS,/arxiv_data1/oa_pdf/16/20/ceor-5-597.PMC3848379.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/16/20/ceor-5-597.PMC3848379.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/20/ceor-5-597.PMC3848379.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/a5/clep-5-483.PMC3848422.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2013:5 483–492Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  483REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S5481 5Epidemiology of idiopathic pulmonary fibrosis Brett Ley Harold R Collard Department of Medicine, Division  of Pulmonary and Critical Care  Medicine, University of California   San Francisco, San Francisco,    California, USA Correspondence: Brett Ley   Department of Medicine, Division of   Pulmonary and Critical Care Medicine,   University of California San Francisco,   505 Parnassus Ave, Box 0111,   San Francisco, CA 94143, USA   Tel +1 415 476 0735   Fax +1 415 502 1321   Email brett.ley@ucsf.ed uAbstract:  Idiopathic pulmonary fibrosis is a chronic fibrotic lung disease of unknown cause that  occurs in adults and has a poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/69/a5/clep-5-483.PMC3848422.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/69/a5/clep-5-483.PMC3848422.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/ba/ijn-8-4391.PMC3848469.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4391–4398International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4391OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S52760Biosensor based on tyrosinase immobilized on  a single-walled carbon nanotube-modified glassy  carbon electrode for detection of epinephrine Irina Mirela apetrei1 constantin apetrei2 1Department of Pharmaceutical  sciences, Faculty of Medicine and  Pharmacy, 2Department of chemistry,   Physics and environment, Faculty of  sciences and environment, Dunarea  de Jos University of galati, romania correspondence: constantin apetrei   Department of chemistry, Physics and  environment, Faculty of sciences and  environment, Dunarea de Jos University  of galati, 47 Domneasca street,   800008 galati, romania   Tel +40 02 3646 0328   Fax +40 02 3646 1353   email apetreic@ugal.r oAbstract:  A biosensor comprising tyrosinase immobilized on a single-walled carbon  nanotube-modified glassy carbon electrode has been developed.",Non-OADS,/arxiv_data1/oa_pdf/d4/ba/ijn-8-4391.PMC3848469.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d4/ba/ijn-8-4391.PMC3848469.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/ba/ijn-8-4391.PMC3848469.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/cia-8-1497.PMC3848471.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1497–1503Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1497OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5398 7evolution of cardiovascular risk factors   and ischemic heart disease in an elderly urban   romanian population over the course of 1 year Dana Pop Alexandra Da ˇdârlat Mihnea Zdrenghea Dumitru T udor Zdrenghea Adela Viviana Sitar-Ta ˇut Faculty of Medicine, Iuliu Haţieganu  University of Medicine and Pharmacy,   Cluj-n apoca, romania Correspondence: Mihnea Zdrenghea   Faculty of Medicine, Iuliu Haţieganu   University of Medicine and Pharmacy,   73/22 Decembrie street,   Cluj-napoca 400124, romania   Tel +40 741 100 480   email m.zdrenghea@yahoo.co mBackground:  Romania has some of the highest mortality figures in the world attribu table  to  ischemic heart disease and stroke among both men and women.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/cia-8-1497.PMC3848471.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3a/79/cia-8-1497.PMC3848471.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/cia-8-1497.PMC3848471.pdf
Available  from: http://epp.eurostat.ec.europa.eu/statistics_explained/index.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/cia-8-1497.PMC3848471.pdf
"Available  from: http://www.who.int/infobas e. Accessed October 21, 2013.",OADS,/arxiv_data1/oa_pdf/3a/79/cia-8-1497.PMC3848471.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 551–559International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  551OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5150 7risk assessment of readmissions following   an initial COPD-related hospitalization Christine l Baker1 Kelly h Zou1 Jun su2 1Pfizer Inc, new Y ork, nY,   Usa; 2Boehringer-Ingelheim  Pharmaceuticals Inc, ridgefield, CT,   Usa Correspondence: Jun su   Boehringer-Ingelheim Pharmaceuticals  Inc, 900 Ridgebury Road, Ridgefield,   CT 06877, Usa   Tel +1 203 798 4788   Fax +1 203 837 4788   email jun.su@boehringer-ingelheim.co mBackground:  Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a   leading cause of hospitalizations and readmissions in the US.",Non-OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
Available from: http://hcupnet.ahrq.gov/HCUPnet.jsp?,OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
"Available from: http://www.healthcare.gov/ center/reports/quality03212011a.htm l. Accessed February 14, 2013.",OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
"Available from:  http://www.qualityforum.org/Projects/n-r/Pulmonary_ Endorsement _ Maintenance/1891_30_Day_RSRR_COPD.asp x. Accessed June 13,  2013.",Non-OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
"Available from: http://www.gpo.gov/fdsys/ pkg/FR-2011–2005–05/pdf/2011–9644.pd f. Accessed February 14,  2013.",OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
Available from: http://www.truvenhealth.,Non-OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
Available from: http://www.hcup-us.,Non-OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/11/copd-8-551.PMC3848494.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/d2/copd-8-545.PMC3848507.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 545–549International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  545ShO rt rePO rtopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S4569 3Over diagnosis of chronic obstructive pulmonary  disease in an underserved patient population Christian Ghattas1 Allen Dai2 David J Gemmel3 Magdi h Awad2 1Department of Internal Medicine,    St elizabeth health Center,   Y oungstown, Oh, USA; 2Northeast  Ohio Medical University College  of Pharmacy, rootstown, Oh, USA;   3Department of Medical education  and research, St elizabeth health  Center, Y oungstown, Oh, USA Correspondence: Christian Ghattas   Department of Internal Medicine,   St elizabeth health Center, 1044 Belmont   Ave, Youngstown, Oh 44504, USA   tel +1 330 550 5524   email christianghattas@gmail.co mIntroduction:  While cross-national studies have documented rates of chronic obstructive pul - monary disease (COPD) misdiagnosis among patients in primary care, US studies are scarce.",Non-OADS,/arxiv_data1/oa_pdf/b5/d2/copd-8-545.PMC3848507.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/b5/d2/copd-8-545.PMC3848507.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b5/d2/copd-8-545.PMC3848507.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/d2/copd-8-545.PMC3848507.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.346 Infect Chemother 2013;45(3):346-348 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Hee Jung Choi, MD Department of Internal Medicine, Ewha Womans University School of Medicine,  1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea Tel: +82-2-2650-6008, Fax: +82-2-2655-2076 E-mail: heechoi@ewha.ac.kr  This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/2b/ic-45-346.PMC3848510.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.346  •  Infect Chemother 2013;45(3) :346-348 www.icjournal.org  347 ty of PCT to differentiate between bacterial and non-bacte - rial meningitis after brain surgery and trauma is due to the  fact that surgery itself kills the cells that stimulate PCT pro - duction.,Non-OADS,/arxiv_data1/oa_pdf/87/2b/ic-45-346.PMC3848510.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.325 Infect Chemother 2013;45(3):325-330 pISSN 2093-2340 · eISSN 2092-6448 Received: April 2, 2013   Revised:  August 10, 2013  Accepted: August 10, 2013 Corresponding Author : Eun Jung Lee, MD Department of Internal Medicine, Soonchunhyang University Seoul Hospital,   Soonchunhyang University College of Medicine, 59 Daesagwan-ro, Yongsan-gu,   Seoul 140-743, Korea Tel: +82-2-709-9194, Fax: +82-2-792-5812 E-mail: shegets@schmc.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/75/ic-45-325.PMC3848511.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.325  •  Infect Chemother 2013;45(3) :325-330 www.icjournal.org  327 Results 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/75/ic-45-325.PMC3848511.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.325  •  Infect Chemother 2013;45(3) :325-330 www.icjournal.org  329 however, one study has reported that mortality did not differ  between patients with CRAB and CSAB bacteremia.",Non-OADS,/arxiv_data1/oa_pdf/a1/75/ic-45-325.PMC3848511.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.349 Infect Chemother 2013;45(3):349 pISSN 2093-2340 · eISSN 2092-6448 Erratum:   Leptospirosis in the Republic of Korea:  Historical Perspectives, Current Status and  Future Challenges Min Ja Kim  Division of Infectious Diseases, Department of Internal Medicine, Korea Univseristy College of Medicine, Seoul, Korea Infect Chemother 2003;45(2):137‐144.",Non-OADS,/arxiv_data1/oa_pdf/2b/72/ic-45-349.PMC3848512.pdf
• http://dx.doi.org/10.3947/ic.2013.45.2.137Erratum We found and error in our publish article.,Non-OADS,/arxiv_data1/oa_pdf/2b/72/ic-45-349.PMC3848512.pdf
"This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/72/ic-45-349.PMC3848512.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.253 Infect Chemother 2013;45(3):253-259 pISSN 2093-2340 · eISSN 2092-6448 Received: August 13, 2013 Corresponding Author : Mark Loeb Departments of Pathology and Molecular Medicine, Clinical Epidemiology and  Biostatistics, and Michael G. DeGrooteInstitute for Infectious Disease Research,  McMaster University, Hamilton, Ontario, Canada, 1280 Main Street West, Hamilton,  Ontario, Canada L8S 4Z1 Tel: +1-905-525-9140 x26066, Fax: +1-905-389-5822 Email: loebm@mcmaster.ca This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/9c/ic-45-253.PMC3848513.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.253  •  Infect Chemother 2013;45(3) :253-259 www.icjournal.org  255 dengue cases progress to life-threatening disease causing  20,000 to 25,000 deaths annually.",Non-OADS,/arxiv_data1/oa_pdf/b6/9c/ic-45-253.PMC3848513.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.253  •  Infect Chemother 2013;45(3) :253-259 www.icjournal.org  257 have been exposed to the virus.,Non-OADS,/arxiv_data1/oa_pdf/b6/9c/ic-45-253.PMC3848513.pdf
Available at: http://www.who.int/tdr/publications/ tdr-research-publications/swg-report-dengue/en/index.,Non-OADS,/arxiv_data1/oa_pdf/b6/9c/ic-45-253.PMC3848513.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.253  •  Infect Chemother 2013;45(3) :253-259 www.icjournal.org  259 ciency increases risk of symptomatic West Nile virus in - fection.,Non-OADS,/arxiv_data1/oa_pdf/b6/9c/ic-45-253.PMC3848513.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.331 Infect Chemother 2013;45(3):331-334 pISSN 2093-2340 · eISSN 2092-6448 Received: February 20, 2013   Revised:  May 21, 2013  Accepted: May 22, 2013 Corresponding Author : Kyung-Ah Han, MD, PhD Department of Internal Medicine, Division of Endocrinology and Metabolism,   Eulji General Hospital, Eulji University, 14 Hangeul-Biseok Gil, Nowon-Gu, Seoul  139-872, Korea Tel: +82-2-970-8214, Fax: +82-2-972-0068 E-mail: hka1114@eulji.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/81/ic-45-331.PMC3848514.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.331  •  Infect Chemother 2013;45(3) :331-334 www.icjournal.org  333 PCN was maintained for 2 weeks and the antibiotic was con - tinued for 6 weeks.,Non-OADS,/arxiv_data1/oa_pdf/33/81/ic-45-331.PMC3848514.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.283 Infect Chemother 2013;45(3):283-291 pISSN 2093-2340 · eISSN 2092-6448 Received: August 22, 2013   Revised:  September 10, 2013  Accepted: September 17, 2013 Corresponding Author : Sungmin Kiem, MD Department of Internal Medicine, Haeundae Paik Hospital, Inje University College  of Medicine, 875 Haeun-daero, Haeundae-gu, Busan 612-896, Korea  Tel: +82-51-797-3220, Fax: +82-51-797-0298 Email: smkimkor@yahoo.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/de/ic-45-283.PMC3848515.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.283  •  Infect Chemother 2013;45(3) :283-291 www.icjournal.org  285 clinical parameters, which are shown in Table 1.",OADS,/arxiv_data1/oa_pdf/93/de/ic-45-283.PMC3848515.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.283  •  Infect Chemother 2013;45(3) :283-291 www.icjournal.org  287 Table 5.,OADS,/arxiv_data1/oa_pdf/93/de/ic-45-283.PMC3848515.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.283  •  Infect Chemother 2013;45(3) :283-291 www.icjournal.org  289 logical relapse (11.0%), 13 colonization (8.9%), 6 superinfec - tion (4.1%), and 1 indeterminate (0.7%), failed eradication was  frequent in cases of infection with Acinetobacter (10/11), En- terobacter (7/12), P .",Non-OADS,/arxiv_data1/oa_pdf/93/de/ic-45-283.PMC3848515.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.283  •  Infect Chemother 2013;45(3) :283-291 www.icjournal.org  291 pneumonia  in intensive care units : comparison  with  imipenem-resistant  extra-respiratory  tract  isolates  from  uninfected  patients .,Non-OADS,/arxiv_data1/oa_pdf/93/de/ic-45-283.PMC3848515.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.272 Infect Chemother 2013;45(3):272-282 pISSN 2093-2340 · eISSN 2092-6448 Received: September 22, 2013 Corresponding Author : Dong-Gun Lee, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, The Catholic  Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic  University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu,  Seoul 137-701, Korea  Tel: +82-2-2258-6003, Fax: +82-2-535-2494 E-mail: symonlee@catholic.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/b2/ic-45-272.PMC3848516.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.272  •  Infect Chemother 2013;45(3) :272-282 www.icjournal.org  273 plastic diseases, particularly hematologic malignancies such  as acute and chronic leukemia, lymphoma, multiple myelo - ma, and myeloproliferative diseases.",Non-OADS,/arxiv_data1/oa_pdf/ff/b2/ic-45-272.PMC3848516.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.272  •  Infect Chemother 2013;45(3) :272-282 www.icjournal.org  275 Recommended vaccines 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/b2/ic-45-272.PMC3848516.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.272  •  Infect Chemother 2013;45(3) :272-282 www.icjournal.org  277 immunogenic [54].,Non-OADS,/arxiv_data1/oa_pdf/ff/b2/ic-45-272.PMC3848516.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.272  •  Infect Chemother 2013;45(3) :272-282 www.icjournal.org  279 ing alternative donors is increasing, prospective, multi-center,  international clinical trials for recommending different vac - cine strategies should be undertaken.",Non-OADS,/arxiv_data1/oa_pdf/ff/b2/ic-45-272.PMC3848516.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.272  •  Infect Chemother 2013;45(3) :272-282 www.icjournal.org  281 poietic cell transplant recipients.,Non-OADS,/arxiv_data1/oa_pdf/ff/b2/ic-45-272.PMC3848516.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.339 Infect Chemother 2013;45(3):339-342 pISSN 2093-2340 · eISSN 2092-6448 Received: January 24, 2013   Revised:  May 27, 2013  Accepted: May 29, 2013 Corresponding Author : Seong-Yeol Ryu, MD                                           Department of Infectious Disease, Dongsan Medical Center, Keimyung University  School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 700-712, Korea               Tel: +82-53-250-7915, Fax: +82-53-250-7994                                 E-mail: 121rsy@dsmc.or.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/f7/ic-45-339.PMC3848517.pdf
"Unambiguously determined sequences  (559 bp) were compared with the GenBank public database,  using the BLASTn program ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ).",OADS,/arxiv_data1/oa_pdf/c6/f7/ic-45-339.PMC3848517.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.339  •  Infect Chemother 2013;45(3) :339-342 www.icjournal.org  341 17].,Non-OADS,/arxiv_data1/oa_pdf/c6/f7/ic-45-339.PMC3848517.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.343 Infect Chemother 2013;45(3):343-345 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Su Eun Park, MD, PhD Department of Pediatrics, Pusan National University Children’s Hospital, 20 Geumo-ro, Yangsan 626-770, Korea Tel: +82-55-360-3155  Fax: +82-55-360-2181 E-mail: psepse@naver.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/fc/ic-45-343.PMC3848518.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.343  •  Infect Chemother 2013;45(3) :343-345 www.icjournal.org  345 intrapartum antibiotic prophylaxis.,Non-OADS,/arxiv_data1/oa_pdf/08/fc/ic-45-343.PMC3848518.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.308 Infect Chemother 2013;45(3):308-314 pISSN 2093-2340 · eISSN 2092-6448 Received: January 28, 2013   Revised:  May 30, 2013  Accepted: May 30, 2013 Corresponding Author : Sang-Ho Choi, MD, PhD  Departments of Infectious Diseases, Asan Medical Center, University of Ulsan   College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea  Tel: +82-2-3010-3304, Fax: +82-2-3010-6970 E-mail: sangho@amc.seoul.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/5b/ic-45-308.PMC3848519.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.308  •  Infect Chemother 2013;45(3) :308-314 www.icjournal.org  309 Introduction Bacterial meningitis is an important potential complication  after brain surgery [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/42/5b/ic-45-308.PMC3848519.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.308  •  Infect Chemother 2013;45(3) :308-314 www.icjournal.org  311 based on a positive CSF bacterial culture.,Non-OADS,/arxiv_data1/oa_pdf/42/5b/ic-45-308.PMC3848519.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.308  •  Infect Chemother 2013;45(3) :308-314 www.icjournal.org  313 No ideal discriminatory marker was identified in this study.,Non-OADS,/arxiv_data1/oa_pdf/42/5b/ic-45-308.PMC3848519.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.335 Infect Chemother 2013;45(3):335-338 pISSN 2093-2340 · eISSN 2092-6448 Received: February 19, 2013   Revised:  May 29, 2013  Accepted: May 29, 2013 Corresponding Author : Sang-Ho Choi, MD, PhD  Departments of Infectious Diseases, Asan Medical Center, University of Ulsan   College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea  Tel: +82-2-3010-3304, Fax: +82-2-3010-6970 E-mail: sangho@amc.seoul.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/c5/ic-45-335.PMC3848520.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.335  •  Infect Chemother 2013;45(3) :335-338 www.icjournal.org  337 Discussion  Enterococci are generally regarded as the normal intestinal  flora [6].,Non-OADS,/arxiv_data1/oa_pdf/bb/c5/ic-45-335.PMC3848520.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.260 Infect Chemother 2013;45(3):260-271 pISSN 2093-2340 · eISSN 2092-6448 Received: June 26, 2013 Corresponding Author :  Raymund R Razonable Division of Infectious Diseases, Department of Medicine and the William J von Liebig  Transplant Center, Mayo Clinic, 200 First Street SW Rochester, Minnesota 55905, USA Tel: +01-507-284-3747, Fax: +01-507-255-7767  E-mail: razonable.raymund@mayo.edu This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/40/ic-45-260.PMC3848521.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.260  •  Infect Chemother 2013;45(3) :260-271 www.icjournal.org  261 Epidemiology CMV is a ubiquitous virus, with a worldwide distribution.",Non-OADS,/arxiv_data1/oa_pdf/fb/40/ic-45-260.PMC3848521.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.260  •  Infect Chemother 2013;45(3) :260-271 www.icjournal.org  263 ent genes, among others, which contribute to significant dif - ferences in viral load reporting [44, 45].",Non-OADS,/arxiv_data1/oa_pdf/fb/40/ic-45-260.PMC3848521.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.260  •  Infect Chemother 2013;45(3) :260-271 www.icjournal.org  265 phylaxis to 200 days in high risk (D+/R-) kidney recipients.,Non-OADS,/arxiv_data1/oa_pdf/fb/40/ic-45-260.PMC3848521.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.260  •  Infect Chemother 2013;45(3) :260-271 www.icjournal.org  267 mortality in SOT patients [81].,Non-OADS,/arxiv_data1/oa_pdf/fb/40/ic-45-260.PMC3848521.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.260  •  Infect Chemother 2013;45(3) :260-271 www.icjournal.org  269 toring and reporting of infectious complications in immu - nosuppression trials in recipients of organ transplanta - tion.,OADS,/arxiv_data1/oa_pdf/fb/40/ic-45-260.PMC3848521.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.260  •  Infect Chemother 2013;45(3) :260-271 www.icjournal.org  271 Boeckh M. High incidence of ganciclovir-resistant cyto - megalovirus infection among lung transplant recipients  receiving preemptive therapy.,Non-OADS,/arxiv_data1/oa_pdf/fb/40/ic-45-260.PMC3848521.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.292 Infect Chemother 2013;45(3):292-298 pISSN 2093-2340 · eISSN 2092-6448 Received: April 23, 2013   Revised:  July 17, 2013  Accepted: July 18, 2013 Corresponding Author : Sang-Oh Lee, MD, PhD Department of Infectious Diseases, Asan Medical Center, University of Ulsan   College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea   Tel: +82-2-3010-3301, Fax: +82-2-3010-6970   E-mail: soleemd@amc.seoul.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/64/ic-45-292.PMC3848522.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.292  •  Infect Chemother 2013;45(3) :292-298 www.icjournal.org  293 infection varies, and can occur in the lungs, the skin and soft  tissue, the rhino-orbito-cerebral region, and the gastrointesti - nal tract.",Non-OADS,/arxiv_data1/oa_pdf/07/64/ic-45-292.PMC3848522.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.292  •  Infect Chemother 2013;45(3) :292-298 www.icjournal.org  295 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/07/64/ic-45-292.PMC3848522.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.292  •  Infect Chemother 2013;45(3) :292-298 www.icjournal.org  297 was 75% (6/8).,OADS,/arxiv_data1/oa_pdf/07/64/ic-45-292.PMC3848522.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.299 Infect Chemother 2013;45(3):299-307 pISSN 2093-2340 · eISSN 2092-6448 Received: February 26, 2012   Revised:  May 7, 2013  Accepted: July 11, 2013 Corresponding Author : Moran Ki, MD Department of Preventive Medicine, Eulji University, 77 Gyeryong-ro   771beon-gil, Jung-gu, Daejeon 301-832, Korea Tel: +82-42-259-1681, Fax: +82-42-259-1689 E-mail: moranki@naver.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/d8/ic-45-299.PMC3848523.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.299  •  Infect Chemother 2013;45(3) :299-307 www.icjournal.org  301 cultures were incubated along with a negative control for 18– 25 h at 35–37oC in ambient air containing 5% CO2.,Non-OADS,/arxiv_data1/oa_pdf/67/d8/ic-45-299.PMC3848523.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.299  •  Infect Chemother 2013;45(3) :299-307 www.icjournal.org  303 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/67/d8/ic-45-299.PMC3848523.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.299  •  Infect Chemother 2013;45(3) :299-307 www.icjournal.org  305 mycin have remained high (35% in a previous study [16] vs.  39.5% in this study); however, the rate was lower than that of  an earlier report from Korea (48.4%) [17].",Non-OADS,/arxiv_data1/oa_pdf/67/d8/ic-45-299.PMC3848523.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.299  •  Infect Chemother 2013;45(3) :299-307 www.icjournal.org  307 NCCLS document M100-S12.,Non-OADS,/arxiv_data1/oa_pdf/67/d8/ic-45-299.PMC3848523.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.3.315 Infect Chemother 2013;45(3):315-324 pISSN 2093-2340 · eISSN 2092-6448 Received: February 18, 2013   Revised:  May 14, 2013  Accepted:  June 3, 2013 Corresponding Author : Young Hwa Choi, MD, PhD Department of Infectious Diseases, Ajou University School of Medicine,   164 World Cup-ro, Yeongtong-gu, Suwon 443-380, Korea Tel: 82-31-219-5112, Fax: 82-31-219-5109 Email: yhwa1805@ajou.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/1f/ic-45-315.PMC3848524.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.315  •  Infect Chemother 2013;45(3) :315-324 www.icjournal.org  317 USA).,Non-OADS,/arxiv_data1/oa_pdf/0f/1f/ic-45-315.PMC3848524.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.315  •  Infect Chemother 2013;45(3) :315-324 www.icjournal.org  319 ICU stay (OR: 1.040, 95% CI: 1.002 to 1.080, P = 0.038) were  significant independent risk factors of post-transplant BSI  (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/0f/1f/ic-45-315.PMC3848524.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.3.315  •  Infect Chemother 2013;45(3) :315-324 www.icjournal.org  321 transplant BSI include diabetes mellitus, low serum albumin  level, lengthy ICU stay, reoperations, acute rejection, higher  MELD score, intraoperative transfusion, biliary complication,  older age, post-transplant hemodialysis, and a greater number  of intravascular catheter days [2, 5, 9, 15].",Non-OADS,/arxiv_data1/oa_pdf/0f/1f/ic-45-315.PMC3848524.pdf
  http://dx.doi.org/10.3947/ic.2013.45.3.315  •  Infect Chemother 2013;45(3) :315-324 www.icjournal.org  323 liver transplant recipients.,Non-OADS,/arxiv_data1/oa_pdf/0f/1f/ic-45-315.PMC3848524.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/f3/btt-7-243.PMC3848525.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2013:7 243–246Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  243Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S3493 5Lessons learned from peginesatide   in the treatment of anemia associated   with chronic kidney disease in patients on dialysis Tarun Kaushik Muhammad Magdi Yaqoob Barts Health NHS Trust, william  Harvey Research Unit, London, UK Correspondence: Muhammad Magdi  Yaqoob   Barts Health NHS Trust, william   Harvey Research Unit, London, UK   Tel +44 20 3594 2658   Fax +44 20 3594 3253   email m.m.yaqoob@qmul.ac.u kAbstract:  Peginesatide is the newest erythropoietin-stimulating agent (ESA) in the quest for  the ideal treatment of anemia in chronic kidney disease (CKD) patients.",Non-OADS,/arxiv_data1/oa_pdf/f3/f3/btt-7-243.PMC3848525.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/f3/f3/btt-7-243.PMC3848525.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f3/f3/btt-7-243.PMC3848525.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.661 Yoon Suk Jung and Chang Seok Song contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/98/42/gnl-7-661.PMC3848533.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Inflammatory bowel disease (IBD), which includes ulcerative  colitis (UC), and Crohn disease (CD), is a chronic relapsing in - flammatory disorder of the gastrointestinal tract.",Non-OADS,/arxiv_data1/oa_pdf/98/42/gnl-7-661.PMC3848533.pdf
"Accepted on June 17, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.688  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION It has been accepted that the particular virulence strain of  Helicobacter pylori  is one of the factors that determine the  clinical outcome of infection.",Non-OADS,/arxiv_data1/oa_pdf/2b/af/gnl-7-688.PMC3848534.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.668  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Migraine is a common chronic debilitating disorder that af - fects 22.3% of the general population in South Korea.1 Various  gastrointestinal symptoms, such as nausea, vomiting, retch - ing, and loss of appetite are characteristic of patients with mi - graine.",Non-OADS,/arxiv_data1/oa_pdf/4b/fa/gnl-7-668.PMC3848535.pdf
"Published online on June 11, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.719 Ye Rim Chang and Jin-Young Jang are contributed equally to this study.",Non-OADS,/arxiv_data1/oa_pdf/63/e1/gnl-7-719.PMC3848536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.has geographical and ethnic variations.",Non-OADS,/arxiv_data1/oa_pdf/63/e1/gnl-7-719.PMC3848536.pdf
"Accepted on February 8, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.756  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.2.44±0.53, and overall performance 1.89±0.33.",Non-OADS,/arxiv_data1/oa_pdf/de/06/gnl-7-756.PMC3848537.pdf
"Accepted on July 4, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.752  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.diseases such as inflammatory bowel diseases, amebiasis, ma - lignancy, and other causes of rectal bleeding such as a juvenile  polyp.2,5,9,19,20 SRUS should be suspected in patients with rectal  discharge of blood and mucus and previous disorders of evacu - ation.",Non-OADS,/arxiv_data1/oa_pdf/00/7f/gnl-7-752.PMC3848538.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.675  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.marker of myocardial ischemia, which has a negative predic - tive value and is highly sensitive.1,2 Acute ischemic conditions  induces oxidative stress which alters the N-terminal region of  albumin.3 IMA is indicated as a marker of ischemia and oxida - tive stress originating as a consequence of tissue hypoxia.4-6  However, IMA is influenced by serum albumin concentration.",Non-OADS,/arxiv_data1/oa_pdf/f7/50/gnl-7-675.PMC3848539.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.696  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Hepatocellular carcinoma (HCC) is the third most common  cause of cancer-related death worldwide, behind only lung and  stomach cancer.1 Early-stage HCC (solitary or up to three nod - ules ≤3 cm in size) with preserved liver function can be effec - tively treated by resection, liver transplantation, or percutane - ous ablation with the possibility of a long-term cure, and 5-year  survival figures range from 50% to 75%.2 However, only about  30% of patients are indicated for such radical therapies.3 HCC  that is diagnosed at an advanced stage has a dismal prognosis  due to the underlying liver disease and lack of effective treat - ment options.",Non-OADS,/arxiv_data1/oa_pdf/8f/c0/gnl-7-696.PMC3848540.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.731  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Pancreatitis remains a disease whose unpredictable course can  humble even the most astute physicians and hence the quint - essential search for prognostic factors remains.",Non-OADS,/arxiv_data1/oa_pdf/f5/2d/gnl-7-731.PMC3848541.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.712  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.sociated with increased risk of adverse liver outcomes, including  progress to cirrhosis, hepatocellular carcinoma, and death.3 The  importance of early viral suppression to reduce the risk of drug  resistance to nucleos(t)ide analogues (NAs) has been addressed  in several studies.4-6 Recently the 2012 European Association for  the Study of the Liver (EASL) HBV Clinical Practice Guidelines  defined partial virologic response (PVR) as a decrease in HBV  DNA of more than 1 log10 IU/mL but still detectable after at least  6 months of therapy.1 Indeed, in patients with a low genetic  barrier to resistance who are receiving NAs such as lamivudine  (LAM) or telbivudine (LdT), or a moderately potent NA such as  adefovir (ADV), PVR is associated with a well-defined risk for  subsequent development of antiviral resistance.4-6 Therefore,  early treatment adaptation with switching to more potent NAs  should be considered in patients showing PVR to LAM, LdT or  ADV.1,2 Entecavir (ETV) is a cyclopentyl guanosine analogue that has  shown superior biochemical, virological, and histological ef - ficacy compared with LAM in large phase III trials.7,8 Moreover,  because of its potent antiviral suppression and a high genetic  barrier to resistance, emergence of resistance to ETV is rare,  with a 1.2% of cumulative probability over 6 years.9,10 In clinical  trials for treatment-naïve patients on ETV monotherapy, 10%  of hepatitis B e antigen (HBeAg)-negative patients and 33% of  HBeAg-positive patients showed a PVR at week 48.7,8 However,  there were limited data for the virologic response to long-term  continuous ETV therapy in patients with a PVR.",Non-OADS,/arxiv_data1/oa_pdf/a5/9d/gnl-7-712.PMC3848542.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.681  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.colorectal cancer (CRC) screening of average-risk individuals  over the age of 50 years.1 However, early studies have shown  that 4% to 5% of cancers may be missed on a single colono - scopic examination.2,3 One of the main reasons for missed CRCs  is incomplete bowel cleaning.4 Several studies have reported  that poor bowel preparation reduces detection of polyps that  may have the potential to be cancerous.5,6 In response, profes - sional societies have proposed measuring the quality of bowel  preparation as an important quality indicator for colonoscopy.7 Polyethylene glycol (PEG) has become the most commonly  used agent for colon cleansing because it does not cause fluid  exchange across the mucosal membrane and thereby limits  fluid and electrolyte disturbances.8 However, the need to ingest  a large volume of fluid reduces patient compliance.",Non-OADS,/arxiv_data1/oa_pdf/cb/e3/gnl-7-681.PMC3848543.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.704  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Portal hypertension is defined as a pathological increase of  portal pressure gradient resulting in the formation of portal-sys - temic collaterals that shunt part of the portal blood flow to the  systemic circulation bypassing the liver.",Non-OADS,/arxiv_data1/oa_pdf/5f/cb/gnl-7-704.PMC3848544.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.739  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Pancreatic cancer is the fourth leading cause of cancer-relat - ed death across the world1 and the fifth most common cause of  cancer-related mortality in Korea.2,3 The prognosis of pancreatic  cancer is dismal with 5-year survival rate being approximately  5% for all stages combined.4 Although resection with curative  intent is the treatment modality that can somewhat increase  survival in these patients, up to 25% to 30% at best, only about  15% to 20% of patients can benefit from pancreatectomy,5 and  the majority of patients have unresectable disease at clinical  presentation or diagnosis.6 Therefore, many efforts have been  put into improving the survival of patients with both resectable  and unresectable pancreatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/cf/94/gnl-7-739.PMC3848545.pdf
"Accepted on May 28, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.747  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.matous disorder with significant gastrointestinal malignant po - tential.",Non-OADS,/arxiv_data1/oa_pdf/6a/de/gnl-7-747.PMC3848546.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.655  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.is a risk factor of gastric cancer and some gastric lymphoma.1,2  The primary eradication regimens comprising proton pump in - hibitor, amoxicillin and clarithromycin, or metronidazole have  been showing decreased eradication rate with geographic differ - ence.",Non-OADS,/arxiv_data1/oa_pdf/ae/93/gnl-7-655.PMC3848547.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.642  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.are thought to originate from the interstitial cells of Cajal.",Non-OADS,/arxiv_data1/oa_pdf/51/1f/gnl-7-642.PMC3848548.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.648  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.terium that colonizes the gastric epithelium and causes three  important upper gastrointestinal diseases: duodenal or gastric  ulcers, gastric cancer, and gastric mucosa-associated lymphoid  tissue lymphoma.1 H. pylori  infection is classified as a group I  human carcinogen for gastric cancer by World Health Organi - zation in 1994.2 H. pylori  is a fascinating enteric pathogen which is disap - pearing from many developed countries in the absence of any  therapeutic or environmental strategy to reduce the prevalence  of infection.",Non-OADS,/arxiv_data1/oa_pdf/d1/35/gnl-7-648.PMC3848549.pdf
"Accepted on October 2, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.629  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tached to the hydroxyl groups of serines or threonines.",Non-OADS,/arxiv_data1/oa_pdf/1d/bf/gnl-7-629.PMC3848550.pdf
"Published online on September 4, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2013.7.6.725  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Covered self-expandable metal stent (C-SEMS) placement is a  widely accepted procedure for the management of distal malig - nant biliary obstruction.1 C-SEMSs can prevent tumor ingrowth  while maintaining stent patency.",Non-OADS,/arxiv_data1/oa_pdf/0b/04/gnl-7-725.PMC3848551.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/f7/dmso-6-477.PMC3848642.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 477–491Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  477Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S3909 3HbA1c for diagnosis of type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/d4/f7/dmso-6-477.PMC3848642.pdf
Available from:  http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en /.,Non-OADS,/arxiv_data1/oa_pdf/d4/f7/dmso-6-477.PMC3848642.pdf
Available  from: http://www.who.int/diabetes/publications/sys_rev_hba1c_web.,Non-OADS,/arxiv_data1/oa_pdf/d4/f7/dmso-6-477.PMC3848642.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/d4/f7/dmso-6-477.PMC3848642.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/f7/dmso-6-477.PMC3848642.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/95/dmso-6-445.PMC3848643.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 445–451Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  445Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S5216 6effects of a recreational physical activity   and healthy habits orientation program, using   an illustrated diary, on the cardiovascular risk   profile of overweight and obese schoolchildren:   a pilot study in a public school in Brasilia,   Federal District, Brazil angeliete garcez Militão1,2 Margô gomes de Oliveira  Karnikowski3 Fernanda rodrigues da Silva4 elba Sancho garcez Militão3 raiane Maiara dos Santos  Pereira5 carmen Silvia grubert  campbell2,5 1Department of Physical education,   Federal University of rondonia, Brazil;   2Post-graduate Program in Physical  education, catholic University of  Brasilia, Brazil; 3University of Brasilia,   Brazil; 4laboratory of Physical  evaluation and Training, 5laboratory of  Physical education and health Studies,   catholic University of Brasilia, Brazil correspondence: angeliete garcez Militão   Departamento de educação Física  Universidade, Federal de rondônia,  Brasil, rua Jatuarana, 1115, cs 37,  Bairro lagoa, ceP 820.100, Porto Velho,  rondonia, Brazil   Tel +55 69 9902 8229   email angeliete@hotmail.co mIntroduction:  Educative strategies need to be adopted to encourage the consumption of healthy  foods and to promote physical activity in childhood and adolescence.",Non-OADS,/arxiv_data1/oa_pdf/98/95/dmso-6-445.PMC3848643.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/98/95/dmso-6-445.PMC3848643.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/95/dmso-6-445.PMC3848643.pdf
"Available from: http://portalsaude.saude.gov.br/portalsaude/arquivos/ pdf/2012/Ago/22/vigitel_2011_final_0812.pd f. Accessed July 31, 2013.",Non-OADS,/arxiv_data1/oa_pdf/98/95/dmso-6-445.PMC3848643.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/22/dmso-6-469.PMC3848645.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 469–475Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  469Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S5350 1The effects of diet- and diet plus exercise-induced  weight loss on basal metabolic rate and acylated  ghrelin in grade 1 obese subjects andré l lopes1 ana Paula T Fayh2,3 luisa g de Souza campos4 Bruno c T eixeira1 randhall B Kreismann  carteri1 Jerri l ribeiro4 rogério Friedman2 Álvaro reischak-Oliveira1 1exercise research laboratory, School  of Physical education, Universidade  Federal do rio grande do Sul, Porto  alegre, rS, Brazil; 2endocrine Unit,  hospital de clínicas de Porto alegre,  Universidade Federal do rio grande  do Sul, Porto alegre, rS, Brazil;   3health Sciences college of Trairi,  Universidade Federal do rio grande  do norte, Santa cruz, rn, Brazil;  4centro Universitário Metodista – iPa,  Porto alegre, rS, Brazil correspondence: Álvaro reischak- Oliveira   exercise research laboratory  (laPeX) School of Physical education,  Universidade Federal do rio grande do  Sul, rua Felizardo, 750, Porto alegre,   rS, Brazil 90690-200   Tel +55 51 3308 5862   Fax +55 51 3308 5842   email alvaro.oliveira@ufrgs.b rBackground:  Diet and exercise are often prescribed as primary intervention regarding  obesity-related disorders.",Non-OADS,/arxiv_data1/oa_pdf/0c/22/dmso-6-469.PMC3848645.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/0c/22/dmso-6-469.PMC3848645.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/22/dmso-6-469.PMC3848645.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/0c/22/dmso-6-469.PMC3848645.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/89/opth-7-2219.PMC3848745.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2219–2224Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2219Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S4680 4Vitrectomy in double-perforation gunshot injury ahmed abd el alim  Mohamed Ophthalmology department,   ain shams University, Cairo, egypt Correspondence: ahmed abd el alim   Mohamed   ain shams University, Khalifa   el-Maamon street, abbziya   square, Cairo 11566, egypt   email ahmed.abdelalim540@yahoo.co mObjective:  This study sought to evaluate the result of pars plana vitrectomy in patients with  gunshot wounds involving double perforation.",Non-OADS,/arxiv_data1/oa_pdf/64/89/opth-7-2219.PMC3848745.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/64/89/opth-7-2219.PMC3848745.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/89/opth-7-2219.PMC3848745.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/e1/idr-6-215.PMC3848746.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2013:6 215–223Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  215RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S3614 0Ceftolozane/tazobactam: a novel antipseudomonal  cephalosporin and β-lactamase-inhibitor  combination Mai-Chi Hong1 Donald I Hsu1,2 Mark Bounthavong3,4 1Department of Pharmacy Practice  and Administration, western  University of Health Sciences,   Pomona, 2Department of Pharmacy,   St Joseph Hospital, Orange,   3Department of Pharmacy, veterans  Affairs San Diego Healthcare System,   San Diego, 4Department of Pharmacy  Practice, University of California,   San Diego, CA, USA Correspondence: Mark Bounthavong   veterans Affairs San Diego Healthcare  System, 3350 La Jolla village Drive – 119,   San Diego, CA 92161, USA   Tel +1 858 642 3158   Fax +1 858 642 1499   email mark.bounthavong@va.go vAbstract:  The management of infections caused by multidrug-resistant Gram-negative  bacteria,  particularly Pseudomonas aeruginosa , continues to be a significant challenge to clinicians.",Non-OADS,/arxiv_data1/oa_pdf/6f/e1/idr-6-215.PMC3848746.pdf
Available  from: http://www.cubist.com/sup/img/drugs/Ceft-Taz-overview_880.,Non-OADS,/arxiv_data1/oa_pdf/6f/e1/idr-6-215.PMC3848746.pdf
Avail - able from: http://www.cubist.com/products/cxa_201.,Non-OADS,/arxiv_data1/oa_pdf/6f/e1/idr-6-215.PMC3848746.pdf
Available from: http://clinicaltrials.gov/ct2/show/NC T00921024?term=CXA ±and±ceftazidime&rank= 1.,OADS,/arxiv_data1/oa_pdf/6f/e1/idr-6-215.PMC3848746.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/6f/e1/idr-6-215.PMC3848746.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/e1/idr-6-215.PMC3848746.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/01/ijn-8-4563.PMC3848747.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4563–4576International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4563OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4553 5The effects of poly L-lactic acid nanofiber scaffold  on mouse spermatogonial stem cell culture Neda eslahi1,2,* Mahmoud reza  hadjighassem1,3 Mohammad Taghi Joghataei1,2 T ooba Mirzapour4 Mehrdad Bakhtiyari1,2 Malak shakeri5 Vahid Pirhajati1,2 Peymaneh Shirinbayan6,* Morteza Koruji1,2 1cellular and Molecular research  center, Iran University of Medical  sciences, T ehran, Iran; 2Department  of anatomical sciences, school of  Medicine, Iran University of Medical  sciences, T ehran, Iran; 3Department of  Neurosciences, school of advanced  Medical T echnologies, T ehran  University of Medical sciences, T ehran,   Iran; 4Department of Biology, Faculty  of science, University of Mohaghegh  Ardabili, Ardabil, Iran; 5Department of  animal science, agricultural campus,   University of T ehran, T ehran, Iran;   6Pediatric Neuro-Rehabilitation  research center, University of social  Welfare and Rehabilitation Sciences,   T ehran, Iran *These authors contributed equally to  this article correspondence: Morteza Koruji   cellular and Molecular research   center & Department of anatomical  sciences, Iran University of Medical  sciences (IUMs), hemmat highway,   PO Box 14155-5983, Tehran, Iran   Tel/Fax +98 21 8862 2689   email koruji@iums.ac.i rIntroduction:  A 3D-nanofiber scaffold acts in a similar way to the extracellular matrix (ECM)/ basement membrane that enhances the proliferation and self-renewal of stem cells.",Non-OADS,/arxiv_data1/oa_pdf/3c/01/ijn-8-4563.PMC3848747.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3c/01/ijn-8-4563.PMC3848747.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/01/ijn-8-4563.PMC3848747.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/81/3f/opth-7-2271.PMC3848924.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2271–2274Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2271Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S5248 9Glistenings in hydrophobic acrylic intraocular  lenses do affect visual function George HH Beiko1,2 Andrzej Grzybowski3,4 1Department of Surgery, McMaster  University, Hamilton, ON, Canada;   2Department of Ophthalmology and  Vision Sciences, University of toronto,   toronto, ON, Canada; 3Department  of Ophthalmology, University of  Warmia and Mazury, Olsztyn, Poland,   4Department of Ophthalmology,   Poznan City Hospital, Poznan, Poland Correspondence: George HH Beiko   180 Vine St., Ste 103, St. Catharines,   ON, Canada, L2r 7P3   email georgebeiko@hotmail.co mDear editor We recently read the paper “Evaluation of in vitro glistening formation in hydrophobic  acrylic intraocular lenses” by Thomes and Callaghan.1 The paper is extremely interesting  in that the authors, employees of Alcon Research Ltd (Forth Worth, TX, USA), report  not only that Alcon lenses have glistenings, but also that “continuous improvements on  glistening formation”1 have been made by Alcon over the years from 2003 to 2012.",Non-OADS,/arxiv_data1/oa_pdf/81/3f/opth-7-2271.PMC3848924.pdf
Avail - able from: http://www.fda.gov/OHRMS/DOCKETS/98fr/994052  gd.,Non-OADS,/arxiv_data1/oa_pdf/81/3f/opth-7-2271.PMC3848924.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/81/3f/opth-7-2271.PMC3848924.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/3f/opth-7-2271.PMC3848924.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/0a/ott-6-1729.PMC3848925.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1729–1735OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1729Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3811 0The potential for targeting extracellular LOX  proteins in human malignancy Alejandro Mayorca-Guiliani Janine T erler Biotech Research and innovation  Centre, University of Copenhagen,   Copenhagen, Denmark Correspondence: Janine T erler   Biotech Research and innovation   Centre, University of Copenhagen,   Ole Maaløes vej 5, Copenhagen   2200, Denmark   email j anine.erler@bric.ku.d kAbstract:  The extracellular matrix (ECM) is the physical scaffold where cells are organized into  tissues and organs.",Non-OADS,/arxiv_data1/oa_pdf/8c/0a/ott-6-1729.PMC3848925.pdf
Available from: http://clinicaltrials.gov/show/NCT0151573 5.,Non-OADS,/arxiv_data1/oa_pdf/8c/0a/ott-6-1729.PMC3848925.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8c/0a/ott-6-1729.PMC3848925.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/0a/ott-6-1729.PMC3848925.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/8d/opth-7-2265.PMC3848926.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2265–2270Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2265Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5362 6Simplified local anesthesia technique for external  dacryocystorhinostomy without nasal packing:   a new technique and pilot study outcome Hatem A Tawfik1 Osama R Y oussef2 1Department of Ophthalmology,  2Department of Anesthesiology,  Ain Shams University, Cairo, Egypt Correspondence: Hatem A Tawfik   Ain Shams University, 5 Ibn Elnafis St, Off  Makram Ebeid St, Nasr City, Cairo, Egypt   Tel +20 101 02 2513   Fax +20 2 274 9374   email hatem35@gmail.co mBackground:  The purpose of this paper is to describe a simplified local anesthesia technique  for external dacryocystorhinostomy (EXT -DCR).",Non-OADS,/arxiv_data1/oa_pdf/0b/8d/opth-7-2265.PMC3848926.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0b/8d/opth-7-2265.PMC3848926.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/8d/opth-7-2265.PMC3848926.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/69/opth-7-2261.PMC3848927.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2261–2264Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2261Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S4873 2First case of fungal keratitis caused   by Pestalotiopsis clavispora Yu Monden1 shohaku Yamamoto1 ryoji Yamakawa1 atsuko sunada2 seishi asari3 Koichi Makimura4 Y oshitsugu Inoue5 1Department of Ophthalmology,   Kurume University school of  Medicine, Fukuoka, 2Laboratory for  Clinical Investigation, 3Department  of Infection Control and prevention,   Osaka University Hospital, Osaka,   4teikyo University Institute of   Medical Mycology, tokyo, 5Division   of Ophthalmology and Visual   sciences, tottori University Faculty   of Medicine, tottori, Japan Correspondence: Yu Monden   Department of Ophthalmology,   Kurume University school of   Medicine, 67 asahi-machi, Kurume,   Fukuoka 830-0011, Japan   tel +81 942 317574   Fax +81 942 370324   email you@med.kurume-u.ac.j pPurpose:  To report the isolation of Pestalotiopsis clavispora  from the cornea of a patient with  recurrent keratitis.",Non-OADS,/arxiv_data1/oa_pdf/b5/69/opth-7-2261.PMC3848927.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b5/69/opth-7-2261.PMC3848927.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/69/opth-7-2261.PMC3848927.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/43/opth-7-2257.PMC3848928.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2257–2260Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2257Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5507 6Diabetic papillopathy with macular edema   treated with intravitreal ranibizumab Moosang Kim* Jang-Hun Lee* seung-Jun Lee Department of Ophthalmology,   Kangwon National University,   Chuncheon, south Korea *these authors contributed equally to  this work Correspondence: seung-Jun Lee   Department of Ophthalmology,   Kangwon National University Hospital,  156 Baengnyeong-ro, Chuncheon,   Gangwon 200-722, south Korea   tel +82 33 258 2014   Fax +82 2 966 7340   email ophkimmoo@gmail.co mAbstract:  We report a case of diabetic papillopathy that demonstrated a resolution of optic  disk swelling and rapid visual recovery when intravitreal ranibizumab was administered.",Non-OADS,/arxiv_data1/oa_pdf/ed/43/opth-7-2257.PMC3848928.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ed/43/opth-7-2257.PMC3848928.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/43/opth-7-2257.PMC3848928.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/23/ott-6-1761.PMC3848929.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1761–1769OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1761Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S4382 8Metastatic colorectal cancer first-line treatment  with bevacizumab: the impact of K-ras mutation luigi rossi1,2 enzo Veltri3 angelo Zullo4 Federica Zoratto1 Maria colonna5 Flavia longo6 Marcella Mottolese7 Diana giannarelli8 luigi ruco9 Paolo Marchetti10 adriana romiti10 Viola Barucca10 giuseppe giannini11 loredana Bianchi1 silverio T omao1 1Department of Medico-Surgical Sciences  and Biotechnologies, sapienza University  of rome, rome, italy; 2Oncology Unit,   icOT hospital, latina, italy; 3Oncology  Unit, sM goretti hospital, latina, italy;   4gastroenterology and Digestive endoscopy  Unit, nuovo regina Margherita hospital,   rome, italy; 5Oncology Unit, Don luigi di  liegro hospital, gaeta, italy; 6Oncology  Unit, Umberto i Policlinico di roma  hospital, sapienza University of rome,   rome, italy; 7Department of Pathology,   8Biostatistics and scientific Direction,   regina elena national cancer institute,   rome, italy; 9Department of Pathology,   10Oncology Unit, sant’andrea hospital,   11Department of Pathology, Umberto i  Policlinico di roma hospital, sapienza  University of rome, rome, italy correspondence: luigi rossi   Oncology Unit, icOT hospital,   1668 Franco Faggiana street,   latina 04100, italy   Tel +39 349 564 3418   Fax +39 0773 651 3342   email dr.rossi@ymail.co mBackground:  Bevacizumab plus chemotherapy prolongs progression-free survival (PFS) and  overall survival (OS) in metastatic colorectal cancer (mCRC).",Non-OADS,/arxiv_data1/oa_pdf/bb/23/ott-6-1761.PMC3848929.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bb/23/ott-6-1761.PMC3848929.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/23/ott-6-1761.PMC3848929.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/5c/ott-6-1771.PMC3848930.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1771–1777OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1771Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5450 2sequential treatment of tyrosine kinase inhibitors  and chemotherapy for egFr-mutated non-small  cell lung cancer: a meta-analysis of Phase iii trials Yiliang Zhang1,* Yihua sun1,* lei Wang1 Ting Ye1 Yunjian Pan1 haichuan hu1 Y ongfu Yu2 naiqing Zhao2 Yanyan song3 David garfield4 haiquan chen1 1Department of Thoracic surgery,   Fudan University shanghai cancer  center, Department of Oncology,   shanghai Medical college, Fudan  University, 2Department of  Biostatistics, school of Public health,   Fudan University, 3Department of  Pharmacology and Biostatistics,   institute of Medical science, shanghai  Jiaotong University school of  Medicine, 4ProMed cancer centers,   shanghai, People’s republic of china *These authors contributed equally to  this work correspondence: haiquan chen   Department of Thoracic surgery, Fudan  University shanghai cancer center,  270 Dong an road, shanghai 200032,  People’s republic of china   Tel +86 21 6417 5590   Fax +86 21 6268 6511   email hqchen1@yahoo.co mBackground:  This aim of this study was to compare the efficacy of first-line tyrosine kinase  inhibitor therapy followed, upon progression, by chemotherapy with the reverse sequence  in patients with EGFR -mutated non-small cell lung cancer (NSCLC) in terms of overall  survival.",Non-OADS,/arxiv_data1/oa_pdf/3b/5c/ott-6-1771.PMC3848930.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3b/5c/ott-6-1771.PMC3848930.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/5c/ott-6-1771.PMC3848930.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/e2/ott-6-1737.PMC3848931.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1737–1749OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1737Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5236 5signal transduction molecule patterns indicating  potential glioblastoma therapy approaches Maria linda cruceru1 ana-Maria enciu1,2,7 adrian claudiu Popa1,3 radu albulescu2,4,7 Monica neagu2,7 cristiana Pistol Tanase2,7 stefan n constantinescu5–7 1carol Davila University of Medicine  and Pharmacy, Department of  cellular and Molecular Medicine,   Bucharest, romania; 2Victor Babes  national institute of Pathology,   Bucharest, romania; 3army centre  for Medical research, Bucharest,   romania; 4national institute for  chemical Pharmaceutical r&D,   Bucharest, romania; 5de Duve  institute, Université catholique de  louvain, Brussels, Belgium; 6ludwig  institute for cancer research,   Brussels, Belgium; 7Operational  sectorial Programme for competitive  economic growth canbioprot at  Victor Babes national institute of  Pathology, Bucharest, romania correspondence: cristiana Pistol Tanase   Victor Babes national institute of  Pathology, 99-101 splaiul independentei,  sector 5, Bucharest, romania   Tel +40 213 194 528   Fax +40 213 194 528   email bioch@vbabes.r o    stefan n constantinescu   ludwig institute for cancer research,  Brussels Branch avenue hippocrate 75,  1200 Brussels, Belgium   Tel +32 2 764 7540   Fax +32 2 764 6566   email stefan.constantinescu@bru.licr.or gPurpose:  The expression of an array of signaling molecules, along with the assessment of  real-time cell proliferation, has been performed in U87 glioma cell line and in patients’ glio - blastoma es tablished cell cultures in order to provide a better understanding of cellular and  molecular events involved in glioblastoma pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/e6/e2/ott-6-1737.PMC3848931.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/e2/ott-6-1737.PMC3848931.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/e2/ott-6-1737.PMC3848931.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/76/ott-6-1707.PMC3848983.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1707–1717OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1707Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5421 7gemcitabine and carboplatin demonstrate  synergistic cytotoxicity in cervical cancer cells  by inhibiting Dna synthesis and increasing cell  apoptosis guixiu Jin1,3 Jing Zhao2 hongyan Qi2 Meng lou2 Xia liu2 Yu Qu3 lingjun Zhao3 Weifeng Zhang3 Jimin shao2 huizhen Zhong3 1school of Medicine, ningbo  University, ningbo, 2Department  of Pathology and Pathophysiology,   Zhejiang University school of  Medicine, hangzhou, 3Department  of gynecological Oncology, ningbo  Women and children’s hospital,   ningbo, People’s republic of china correspondence: huizhen Zhong   Department of gynecological Oncology,  ningbo Women and children’s hospital,  ningbo, Zhejiang 315012,   People’s republic of china   Tel +86 574 8711 6761   Fax +86 574 8711 6761   email nbfeyyzhz@163.co m Jimin shao  Department of Pathology and  Pathophysiology, Zhejiang University  school of Medicine, hangzhou,  Zhejiang 310058, People’s republic  of china   Tel +86 571 8820 8209   Fax +86 571 8820 8209   email shaojimin@zju.edu.c nBackground:  The present study aims to investigate the subunit expression and enzyme activity  of ribonucleotide reductase in cervical cancer patients, and detect the combined effect of the  ribonucleotide reductase inhibitor gemcitabine and the chemotherapeutic agent carboplatin on  cervical cancer cell lines.",Non-OADS,/arxiv_data1/oa_pdf/01/76/ott-6-1707.PMC3848983.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/01/76/ott-6-1707.PMC3848983.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/76/ott-6-1707.PMC3848983.pdf
"jnci.oxfordjournals.org This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits   non-commercial re-use, distribution, and reproduction in any medium, provided the original   work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/1b/djt315.PMC3848986.pdf
https://www.itsundhed.dk/laboratorie_liste/Prog/d_ udskriftsvenlig_udgave.aspx?id=179 .,Non-OADS,/arxiv_data1/oa_pdf/d4/1b/djt315.PMC3848986.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/98/cia-8-1585.PMC3849000.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1585–1590Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1585OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5269 8rates, variability, and associated factors   of polypharmacy in nursing home patients Yichayaou Beloosesky1,3 Olga nenaydenko2 revital Feige gross n evo1,3 Abraham Adunsky2,3 Avraham Weiss1,3 1Department of geriatrics, rabin  Medical Center, Beilinson hospital,   Petah Tikva, 2Department of geriatric  rehabilitation, sheba Medical Center,   T el hashomer, 3sackler school of  Medicine, T el Aviv University, Petah  Tikva, Israel Correspondence: Yichayaou Beloosesky   rabin Medical Center, Beilinson hospital,   Petah Tikva, 49372, Israel   Tel +972 3937 6820   Fax +972 3937 6817   email beloy@clalit.org.i l    Avraham Weiss   Department of geriatrics,   rabin Medical Center, Beilinson hospital,   Petah Tikva, 49372, Israel   Tel +972 3937 6821   email avraham@clalit.org.i lObjectives:  To determine the rate and variability of polypharmacy in nursing home (NH)  residents and investigate its relationship to age, sex, functional status, length of stay, and  comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/50/98/cia-8-1585.PMC3849000.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/50/98/cia-8-1585.PMC3849000.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/98/cia-8-1585.PMC3849000.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/60/vhrm-9-747.PMC3849001.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2013:9 747–761Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  747ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5171 0Vitamin e tocotrienol supplementation improves  lipid profiles in chronic hemodialysis patients Zulfitri a Mat Daud1 Boniface T ubie2 Marina Sheyman2 Robert Osia2 Judy Adams2 sharon T ubie2 Pramod Khosla1 1Department of nutrition and Food  Science, Wayne State University,   Detroit, MI, USA; 2Great Lake Dialysis  Clinic, LLC, Detroit, MI, USA correspondence: Pramod Khosla   3002 science Hall, Department of   Nutrition and Food Science, Wayne State   University, Detroit, MI 48202, USA   Tel +1 313 577 0448   email aa0987@wayne.ed uPurpose:  Chronic hemodialysis patients experience accelerated atherosclerosis contributed to  by dyslipidemia, inflammation, and an impaired antioxidant system.",Non-OADS,/arxiv_data1/oa_pdf/0d/60/vhrm-9-747.PMC3849001.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/0d/60/vhrm-9-747.PMC3849001.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/60/vhrm-9-747.PMC3849001.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/45/dddt-7-1421.PMC3849002.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1421–1426Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1421Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5424 5conversion to generic cyclosporine a in s table  chronic patients after heart transplantation Maximilian Kraeuter1 Matthias helmschrott1 christian erbel1 christian a gleissner1 lutz Frankenstein1 Bastian schmack2 arjang ruhparwar2 Philipp ehlermann1 hugo a Katus1 andreas O Doesch1 1Department of cardiology,   2Department of cardiac surgery,   University of heidelberg, heidelberg,   germany correspondence: andreas O Doesch   Medizinische Klinik iii, Kardiologie,  angiologie and Pneumologie, ebene 00,   im neuenheimer Feld 410, 69120  heidelberg, germany   Tel +49 6221 56 39 936   Fax +49 6221 56 41 05   email andreas.",Non-OADS,/arxiv_data1/oa_pdf/c9/45/dddt-7-1421.PMC3849002.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c9/45/dddt-7-1421.PMC3849002.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/45/dddt-7-1421.PMC3849002.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/59/copd-8-605.PMC3849003.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 605–611International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  605OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5288 3Use of a care bundle in the emergency  department for acute exacerbations of chronic  obstructive pulmonary disease: a feasibility study Cormac McCarthy1 John r Brennan1 lindsay Brown1 Deirdre Donaghy1 Patricia Jones1 rory Whelan2 niamh McCormack3 Ian Callanan4 John ryan2 Timothy J McDonnell1,3 1Department of respiratory Medicine,   st Vincent’s University hospital,   Dublin, Ireland; 2Department of  emergency Medicine, st Vincent’s  University hospital, Dublin, Ireland;   3Clinical strategy and Programmes  Directorate, health service executive,   Dublin, Ireland; 4Department of audit,    st Vincent’s University hospital,   Dublin, Ireland Correspondence: Cormac McCarthy   education and research Centre, royal  College of surgeons in Ireland, Beaumont  hospital, Dublin 9, Ireland   T el +353 1809 3796   email cmccarthy@rcsi.i eAim:  To determine the efficacy and usefulness of a chronic obstructive pulmonary disease  (COPD) care bundle designed for the initial management of acute exacerbations of COPD and  to assess whether it improves quality of care and provides better outcomes.",Non-OADS,/arxiv_data1/oa_pdf/ce/59/copd-8-605.PMC3849003.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ce/59/copd-8-605.PMC3849003.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/59/copd-8-605.PMC3849003.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/81/ppa-7-1207.PMC3849079.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1207–1212Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1207REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5348 4Review of the rational use and adverse   reactions to human serum albumin   in the People’s Republic of China Ting Zhou Saihua Lu Xiufeng Liu Ye Zhang Feng Xu Department of Clinical Pharmacology,   Fengxian Hospital, Shanghai Jiao T ong  University, Shanghai, People’s Republic  of China Correspondence: Feng Xu   Department of Clinical Pharmacology,  Fengxian Hospital, Shanghai Jiao   Tong University, Shanghai,   People’s Republic of China   Tel +86 021 5742 2032   Email andrewfxu1998@gmail.co mAbstract:  Human serum albumin (HSA) is an ideal natural colloid that has been widely used  in clinical practice for supplemental albumin or as a plasma substitute during therapeutic plasma  exchanges to redress hypoproteinemia.",Non-OADS,/arxiv_data1/oa_pdf/62/81/ppa-7-1207.PMC3849079.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/62/81/ppa-7-1207.PMC3849079.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/81/ppa-7-1207.PMC3849079.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/jpr-6-837.PMC3849080.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 837–841Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  837ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S5056 1Feasibility and analgesic efficacy of the transversus  abdominis plane block after single-port  laparoscopy in patients having bariatric surgery Michael Wassef David Y lee Jun l levine Ronald e Ross hamza guend catherine Vandepitte admir hadzic Julio T eixeira Department of anesthesiology,   st luke’s-Roosevelt hospital   center, new York, nY, Usa correspondence: Michael Wassef   st. luke’s-Roosevelt hospital center,  Department on anesthesiology, 515 W  59th st, new York, nY 10019, Usa   email wadsha2y@gmail.co mPurpose:  The transversus abdominis plane (TAP) block is a technique increasingly used for  analgesia after surgery on the anterior abdominal wall.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/jpr-6-837.PMC3849080.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/jpr-6-837.PMC3849080.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/jpr-6-837.PMC3849080.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/77/ndt-9-1835.PMC3849081.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1835–1845Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1835PersPecTivesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5368 7Why it is time to develop the use of cognitive  event-related potentials in the treatment   of psychiatric diseases salvatore campanella Laboratory of Medical Psychology  and Addictology, ULB Neuroscience  institute (UN i), Université Libre de  Bruxelles, Brussels, Belgium correspondence: salvatore campanella   Laboratory of Psychological Medicine  and Addictology (UNi-ULB), cHU  Brugmann - secretary of the Department  of Psychiatry, 4 Place vangehuchten,   1020 Brussels, Belgium   Tel +32 2477 3465   Fax +32 2477 2162   email salvatore.campanella@chu- brugmann.b e; salvatore.campanella@ulb.",Non-OADS,/arxiv_data1/oa_pdf/05/77/ndt-9-1835.PMC3849081.pdf
Available from: http://eeg.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/05/77/ndt-9-1835.PMC3849081.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/05/77/ndt-9-1835.PMC3849081.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/77/ndt-9-1835.PMC3849081.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/95/dhps-5-211.PMC3849082.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2013:5 211–219Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  211ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S4544 5The risk of bleeding with duloxetine treatment in  patients who use nonsteroidal anti-inflammatory  drugs (NSAIDs): analysis of placebo-controlled  trials and post-marketing adverse event reports David G Perahia1 Mark E Bangs2 Qi Zhang2 Yingkai Cheng2 Jonna Ahl2 Elijah P Frakes2 Michael J Adams2 James M Martinez2 1Neurosciences, Lilly Research  Centre, Windlesham, Surrey, UK;   2Neurosciences, Eli Lilly and Company,   Indianapolis, IN, USA Correspondence: David G Perahia   Lilly Research Centre, Erl Wood,  Sunninghill Rd, Windlesham, Surrey,   UK GU20 6PH   Tel +44 1276 413 755   Fax +44 1276 483 711   Email d.perahia@lilly.co mPurpose:  To assess the safety of duloxetine with regards to bleeding-related events in patients  who concomitantly did , versus did not, use nonsteroidal anti-inflammatory drugs (NSAIDs),  including aspirin.",Non-OADS,/arxiv_data1/oa_pdf/4c/95/dhps-5-211.PMC3849082.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/4c/95/dhps-5-211.PMC3849082.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/95/dhps-5-211.PMC3849082.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/b0/ott-6-1649.PMC3849083.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1649–1658OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1649Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5255 2synchronous BraFV600e and MeK inhibition leads  to superior control of murine melanoma   by limiting MeK inhibitor induced skin toxicity Jules gadiot1,* anna i hooijkaas1,* Marcel a Deken1 christian U Blank1,2 1Department of immunology,   2Department of Medical Oncology,   netherlands cancer institute,   amsterdam, The netherlands * These authors contributed equally  to this work correspondence: christian U Blank   Division of immunology, nKi-aVl,   Plesmanlaan 121, 1066cX, amsterdam,   The netherlands   Tel +31 20 512 2960   Fax +31 20 512 2572   email c.blank@nki.n lAbstract:  The BRAF inhibitor (BRAFi) treatment has led to impressive responses in BRAFV600E  mutation-positive melanomas, but responses are not durable in many patients.",Non-OADS,/arxiv_data1/oa_pdf/7f/b0/ott-6-1649.PMC3849083.pdf
Available from:  http://abstracts.webges.com/esmo2012/myitinerar y.,Non-OADS,/arxiv_data1/oa_pdf/7f/b0/ott-6-1649.PMC3849083.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7f/b0/ott-6-1649.PMC3849083.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/b0/ott-6-1649.PMC3849083.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/8f/ijnrd-6-259.PMC3849084.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2013:6 259–268International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  259ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S5066 4effects of dopamine on leptin release   and leptin gene ( OB) expression in adipocytes   from obese and hypertensive patients cleto alvarez-aguilar1–3 alfonso Rafael alvarez- Paredes2 Bengt lindholm4 Peter stenvinkel4 elvia garcía-lópez4 Oliva Mejía-Rodríguez5 Joel edmundo lópez-Meza6 Dante amato7 Ramon Paniagua8 1hospital general Regional N°1,   Instituto Mexicano del seguro social   (IMss), Morelia, 2Facultad de ciencias  Médicas y Biológicas “Dr.",Non-OADS,/arxiv_data1/oa_pdf/37/8f/ijnrd-6-259.PMC3849084.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/37/8f/ijnrd-6-259.PMC3849084.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/8f/ijnrd-6-259.PMC3849084.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/d6/copd-8-595.PMC3849086.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 595–603International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  595OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S4857 0Impact of night-time symptoms in COPD:   a real-world study in five European countries David Price1 Mark small2 gary Milligan2 Victoria higgins2 esther garcia gil3 Jordi estruch3 1Centre of academic Primary Care,   University of aberdeen, aberdeen,   UK; 2adelphi real World, adelphi  Mill, Bollington, UK; 3almirall s.a.,   Barcelona, spain Correspondence: David Price   Centre of academic Primary Care,  University of aberdeen,   Polwarth Building, Foresterhill,   aberdeen aB25 2ZD, UK   Tel +44 208 123 3923   Fax +44 808 280 0792   email david@rirl.or gBackground:  Sleep quality is often poor in patients with chronic obstructive pulmonary  disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/16/d6/copd-8-595.PMC3849086.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/copd-8-595.PMC3849086.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/d6/copd-8-595.PMC3849086.pdf
Available from:  http://www.ephmra.org /.,Non-OADS,/arxiv_data1/oa_pdf/16/d6/copd-8-595.PMC3849086.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/ad/ijn-8-4593.PMC3849141.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4593–4600International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4593Short reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/IJN.S5301 2human neural progenitor cells retain viability,  phenotype, proliferation, and lineage differentiation  when labeled with a novel iron oxide nanoparticle,  Molday IoN rhodamine B Wei-Bin Shen1,2 Celine plachez2,3 Amanda Chan4 Deborah Yarnell1 Adam C puche3 paul S Fishman1,5 paul Yarowsky1,2 1research Service, VA Maryland  health Care System, Baltimore, MD,  USA; 2Department of pharmacology,  University of Maryland School of  Medicine, Baltimore, MD, USA;  3Department of Anatomy and  Neurobiology, University of Maryland  School of Medicine, Baltimore, MD,  USA; 4Notre Dame of Maryland  School of p harmacy, Baltimore, MD,  USA; 5Department of Neurology,  University of Maryland School of  Medicine, Baltimore, MD, USA Correspondence: paul Yarowsky   Department of pharmacology, University  of Maryland School of Medicine, 655 W  Baltimore St, 11-045A BrB, Baltimore,  MD 21201, USA   tel +1 410 706 3134   Fax +1 410 706 0032   email pyarowsky@som.umaryland.ed uAbstract:  Ultrasmall superparamagnetic iron-oxide particles (USPIOs) loaded into stem cells  have been suggested as a way to track stem cell transplantation with magnetic resonance imag - ing, but the labeling, and post-labeling proliferation, viability, differentiation, and retention of  USPIOs within the stem cells have yet to be determined for each type of stem cell and for each  type of USPIO.",Non-OADS,/arxiv_data1/oa_pdf/34/ad/ijn-8-4593.PMC3849141.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/34/ad/ijn-8-4593.PMC3849141.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/ad/ijn-8-4593.PMC3849141.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/5c/ndt-9-1853.PMC3849142.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1853–1858Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1853Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5294 7Influence of cerebellar stereotactic stimulation   on left–right electrodermal information  transference in a patient with cerebral palsy Petr Bob1,2 T omas Galanda3 Peter Jombik4 Jiri Raboch1 Miroslav Galanda3 1Center for Neuropsychiatric  Research of Traumatic Stress,   Department of Psychiatry, 1st Faculty  of Medicine, Charles University,   Prague, Czech Republic; 2Central  European Institute of T echnology,   Faculty of Medicine, Masaryk  University, Brno, Czech Republic;   3Department of Neurosurgery,   Slovak Medical University,   Roosevelt Hospital, Banska Bystrica,   Slovak Republic; 4Department of  Neurology, Laboratory of Clinical  Neurophysiology, Zvolen Hospital,   Zvolen, Slovak Republic Correspondence: Petr Bob,   Department of Psychiatry,   Charles University, 1st Faculty   of Medicine, Ke Karlovu 11,   128 00 Prague, Czech Republic   T el +420 22 4965314   email petrbob@netscape.ne tBackground and objectives:  Recent evidence indicates that cerebral palsy is connected to  specific autonomic dysregulation between sympathetic and parasympathetic efferent pathways,  likely linked to hemispheric influences.",Non-OADS,/arxiv_data1/oa_pdf/be/5c/ndt-9-1853.PMC3849142.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/be/5c/ndt-9-1853.PMC3849142.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/5c/ndt-9-1853.PMC3849142.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 463–468Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  463LeTTeRopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5460 7Sampling times and genotyping concerns   in bioequivalence evaluation of branded   and generic formulations Xiao-Ying Zhao1 Hui-Min Xu2 Quan Zhou2 1The Medical ethics Committee,   2Department of Pharmacy, The  Second Affiliated Hospital, School  of Medicine, Zhejiang University,   Hangzhou, Zhejiang Province,    People’s Republic of China Correspondence: Quan Zhou   Department of Pharmacy, The Second  Affiliated Hospital, School of Medicine,  Zhejiang University, Zhejiang 310009,  People’s Republic of China   Tel +86 571 8778 4615   Fax +86 571 8702 2776   email zhouquan142602@zju.edu.c nDear editor We read with great interest the study by Del Tacca et al,1 who performed a comparative  pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of branded and generic  formulations of meloxicam in healthy male subjects, and concluded that the two prod - ucts can be used interchangeably in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
Available from: http://www.hc-sc.gc.ca/ dhp-mps/alt_formats/pdf/prodpharma/applic-demande/guide-ld/bio/ gd_cbs_ebc_ld-eng.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
Available from: http://www.sfda.gov.cn/ WS01/CL0055/10368.html .,OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
http://www.realgene.it/dettaglio_prodotto.asp?languag e=  eng&id_a =42.,OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
Available from: http://www.emea.europa.,Non-OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/bd/2c/tcrm-9-463.PMC3849151.pdf
"http://www.landesbioscience.com/journals/ nucleus/article/25187   Reference Varia S, et al.",OADS,/arxiv_data1/oa_pdf/d2/d7/rna-10-1071.PMC3849153.pdf
"Nucleus 2013; 4:229-40; PMid:23778535;   http://dx.doi.org/10.4161/nucl.25187 Long non-coding RNAs (lncRNAs), tran- scribed from the intergenic regions of ani-mal genomes, play important roles in key  biological processes.",OADS,/arxiv_data1/oa_pdf/d2/d7/rna-10-1071.PMC3849153.pdf
"the  study findings also suggest that lncRNAs with highly conserved epigenetic and tran- scriptional regulation across species arose by  divergent evolution from a common ancestor, if they do not have identical exon structures.http://www.landesbioscience.com/journals/ epigenetics/article/24887 Reference Kobayashi h, et al.",OADS,/arxiv_data1/oa_pdf/d2/d7/rna-10-1071.PMC3849153.pdf
Epigenetics 2013; 8:635-45;  PMid:23764515; http://dx.doi.org/10.4161/epi.24887,Non-OADS,/arxiv_data1/oa_pdf/d2/d7/rna-10-1071.PMC3849153.pdf
"http://www.landesbioscience.com/journals/ translation/article/24400 Breast cancer is a heterogeneous tumor type characterized by a complex spectrum of molecular aberrations, resulting in a diverse  array of malignant features and clinical out - comes.",Non-OADS,/arxiv_data1/oa_pdf/d2/d7/rna-10-1071.PMC3849153.pdf
"http://www.landesbioscience.com/journals/cc/article/24757 Reference Bisso A, et al.",Non-OADS,/arxiv_data1/oa_pdf/d2/d7/rna-10-1071.PMC3849153.pdf
"Cell Cycle 2013; 12:1679-87; PMid:23656790;  http://dx.doi.org/10.4161/cc.24757  Reference Koh d , et al.",OADS,/arxiv_data1/oa_pdf/d2/d7/rna-10-1071.PMC3849153.pdf
translation 2013; 1:e24400; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/d7/rna-10-1071.PMC3849153.pdf
"RNA Biology 10:7, 1080–1086; July 2013; © 2013 Landes Bioscience BRief CommuNiCA tioN 1080 RNA Biology Volume 10 issue 7*Correspondence to: Kenneth W. Witwer; Email: kwitwer1@jhmi.edu Submitted: 03/06/2013; Revised: 05/07/13; Accepted: 06/01/13http://dx.doi.org/10.4161/rna.25246Introduction In 2012 L. Zhang et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Cell Res 2012; 22:107- 26; PMID:21931358; http://dx.doi.org/10.1038/ cr.2011.158 2.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Cell 2009; 136:215-33; PMID:19167326;  http://dx.doi.org/10.1016/j.cell.2009.01.002 3.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Cell 2012; 148:1172- 87; PMID:22424228; http://dx.doi.org/10.1016/j.cell.2012.02.005 4.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Nat Cell Biol 2007; 9:654-9;  PMID:17486113; http://dx.doi.org/10.1038/ncb1596 5.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Proc Natl Acad Sci USA 2010; 107:6328- 33; PMID:20304794; http://dx.doi.org/10.1073/ pnas.0914843107 6.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Journal of Extracellular Vesicles 2013; 2:20360; http://dx.doi.org/10.3402/jev.v2i0.20360.,Non-OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Proc Natl Acad Sci USA  2011; 108:5003-8; PMID:21383194; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Nucleic Acids Res 2011; 39:7223-33;  PMID:21609964; http://dx.doi.org/10.1093/nar/ gkr254 9.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Trends Biochem Sci 2012; 37:460-5; PMID:22944280;  http://dx.doi.org/10.1016/j.tibs.2012.08.003 10.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
RNA Biol 2012; 9:1147-54; PMID:22951590; http://dx.doi.org/10.4161/ rna.21619 11.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
BMC Genomics 2012; 13:381;  PMID:22873950; http://dx.doi.org/10.1186/1471-2164-13-38113.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Regul Toxicol Pharmacol  2013; 66:167-76; PMID:23557984; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
PLoS  One 2012; 7:e51009; PMID:23251414; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Front Genet 2013;  4:83; PMID:23720669; http://dx.doi.org/10.3389/ fgene.2013.00083 16.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Anal Chem 2011; 83:8604-10; PMID:22035192; http://dx.doi.org/10.1021/ ac202028g 17.,Non-OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
"Clin Chem 2012; 58:472-4, author reply 474-5; PMID:22048406;  http://dx.doi.org/10.1373/clinchem.2011.175281 18.",Non-OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Nat Methods 2012;  9:840-6; PMID:22751203; http://dx.doi.org/10.1038/ nmeth.2078 19.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
"Nature  2006; 443:E8, discussion E8-9; PMID:17006468;  http://dx.doi.org/10.1038/nature05251 20.",Non-OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Nature 2005; 434:505- 9; PMID:15785770; http://dx.doi.org/10.1038/ nature03380 21.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Genome Biol 2011; 12:R53;  PMID:21679406; http://dx.doi.org/10.1186/gb-2011- 12-6-r53 22.,Non-OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Trends Plant Sci 2012; 17:123-5; PMID:22265093; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Front Genet 2011;  2:97; PMID:22303391; http://dx.doi.org/10.3389/ fgene.2011.0009724.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
Expert Opin Biol Ther 2012;  12(Suppl 1):S43-51; PMID:22509727; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/7b/rna-10-1080.PMC3849155.pdf
